data_1l7y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1l7y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.391 0.615 . . . . 2.3100000000000001 110.426 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 16' ' ' PHE . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 1.5900000000000001 109.654 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.4199999999999999 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.85999999999999999 110.058 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 82' ' ' SER . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 3.2799999999999998 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 1.3 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 1.21 108.957 178.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.9299999999999999 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.53 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.71 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.3500000000000001 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 1.3999999999999999 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.25 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.4199999999999999 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.9199999999999999 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 1.3500000000000001 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.85999999999999999 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.82999999999999996 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.51 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 1.3899999999999999 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 31' ' ' LEU . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 1.3200000000000001 109.315 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 1.24 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.7999999999999998 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.8200000000000001 109.921 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 1.27 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 1.1899999999999999 109.783 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.97999999999999998 110.856 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.4700000000000002 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 1.73 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.90000000000000002 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HB1' ' HG ' ' A' ' 43' ' ' LEU . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 1.3999999999999999 110.153 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 1.3 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 1.47 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 1.0600000000000001 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 1.1399999999999999 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HD12 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 1.23 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 87' ' ' ILE . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 1.27 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 1.24 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.23 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77000000000000002 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 1.25 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.69999999999999996 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 HG23 ' A' ' 61' ' ' THR . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 1.1699999999999999 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.9299999999999999 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68999999999999995 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 1.3799999999999999 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 2.0699999999999998 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 1.02 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 1.3999999999999999 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.97999999999999998 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 2.0800000000000001 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 1.3 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 1.1100000000000001 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.72 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 2.1000000000000001 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.4099999999999999 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.80000000000000004 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.24 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.6299999999999999 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 HG21 ' A' ' 59' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 1.26 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.96 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 1.49 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 1.3999999999999999 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.28 110.849 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 2.9900000000000002 109.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 73' ' ' ALA . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 1.53 109.959 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.51 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.82999999999999996 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 3.25 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 1.27 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 1.4399999999999999 109.131 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 1.6899999999999999 109.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.5900000000000001 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.8100000000000001 109.536 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.5800000000000001 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 1.6000000000000001 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.1499999999999999 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.4299999999999999 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 1.4299999999999999 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.96999999999999997 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.62 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 1.26 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.89000000000000001 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 1.3 109.313 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 1.28 109.674 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.6400000000000001 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 2.54 109.721 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 18' ' ' ILE . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.79000000000000004 109.522 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 1.1899999999999999 109.747 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.1899999999999999 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.81999999999999995 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 1.02 110.71 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 4.21 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 1.3600000000000001 109.018 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.25 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.71 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 2.1000000000000001 110.321 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.59 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 2.0 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 1.01 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 1.27 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 1.1599999999999999 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 1.3799999999999999 110.046 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 80' ' ' HIS . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 1.2 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' H ' HG23 ' A' ' 61' ' ' THR . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 2.0099999999999998 111.207 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.94999999999999996 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.69999999999999996 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 1.1799999999999999 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.53000000000000003 110.069 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG1' HD13 ' A' ' 76' ' ' ILE . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.81000000000000005 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.53 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.96999999999999997 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.69999999999999996 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 1.27 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.6699999999999999 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.89000000000000001 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 1.23 110.38 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.92000000000000004 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.95 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 71' ' ' GLN . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 1.1799999999999999 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.3899999999999999 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.54 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 3.0800000000000001 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.596 ' HB3' HG22 ' A' ' 61' ' ' THR . 41.6 m-70 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92000000000000004 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.93000000000000005 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.4199999999999999 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 1.29 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.1399999999999999 109.681 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 1.54 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 1.5 109.751 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.0900000000000001 109.451 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 2.1200000000000001 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 1.03 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 1.1200000000000001 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 76' ' ' ILE . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.69999999999999996 109.964 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 2.54 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 1.29 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.43 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.611 -0.514 . . . . 1.8400000000000001 109.611 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 1.29 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 1.26 109.363 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 1.3100000000000001 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 1.25 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.68999999999999995 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.51 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 1.3 109.422 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.81999999999999995 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.68999999999999995 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 1.1000000000000001 108.74 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.69999999999999996 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 1.23 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 59' ' ' ILE . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 1.3300000000000001 109.78 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 2.3900000000000001 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 1.1599999999999999 110.118 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 1.0800000000000001 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 1.1000000000000001 110.214 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.95999999999999996 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.71999999999999997 110.764 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 3.1099999999999999 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.556 HG23 HD22 ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 1.25 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.67000000000000004 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 1.23 110.077 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 1.2 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 1.1499999999999999 109.793 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.94999999999999996 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 1.1499999999999999 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 43' ' ' LEU . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 1.1899999999999999 109.096 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG21 ' HA2' ' A' ' 66' ' ' GLY . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 1.1599999999999999 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 80' ' ' HIS . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 1.1899999999999999 109.699 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.22 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.90000000000000002 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.68999999999999995 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 1.3500000000000001 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.59999999999999998 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 76' ' ' ILE . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 1.22 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.98999999999999999 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.60999999999999999 110.316 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.1899999999999999 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.628 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.98999999999999999 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.57999999999999996 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 37' ' ' THR . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 1.1200000000000001 110.003 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.51000000000000001 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.55 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 16' ' ' PHE . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 1.03 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.94999999999999996 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 1.4199999999999999 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 2.3599999999999999 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.423 ' HB3' HG23 ' A' ' 61' ' ' THR . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.70999999999999996 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.68999999999999995 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.92000000000000004 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 1.28 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 2.4500000000000002 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.556 HD22 HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.6499999999999999 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 1.3400000000000001 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.72999999999999998 110.48 179.645 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 2.0499999999999998 109.805 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 1.3200000000000001 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 1.26 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.82999999999999996 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 3.3700000000000001 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 1.3100000000000001 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 1.23 109.265 179.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.617 -0.512 . . . . 1.9399999999999999 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 1.45 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.71 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.53 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 1.25 109.646 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.4 ' HD2' HG21 ' A' ' 37' ' ' THR . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.66000000000000003 110.734 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.85999999999999999 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 1.24 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 34' ' ' PRO . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 1.25 109.433 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.72999999999999998 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.94999999999999996 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 1.3899999999999999 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 1.04 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 1.3200000000000001 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 1.3300000000000001 109.561 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HG2' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.5499999999999998 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.7 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.89000000000000001 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 1.2 109.634 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91000000000000003 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.70999999999999996 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 3.02 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 1.29 109.28 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.75 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 1.3 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 1.24 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.491 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 1.4399999999999999 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 1.22 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 1.1599999999999999 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 1.1699999999999999 109.523 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 1.26 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.96999999999999997 109.861 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.6299999999999999 110.802 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.1599999999999999 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.81999999999999995 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 1.4099999999999999 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.55000000000000004 109.803 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 1.3700000000000001 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.6499999999999999 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.72999999999999998 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 1.1699999999999999 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.8999999999999999 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.77000000000000002 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 1.1799999999999999 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.68999999999999995 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.2 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 1.3 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 1.0800000000000001 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 1.6499999999999999 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.9700000000000002 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 67' ' ' VAL . 6.9 m-70 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.98999999999999999 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79000000000000004 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 1.22 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.1699999999999999 109.248 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 1.5700000000000001 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.75 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 1.52 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 1.3899999999999999 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo . . . . . 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.96999999999999997 110.202 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.409 0.624 . . . . 3.2599999999999998 110.224 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 1.26 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 1.3300000000000001 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.476 ' CE1' HG21 ' A' ' 76' ' ' ILE . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.78000000000000003 109.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.5600000000000001 108.933 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.53 HG22 HD13 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 1.24 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 1.1399999999999999 108.862 179.706 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.155 0.502 . . . . 1.6100000000000001 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 1.3700000000000001 108.758 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.78 110.111 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 1.0700000000000001 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 1.26 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.81000000000000005 110.881 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91000000000000003 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.98999999999999999 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 1.3400000000000001 109.48 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.59999999999999998 111.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.64000000000000001 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 1.25 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 1.1200000000000001 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 1.1899999999999999 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 1.3500000000000001 109.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.9700000000000002 109.998 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.6599999999999999 109.631 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 1.1100000000000001 109.622 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 1.0 109.803 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89000000000000001 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.78000000000000003 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.82999999999999996 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 3.3300000000000001 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.415 HG23 HD23 ' A' ' 86' ' ' LEU . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 1.23 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.83999999999999997 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 1.3799999999999999 110.018 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 1.0600000000000001 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 1.47 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 1.0 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 1.1499999999999999 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 18' ' ' ILE . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 1.0800000000000001 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 1.25 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 1.1599999999999999 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.6100000000000001 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.0499999999999998 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.73999999999999999 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 1.27 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.516 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.59999999999999998 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 1.27 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.85999999999999999 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.58999999999999997 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 1.23 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.594 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.7 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.52000000000000002 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 1.27 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.56999999999999995 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 1.0700000000000001 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.594 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 1.23 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 1.0800000000000001 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 1.4399999999999999 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 4.04 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.441 ' CE1' HG23 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.75 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.59999999999999998 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 1.0800000000000001 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 1.53 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.419 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 2.23 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.6000000000000001 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 60' ' ' ILE . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 1.1699999999999999 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo . . . . . 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.72999999999999998 110.519 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.327 -0.619 . . . . 2.2200000000000002 109.327 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 77' ' ' PHE . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 1.3600000000000001 109.758 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 1.24 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 1.1699999999999999 109.832 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.95 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 HG12 HD12 ' A' ' 59' ' ' ILE . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 1.28 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 1.3600000000000001 108.782 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.259 0.552 . . . . 1.51 110.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 1.3500000000000001 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 1.46 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 1.04 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 1.1599999999999999 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 37' ' ' THR . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.95999999999999996 110.846 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.1399999999999999 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.3300000000000001 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.459 HG21 ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 1.3899999999999999 109.706 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.75 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.64000000000000001 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 1.1299999999999999 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.72999999999999998 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 31' ' ' LEU . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 1.25 109.11 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 1.3 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 3.2000000000000002 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 2.02 110.22 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 1.1399999999999999 109.277 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 1.0800000000000001 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6000000000000001 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HB2' HG21 ' A' ' 52' ' ' VAL . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.72999999999999998 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.5099999999999998 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 50' ' ' PHE . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.81999999999999995 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 1.26 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.88 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 1.29 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.51 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 HG12 ' A' ' 18' ' ' ILE . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 1.1200000000000001 109.773 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 1.48 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.543 HG21 ' HB ' ' A' ' 65' ' ' VAL . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 1.4099999999999999 110.06 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.3300000000000001 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.1699999999999999 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.1100000000000001 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 61' ' ' THR . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.6599999999999999 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.93999999999999995 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 1.3600000000000001 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.21 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67000000000000004 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 1.3200000000000001 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.3400000000000001 109.715 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.94999999999999996 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 1.3 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.84999999999999998 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.475 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.72 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 1.3899999999999999 109.647 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.401 ' CB ' HG12 ' A' ' 14' ' ' VAL . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 1.1899999999999999 110.072 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.5800000000000001 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 2.3599999999999999 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 1.05 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.80000000000000004 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 1.01 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 1.4299999999999999 109.731 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.49 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 1.3100000000000001 109.995 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 1.51 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.83999999999999997 111.034 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mttm . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.098 0.475 . . . . 2.73 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 1.26 109.368 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 1.3999999999999999 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' A' ' 76' ' ' ILE . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.83999999999999997 109.898 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.8100000000000001 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 HD13 ' A' ' 59' ' ' ILE . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 1.3500000000000001 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 1.1399999999999999 109.109 179.732 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.494 -0.558 . . . . 1.7 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 1.3799999999999999 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.76 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 1.3600000000000001 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 1.45 109.837 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 1.0600000000000001 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.467 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.1599999999999999 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.45 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 1.46 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.71999999999999997 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 1.1200000000000001 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 1.2 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 1.25 109.492 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 1.25 109.819 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HG3' ' CB ' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 2.1299999999999999 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.8 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 1.1499999999999999 110.196 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.89000000000000001 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.98999999999999999 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.90000000000000002 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.91000000000000003 109.52 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.6899999999999999 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 1.23 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.82999999999999996 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HG3' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 1.3999999999999999 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 1.4199999999999999 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 1.4399999999999999 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 1.1000000000000001 109.523 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG12 ' A' ' 18' ' ' ILE . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 1.21 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 1.28 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.1299999999999999 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.93999999999999995 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 1.4399999999999999 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.69999999999999996 109.966 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 1.3799999999999999 109.362 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.8799999999999999 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.69999999999999996 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 1.1200000000000001 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.6200000000000001 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.82999999999999996 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 1.1399999999999999 110.226 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.80000000000000004 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.45 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 71' ' ' GLN . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 1.21 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 1.22 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 1.5600000000000001 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.6400000000000001 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.1899999999999999 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76000000000000001 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 1.2 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.90000000000000002 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 1.3899999999999999 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 3.1699999999999999 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 18' ' ' ILE . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.6599999999999999 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.636 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 1.46 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.636 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo . . . . . 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.23 110.078 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.33 0.586 . . . . 2.5099999999999998 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 1.4199999999999999 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 1.3 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.92000000000000004 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 2.4900000000000002 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 1.27 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.108 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.369 -0.604 . . . . 1.8300000000000001 109.369 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 1.3899999999999999 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.6499999999999999 109.79 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 1.3100000000000001 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.7 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.0900000000000001 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.03 110.205 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.46 110.469 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.5700000000000001 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.1699999999999999 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.84999999999999998 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 69' ' ' PRO . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 1.6100000000000001 108.606 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 1.3300000000000001 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 1.29 109.165 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 1.27 109.574 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.4900000000000002 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.9300000000000002 110.215 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 1.23 109.718 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 1.04 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.97999999999999998 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.72999999999999998 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 3.1600000000000001 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 1.45 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.87 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 1.24 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 1.3600000000000001 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.4299999999999999 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.3799999999999999 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 1.4199999999999999 109.232 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 1.21 109.391 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 1.3899999999999999 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB ' ' A' ' 65' ' ' VAL . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 1.1799999999999999 110.065 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.1399999999999999 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.0600000000000001 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.598 ' HB ' HG22 ' A' ' 61' ' ' THR . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.5 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.92000000000000004 109.701 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 1.4099999999999999 109.446 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.28 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.95999999999999996 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.73 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.78 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.24 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 1.28 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.97999999999999998 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.8899999999999999 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.475 HG13 ' CD1' ' A' ' 39' ' ' PHE . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 1.3400000000000001 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 1.01 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.6200000000000001 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 2.2000000000000002 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.47 110.138 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.95999999999999996 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.92000000000000004 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 1.3300000000000001 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 3.4700000000000002 109.92 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 1.4399999999999999 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 1.4099999999999999 109.068 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.85999999999999999 110.655 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.301 0.572 . . . . 2.5099999999999998 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 73' ' ' ALA . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 1.25 109.176 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.79000000000000004 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.8399999999999999 108.889 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 1.24 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 1.3899999999999999 108.987 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 109.541 -0.54 . . . . 2.7000000000000002 109.541 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 1.4299999999999999 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 1.5600000000000001 108.999 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.3600000000000001 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 1.23 109.511 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.48999999999999999 110.759 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78000000000000003 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.3999999999999999 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 1.0700000000000001 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.48999999999999999 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 1.3799999999999999 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 1.1799999999999999 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 1.1200000000000001 109.229 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 HD23 ' HB1' ' A' ' 54' ' ' ALA . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 1.26 109.665 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 3.3300000000000001 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HB3' HD12 ' A' ' 31' ' ' LEU . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.53 110.25 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 1.1799999999999999 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 1.1399999999999999 109.882 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.3500000000000001 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.96999999999999997 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' HD2' HD12 ' A' ' 86' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.71999999999999997 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 3.4399999999999999 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 1.3 109.041 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.98999999999999999 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 1.6599999999999999 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.54 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 1.0800000000000001 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 1.23 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 1.0700000000000001 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 1.3400000000000001 109.388 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.4299999999999999 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.1399999999999999 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.78000000000000003 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 1.1000000000000001 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.62 109.812 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 1.0600000000000001 109.385 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 1.1000000000000001 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.66000000000000003 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 1.25 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' A' ' 76' ' ' ILE . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.5600000000000001 110.103 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.45000000000000001 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 1.0600000000000001 110.355 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.42999999999999999 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 1.0700000000000001 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 71' ' ' GLN . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 1.22 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.68000000000000005 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 1.24 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 2.29 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.70999999999999996 110.06 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68000000000000005 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.6100000000000001 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 1.6000000000000001 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.79 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 1.52 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 1.3100000000000001 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.0600000000000001 110.12 179.124 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.274 0.559 . . . . 1.77 109.762 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 1.3500000000000001 109.388 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 1.5600000000000001 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 76' ' ' ILE . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.82999999999999996 109.866 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.6599999999999999 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 1.23 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.95999999999999996 109.219 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.6499999999999999 109.057 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 1.25 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.6100000000000001 109.506 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 1.1599999999999999 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 1.3100000000000001 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.81000000000000005 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.8100000000000001 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 1.26 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.75 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.73999999999999999 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.8200000000000001 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 1.2 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 1.27 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 1.3200000000000001 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 4.1799999999999997 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 2.04 110.233 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 1.22 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 52' ' ' VAL . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 1.0900000000000001 109.908 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.70999999999999996 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 1.04 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.8399999999999999 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.608 HG23 HD22 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 1.3100000000000001 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.88 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 1.29 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 1.03 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 1.3999999999999999 109.549 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 1.1299999999999999 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 1.25 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 1.04 109.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 1.3300000000000001 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 1.26 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 1.1799999999999999 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89000000000000001 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 1.45 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.68000000000000005 109.865 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 80' ' ' HIS . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 1.29 109.522 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89000000000000001 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81000000000000005 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.5 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.45 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.93000000000000005 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 1.3300000000000001 110.373 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.82999999999999996 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 2.0299999999999998 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 71' ' ' GLN . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 1.24 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 1.1000000000000001 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 1.4199999999999999 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.5299999999999998 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.528 ' CD2' HG21 ' A' ' 67' ' ' VAL . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.1599999999999999 110.451 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.82999999999999996 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 1.26 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.9099999999999999 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 59' ' ' ILE . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 1.55 109.822 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 2.3100000000000001 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.608 HD22 HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 1.3899999999999999 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 1.3600000000000001 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.95999999999999996 110.884 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.637 . . . . 1.8700000000000001 110.438 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 73' ' ' ALA . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 1.1699999999999999 109.343 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.55000000000000004 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.9099999999999999 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 1.23 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 HG23 ' HG3' ' A' ' 85' ' ' ARG . 13.6 t . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.95999999999999996 109.046 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.409 -0.589 . . . . 1.6899999999999999 109.409 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 1.27 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.6899999999999999 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 1.3500000000000001 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 1.24 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.92000000000000004 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.82999999999999996 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 1.25 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 1.3200000000000001 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 1.1000000000000001 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.464 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.66000000000000003 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 1.0600000000000001 108.704 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 1.24 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 1.21 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 1.26 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 4.4800000000000004 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD23 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 2.1099999999999999 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 1.23 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 1.1799999999999999 109.55 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.96999999999999997 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 1.0600000000000001 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.5699999999999998 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.539 HG22 HD23 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 1.45 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 1.0 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 1.29 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 1.01 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 2.0099999999999998 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.83999999999999997 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 1.0800000000000001 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.94999999999999996 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 87' ' ' ILE . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 1.3 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 1.1799999999999999 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.3100000000000001 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.3600000000000001 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.84999999999999998 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 1.4399999999999999 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG23 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.65000000000000002 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 80' ' ' HIS . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 1.2 109.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.83999999999999997 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.58999999999999997 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 1.4299999999999999 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.625 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.3300000000000001 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.80000000000000004 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 1.0800000000000001 110.145 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.46999999999999997 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.412 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.9399999999999999 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 76' ' ' ILE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 1.1100000000000001 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.91000000000000003 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 1.3799999999999999 110.107 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.5600000000000001 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 67' ' ' VAL . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.5600000000000001 110.014 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.58999999999999997 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 1.03 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.3899999999999999 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 1.46 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.477 ' HG3' HG23 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.8300000000000001 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.605 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 1.45 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 60' ' ' ILE . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 1.26 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.609 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.75 110.32 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 mttt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 2.4399999999999999 110.325 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 1.3600000000000001 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.97 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.88 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 2.2200000000000002 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 1.4399999999999999 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 1.26 108.553 179.531 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.252 0.549 . . . . 1.78 110.139 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 1.28 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 1.5700000000000001 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.79 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 1.3700000000000001 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.85999999999999999 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.1399999999999999 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.7 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 1.21 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.89000000000000001 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 76' ' ' ILE . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.69999999999999996 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 1.22 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 1.26 109.281 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD22 ' HB1' ' A' ' 54' ' ' ALA . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 1.24 109.659 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 2.0600000000000001 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 2.3500000000000001 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.88 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 1.23 109.976 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.8900000000000001 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.82999999999999996 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.8500000000000001 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 1.3899999999999999 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.84999999999999998 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 1.1799999999999999 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 1.3300000000000001 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 1.47 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 1.2 109.671 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 1.0 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.58 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 1.3300000000000001 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 1.3799999999999999 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.23 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 1.0 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 1.3500000000000001 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.60999999999999999 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 1.1200000000000001 109.32 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.90000000000000002 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.63 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 1.24 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 1.0700000000000001 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.78000000000000003 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 1.29 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.83999999999999997 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 1.1299999999999999 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.414 HG13 ' CD1' ' A' ' 39' ' ' PHE . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 1.1799999999999999 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 1.0800000000000001 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.6100000000000001 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 2.0800000000000001 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.5600000000000001 110.101 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.83999999999999997 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 1.3200000000000001 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.6299999999999999 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.6100000000000001 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.73 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 1.52 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.589 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 1.27 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.90000000000000002 110.321 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.193 0.52 . . . . 1.9299999999999999 109.756 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 1.24 109.391 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 1.4199999999999999 109.943 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' CE1' HG21 ' A' ' 76' ' ' ILE . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.83999999999999997 109.978 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.73 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 1.3 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 1.29 109.582 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.23 0.538 . . . . 1.51 109.995 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 1.3200000000000001 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 1.52 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.4199999999999999 109.316 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 1.3200000000000001 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.96999999999999997 110.731 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 1.28 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 HG21 ' HD2' ' A' ' 38' ' ' PRO . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 1.3899999999999999 109.09 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' HG21 ' A' ' 37' ' ' THR . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.87 111.418 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.65000000000000002 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.5900000000000001 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 1.3 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 1.3500000000000001 109.783 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.9300000000000002 109.667 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.482 ' HB2' HD22 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.5800000000000001 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 1.05 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 1.1599999999999999 109.833 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.94999999999999996 111.068 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 2.0600000000000001 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 47' ' ' ALA . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 1.3500000000000001 109.488 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 1.02 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 1.4399999999999999 110.294 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.23 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.55 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 1.0700000000000001 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 1.0800000000000001 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 18' ' ' ILE . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 1.1799999999999999 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.538 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 1.3100000000000001 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 1.2 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.25 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.1699999999999999 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.93000000000000005 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 1.26 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.72999999999999998 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD2' ' A' ' 80' ' ' HIS . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 1.27 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.1699999999999999 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78000000000000003 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.05 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB2' HD12 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.5900000000000001 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.78000000000000003 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 1.29 110.216 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.65000000000000002 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 2.0600000000000001 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 71' ' ' GLN . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 1.2 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.90000000000000002 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 1.3899999999999999 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.4900000000000002 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.474 ' CD2' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.24 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.80000000000000004 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 1.1699999999999999 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 1.3600000000000001 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 2.1800000000000002 109.983 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 1.3200000000000001 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 60' ' ' ILE . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 1.45 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo . . . . . 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.80000000000000004 110.152 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.132 0.491 . . . . 1.9199999999999999 109.909 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 73' ' ' ALA . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 1.27 109.303 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.51 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.80000000000000004 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.8399999999999999 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 1.26 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 1.23 108.982 179.342 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.627 -0.509 . . . . 1.55 109.627 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 1.3300000000000001 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 1.52 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.54 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 1.26 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 37' ' ' THR . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.91000000000000003 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.97999999999999998 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 1.2 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 ' HD2' ' A' ' 34' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 1.4099999999999999 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.62 111.418 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.65000000000000002 109.705 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.6699999999999999 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 1.21 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 31' ' ' LEU . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 1.21 109.293 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 1.1799999999999999 109.559 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 3.2799999999999998 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.98 110.092 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 1.1799999999999999 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 1.2 109.97 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.0600000000000001 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.88 111.27 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.9100000000000001 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 1.29 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.70999999999999996 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 1.24 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 1.28 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 1.23 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.89000000000000001 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 1.1100000000000001 109.291 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.474 HG12 HG23 ' A' ' 18' ' ' ILE . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 1.1000000000000001 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 1.3100000000000001 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 1.22 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 1.0900000000000001 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.1200000000000001 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.72999999999999998 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 1.1899999999999999 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.51000000000000001 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' NE2' ' A' ' 80' ' ' HIS . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 1.1699999999999999 109.519 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.46 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.59999999999999998 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 1.1799999999999999 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.6899999999999999 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.78000000000000003 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB3' HG21 ' A' ' 14' ' ' VAL . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 1.27 110.135 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.78000000000000003 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.29 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 71' ' ' GLN . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 1.1899999999999999 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 1.0900000000000001 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 1.4399999999999999 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 2.2200000000000002 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.525 ' NE2' HG22 ' A' ' 67' ' ' VAL . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.5600000000000001 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.72999999999999998 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 1.0700000000000001 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.98999999999999999 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 1.49 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 2.23 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 1.3100000000000001 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.514 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 1.3700000000000001 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.85999999999999999 109.573 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.418 0.628 . . . . 2.8599999999999999 110.25 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 1.55 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 1.3799999999999999 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 76' ' ' ILE . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.92000000000000004 110.09 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 1.45 108.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.712 HG21 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 1.3500000000000001 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.97999999999999998 109.573 179.643 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.624 -0.51 . . . . 1.54 109.624 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 1.52 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.6699999999999999 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 1.0700000000000001 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.439 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 1.3600000000000001 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.81999999999999995 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.4399999999999999 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.8999999999999999 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 1.1200000000000001 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.90000000000000002 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.461 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.77000000000000002 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 1.4199999999999999 108.705 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 1.25 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 1.28 108.933 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 1.3300000000000001 109.18 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 3.1299999999999999 109.846 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD11 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 2.1000000000000001 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 1.2 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 1.1899999999999999 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65000000000000002 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.81999999999999995 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 4.2699999999999996 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 1.29 108.947 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.98999999999999999 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 1.48 110.117 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.3999999999999999 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 1.46 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 1.23 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 1.25 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 1.27 108.99 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 1.26 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 1.3200000000000001 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.76 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.4299999999999999 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 1.46 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.68000000000000005 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 76' ' ' ILE . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 1.25 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.1200000000000001 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.85999999999999999 110.145 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.622 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.27 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.622 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 1.05 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.98999999999999999 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.98999999999999999 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.6799999999999999 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 76' ' ' ILE . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 1.46 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.23 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.6599999999999999 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.1299999999999999 110.688 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.92000000000000004 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 1.0900000000000001 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93000000000000005 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 1.3400000000000001 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 2.1800000000000002 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.712 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 1.3799999999999999 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 HG21 ' A' ' 60' ' ' ILE . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 1.3100000000000001 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.78000000000000003 110.572 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.284 0.564 . . . . 1.95 109.733 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 1.0900000000000001 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 1.04 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.71999999999999997 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.6499999999999999 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 1.1599999999999999 109.634 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 1.22 109.527 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.196 0.522 . . . . 2.0099999999999998 109.602 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 1.3 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.71 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 1.03 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 1.1499999999999999 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.54000000000000004 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.70999999999999996 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 1.3799999999999999 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.87 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.58999999999999997 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.461 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.68000000000000005 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 1.25 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 1.1799999999999999 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 1.1699999999999999 109.32 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 1.3700000000000001 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 3.0499999999999998 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 1.26 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 1.0600000000000001 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 1.0600000000000001 110.056 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.0900000000000001 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.69999999999999996 109.27 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.5600000000000001 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD22 ' A' ' 86' ' ' LEU . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 1.1000000000000001 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.73999999999999999 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 44' ' ' LYS . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 1.24 110.314 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 1.4399999999999999 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 2.02 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 1.0600000000000001 110.18 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 1.0900000000000001 109.369 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 1.1399999999999999 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 1.3300000000000001 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 1.1899999999999999 110.156 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 1.01 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.4099999999999999 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.90000000000000002 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 1.29 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.67000000000000004 109.93 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 1.1000000000000001 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.8100000000000001 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.62 110.128 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 1.28 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.545 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.3700000000000001 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.54000000000000004 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 1.1299999999999999 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.45000000000000001 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 1.24 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 1.22 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.78000000000000003 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 1.3 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 3.1600000000000001 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.6000000000000001 110.618 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57999999999999996 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.87 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.0700000000000001 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 1.3200000000000001 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.90000000000000002 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.428 HD22 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 1.4299999999999999 109.997 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 1.21 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo . . . . . 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.69999999999999996 110.672 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 2.4100000000000001 109.601 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' CZ ' ' A' ' 16' ' ' PHE . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 1.21 109.465 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 1.24 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.66000000000000003 110.196 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 3.2200000000000002 108.679 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 1.21 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 1.1399999999999999 108.73 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.083 0.468 . . . . 1.46 109.746 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 1.3100000000000001 109.291 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.6100000000000001 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.4399999999999999 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.88 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.47999999999999998 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66000000000000003 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 1.48 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 1.1299999999999999 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.46999999999999997 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.68999999999999995 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 1.05 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 1.1200000000000001 109.319 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 1.28 109.805 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.9300000000000002 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.49 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 1.1000000000000001 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 1.1200000000000001 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.73999999999999999 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.58999999999999997 110.968 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.71 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 1.28 109.399 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.68999999999999995 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 1.24 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.91000000000000003 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 1.45 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 1.04 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 1.1499999999999999 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 18' ' ' ILE . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 1.28 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 HG21 ' A' ' 87' ' ' ILE . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 1.23 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 62' ' ' ASN . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.1699999999999999 109.331 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 61' ' ' THR . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91000000000000003 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68000000000000005 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 1.1499999999999999 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.59999999999999998 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 1.22 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.9399999999999999 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.66000000000000003 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.1499999999999999 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.3 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.5 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.95999999999999996 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.42999999999999999 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.434 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.72 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' ILE . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 1.21 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 1.0600000000000001 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 1.3799999999999999 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.48 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.469 ' NE2' HG21 ' A' ' 67' ' ' VAL . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.51 110.252 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.71999999999999997 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.94999999999999996 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.3200000000000001 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 1.46 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.8700000000000001 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 1.3300000000000001 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 1.22 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.88 110.412 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.5899999999999999 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 1.28 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 1.46 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.78000000000000003 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.5899999999999999 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 1.3100000000000001 109.85 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 1.29 109.202 179.56 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.53 -0.545 . . . . 1.8 109.53 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 1.28 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 1.4399999999999999 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 1.26 109.601 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 1.23 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.65000000000000002 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 1.05 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 1.26 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.68999999999999995 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 69' ' ' PRO . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 1.28 108.513 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.71999999999999997 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 1.21 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HG ' HD13 ' A' ' 59' ' ' ILE . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 1.22 109.905 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.96 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 2.3399999999999999 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 1.1399999999999999 109.4 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 1.1399999999999999 109.993 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.4900000000000002 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.3200000000000001 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.63 111.133 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 3.21 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 HG23 HD22 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 1.21 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.75 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 1.3 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 1.28 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 1.5600000000000001 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 1.0700000000000001 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 1.0900000000000001 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.521 HD13 ' HG ' ' A' ' 43' ' ' LEU . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 1.1799999999999999 109.426 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 1.24 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.1899999999999999 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.3599999999999999 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.73999999999999999 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 1.22 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.54000000000000004 110.002 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 1.22 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 1.01 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56000000000000005 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 1.3 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.47 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.63 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.85999999999999999 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67000000000000004 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 2.04 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 1.1899999999999999 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 1.0800000000000001 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 1.4199999999999999 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 3.1499999999999999 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.98999999999999999 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78000000000000003 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 1.1100000000000001 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.3100000000000001 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 59' ' ' ILE . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 1.49 110.199 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 3.0899999999999999 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.525 HD22 HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 1.5700000000000001 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 1.1200000000000001 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo . . . . . 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64000000000000001 110.804 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.192 0.52 . . . . 2.5899999999999999 109.902 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 73' ' ' ALA . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 1.3700000000000001 109.283 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.2 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.79000000000000004 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.4700000000000002 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 1.3200000000000001 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.9 m . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 1.27 109.166 179.316 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.518 -0.549 . . . . 1.78 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 1.51 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.52 109.7 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.5900000000000001 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 1.45 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.22 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.1899999999999999 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 2.04 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.407 HG23 ' HD2' ' A' ' 38' ' ' PRO . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.77 109.296 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.2 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.84999999999999998 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 1.3600000000000001 108.783 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 1.3300000000000001 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 1.3999999999999999 109.309 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 1.3600000000000001 109.709 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.9300000000000002 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 2.1200000000000001 110.225 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 1.3500000000000001 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 1.04 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.3100000000000001 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.97999999999999998 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.73999999999999999 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 3.1099999999999999 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 1.25 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.82999999999999996 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 1.3700000000000001 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.49 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.47 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 1.0700000000000001 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 1.29 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 1.1299999999999999 109.347 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 1.24 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 1.1100000000000001 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.5 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76000000000000001 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 1.3 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.65000000000000002 109.944 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 1.1899999999999999 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.27 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89000000000000001 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.25 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.3200000000000001 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 1.0600000000000001 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 1.2 109.958 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.92000000000000004 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.29 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.467 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 1.25 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 1.0900000000000001 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 1.4399999999999999 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.5299999999999998 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.81000000000000005 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77000000000000002 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.3400000000000001 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 1.3400000000000001 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 2.0499999999999998 109.478 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.463 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 1.3400000000000001 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 1.4399999999999999 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.85999999999999999 110.289 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.384 0.611 . . . . 2.4500000000000002 109.898 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 1.3400000000000001 109.88 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.3100000000000001 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.79000000000000004 110.013 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.55 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 1.3 110.077 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 1.3500000000000001 109.026 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.95 109.14 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 1.3500000000000001 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.8300000000000001 109.527 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 1.1299999999999999 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 1.27 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.80000000000000004 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.6200000000000001 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 1.1699999999999999 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.56999999999999995 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.66000000000000003 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 1.1000000000000001 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 1.1699999999999999 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 1.24 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HG ' HD12 ' A' ' 59' ' ' ILE . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 1.3400000000000001 109.453 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.6200000000000001 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 2.1099999999999999 110.15 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 1.1000000000000001 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 1.1200000000000001 109.922 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.9099999999999999 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.1399999999999999 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.80000000000000004 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.71 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 47' ' ' ALA . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 1.3200000000000001 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.91000000000000003 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 1.3200000000000001 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.2 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.501 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.53 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 1.27 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 1.1399999999999999 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 43' ' ' LEU . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 1.1399999999999999 109.122 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.618 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 1.3 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 1.3100000000000001 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.84999999999999998 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.1800000000000002 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.69999999999999996 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 1.3200000000000001 108.946 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.52000000000000002 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 76' ' ' ILE . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 1.0700000000000001 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.56999999999999995 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 1.03 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.0800000000000001 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.54000000000000004 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 1.1499999999999999 110.213 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.6799999999999999 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.437 HD13 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 1.29 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.93999999999999995 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 1.48 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.7799999999999998 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 1.04 109.897 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.70999999999999996 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 1.1200000000000001 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 1.54 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.5 109.908 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 1.28 109.736 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.607 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 1.23 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.70999999999999996 109.688 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.406 0.622 . . . . 2.46 109.782 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.5 HG22 ' CE2' ' A' ' 16' ' ' PHE . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 1.25 109.603 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 1.28 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CE2' HG22 ' A' ' 14' ' ' VAL . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68000000000000005 109.967 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.8700000000000001 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 1.4199999999999999 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 1.3799999999999999 108.777 179.287 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.18 0.514 . . . . 1.52 109.912 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 1.3700000000000001 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 1.27 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 1.1699999999999999 109.057 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 1.4099999999999999 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.68999999999999995 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.54 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 1.1599999999999999 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.52000000000000002 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.69999999999999996 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 1.49 108.547 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 1.1399999999999999 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.518 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 1.2 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 1.24 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.5299999999999998 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 2.0 110.124 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 18' ' ' ILE . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 1.1399999999999999 109.404 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 1.1699999999999999 109.978 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.90000000000000002 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.526 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 1.29 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 3.1099999999999999 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 1.23 109.46 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.69999999999999996 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 1.25 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.82999999999999996 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.411 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 1.3100000000000001 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 1.1200000000000001 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 1.1699999999999999 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 1.01 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 1.3700000000000001 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 65' ' ' VAL . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 1.2 110.22 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.1399999999999999 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 61' ' ' THR . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 1.3899999999999999 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.571 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.66000000000000003 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.479 HG11 HD11 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 1.46 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.1200000000000001 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.55000000000000004 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 1.01 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.3700000000000001 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.51000000000000001 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 1.27 110.371 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.41999999999999998 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 1.1399999999999999 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 1.22 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.76000000000000001 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 1.3700000000000001 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 3.2799999999999998 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CD2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.4399999999999999 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64000000000000001 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.95999999999999996 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.3100000000000001 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 1.3300000000000001 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 2.2400000000000002 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 1.52 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 1.27 109.333 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.62 110.712 179.859 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.499 2.024 0 CA-C-O 121.278 0.561 . . . . 2.02 109.701 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 73' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 1.23 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 1.1299999999999999 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.78000000000000003 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.5600000000000001 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 1.25 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 1.3 109.401 179.55 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.684 -0.487 . . . . 2.1899999999999999 109.684 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 1.3899999999999999 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 1.52 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 1.1399999999999999 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 1.29 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.77000000000000002 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.0800000000000001 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.5600000000000001 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 1.1000000000000001 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.55000000000000004 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.67000000000000004 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 1.2 108.899 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 1.04 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 1.21 109.299 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 1.3799999999999999 109.736 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 3.1899999999999999 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 2.1899999999999999 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.79000000000000004 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 1.1699999999999999 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.1299999999999999 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76000000000000001 110.791 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 2.1600000000000001 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 1.27 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.26 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 1.3999999999999999 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.51 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.6399999999999999 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 1.1299999999999999 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 1.1000000000000001 109.369 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.457 HG21 HG23 ' A' ' 87' ' ' ILE . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 1.22 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.404 HG21 ' CG ' ' A' ' 80' ' ' HIS . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 1.21 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 2.2200000000000002 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91000000000000003 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 1.4299999999999999 108.933 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.68999999999999995 109.88 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 1.23 109.527 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.74 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.64000000000000001 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.89000000000000001 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.616 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 1.2 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.68000000000000005 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.72999999999999998 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.82999999999999996 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.1200000000000001 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 1.24 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 1.0700000000000001 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.78 109.982 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 2.1800000000000002 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.404 ' CG ' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.1799999999999999 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.81000000000000005 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 16' ' ' PHE . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 1.26 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.97 109.475 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 1.53 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 60' ' ' ILE . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 1.22 108.814 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 1.05 110.554 -179.484 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.492 0.663 . . . . 2.5899999999999999 110.816 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 1.1100000000000001 108.961 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 1.21 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.81000000000000005 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.8999999999999999 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 1.28 109.889 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 1.3100000000000001 109.285 179.564 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.118 0.485 . . . . 2.2000000000000002 109.695 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 1.25 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 1.48 109.859 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 1.0700000000000001 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 1.22 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.55000000000000004 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91000000000000003 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 1.3500000000000001 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 1.1499999999999999 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.5 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.56000000000000005 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 1.6200000000000001 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 1.1100000000000001 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 1.1799999999999999 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 1.25 109.828 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.9900000000000002 110.108 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.21 109.926 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 1.25 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 1.1799999999999999 110.092 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76000000000000001 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.71999999999999997 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.8399999999999999 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 1.21 109.41 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.81000000000000005 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 1.3500000000000001 109.96 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.82999999999999996 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 1.3899999999999999 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 1.1399999999999999 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 1.1000000000000001 109.266 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 43' ' ' LEU . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 1.21 109.8 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.468 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 1.21 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 65' ' ' VAL . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 1.1200000000000001 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.5800000000000001 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.70999999999999996 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.589 ' HB ' HG23 ' A' ' 61' ' ' THR . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 1.27 108.92 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.40000000000000002 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 1.05 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.59999999999999998 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.62 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 1.1899999999999999 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.1399999999999999 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.57999999999999996 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 1.02 110.336 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.52000000000000002 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.53 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.533 HD11 HG22 ' A' ' 76' ' ' ILE . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 1.0800000000000001 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 1.0600000000000001 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 1.47 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.73 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.447 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68000000000000005 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65000000000000002 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.98999999999999999 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 1.3500000000000001 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.6599999999999999 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 1.29 109.695 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.455 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 1.21 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.67000000000000004 110.431 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.354 0.597 . . . . 2.3700000000000001 110.086 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.522 HG22 ' CE2' ' A' ' 16' ' ' PHE . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 1.1499999999999999 109.787 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 1.1799999999999999 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 14' ' ' VAL . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.71999999999999997 110.167 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.9199999999999999 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 1.25 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 1.6699999999999999 109.256 179.42 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.5600000000000001 108.84 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 1.3 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 1.45 109.318 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 1.3799999999999999 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 1.3 109.412 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.68999999999999995 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 1.03 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.89000000000000001 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.54000000000000004 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.66000000000000003 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.69999999999999996 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.94999999999999996 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 1.23 109.359 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 1.23 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 3.0699999999999998 109.921 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.8500000000000001 109.53 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 1.0 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 1.1299999999999999 109.626 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.73999999999999999 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.68999999999999995 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.68999999999999995 110.785 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 2.0600000000000001 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 1.24 109.521 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.67000000000000004 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 1.1799999999999999 110.161 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 1.29 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 1.3 109.555 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.3999999999999999 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 1.1599999999999999 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 1.1699999999999999 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 1.27 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 80' ' ' HIS . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 1.3100000000000001 109.897 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89000000000000001 109.817 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.3600000000000001 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.71999999999999997 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 61' ' ' THR . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 1.3799999999999999 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.57999999999999996 110.019 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 1.22 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.471 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.3700000000000001 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.64000000000000001 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 1.24 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.6100000000000001 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.57999999999999996 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.93999999999999995 110.326 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52000000000000002 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 2.0800000000000001 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 71' ' ' GLN . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 1.1899999999999999 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 1.3200000000000001 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 1.4299999999999999 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.9900000000000002 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 61' ' ' THR . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.85999999999999999 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.68000000000000005 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 1.0600000000000001 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 1.45 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 2.29 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.616 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 1.3300000000000001 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 1.3200000000000001 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.97999999999999998 110.746 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 9.2599999999999998 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -102.84 123.25 46.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.672 -0.642 . . . . 7.0099999999999998 109.337 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.13 25.17 32.21 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.301 -1.12 . . . . 6.0599999999999996 110.301 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.73 61.07 0.5 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.862 -1.695 . . . . 5.0999999999999996 108.862 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 p -97.6 124.48 41.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.793 -0.828 . . . . 3.8599999999999999 109.517 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.34 83.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.235 -1.024 . . . . 4.04 108.235 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.8 147.77 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.504 -0.925 . . . . 3.25 108.504 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -82.97 111.75 19.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.431 -0.793 . . . . 2.6699999999999999 109.866 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 m -125.18 112.21 16.18 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.573 -0.899 . . . . 2.98 108.573 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.71 -20.15 16.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.618 -0.676 . . . . 2.7599999999999998 110.248 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.96 -89.92 0.19 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.073 -1.611 . . . . 2.3300000000000001 109.073 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.33 93.89 7.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.817 . . . . 2.3199999999999998 108.866 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -143.05 156.81 44.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.725 . . . . 2.3100000000000001 110.426 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 16' ' ' PHE . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 1.5900000000000001 109.654 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.4199999999999999 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.85999999999999999 110.058 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 3.2799999999999998 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 1.3 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p -125.35 155.58 40.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 1.21 108.957 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -77.96 117.18 19.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 1.54 109.644 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.4 t -97.12 -29.4 13.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.746 -0.596 . . . . 1.4199999999999999 110.077 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -76.28 -39.8 53.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.471 -0.768 . . . . 1.22 110.079 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.501 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.2 m-20 -83.74 166.03 36.39 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 1.28 110.051 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.6 Cg_endo -74.87 -31.17 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.543 2.162 . . . . 1.6100000000000001 110.273 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 155.46 30.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.694 -0.628 . . . . 3.2000000000000002 109.49 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.59 69.55 72.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 1.79 109.616 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 20' ' ' LEU . 33.8 Cg_endo -77.22 96.04 1.09 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.638 2.225 . . . . 1.1499999999999999 109.615 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.596 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.3 p90 -56.8 147.49 23.06 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.555 0.693 . . . . 1.4099999999999999 110.535 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -127.68 119.18 25.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.9299999999999999 108.896 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.53 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.71 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.3500000000000001 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 1.3999999999999999 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.25 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.4199999999999999 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.9199999999999999 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 1.3500000000000001 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.85999999999999999 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.82999999999999996 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.51 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 1.3899999999999999 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 31' ' ' LEU . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 1.3200000000000001 109.315 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 1.24 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.7999999999999998 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.8200000000000001 109.921 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 1.27 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 1.1899999999999999 109.783 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 27' ' ' PRO . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.97999999999999998 110.856 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.4700000000000002 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.519 HG22 ' CD2' ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 1.73 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.90000000000000002 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HB1' ' HG ' ' A' ' 43' ' ' LEU . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 1.3999999999999999 110.153 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 1.3 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 1.47 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 1.0600000000000001 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 1.1399999999999999 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.606 HG12 HD12 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 1.23 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 87' ' ' ILE . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 1.27 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 HG22 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 1.24 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.23 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77000000000000002 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 1.25 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.69999999999999996 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG21 HG23 ' A' ' 61' ' ' THR . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 1.1699999999999999 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.9299999999999999 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68999999999999995 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 1.3799999999999999 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 2.0699999999999998 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 1.02 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 1.3999999999999999 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.97999999999999998 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 2.0800000000000001 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HG13 ' CD1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 1.3 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 1.1100000000000001 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.72 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 2.1000000000000001 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CE1' HG22 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.4099999999999999 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.80000000000000004 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.24 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.6299999999999999 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 HG21 ' A' ' 59' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 1.26 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.96 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 1.49 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.522 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 1.3999999999999999 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo -75.14 133.09 15.96 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.28 110.849 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -76.44 124.76 28.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.856 -0.528 . . . . 2.1400000000000001 109.87 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -41.46 9.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.719 -0.613 . . . . 3.0 109.858 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 171.7 7.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.571 -0.706 . . . . 5.5800000000000001 109.837 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.87 111.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.675 -0.861 . . . . 2.2999999999999998 108.675 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 94' ' ' HIS . . . 79.49 51.57 5.17 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.378 -1.889 . . . . 1.8799999999999999 108.378 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.442 ' NE2' HG21 ' A' ' 87' ' ' ILE . 2.9 t-80 . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 117.681 -1.152 . . . . 2.6699999999999999 110.028 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.019 -0.734 . . . . 5.9500000000000002 109.019 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 p -94.3 79.64 3.95 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.595 0.712 . . . . 4.2699999999999996 109.797 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 10' ' ' ALA . . . 60.95 58.57 13.02 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 111.613 -0.595 . . . . 2.5 111.613 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.33 -102.74 2.96 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.233 -0.984 . . . . 4.7000000000000002 111.234 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 m -112.2 -70.4 0.81 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.59 -0.947 . . . . 6.1100000000000003 111.379 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.04 -120.76 0.11 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.133 -0.979 . . . . 4.7699999999999996 110.729 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 55.1 0.74 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.166 -0.959 . . . . 4.6799999999999997 109.745 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.64 176.95 5.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.284 -0.885 . . . . 3.27 109.255 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -65.72 154.38 39.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.558 -0.714 . . . . 2.48 110.536 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.715 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . . . -74.1 103.68 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.542 -0.54 . . . . 1.9099999999999999 109.542 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.84 94.36 0.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.928 -1.269 . . . . 1.46 109.928 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 p -85.49 97.79 10.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.935 . . . . 2.7599999999999998 109.086 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -129.14 152.97 48.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.618 -0.676 . . . . 2.9900000000000002 109.732 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 73' ' ' ALA . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 1.53 109.959 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.51 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.82999999999999996 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 3.25 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 46' ' ' ALA . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 1.27 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -127.58 163.51 24.02 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 1.4399999999999999 109.131 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.78 152.27 42.85 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 1.8600000000000001 109.756 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 p -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.595 -0.69 . . . . 1.6200000000000001 109.893 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.0 p -68.83 -47.12 66.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.507 -0.746 . . . . 2.1099999999999999 109.967 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -118.15 157.38 48.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.684 -0.635 . . . . 1.8700000000000001 109.934 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.96 -38.6 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.638 2.226 . . . . 2.1800000000000002 110.111 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.397 0.617 . . . . 2.1699999999999999 110.447 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.517 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -61.56 -55.21 44.78 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.668 -0.645 . . . . 2.5299999999999998 109.917 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -78.43 131.22 10.42 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 122.382 2.055 . . . . 1.6799999999999999 110.552 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.58 148.86 27.77 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.564 -0.71 . . . . 1.5900000000000001 109.727 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt -86.93 99.74 12.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 1.6899999999999999 109.108 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.5900000000000001 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.8100000000000001 109.536 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.5800000000000001 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.479 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 1.6000000000000001 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.1499999999999999 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.4299999999999999 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 1.4299999999999999 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.96999999999999997 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.62 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 1.26 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.89000000000000001 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 1.3 109.313 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 1.28 109.674 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.6400000000000001 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 2.54 109.721 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.515 ' HB3' HD11 ' A' ' 18' ' ' ILE . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.79000000000000004 109.522 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 1.1899999999999999 109.747 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.1899999999999999 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.81999999999999995 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 1.02 110.71 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 4.21 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 1.3600000000000001 109.018 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.59 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.25 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.71 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 91' ' ' ARG . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 2.1000000000000001 110.321 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.59 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 2.0 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 1.01 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 1.27 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 1.1599999999999999 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 1.3799999999999999 110.046 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.596 HG22 ' HB3' ' A' ' 80' ' ' HIS . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 1.2 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' H ' HG23 ' A' ' 61' ' ' THR . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 2.0099999999999998 111.207 -179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.94999999999999996 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.69999999999999996 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 1.1799999999999999 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.53000000000000003 110.069 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG1' HD13 ' A' ' 76' ' ' ILE . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.81000000000000005 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.53 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.96999999999999997 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.69999999999999996 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 1.27 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.6699999999999999 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.89000000000000001 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 1.23 110.38 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.92000000000000004 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.95 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 71' ' ' GLN . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 1.1799999999999999 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.3899999999999999 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.54 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 3.0800000000000001 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.596 ' HB3' HG22 ' A' ' 61' ' ' THR . 41.6 m-70 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92000000000000004 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.93000000000000005 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.4199999999999999 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 1.29 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.1399999999999999 109.681 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 1.54 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 1.5 109.751 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.12 94.84 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.0900000000000001 109.451 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.64 130.39 52.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.755 -0.591 . . . . 3.7400000000000002 110.066 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.28 146.85 52.93 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.072 -0.714 . . . . 1.8100000000000001 109.072 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -95.63 116.34 28.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 2.2200000000000002 109.783 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.58 83.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.067 -0.716 . . . . 3.4500000000000002 109.067 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.84 49.1 0.87 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.407 -1.477 . . . . 4.8700000000000001 109.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.66 -0.906 . . . . 6.21 110.176 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.845 -0.428 . . . . 5.0899999999999999 109.845 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.29 139.59 32.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.697 -0.627 . . . . 2.5600000000000001 109.638 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.96 -74.04 0.28 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.021 -1.631 . . . . 2.3599999999999999 109.021 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.39 55.25 0.7 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.975 -1.65 . . . . 2.4100000000000001 108.975 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.1 t -143.03 -44.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.656 -0.908 . . . . 2.52 110.164 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.43 133.4 32.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.904 . . . . 2.25 110.353 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 12' ' ' SER . . . -90.33 103.18 15.89 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.966 -0.753 . . . . 1.72 108.966 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.7 m -128.43 -72.21 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.574 -0.703 . . . . 2.5800000000000001 109.195 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -138.09 -62.83 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.041 -0.726 . . . . 2.1800000000000002 109.041 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.68 130.69 38.23 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.921 -0.77 . . . . 2.71 108.921 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.25 58.98 9.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.686 -1.365 . . . . 1.5900000000000001 109.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 1.3 m -82.38 -42.71 18.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.605 -0.938 . . . . 1.1599999999999999 109.324 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -117.96 161.59 19.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 2.1200000000000001 109.383 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 1.03 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 1.1200000000000001 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE1' HG23 ' A' ' 76' ' ' ILE . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.69999999999999996 109.964 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 2.54 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.489 HG21 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 1.29 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m -110.26 128.73 55.67 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -66.38 111.64 3.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.453 -0.779 . . . . 1.95 109.3 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 t -93.46 -28.85 15.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 1.3600000000000001 110.632 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.437 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 60.2 p -67.79 -41.63 82.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.303 -0.873 . . . . 1.51 109.735 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' HB3' HD12 ' A' ' 26' ' ' LEU . 3.4 t70 -100.94 124.47 41.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.707 -0.621 . . . . 1.5700000000000001 109.407 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 161.17 29.24 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.783 2.322 . . . . 1.8200000000000001 111.151 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.68 59.17 1.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.455 0.645 . . . . 3.7000000000000002 109.94 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -149.25 134.5 9.54 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.411 -0.806 . . . . 1.54 109.964 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 156.69 33.7 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 123.0 2.467 . . . . 1.1899999999999999 111.424 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -79.01 157.56 28.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.715 -0.616 . . . . 1.3400000000000001 110.356 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 131.94 55.51 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.585 -0.697 . . . . 1.8400000000000001 109.611 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 1.29 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 1.26 109.363 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 1.3100000000000001 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 1.25 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.68999999999999995 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.51 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.429 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 1.3 109.422 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.81999999999999995 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.68999999999999995 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 1.1000000000000001 108.74 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.69999999999999996 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 1.23 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 HD11 ' A' ' 59' ' ' ILE . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 1.3300000000000001 109.78 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 2.3900000000000001 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 1.1599999999999999 110.118 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 1.0800000000000001 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 1.1000000000000001 110.214 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.95999999999999996 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.569 ' CD1' HD13 ' A' ' 20' ' ' LEU . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.71999999999999997 110.764 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 3.1099999999999999 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.556 HG23 HD22 ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 1.25 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.67000000000000004 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 1.23 110.077 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 1.2 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 1.1499999999999999 109.793 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.94999999999999996 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 1.1499999999999999 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 43' ' ' LEU . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 1.1899999999999999 109.096 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG21 ' HA2' ' A' ' 66' ' ' GLY . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 1.1599999999999999 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' HB3' ' A' ' 80' ' ' HIS . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 1.1899999999999999 109.699 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.22 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.90000000000000002 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.68999999999999995 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 1.3500000000000001 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.59999999999999998 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 76' ' ' ILE . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 1.22 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.98999999999999999 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.60999999999999999 110.316 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.1899999999999999 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.628 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.98999999999999999 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.57999999999999996 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 37' ' ' THR . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 1.1200000000000001 110.003 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.51000000000000001 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.55 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.443 HG23 ' CE1' ' A' ' 16' ' ' PHE . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 1.03 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.94999999999999996 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 1.4199999999999999 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 2.3599999999999999 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.423 ' HB3' HG23 ' A' ' 61' ' ' THR . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.70999999999999996 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.68999999999999995 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.92000000000000004 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 1.28 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 2.4500000000000002 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.556 HD22 HG23 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.6499999999999999 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.569 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 1.3400000000000001 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 35.5 Cg_endo -78.36 123.04 5.86 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.72999999999999998 110.48 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -56.37 2.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 1.6699999999999999 109.402 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -135.3 164.82 26.85 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.62 -0.675 . . . . 1.49 109.867 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 128.3 53.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 3.1699999999999999 109.29 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.3 m -88.05 -37.72 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.472 -0.768 . . . . 2.8799999999999999 109.781 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.85 82.15 1.5 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.478 -1.449 . . . . 2.6699999999999999 109.478 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.5 m80 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.862 -1.066 . . . . 4.4199999999999999 109.976 -179.734 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.926 0.393 . . . . 7.6900000000000004 110.007 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 49.78 52.07 15.31 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.603 0.716 . . . . 5.3499999999999996 110.144 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.97 30.86 7.25 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.913 -1.275 . . . . 2.6400000000000001 109.913 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 5' ' ' THR . . . -99.82 -72.59 1.02 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.718 -1.753 . . . . 2.54 108.718 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.546 HG21 ' HA ' ' A' ' 33' ' ' VAL . 99.6 m 67.91 130.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.335 0.588 . . . . 2.8900000000000001 110.141 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 135.38 35.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.756 -0.59 . . . . 3.0499999999999998 109.863 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.37 -41.64 72.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.637 -0.664 . . . . 2.48 109.424 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.3 m 53.24 59.42 4.42 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.334 0.587 . . . . 4.1299999999999999 109.871 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p 43.08 54.09 4.99 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.238 0.542 . . . . 4.4000000000000004 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . . . -129.61 109.89 11.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -0.769 . . . . 2.1800000000000002 109.509 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.58 -52.29 8.57 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.739 -1.344 . . . . 1.78 109.739 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.2 p -82.62 135.7 34.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.745 -0.856 . . . . 1.4299999999999999 109.897 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -131.47 150.5 52.13 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 2.0499999999999998 109.805 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 1.3200000000000001 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 1.26 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.82999999999999996 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 3.3700000000000001 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 1.3100000000000001 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 14.0 t -121.62 143.39 49.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 1.23 109.265 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 tp -67.6 136.24 54.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.432 -0.793 . . . . 1.6200000000000001 110.053 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.2 p -107.35 -3.76 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.698 -0.626 . . . . 1.29 110.489 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -58.03 3.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.1800000000000002 109.527 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -96.82 136.54 21.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.745 -0.597 . . . . 1.6699999999999999 109.661 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 23' ' ' ASP . 35.4 Cg_endo -78.76 155.98 27.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.708 2.272 . . . . 1.1499999999999999 110.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 57.77 0.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.431 0.634 . . . . 4.7999999999999998 109.822 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 143.78 50.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.476 -0.765 . . . . 1.6599999999999999 109.689 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.36 160.58 35.57 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.964 2.442 . . . . 0.81000000000000005 111.256 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 43.1 p90 -99.32 161.37 13.65 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 1.04 110.203 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -117.39 135.43 53.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.564 -0.71 . . . . 1.9399999999999999 109.617 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 1.45 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.71 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.53 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HA ' HG21 ' A' ' 5' ' ' THR . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 1.25 109.646 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.66000000000000003 110.734 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.85999999999999999 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 1.24 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 34' ' ' PRO . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 1.25 109.433 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.72999999999999998 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.94999999999999996 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.487 ' HA ' ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 1.3899999999999999 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 1.04 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 1.3200000000000001 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 1.3300000000000001 109.561 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HG2' ' HB3' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.5499999999999998 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.7 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.89000000000000001 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 1.2 109.634 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91000000000000003 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.70999999999999996 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 3.02 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 1.29 109.28 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.75 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.573 ' HB3' ' HG2' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 1.3 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 1.24 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.491 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 1.4399999999999999 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 1.22 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 1.1599999999999999 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 1.1699999999999999 109.523 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 1.26 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.96999999999999997 109.861 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.6299999999999999 110.802 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.1599999999999999 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.81999999999999995 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 1.4099999999999999 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.55000000000000004 109.803 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 1.3700000000000001 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.6499999999999999 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.72999999999999998 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 1.1699999999999999 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.8999999999999999 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.481 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.77000000000000002 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 1.1799999999999999 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.68999999999999995 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.2 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 1.3 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 1.0800000000000001 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 1.6499999999999999 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.9700000000000002 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CE1' HG13 ' A' ' 67' ' ' VAL . 6.9 m-70 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.98999999999999999 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79000000000000004 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 1.22 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.1699999999999999 109.248 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 1.5700000000000001 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.75 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 1.52 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 1.3899999999999999 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo -74.65 95.47 0.95 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.96999999999999997 110.202 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -140.62 134.88 31.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.191 -0.67 . . . . 3.0600000000000001 109.191 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.8 156.48 18.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.511 -0.743 . . . . 2.0099999999999998 110.101 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.09 102.04 5.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.266 -0.642 . . . . 1.9199999999999999 109.266 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.95 -63.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.704 -0.622 . . . . 3.3500000000000001 109.349 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.03 -56.67 0.83 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.532 -1.427 . . . . 3.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.849 -1.072 . . . . 4.5800000000000001 109.745 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 mtt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.568 -0.53 . . . . 4.2599999999999998 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.28 96.46 7.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.535 0.683 . . . . 3.3799999999999999 110.315 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.07 58.62 2.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.084 -2.406 . . . . 4.7300000000000004 107.084 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.85 -69.61 2.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.46 -1.856 . . . . 5.4299999999999997 108.46 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -155.0 49.05 0.56 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 108.439 -0.949 . . . . 5.8200000000000003 108.439 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.73 99.86 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.693 -0.629 . . . . 2.9399999999999999 109.72 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.94 98.81 1.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.434 0.635 . . . . 3.8799999999999999 109.346 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -146.23 151.56 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.39 -0.596 . . . . 1.98 109.39 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.56 -44.7 73.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.74 -0.6 . . . . 2.1200000000000001 109.736 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.5 -61.22 1.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.649 -0.657 . . . . 2.2400000000000002 110.074 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.38 -99.67 1.22 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.213 -1.555 . . . . 1.3899999999999999 109.213 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.53 129.18 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.658 -0.907 . . . . 1.5900000000000001 109.122 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.87 155.34 46.34 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.505 -0.747 . . . . 3.2599999999999998 110.224 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 1.26 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 1.3300000000000001 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.476 ' CE1' HG21 ' A' ' 76' ' ' ILE . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.78000000000000003 109.703 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.5600000000000001 108.933 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.53 HG22 HD13 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 1.24 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -111.83 133.94 53.71 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 1.1399999999999999 108.862 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.86 145.86 51.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 1.54 109.998 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.417 HG21 HG21 ' A' ' 87' ' ' ILE . 5.2 p -70.56 -26.51 63.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.605 . . . . 1.25 110.245 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -46.59 87.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 2.04 109.697 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.8 p30 -86.12 161.96 47.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.603 -0.686 . . . . 1.2 109.66 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 23' ' ' ASP . 34.0 Cg_endo -77.01 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.602 2.202 . . . . 1.3600000000000001 110.602 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.73 73.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.52 -0.737 . . . . 1.72 109.769 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.677 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -145.96 -66.1 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.49 -0.756 . . . . 1.76 109.653 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.677 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.9 Cg_endo -79.51 86.44 1.68 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.082 1.855 . . . . 1.0800000000000001 110.122 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -128.05 163.19 25.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.523 -0.736 . . . . 1.24 110.064 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.6 136.4 50.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.565 -0.709 . . . . 1.6100000000000001 110.15 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 1.3700000000000001 108.758 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.78 110.111 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 1.0700000000000001 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 1.26 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.81000000000000005 110.881 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91000000000000003 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.98999999999999999 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 1.3400000000000001 109.48 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.59999999999999998 111.173 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.64000000000000001 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 1.25 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 1.1200000000000001 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 1.1899999999999999 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 1.3500000000000001 109.63 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.9700000000000002 109.998 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.6599999999999999 109.631 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 1.1100000000000001 109.622 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 1.0 109.803 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89000000000000001 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.78000000000000003 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.82999999999999996 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 3.3300000000000001 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG23 HD23 ' A' ' 86' ' ' LEU . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 1.23 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.83999999999999997 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 1.3799999999999999 110.018 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 1.0600000000000001 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 1.47 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 1.0 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 1.1499999999999999 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 18' ' ' ILE . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 1.0800000000000001 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 1.25 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 1.1599999999999999 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.6100000000000001 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.0499999999999998 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.73999999999999999 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 1.27 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.516 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.59999999999999998 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.441 HG23 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 1.27 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.85999999999999999 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.58999999999999997 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 1.23 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.594 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.7 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.52000000000000002 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 1.27 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.56999999999999995 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 1.0700000000000001 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.594 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 1.23 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 1.0800000000000001 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 1.4399999999999999 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 4.04 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.441 ' CE1' HG23 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.75 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.59999999999999998 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 1.0800000000000001 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 1.53 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.419 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 2.23 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD13 HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.6000000000000001 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 60' ' ' ILE . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 1.1699999999999999 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo -77.24 86.87 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.72999999999999998 110.519 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 71.38 144.26 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.45 0.643 . . . . 1.54 110.547 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.63 179.81 4.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 0.69999999999999996 109.477 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.57 22.38 12.86 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.504 -0.748 . . . . 3.6400000000000001 110.594 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.06 53.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.268 -0.895 . . . . 1.6899999999999999 109.175 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.95 -41.17 2.21 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.529 -1.429 . . . . 1.4199999999999999 109.529 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.631 -0.923 . . . . 2.5800000000000001 110.031 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.735 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.9 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 7.7800000000000002 109.385 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.37 97.06 0.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.668 -0.864 . . . . 8.1600000000000001 108.668 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.04 47.2 11.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 107.501 -2.24 . . . . 4.9299999999999997 107.501 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 61.19 0.13 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.076 -2.01 . . . . 3.0600000000000001 108.076 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 29.9 m -53.33 110.82 0.6 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.919 -0.754 . . . . 4.7300000000000004 109.851 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.6 89.67 6.34 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.184 0.516 . . . . 3.1899999999999999 110.397 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -46.98 7.97 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.447 -0.783 . . . . 5.5599999999999996 109.064 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.7 p -95.07 -56.28 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.614 -0.884 . . . . 6.5800000000000001 108.614 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -82.99 175.0 10.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 4.8099999999999996 109.402 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.63 -25.81 26.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.694 -0.854 . . . . 2.6099999999999999 108.694 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.97 -85.08 0.3 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.496 -1.442 . . . . 2.54 109.496 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -97.13 138.91 33.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 122.06 -0.671 . . . . 1.6399999999999999 109.203 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 146.28 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.625 -0.672 . . . . 2.2200000000000002 109.327 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 77' ' ' PHE . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 1.3600000000000001 109.758 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 1.24 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 1.1699999999999999 109.832 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.95 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 HG12 HD12 ' A' ' 59' ' ' ILE . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 1.28 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m -121.51 111.94 17.89 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 1.3600000000000001 108.782 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 HD13 ' HB3' ' A' ' 23' ' ' ASP . 1.8 pt? -64.75 140.53 58.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.436 -0.79 . . . . 1.3100000000000001 109.861 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.1 t -107.33 -1.93 21.15 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.673 -0.642 . . . . 1.3899999999999999 110.69 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.3 -45.9 14.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.08 -1.013 . . . . 1.6399999999999999 109.787 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' HB3' HD13 ' A' ' 20' ' ' LEU . 4.8 t70 -112.18 119.44 43.97 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.604 -0.685 . . . . 0.98999999999999999 109.742 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.85 -30.69 3.57 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.88 2.386 . . . . 1.3799999999999999 111.283 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -65.54 -42.98 91.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.773 . . . . 2.8199999999999998 110.061 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 136.05 84.8 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.434 -0.791 . . . . 1.6899999999999999 109.933 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.59 170.39 18.36 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.948 2.432 . . . . 0.88 111.369 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -76.98 163.0 27.11 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.636 -0.665 . . . . 1.26 109.895 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -119.67 137.6 53.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 1.51 110.427 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 1.3500000000000001 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD12 HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 1.46 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 1.04 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 1.1599999999999999 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 37' ' ' THR . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.95999999999999996 110.846 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.1399999999999999 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.3300000000000001 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.459 HG21 ' HD2' ' A' ' 34' ' ' PRO . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 1.3899999999999999 109.706 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.75 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.64000000000000001 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 1.1299999999999999 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.72999999999999998 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.403 HG11 HD12 ' A' ' 31' ' ' LEU . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 1.25 109.11 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 1.3 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 3.2000000000000002 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 2.02 110.22 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 1.1399999999999999 109.277 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.415 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 1.0800000000000001 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6000000000000001 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HB2' HG21 ' A' ' 52' ' ' VAL . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.72999999999999998 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.5099999999999998 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 50' ' ' PHE . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 1.3500000000000001 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.81999999999999995 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 1.26 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.88 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 1.29 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.51 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 1.21 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD12 HG12 ' A' ' 18' ' ' ILE . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 1.1200000000000001 109.773 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.485 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 1.48 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.543 HG21 ' HB ' ' A' ' 65' ' ' VAL . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 1.4099999999999999 110.06 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.3300000000000001 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.1699999999999999 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.1100000000000001 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.543 ' HB ' HG21 ' A' ' 61' ' ' THR . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.6599999999999999 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.93999999999999995 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 1.3600000000000001 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.21 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67000000000000004 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 1.3200000000000001 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.3400000000000001 109.715 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.94999999999999996 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 1.3 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.84999999999999998 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.475 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.72 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 1.3899999999999999 109.647 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.401 ' CB ' HG12 ' A' ' 14' ' ' VAL . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 1.1899999999999999 110.072 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.5800000000000001 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 2.3599999999999999 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 1.05 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.80000000000000004 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 1.01 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 1.4299999999999999 109.731 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.49 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 1.3100000000000001 109.995 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 1.51 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.695 ' HB2' ' HB2' ' A' ' 91' ' ' ARG . 36.4 Cg_endo -77.66 131.48 11.39 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.83999999999999997 111.034 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -76.64 -57.8 3.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.259 -0.645 . . . . 2.3999999999999999 109.259 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.93 78.25 1.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.125 -0.694 . . . . 1.6499999999999999 109.125 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.695 ' HB2' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -151.62 156.23 40.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.532 -0.73 . . . . 2.7000000000000002 109.833 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.9 -28.46 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 2.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.5 76.89 0.51 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.322 -1.511 . . . . 2.1499999999999999 109.322 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.479 -0.772 . . . . 3.6600000000000001 110.121 -179.707 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.263 0.554 . . . . 4.0800000000000001 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -84.53 -53.94 5.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.649 -0.657 . . . . 2.2999999999999998 109.507 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.66 130.7 9.97 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.543 -1.423 . . . . 3.9300000000000002 109.543 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.74 -98.01 0.18 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.076 -1.209 . . . . 4.2199999999999998 110.076 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 m -100.26 -58.57 1.88 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.869 -0.783 . . . . 5.6399999999999997 108.958 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 147.43 36.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.84 -0.537 . . . . 4.4000000000000004 109.802 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.56 34.51 1.17 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.167 -0.679 . . . . 3.7200000000000002 109.167 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.449 ' O ' ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -103.61 137.93 40.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.334 -0.854 . . . . 5.3799999999999999 109.749 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 8' ' ' THR . 20.7 m 73.89 135.28 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.515 0.674 . . . . 4.6200000000000001 110.0 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.57 14.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 3.23 109.822 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.94 -76.75 1.16 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.19 -1.164 . . . . 1.55 110.19 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -138.25 108.11 6.31 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.46 -1.024 . . . . 2.0800000000000001 110.26 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -119.12 159.77 23.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.724 -0.61 . . . . 2.73 109.788 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 1.26 109.368 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 1.3999999999999999 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' A' ' 76' ' ' ILE . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.83999999999999997 109.898 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.8100000000000001 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 HD13 ' A' ' 59' ' ' ILE . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 1.3500000000000001 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -133.08 141.97 48.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 1.1399999999999999 109.109 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.08 115.76 3.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.459 -0.776 . . . . 1.54 109.597 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -72.55 -32.94 66.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.777 -0.577 . . . . 1.3500000000000001 110.151 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.46 -51.08 21.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.446 -0.784 . . . . 1.9299999999999999 109.672 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.48 105.35 1.83 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.621 -0.674 . . . . 2.75 109.865 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.56 138.63 17.45 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.796 2.331 . . . . 2.2999999999999998 110.545 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.11 -64.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.657 . . . . 2.7799999999999998 109.855 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -176.42 -58.22 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 109.389 -0.597 . . . . 2.3900000000000001 109.389 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -77.81 124.6 6.93 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 C-N-CA 122.344 2.03 . . . . 1.77 110.188 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -92.88 151.47 19.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.57 -0.706 . . . . 1.8999999999999999 109.807 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 99.39 10.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 1.7 109.494 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 1.3799999999999999 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.76 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 1.3600000000000001 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 1.45 109.837 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 1.0600000000000001 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.1599999999999999 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.45 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 1.46 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.81999999999999995 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.71999999999999997 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 1.1200000000000001 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 1.2 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 1.25 109.492 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 1.25 109.819 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HG3' ' CB ' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 2.1299999999999999 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.8 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 1.1499999999999999 110.196 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.579 ' HB2' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.89000000000000001 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.98999999999999999 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.90000000000000002 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.91000000000000003 109.52 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.6899999999999999 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 1.23 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.82999999999999996 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' HG3' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 1.3999999999999999 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 1.4199999999999999 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 1.4399999999999999 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.5800000000000001 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 1.1000000000000001 109.523 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.458 HD13 HG12 ' A' ' 18' ' ' ILE . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 1.21 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 1.28 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 1.1699999999999999 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.1299999999999999 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.93999999999999995 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 1.4399999999999999 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.69999999999999996 109.966 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 1.3799999999999999 109.362 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.8799999999999999 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.69999999999999996 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 1.1200000000000001 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.6200000000000001 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.82999999999999996 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 1.1399999999999999 110.226 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.80000000000000004 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.45 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 71' ' ' GLN . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 1.21 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 1.22 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 1.5600000000000001 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.6400000000000001 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.1899999999999999 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76000000000000001 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 1.2 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.90000000000000002 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 1.3899999999999999 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.522 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 3.1699999999999999 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB2' HG22 ' A' ' 18' ' ' ILE . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.6599999999999999 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.636 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 1.46 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.636 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo -75.8 75.08 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.23 110.078 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.46 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.358 0.599 . . . . 1.96 110.095 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.06 -47.2 75.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.591 -0.693 . . . . 1.6399999999999999 109.399 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -91.65 -153.38 0.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.258 -0.645 . . . . 3.7200000000000002 109.258 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.06 156.51 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.26 -0.9 . . . . 2.8700000000000001 110.102 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.0 89.28 0.32 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.901 -1.279 . . . . 1.5700000000000001 109.901 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.858 -1.068 . . . . 3.77 109.777 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 1.1 mtt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.341 0.591 . . . . 5.2699999999999996 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -110.57 101.0 9.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.161 -0.962 . . . . 6.2400000000000002 110.495 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.9 -82.23 0.33 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.365 -0.921 . . . . 8.5999999999999996 111.116 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.96 -98.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.936 0 O-C-N 122.085 -0.656 . . . . 9.0 111.835 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.21 146.93 23.65 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.446 -1.032 . . . . 7.4699999999999998 110.975 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.644 ' HA ' ' HB3' ' A' ' 1' ' ' MET . . . -121.73 43.29 2.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.164 -1.421 . . . . 6.0499999999999998 107.164 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.15 85.62 2.39 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.864 -0.607 . . . . 3.9399999999999999 111.701 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.64 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 43.0 m -70.36 -43.02 71.04 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.515 -1.291 . . . . 3.0800000000000001 107.515 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.5 m 43.08 68.22 0.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.537 0.684 . . . . 2.1000000000000001 110.448 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.83 -31.65 25.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 1.75 109.904 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -68.51 1.63 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.913 -1.275 . . . . 1.4399999999999999 109.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 p -81.6 140.67 34.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.535 -0.979 . . . . 1.3600000000000001 109.75 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -131.19 159.55 37.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.562 -0.711 . . . . 2.5099999999999998 110.037 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 1.4199999999999999 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 1.3 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.92000000000000004 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 2.4900000000000002 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 1.27 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m -113.43 134.31 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -67.63 128.46 36.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.366 -0.834 . . . . 1.73 109.891 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 p -85.22 -39.21 18.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.664 -0.647 . . . . 1.6100000000000001 109.586 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -71.69 -35.65 70.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.638 -0.664 . . . . 1.9099999999999999 110.317 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -106.29 115.6 60.7 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 2.0699999999999998 110.035 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.28 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.849 2.366 . . . . 2.02 110.591 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -63.63 -49.68 72.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.626 -0.671 . . . . 3.6099999999999999 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD13 ' HD2' ' A' ' 27' ' ' PRO . 2.8 mm? -55.65 118.17 18.45 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.859 -0.526 . . . . 2.1000000000000001 109.911 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD2' HD13 ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.43 166.58 27.21 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.701 2.267 . . . . 1.0600000000000001 111.183 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -62.92 155.49 27.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.722 -0.611 . . . . 0.87 110.485 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -119.16 132.5 55.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.651 -0.656 . . . . 1.8300000000000001 109.369 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 1.3899999999999999 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.6499999999999999 109.79 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 1.3100000000000001 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.7 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.0900000000000001 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.03 110.205 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.64 ' HB3' ' HA ' ' A' ' 8' ' ' THR . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.46 110.469 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.5700000000000001 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.1699999999999999 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.528 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.84999999999999998 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 69' ' ' PRO . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 1.6100000000000001 108.606 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 1.3300000000000001 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 1.29 109.165 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 1.27 109.574 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.4900000000000002 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.9300000000000002 110.215 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 1.23 109.718 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 1.04 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.97999999999999998 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB3' HD12 ' A' ' 20' ' ' LEU . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.72999999999999998 110.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 3.1600000000000001 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 1.45 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.87 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 1.24 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 1.3600000000000001 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.4299999999999999 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.3799999999999999 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 1.4199999999999999 109.232 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 1.21 109.391 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 1.3899999999999999 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.598 HG22 ' HB ' ' A' ' 65' ' ' VAL . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 1.1799999999999999 110.065 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.1399999999999999 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.0600000000000001 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.598 ' HB ' HG22 ' A' ' 61' ' ' THR . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.5 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.92000000000000004 109.701 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 1.4099999999999999 109.446 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.28 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.95999999999999996 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.73 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.78 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.24 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 1.28 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.97999999999999998 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.8899999999999999 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.475 HG13 ' CD1' ' A' ' 39' ' ' PHE . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 1.3400000000000001 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 1.01 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.6200000000000001 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 2.2000000000000002 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.47 110.138 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.95999999999999996 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.92000000000000004 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.8999999999999999 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 1.3300000000000001 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 3.4700000000000002 109.92 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 1.4399999999999999 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 1.4099999999999999 109.068 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.6 116.79 4.57 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.85999999999999999 110.655 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -71.57 -52.38 18.45 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.77 -0.581 . . . . 3.48 109.882 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 63.9 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.356 0.598 . . . . 1.8 110.353 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 ttm105 -86.88 -56.08 3.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.523 -0.736 . . . . 6.4100000000000001 109.878 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.1 130.45 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.292 -0.88 . . . . 2.8900000000000001 110.009 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.36 58.13 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.766 -1.333 . . . . 2.5 109.766 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.794 -1.098 . . . . 3.54 109.703 179.738 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 tpt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.082 0.468 . . . . 2.23 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 -55.83 1.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.749 -0.594 . . . . 1.1499999999999999 109.528 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.8 69.19 0.72 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.502 -1.439 . . . . 0.73999999999999999 109.502 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.21 -76.66 0.05 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.106 -1.198 . . . . 0.94999999999999996 110.106 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -105.81 -64.19 1.18 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.917 . . . . 1.8500000000000001 109.697 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.74 111.14 21.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.585 -0.697 . . . . 1.6799999999999999 109.783 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.02 -46.11 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.69 -0.631 . . . . 1.6299999999999999 109.642 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 p -80.52 95.08 6.38 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.672 -0.642 . . . . 1.9299999999999999 109.471 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.31 131.08 14.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.529 -0.732 . . . . 1.6299999999999999 109.355 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.13 109.38 20.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 1.3799999999999999 109.598 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.04 71.26 1.16 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.834 -1.306 . . . . 0.97999999999999998 109.834 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.25 142.91 42.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.693 -0.886 . . . . 1.24 109.639 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.29 171.49 8.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.68 -0.637 . . . . 2.5099999999999998 110.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.544 ' HA ' ' HE2' ' A' ' 1' ' ' MET . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 1.25 109.176 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 1.3200000000000001 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.79000000000000004 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' HE3' ' CG ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.8399999999999999 108.889 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 1.24 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m -118.79 134.19 55.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 1.3899999999999999 108.987 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.58 HD22 ' HB3' ' A' ' 23' ' ' ASP . 7.5 tp -73.56 114.89 12.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 1.73 109.527 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 t -82.1 -24.28 35.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.72 -0.613 . . . . 1.3200000000000001 109.915 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.26 -49.07 53.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.533 -0.73 . . . . 1.6200000000000001 109.628 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.58 ' HB3' HD22 ' A' ' 20' ' ' LEU . 9.2 t70 -103.9 120.02 52.6 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.547 -0.721 . . . . 1.1000000000000001 109.63 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.79 -30.61 4.6 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.72 2.28 . . . . 1.0700000000000001 110.968 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -44.54 95.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.556 -0.715 . . . . 2.4700000000000002 109.465 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.2 121.9 82.05 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.486 -0.759 . . . . 1.79 109.627 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.14 174.85 11.55 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.79 2.326 . . . . 1.1699999999999999 111.235 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.456 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 44.5 p90 -71.87 161.55 30.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 1.5700000000000001 109.793 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? -137.83 143.5 41.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.53 -0.731 . . . . 2.7000000000000002 109.541 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 1.4299999999999999 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 1.5600000000000001 108.999 179.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.3600000000000001 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 1.23 109.511 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.48999999999999999 110.759 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78000000000000003 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.3999999999999999 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 1.0700000000000001 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.48999999999999999 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.492 HG23 ' HB2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 1.3799999999999999 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 1.1799999999999999 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 1.1200000000000001 109.229 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 HD23 ' HB1' ' A' ' 54' ' ' ALA . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 1.26 109.665 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 3.3300000000000001 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HB3' HD12 ' A' ' 31' ' ' LEU . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.53 110.25 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 1.1799999999999999 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 1.1399999999999999 109.882 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.3500000000000001 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.96999999999999997 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.71999999999999997 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 3.4399999999999999 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 1.3 109.041 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.98999999999999999 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' HD23 ' A' ' 43' ' ' LEU . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 1.6599999999999999 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.54 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 1.0800000000000001 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 1.23 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 1.0700000000000001 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 1.3400000000000001 109.388 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 1.0700000000000001 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.4299999999999999 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.1399999999999999 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.78000000000000003 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 1.1000000000000001 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.62 109.812 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 1.0600000000000001 109.385 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 1.1000000000000001 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.66000000000000003 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 1.25 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' A' ' 76' ' ' ILE . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.5600000000000001 110.103 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.45000000000000001 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 1.0600000000000001 110.355 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.42999999999999999 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 1.0700000000000001 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 71' ' ' GLN . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 1.22 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.68000000000000005 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 1.24 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 2.29 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.70999999999999996 110.06 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68000000000000005 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.6100000000000001 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 1.6000000000000001 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.79 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 1.52 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 1.3100000000000001 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.95 83.67 2.21 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.0600000000000001 110.12 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.427 ' NH2' ' HD3' ' A' ' 91' ' ' ARG . 26.9 ttp180 -92.49 104.35 16.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.901 -0.777 . . . . 3.5499999999999998 108.901 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.92 112.31 23.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.513 -0.742 . . . . 1.9399999999999999 109.502 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.427 ' HD3' ' NH2' ' A' ' 89' ' ' ARG . 2.0 ptt-85 -128.63 150.29 50.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 3.6800000000000002 109.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.7 t 57.41 89.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.644 -0.502 . . . . 3.3999999999999999 109.644 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.14 100.09 0.09 OUTLIER Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.376 -1.49 . . . . 4.3799999999999999 109.376 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.653 -1.165 . . . . 7.0499999999999998 109.576 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.445 0.641 . . . . 4.25 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -105.27 130.55 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.83 -0.544 . . . . 4.0599999999999996 109.614 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.25 80.17 0.66 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.922 -1.271 . . . . 5.0499999999999998 109.922 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.99 -81.62 0.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.154 -1.178 . . . . 5.21 110.154 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.7 p -109.94 107.26 17.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.823 -0.81 . . . . 5.1100000000000003 109.916 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.21 107.08 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.107 -1.442 . . . . 4.0300000000000002 107.107 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.74 112.62 24.44 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.404 0.621 . . . . 3.9900000000000002 110.653 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -102.42 113.67 27.2 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.847 -1.168 . . . . 3.04 107.847 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.1 m -69.23 104.94 2.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.683 -0.635 . . . . 3.1499999999999999 109.821 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -150.29 126.81 10.84 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.169 -0.678 . . . . 1.75 109.169 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.62 -99.4 0.05 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.529 -1.428 . . . . 1.1799999999999999 109.529 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -63.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.767 -0.843 . . . . 1.96 109.346 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt -140.32 149.52 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 1.77 109.762 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 1.3500000000000001 109.388 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 1.5600000000000001 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.419 ' CE1' HG23 ' A' ' 76' ' ' ILE . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.82999999999999996 109.866 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.6599999999999999 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 1.23 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -119.75 143.48 47.78 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.95999999999999996 109.219 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 119.33 11.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.358 -0.838 . . . . 1.4199999999999999 109.897 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -98.44 -27.98 13.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.619 . . . . 1.3899999999999999 110.189 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -40.52 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.414 -0.804 . . . . 1.5900000000000001 109.738 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.492 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -72.81 166.49 42.49 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.659 -0.651 . . . . 1.2 109.809 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.0 Cg_endo -74.85 -27.44 10.31 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.535 2.157 . . . . 1.3300000000000001 110.509 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.61 -173.92 4.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.67 . . . . 4.6799999999999997 109.74 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 70.86 13.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.201 -0.666 . . . . 2.1099999999999999 109.201 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HG2' ' HE1' ' A' ' 50' ' ' PHE . 34.3 Cg_endo -77.25 96.15 1.09 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.615 2.21 . . . . 0.75 109.95 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -69.49 152.8 44.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.553 0.692 . . . . 1.1699999999999999 110.597 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.75 124.31 23.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.6499999999999999 109.057 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 1.25 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.6100000000000001 109.506 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 1.1599999999999999 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 1.3100000000000001 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.81000000000000005 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.8100000000000001 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 1.26 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.75 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.73999999999999999 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.8200000000000001 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 1.2 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 1.27 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 1.3200000000000001 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 4.1799999999999997 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 2.04 110.233 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 1.22 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 52' ' ' VAL . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 1.0900000000000001 109.908 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.70999999999999996 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 1.04 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.8399999999999999 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.608 HG23 HD22 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 1.3100000000000001 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.88 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 1.29 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 1.03 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 90' ' ' ASP . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 1.3999999999999999 109.549 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 1.1299999999999999 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 1.25 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG22 HD21 ' A' ' 84' ' ' LEU . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 1.04 109.212 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 1.3300000000000001 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 1.26 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 1.1799999999999999 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89000000000000001 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 1.45 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.68000000000000005 109.865 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 80' ' ' HIS . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 1.29 109.522 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89000000000000001 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81000000000000005 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.5 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.45 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.93000000000000005 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 1.3300000000000001 110.373 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.82999999999999996 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.476 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 2.0299999999999998 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 71' ' ' GLN . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 1.24 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 1.1000000000000001 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 1.4199999999999999 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.5299999999999998 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.528 ' CD2' HG21 ' A' ' 67' ' ' VAL . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.1599999999999999 110.451 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.82999999999999996 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 1.26 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.9099999999999999 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD21 HG22 ' A' ' 59' ' ' ILE . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 1.55 109.822 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.447 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 2.3100000000000001 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.608 HD22 HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 1.3899999999999999 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.538 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 1.3600000000000001 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.89 90.49 1.07 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.95999999999999996 110.884 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.4 mmm-85 -105.24 106.24 16.64 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.106 -0.702 . . . . 3.6299999999999999 109.106 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.572 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -72.12 -19.38 61.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.725 -0.609 . . . . 3.1699999999999999 110.918 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -179.55 4.4 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.327 -0.858 . . . . 7.2199999999999998 110.523 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.8 -17.68 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.8 -0.563 . . . . 4.21 109.607 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.21 -70.36 0.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.74 -1.344 . . . . 2.8599999999999999 109.74 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.892 -0.769 . . . . 3.2599999999999998 109.511 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.98 -0.378 . . . . 4.2800000000000002 109.98 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -105.26 121.8 44.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.532 -0.73 . . . . 2.6899999999999999 109.433 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.1 -70.21 0.67 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.162 -1.575 . . . . 2.9500000000000002 109.162 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.29 -92.25 0.09 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.673 -1.371 . . . . 2.6099999999999999 109.673 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.662 ' HB ' ' CD1' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -103.36 -40.57 6.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.885 -0.774 . . . . 2.8199999999999998 109.114 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 70.82 100.19 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.319 0.581 . . . . 1.6000000000000001 109.715 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' HG ' ' A' ' 78' ' ' LEU . . . -102.36 118.61 37.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.77 . . . . 2.02 109.621 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.1 m -79.64 115.75 19.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.949 -0.76 . . . . 1.74 108.949 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.6 m -95.04 -54.04 3.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.609 -0.682 . . . . 1.5700000000000001 109.464 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.04 -57.14 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.612 -0.68 . . . . 1.6599999999999999 109.809 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.54 -74.16 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.557 -1.417 . . . . 1.25 109.557 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.61 40.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.775 -0.838 . . . . 1.53 109.474 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 166.32 33.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.403 -0.81 . . . . 1.8700000000000001 110.438 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.471 HG23 ' HB2' ' A' ' 73' ' ' ALA . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 1.1699999999999999 109.343 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 1.1899999999999999 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.55000000000000004 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.9099999999999999 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 1.23 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 13.6 t -113.27 151.79 30.64 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.95999999999999996 109.046 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.91 131.65 45.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.412 -0.805 . . . . 1.6000000000000001 110.105 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.439 ' CG2' ' HB3' ' A' ' 85' ' ' ARG . 36.4 p -85.2 -42.84 14.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.675 -0.641 . . . . 1.5 109.541 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -41.36 95.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.708 -0.62 . . . . 1.6299999999999999 109.612 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.561 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 1.2 m-20 -76.11 158.11 82.45 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.682 -0.636 . . . . 1.6599999999999999 109.626 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.71 98.39 1.21 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.68 2.254 . . . . 2.1499999999999999 110.448 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 -88.04 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.053 -0.404 . . . . 2.9900000000000002 109.978 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mp 66.25 163.39 0.13 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.616 -0.677 . . . . 2.0800000000000001 110.183 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.65 133.9 14.63 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.666 2.244 . . . . 1.1799999999999999 110.652 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.592 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 28.7 p90 -86.93 154.27 20.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.707 -0.621 . . . . 1.24 110.119 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 132.93 42.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.623 -0.673 . . . . 1.6899999999999999 109.409 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 1.27 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.6899999999999999 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 1.3500000000000001 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 1.24 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.92000000000000004 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.82999999999999996 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 1.25 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 1.3200000000000001 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 1.1000000000000001 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.464 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.66000000000000003 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 1.0600000000000001 108.704 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 1.24 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 1.21 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 1.26 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 4.4800000000000004 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD23 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 2.1099999999999999 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 1.23 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 1.1799999999999999 109.55 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.96999999999999997 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 1.0600000000000001 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.5699999999999998 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.539 HG22 HD23 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 1.45 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 1.0 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 1.29 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 1.01 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 2.0099999999999998 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.83999999999999997 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 1.0800000000000001 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.94999999999999996 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 87' ' ' ILE . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 1.3 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 1.1799999999999999 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.3100000000000001 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.3600000000000001 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.84999999999999998 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 1.4399999999999999 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG23 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.65000000000000002 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG23 ' NE2' ' A' ' 80' ' ' HIS . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 1.2 109.571 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.83999999999999997 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.464 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.58999999999999997 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 1.4299999999999999 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.625 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.3300000000000001 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.625 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.80000000000000004 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 1.0800000000000001 110.145 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.46999999999999997 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.412 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.9399999999999999 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 76' ' ' ILE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 1.1100000000000001 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.91000000000000003 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.662 ' CD1' ' HB ' ' A' ' 5' ' ' THR . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 1.3799999999999999 110.107 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.5600000000000001 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.463 ' NE2' HG23 ' A' ' 67' ' ' VAL . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.5600000000000001 110.014 -178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.58999999999999997 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 1.03 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.3899999999999999 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 1.46 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.477 ' HG3' HG23 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.8300000000000001 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.605 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 1.45 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 60' ' ' ILE . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 1.26 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.609 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo -75.58 77.32 3.35 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.75 110.32 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -84.98 101.14 12.13 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.79 108.899 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -154.74 176.51 12.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.547 -0.721 . . . . 1.6499999999999999 109.997 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.7 -65.58 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 5.5599999999999996 109.433 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.96 153.0 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.526 -0.733 . . . . 4.5 110.357 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.4 -77.77 0.37 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.199 -1.56 . . . . 3.9900000000000002 109.199 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.9 p-80 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.376 -0.821 . . . . 4.6399999999999997 109.256 -179.737 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HG3' ' N ' ' A' ' 2' ' ' SER . 1.7 ptt? . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 110.022 -0.362 . . . . 5.5700000000000003 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.515 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER -104.2 -41.42 5.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 4.1699999999999999 109.471 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.38 -82.52 1.6 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.112 -1.195 . . . . 3.1299999999999999 110.112 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.77 92.88 0.72 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.063 -1.215 . . . . 2.9399999999999999 110.063 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.6 m -93.09 116.05 28.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.709 -0.848 . . . . 3.0600000000000001 108.709 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 130.51 36.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.451 -0.781 . . . . 2.23 109.804 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 122.65 25.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 2.0499999999999998 109.696 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -89.58 120.29 30.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.597 -0.69 . . . . 2.4900000000000002 109.25 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 m -91.17 123.78 34.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.51 -0.744 . . . . 2.5299999999999998 109.554 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 -48.34 17.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.604 -0.685 . . . . 2.3599999999999999 109.664 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.31 80.28 0.09 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.306 -1.118 . . . . 1.9299999999999999 110.306 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -92.89 124.67 37.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.557 -0.966 . . . . 1.4199999999999999 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -134.55 158.07 44.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.506 -0.746 . . . . 2.4399999999999999 110.325 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 1.3600000000000001 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.97 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.88 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 2.2200000000000002 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 1.4399999999999999 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m -122.91 125.26 45.0 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 1.26 108.553 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -55.38 137.91 46.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.561 -0.712 . . . . 1.74 110.078 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 p -62.53 -44.63 95.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.794 -0.566 . . . . 1.3899999999999999 109.969 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -65.26 -43.88 89.86 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.646 -0.659 . . . . 1.51 109.592 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.3 m-20 -71.71 160.58 82.21 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.721 -0.612 . . . . 1.1799999999999999 109.644 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.43 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.647 2.231 . . . . 0.91000000000000003 110.475 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -84.73 -25.91 28.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 3.52 110.952 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -52.75 -56.52 22.32 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.454 -0.779 . . . . 2.2000000000000002 110.88 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.8 Cg_endo -80.1 110.55 2.54 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.511 2.141 . . . . 0.95999999999999996 110.801 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.49 159.81 43.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.532 -0.73 . . . . 1.1399999999999999 109.705 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.35 138.69 48.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.78 110.139 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 1.28 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 1.5700000000000001 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.79 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 1.3700000000000001 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.85999999999999999 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.1399999999999999 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.7 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 1.21 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.89000000000000001 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.414 ' CD1' HG13 ' A' ' 76' ' ' ILE . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.69999999999999996 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 1.22 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 1.26 109.281 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD22 ' HB1' ' A' ' 54' ' ' ALA . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 1.24 109.659 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HA ' ' CB ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 2.0600000000000001 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 2.3500000000000001 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.88 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 1.23 109.976 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.8900000000000001 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.82999999999999996 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.8500000000000001 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG23 HD23 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 1.3899999999999999 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.84999999999999998 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 1.1799999999999999 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 1.3300000000000001 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 1.47 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 1.1799999999999999 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 89' ' ' ARG . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 1.2 109.671 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 1.0 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.58 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 1.3300000000000001 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 1.3799999999999999 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.23 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 1.0 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 1.3500000000000001 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.58 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.60999999999999999 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 1.1200000000000001 109.32 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.468 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.90000000000000002 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.63 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 1.24 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 1.0700000000000001 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.78000000000000003 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 1.29 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.83999999999999997 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 1.1299999999999999 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 HG13 ' CD1' ' A' ' 39' ' ' PHE . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 1.1799999999999999 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 1.0800000000000001 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.6100000000000001 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 2.0800000000000001 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.5600000000000001 110.101 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.83999999999999997 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 1.3200000000000001 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.6299999999999999 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 1.6100000000000001 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.73 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 1.52 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.589 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 1.27 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.589 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo -76.4 69.65 6.5 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.90000000000000002 110.321 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' HB3' ' HB1' ' A' ' 58' ' ' ALA . 2.7 ttp180 -91.91 115.19 27.85 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.663 -0.865 . . . . 2.0800000000000001 108.663 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.12 134.37 42.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.734 -0.604 . . . . 2.3399999999999999 110.735 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.3 107.08 8.29 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.533 -0.914 . . . . 1.6000000000000001 108.533 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 93' ' ' GLY . 68.1 t -95.9 -103.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.618 -0.676 . . . . 2.9900000000000002 109.182 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 92' ' ' VAL . . . -91.87 -28.93 12.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 4.4299999999999997 109.452 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.682 -0.893 . . . . 8.1099999999999994 109.911 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.475 0.655 . . . . 9.4900000000000002 109.569 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 m -71.01 110.95 6.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 6.0800000000000001 109.051 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.27 -157.36 1.01 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.398 -1.081 . . . . 4.6900000000000004 110.398 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.57 87.95 0.35 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.726 -1.349 . . . . 3.5800000000000001 109.726 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -54.21 -29.93 48.0 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.813 -0.816 . . . . 4.0 109.599 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.16 72.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.698 -1.223 . . . . 2.71 107.698 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.13 80.39 5.48 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.738 -0.601 . . . . 2.48 109.572 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 42.36 55.34 4.07 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.492 0.663 . . . . 3.1899999999999999 109.844 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' HB2' ' A' ' 34' ' ' PRO . 22.3 m -118.75 97.84 5.92 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.893 -0.78 . . . . 1.47 108.893 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.56 139.69 49.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 1.6899999999999999 110.007 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.04 -73.55 0.22 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.478 -1.449 . . . . 1.1899999999999999 109.478 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.89 115.42 22.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.792 -0.828 . . . . 1.9099999999999999 109.282 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -133.41 153.12 51.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.611 -0.681 . . . . 1.9299999999999999 109.756 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 1.24 109.391 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 1.4199999999999999 109.943 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' CE1' HG21 ' A' ' 76' ' ' ILE . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.83999999999999997 109.978 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.73 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 1.3 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -107.28 147.12 30.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 1.29 109.582 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.408 HD22 HD12 ' A' ' 26' ' ' LEU . 21.0 tp -67.09 137.87 56.7 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.492 -0.755 . . . . 1.8500000000000001 110.182 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.542 HG21 ' HB3' ' A' ' 85' ' ' ARG . 28.5 p -98.96 52.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.284 -0.636 . . . . 1.5900000000000001 109.284 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.58 -54.89 0.17 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 2.1299999999999999 109.686 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.2 152.67 65.19 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.64 -0.662 . . . . 2.1600000000000001 109.9 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.94 -17.01 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.77 2.313 . . . . 2.4700000000000002 110.937 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -56.4 -52.55 64.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.544 -0.722 . . . . 3.1800000000000002 109.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -62.28 126.11 87.11 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.538 -0.541 . . . . 1.97 109.538 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.39 141.55 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.678 2.252 . . . . 1.1699999999999999 110.825 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -65.75 157.09 31.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.776 -0.578 . . . . 1.21 110.055 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? -106.05 129.58 54.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.556 -0.715 . . . . 1.51 109.995 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 1.3200000000000001 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.482 HD22 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 1.52 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.4199999999999999 109.316 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 1.3200000000000001 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' HB2' HG23 ' A' ' 9' ' ' THR . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.96999999999999997 110.731 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 1.28 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 HG21 ' HD2' ' A' ' 38' ' ' PRO . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 1.3899999999999999 109.09 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' HG21 ' A' ' 37' ' ' THR . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.87 111.418 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.552 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.65000000000000002 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.5900000000000001 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 1.3 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 1.3500000000000001 109.783 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.9300000000000002 109.667 179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.482 ' HB2' HD22 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.5800000000000001 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 1.05 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.529 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 1.1599999999999999 109.833 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.94999999999999996 111.068 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 2.0600000000000001 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG23 ' HB3' ' A' ' 47' ' ' ALA . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 1.3500000000000001 109.488 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 1.02 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 1.4399999999999999 110.294 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.23 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.55 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 1.0700000000000001 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 1.0800000000000001 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 HD11 HG12 ' A' ' 18' ' ' ILE . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 1.1799999999999999 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.538 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 1.3100000000000001 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 1.2 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.25 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.1699999999999999 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.93000000000000005 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 1.26 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.72999999999999998 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG22 ' CD2' ' A' ' 80' ' ' HIS . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 1.27 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.1699999999999999 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78000000000000003 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 1.05 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' HB2' HD12 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.5900000000000001 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.553 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.78000000000000003 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 1.29 110.216 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.65000000000000002 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.553 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 2.0600000000000001 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 71' ' ' GLN . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 1.2 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.90000000000000002 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 1.3899999999999999 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.4900000000000002 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.474 ' CD2' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.24 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.80000000000000004 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 1.1699999999999999 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 1.3600000000000001 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.542 ' HB3' HG21 ' A' ' 21' ' ' THR . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 2.1800000000000002 109.983 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 1.3200000000000001 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 HG23 HG23 ' A' ' 60' ' ' ILE . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 1.45 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo -75.57 88.63 1.27 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.80000000000000004 110.152 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 90.53 5.4 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.63 . . . . 2.1000000000000001 109.572 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -114.29 -53.23 2.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.23 109.43 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -102.05 -173.37 2.33 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.731 -0.605 . . . . 2.8799999999999999 109.988 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.45 -45.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.42 -0.8 . . . . 2.4900000000000002 109.683 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.49 36.12 4.6 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.86 -1.296 . . . . 2.1800000000000002 109.86 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.959 -1.02 . . . . 1.98 109.491 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.947 -0.39 . . . . 5.1399999999999997 109.947 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.22 100.03 11.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.338 -0.851 . . . . 5.2800000000000002 110.397 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.53 120.54 2.19 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.219 -1.152 . . . . 4.3499999999999996 110.219 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.37 68.93 0.54 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.979 -1.648 . . . . 4.21 108.979 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -66.88 112.39 4.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.811 -0.817 . . . . 3.96 109.555 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.17 -39.65 13.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.844 -0.798 . . . . 2.7799999999999998 108.844 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.16 98.32 5.61 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.375 -0.602 . . . . 2.4900000000000002 109.375 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.4 m -96.15 -50.02 5.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.724 -0.843 . . . . 2.5299999999999998 108.724 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -88.07 178.93 6.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.916 -0.772 . . . . 2.3599999999999999 108.916 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.14 138.24 43.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.229 -0.92 . . . . 4.0800000000000001 109.276 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -107.25 3.0 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.666 -1.373 . . . . 2.1400000000000001 109.666 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -162.36 152.92 17.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.907 . . . . 2.2000000000000002 110.171 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -126.0 149.09 49.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.747 -0.596 . . . . 1.9199999999999999 109.909 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 73' ' ' ALA . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 1.27 109.303 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.51 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.80000000000000004 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.8399999999999999 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.702 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 1.26 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p -113.14 128.13 56.4 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 1.23 108.982 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.65 HD13 ' HB3' ' A' ' 86' ' ' LEU . 12.4 tp -67.58 130.58 43.48 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.54 -0.725 . . . . 1.52 109.975 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 p -74.95 -38.77 61.64 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.803 -0.561 . . . . 1.22 109.757 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -91.7 57.8 3.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.598 -0.688 . . . . 1.4099999999999999 109.485 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -148.47 139.02 13.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.397 -0.814 . . . . 1.2 109.503 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.53 161.7 33.96 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.559 2.173 . . . . 1.77 111.164 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 65.4 -154.74 0.27 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.942 -0.474 . . . . 4.1399999999999997 109.832 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.98 74.71 48.45 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.109 -0.994 . . . . 2.3599999999999999 110.362 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 37.0 Cg_endo -82.3 130.96 6.46 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 122.973 2.449 . . . . 1.71 110.186 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -137.97 154.53 49.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 1.6200000000000001 110.354 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 121.07 34.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 1.55 109.627 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 1.3300000000000001 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 HD13 HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 1.52 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.54 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 1.26 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 37' ' ' THR . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.91000000000000003 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.97999999999999998 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 1.2 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 ' HD2' ' A' ' 34' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 1.4099999999999999 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.62 111.418 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.65000000000000002 109.705 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.6699999999999999 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 1.21 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.404 HG13 HD13 ' A' ' 31' ' ' LEU . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 1.21 109.293 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 1.1799999999999999 109.559 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 3.2799999999999998 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.98 110.092 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 1.1799999999999999 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 1.2 109.97 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.0600000000000001 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.489 ' HE1' ' HB2' ' A' ' 27' ' ' PRO . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.88 111.27 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.9100000000000001 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 1.29 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.70999999999999996 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 1.24 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 1.28 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 1.23 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.89000000000000001 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 90' ' ' ASP . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 1.1100000000000001 109.291 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.474 HG12 HG23 ' A' ' 18' ' ' ILE . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 1.1000000000000001 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.589 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 1.3100000000000001 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 1.22 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 1.0900000000000001 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.1200000000000001 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.72999999999999998 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 1.1899999999999999 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.589 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.51000000000000001 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' NE2' ' A' ' 80' ' ' HIS . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 1.1699999999999999 109.519 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.46 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.409 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.59999999999999998 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 1.1799999999999999 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HB2' HD13 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.6899999999999999 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.78000000000000003 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB3' HG21 ' A' ' 14' ' ' VAL . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 1.27 110.135 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.78000000000000003 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.416 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.29 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 71' ' ' GLN . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 1.1899999999999999 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 1.0900000000000001 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 1.4399999999999999 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 2.2200000000000002 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.525 ' NE2' HG22 ' A' ' 67' ' ' VAL . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.5600000000000001 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.72999999999999998 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 1.0700000000000001 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.98999999999999999 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 1.49 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.501 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 2.23 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.702 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 1.3100000000000001 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.514 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 1.3700000000000001 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.514 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.44 59.99 6.31 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.85999999999999999 109.573 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.96 113.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 3.25 109.605 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.629 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -76.51 113.43 14.12 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.707 -0.849 . . . . 1.0800000000000001 108.707 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 164.72 33.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.536 -0.728 . . . . 3.96 110.586 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 -53.84 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.788 -0.57 . . . . 1.8999999999999999 110.584 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.18 -66.91 1.42 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.441 -1.064 . . . . 1.6599999999999999 110.441 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.644 -0.915 . . . . 4.2599999999999998 109.93 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.151 0.5 . . . . 5.2400000000000002 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -150.53 -54.93 0.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.525 -0.546 . . . . 6.0099999999999998 109.525 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.57 -92.66 0.57 Allowed Glycine 0 N--CA 1.501 2.982 0 N-CA-C 108.982 -1.647 . . . . 6.21 108.982 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.03 88.44 0.78 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.665 -1.774 . . . . 7.0099999999999998 108.665 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.91 163.56 25.03 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.569 -0.96 . . . . 4.5999999999999996 109.933 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 5' ' ' THR . . . -68.91 122.97 19.74 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.792 -0.568 . . . . 3.7000000000000002 110.66 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 106.59 6.79 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.99 -1.115 . . . . 3.2000000000000002 107.99 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.17 160.02 14.65 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.667 0.746 . . . . 2.77 111.418 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 m -104.69 -2.15 25.35 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.746 -0.596 . . . . 3.02 109.774 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.27 -57.59 2.22 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.297 -0.877 . . . . 2.1600000000000001 109.854 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.59 63.46 0.27 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.259 -1.136 . . . . 1.1100000000000001 110.259 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.43 132.04 14.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.91 . . . . 1.5900000000000001 109.325 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt -116.76 153.85 31.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.631 -0.668 . . . . 2.8599999999999999 110.25 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 1.55 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 1.3799999999999999 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE1' HG23 ' A' ' 76' ' ' ILE . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.92000000000000004 110.09 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 1.45 108.428 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.712 HG21 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 1.3500000000000001 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -118.74 154.05 33.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.97999999999999998 109.573 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -64.32 135.38 56.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.372 -0.83 . . . . 1.55 109.894 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 85' ' ' ARG . 2.9 m -104.32 -49.9 3.47 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.709 -0.619 . . . . 1.49 110.055 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -52.34 64.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.694 -0.628 . . . . 1.77 110.14 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.79 146.85 34.61 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.624 -0.672 . . . . 2.1400000000000001 110.203 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.99 -16.97 13.97 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.665 2.243 . . . . 1.3799999999999999 109.786 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.243 0.544 . . . . 3.7799999999999998 110.424 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.34 124.74 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 122.136 -0.353 . . . . 2.4199999999999999 110.741 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.74 165.21 30.65 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.917 2.411 . . . . 1.0900000000000001 111.156 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.7 p90 -69.44 158.88 34.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.625 -0.672 . . . . 0.91000000000000003 110.39 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -121.24 135.67 55.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.671 -0.643 . . . . 1.54 109.624 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 1.52 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.6699999999999999 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 1.0700000000000001 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.439 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 1.3600000000000001 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.81999999999999995 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.4399999999999999 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.8999999999999999 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 1.1200000000000001 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.90000000000000002 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.461 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.77000000000000002 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 1.4199999999999999 108.705 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 1.25 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 1.28 108.933 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 1.3300000000000001 109.18 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 3.1299999999999999 109.846 179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD11 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 2.1000000000000001 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 1.2 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 1.1899999999999999 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65000000000000002 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.81999999999999995 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 4.2699999999999996 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 1.29 108.947 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.98999999999999999 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 1.48 110.117 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.3999999999999999 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 1.46 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 1.23 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 1.25 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 1.27 108.99 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 85' ' ' ARG . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 1.26 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 1.3200000000000001 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.76 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.4299999999999999 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 1.46 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.68000000000000005 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 76' ' ' ILE . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 1.25 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.1200000000000001 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.85999999999999999 110.145 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.622 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.27 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.622 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 1.05 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.98999999999999999 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.98999999999999999 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.6799999999999999 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.493 HG21 HD11 ' A' ' 76' ' ' ILE . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 1.46 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.23 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.6599999999999999 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.6600000000000001 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.1299999999999999 110.688 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.92000000000000004 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 1.0900000000000001 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93000000000000005 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 1.3400000000000001 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.54 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 2.1800000000000002 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.712 ' HB2' HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 1.3799999999999999 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 HG21 ' A' ' 60' ' ' ILE . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 1.3100000000000001 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.473 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo -75.85 123.85 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.78000000000000003 110.572 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -89.13 147.15 24.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.766 -0.584 . . . . 1.6599999999999999 109.572 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.83 56.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 2.04 108.84 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 -58.38 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.257 -0.646 . . . . 2.9300000000000002 109.257 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.49 -57.29 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.592 . . . . 2.5600000000000001 109.4 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.34 -115.7 0.93 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.691 -1.364 . . . . 1.6699999999999999 109.691 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.719 -1.134 . . . . 1.8700000000000001 110.282 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttm . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.603 0.716 . . . . 4.6699999999999999 110.342 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.06 174.23 10.85 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.361 -0.607 . . . . 5.3899999999999997 109.361 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.06 -98.24 1.83 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.676 -1.37 . . . . 3.23 109.676 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.98 -126.85 2.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.47 -1.452 . . . . 1.9299999999999999 109.47 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.7 p -114.88 140.41 48.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.919 . . . . 2.0 109.35 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.84 125.75 35.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.891 -0.781 . . . . 1.5700000000000001 108.891 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.32 110.76 20.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 1.55 109.871 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.9 m -99.87 96.0 7.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.053 -0.721 . . . . 1.5 109.053 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.547 -0.721 . . . . 1.4099999999999999 109.78 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.22 143.27 34.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.668 -0.645 . . . . 1.3 109.777 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.49 -77.17 0.38 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.48 -1.448 . . . . 0.81000000000000005 109.48 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 p -88.19 -52.68 5.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.729 -0.865 . . . . 1.1799999999999999 109.458 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -136.99 153.92 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.586 -0.696 . . . . 1.95 109.733 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 1.0900000000000001 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 1.04 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.71999999999999997 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.6499999999999999 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.415 HG23 ' HB2' ' A' ' 86' ' ' LEU . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 1.1599999999999999 109.634 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 26.5 p -116.54 134.38 54.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 1.22 109.527 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HB2' ' CD1' ' A' ' 50' ' ' PHE . 26.9 tp -85.12 117.52 24.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.549 -0.719 . . . . 1.27 109.8 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 t -110.5 -10.94 14.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.695 -0.628 . . . . 1.28 110.435 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -56.53 3.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.159 -0.963 . . . . 1.6599999999999999 109.786 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' HB2' HD22 ' A' ' 20' ' ' LEU . 6.8 m-20 -97.53 152.74 38.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.581 -0.7 . . . . 1.4199999999999999 110.077 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.87 -29.15 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.696 2.264 . . . . 1.25 110.774 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 133.17 48.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.635 -0.666 . . . . 4.1600000000000001 109.956 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER 65.39 106.35 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.98 -0.45 . . . . 1.49 109.821 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.41 -46.8 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.641 2.227 . . . . 0.85999999999999999 110.955 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 47.8 p90 -150.95 163.73 38.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.435 -0.79 . . . . 1.5 110.114 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -145.38 131.08 18.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.651 -0.655 . . . . 2.0099999999999998 109.602 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 1.3 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.71 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 1.03 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 1.1499999999999999 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.54000000000000004 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.70999999999999996 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 1.3799999999999999 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.87 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.58999999999999997 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.461 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.68000000000000005 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 1.25 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 1.1799999999999999 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 1.1699999999999999 109.32 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 1.3700000000000001 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 3.0499999999999998 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 1.26 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 1.0600000000000001 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 1.0600000000000001 110.056 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.0900000000000001 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 20' ' ' LEU . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.69999999999999996 109.27 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.5600000000000001 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.428 ' CG2' HD22 ' A' ' 86' ' ' LEU . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 1.1000000000000001 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.73999999999999999 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 44' ' ' LYS . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 1.24 110.314 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 1.4399999999999999 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 2.02 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 1.0600000000000001 110.18 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 1.0900000000000001 109.369 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 1.1399999999999999 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 1.3300000000000001 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 1.1899999999999999 110.156 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 1.01 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.4099999999999999 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.90000000000000002 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 1.29 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.559 ' HA3' HG13 ' A' ' 92' ' ' VAL . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.67000000000000004 109.93 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 1.1000000000000001 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.8100000000000001 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.62 110.128 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 1.28 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.545 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.3700000000000001 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.54000000000000004 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 1.1299999999999999 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.45000000000000001 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 1.24 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.461 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 1.22 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.78000000000000003 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 1.3 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 3.1600000000000001 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.6000000000000001 110.618 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57999999999999996 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.87 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.0700000000000001 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 1.3200000000000001 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.90000000000000002 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.428 HD22 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 1.4299999999999999 109.997 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.611 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 1.21 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.611 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo -74.34 95.6 0.93 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.69999999999999996 110.672 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 89.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.524 0.678 . . . . 1.8500000000000001 109.718 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 1.2 p-10 -90.78 156.98 17.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.605 -0.685 . . . . 1.26 110.313 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.95 103.94 15.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.821 -0.549 . . . . 3.7999999999999998 109.531 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.559 HG13 ' HA3' ' A' ' 66' ' ' GLY . 8.2 p -144.01 99.18 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.563 -0.71 . . . . 3.5600000000000001 110.382 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.54 -83.14 0.08 OUTLIER Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.458 -1.057 . . . . 2.79 110.458 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.9 m80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 117.452 -1.261 . . . . 5.5300000000000002 109.724 -179.779 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.502 -0.555 . . . . 3.7400000000000002 109.502 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -89.13 127.92 35.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 2.9100000000000001 109.819 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.87 76.15 1.17 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.76 -1.336 . . . . 3.4700000000000002 109.76 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.66 -94.81 0.27 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.176 -1.569 . . . . 3.9199999999999999 109.176 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.461 ' HB ' ' OG1' ' A' ' 8' ' ' THR . 20.4 p -104.34 86.68 2.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.821 . . . . 3.8999999999999999 109.743 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.75 129.93 37.84 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.39 -0.818 . . . . 2.3700000000000001 109.526 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 49.33 72.72 0.28 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.449 -0.945 . . . . 3.1800000000000002 108.449 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.503 HG21 ' N ' ' A' ' 9' ' ' THR . 97.0 m -128.31 149.06 50.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.66 -0.65 . . . . 3.8500000000000001 110.511 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' N ' HG21 ' A' ' 8' ' ' THR . 16.4 m -117.68 139.14 51.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 4.4699999999999998 109.077 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.99 102.65 15.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 2.6200000000000001 110.195 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.39 78.02 2.05 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.619 -1.392 . . . . 1.3700000000000001 109.619 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.9 -62.65 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.688 -0.89 . . . . 1.6599999999999999 109.01 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt -139.13 151.05 46.35 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 2.4100000000000001 109.601 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG21 ' CZ ' ' A' ' 16' ' ' PHE . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 1.21 109.465 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 1.24 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.66000000000000003 110.196 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 3.2200000000000002 108.679 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 1.21 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m -114.04 129.2 56.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 1.1399999999999999 108.73 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.19 109.57 1.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.449 -0.782 . . . . 1.3200000000000001 109.584 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -76.81 -28.03 55.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.616 -0.678 . . . . 1.29 109.752 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.68 -36.08 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.449 -0.782 . . . . 1.4299999999999999 109.712 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 109.65 58.12 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 1.49 109.919 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.12 -25.5 8.61 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.773 2.316 . . . . 0.84999999999999998 110.901 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -48.32 76.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.568 -0.708 . . . . 3.1200000000000001 109.737 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.74 130.33 88.8 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.72 109.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.19 175.6 11.15 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.049 2.499 . . . . 0.70999999999999996 111.283 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -76.32 163.85 26.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.588 -0.695 . . . . 0.81000000000000005 110.396 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt -128.38 133.89 48.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.516 -0.74 . . . . 1.46 109.746 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 1.3100000000000001 109.291 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.6100000000000001 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.4399999999999999 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.88 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.47999999999999998 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66000000000000003 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 1.48 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 1.1299999999999999 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.46999999999999997 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.68999999999999995 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 1.05 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 1.1200000000000001 109.319 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 1.28 109.805 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HA ' ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.9300000000000002 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.49 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 1.1000000000000001 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 1.1200000000000001 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.73999999999999999 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.58999999999999997 110.968 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.71 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 1.28 109.399 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.68999999999999995 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 1.24 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.91000000000000003 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 1.45 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 1.04 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 1.1499999999999999 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 18' ' ' ILE . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 1.28 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.515 HG23 HG21 ' A' ' 87' ' ' ILE . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 1.23 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 62' ' ' ASN . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 1.1699999999999999 109.331 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 61' ' ' THR . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91000000000000003 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68000000000000005 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 1.1499999999999999 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.59999999999999998 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 1.22 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.9399999999999999 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.66000000000000003 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.1499999999999999 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.3 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.5 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.95999999999999996 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.42999999999999999 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.434 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.72 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 76' ' ' ILE . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 1.21 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 1.0600000000000001 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 1.3799999999999999 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.48 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.469 ' NE2' HG21 ' A' ' 67' ' ' VAL . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.51 110.252 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.71999999999999997 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.94999999999999996 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.3200000000000001 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 1.46 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.8700000000000001 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 1.3300000000000001 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 1.22 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo -76.12 121.24 6.05 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.88 110.412 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 130.21 35.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.453 -0.573 . . . . 1.1399999999999999 109.453 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.41 103.35 9.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.868 -0.79 . . . . 1.1599999999999999 108.868 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.04 -68.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.677 -0.639 . . . . 3.1099999999999999 109.293 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.3 t -128.7 117.81 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 5.3099999999999996 109.402 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.45 -72.29 1.31 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.56 -1.416 . . . . 4.2199999999999998 109.56 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.884 . . . . 3.2400000000000002 109.92 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HE3' ' HA ' ' A' ' 6' ' ' ALA . 1.5 ttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.175 0.512 . . . . 5.1600000000000001 109.829 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -89.67 -39.28 13.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.566 -0.709 . . . . 3.4300000000000002 109.724 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' HA3' ' OG ' ' A' ' 32' ' ' SER . . . -175.0 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.955 -1.258 . . . . 2.1499999999999999 109.955 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.64 70.2 0.22 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.049 -1.22 . . . . 2.3500000000000001 110.049 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.487 ' O ' HG21 ' A' ' 5' ' ' THR . 5.2 t -161.21 117.34 2.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.802 -0.822 . . . . 2.6099999999999999 109.227 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.478 ' HA ' ' HE3' ' A' ' 1' ' ' MET . . . -84.55 -55.93 3.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.473 -0.767 . . . . 3.3399999999999999 109.614 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.25 -58.8 0.84 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.313 -0.625 . . . . 3.8599999999999999 109.313 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -109.82 -49.21 3.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.551 -0.718 . . . . 3.9199999999999999 109.403 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -159.68 146.5 16.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.698 . . . . 2.73 109.63 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.42 140.9 49.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.686 -0.634 . . . . 2.6899999999999999 109.379 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.18 47.45 3.12 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.994 -1.242 . . . . 1.76 109.994 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.47 -54.12 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.644 -0.915 . . . . 1.75 109.407 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -138.25 166.51 24.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.5899999999999999 110.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 1.28 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 1.46 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.78000000000000003 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.5899999999999999 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 1.3100000000000001 109.85 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 29.2 m -103.81 131.83 50.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 1.29 109.202 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.35 125.75 26.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.559 -0.713 . . . . 1.5 109.784 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.2 p -83.87 -41.95 16.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.703 -0.623 . . . . 1.3400000000000001 109.768 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -61.98 -36.97 83.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.592 -0.693 . . . . 1.21 109.916 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.8 139.71 97.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.68 -0.638 . . . . 1.03 109.902 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.27 -29.79 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.532 2.155 . . . . 0.93999999999999995 110.486 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -26.12 51.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.572 -0.705 . . . . 3.5600000000000001 109.95 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 62.61 65.25 1.5 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.692 -0.63 . . . . 1.77 109.318 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.65 111.49 3.26 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.046 2.497 . . . . 0.64000000000000001 110.6 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 43.7 p90 -83.06 154.65 24.29 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.713 -0.617 . . . . 1.1100000000000001 110.064 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -134.83 134.46 40.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.712 -0.617 . . . . 1.8 109.53 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 1.28 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 1.4399999999999999 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' OG ' ' HA3' ' A' ' 3' ' ' GLY . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 1.26 109.601 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 1.23 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.65000000000000002 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 1.05 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 1.26 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.515 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.68999999999999995 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 69' ' ' PRO . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 1.28 108.513 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.71999999999999997 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 1.21 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' HG ' HD13 ' A' ' 59' ' ' ILE . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 1.22 109.905 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.96 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 2.3399999999999999 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 1.1399999999999999 109.4 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 1.1399999999999999 109.993 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.4900000000000002 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.3200000000000001 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.63 111.133 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 3.21 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 HG23 HD22 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 1.21 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.75 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 1.3 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 1.28 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.584 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 1.5600000000000001 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 1.0700000000000001 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 1.0900000000000001 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.521 HD13 ' HG ' ' A' ' 43' ' ' LEU . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 1.1799999999999999 109.426 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 1.24 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 1.1200000000000001 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.1899999999999999 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.3599999999999999 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.73999999999999999 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 1.22 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.54000000000000004 110.002 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 1.22 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 1.01 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56000000000000005 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 1.3 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.47 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.63 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.85999999999999999 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67000000000000004 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 2.04 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 1.1899999999999999 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 1.0800000000000001 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 1.4199999999999999 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 3.1499999999999999 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.98999999999999999 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78000000000000003 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 1.1100000000000001 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.3100000000000001 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 59' ' ' ILE . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 1.49 110.199 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 3.0899999999999999 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.525 HD22 HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 1.5700000000000001 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 1.1200000000000001 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo -74.45 108.19 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64000000000000001 110.804 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -83.38 87.26 6.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 1.48 109.627 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -132.19 -50.87 0.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 1.3600000000000001 109.415 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -53.03 3.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.689 -0.632 . . . . 4.0899999999999999 109.424 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -90.5 156.85 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.765 -0.584 . . . . 1.8200000000000001 110.218 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.06 65.2 2.92 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.417 -1.473 . . . . 1.1399999999999999 109.417 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.803 -1.094 . . . . 2.46 109.832 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HG2' ' HA ' ' A' ' 5' ' ' THR . 4.9 mtm . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.658 -0.497 . . . . 4.0499999999999998 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -124.98 124.82 42.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.74 . . . . 5.1399999999999997 109.842 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.25 -98.3 0.5 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.554 -1.418 . . . . 3.9300000000000002 109.554 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.32 -64.64 1.07 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.668 -1.373 . . . . 3.8900000000000001 109.668 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.457 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 10.0 t -152.98 171.92 17.61 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.691 -0.888 . . . . 5.3200000000000003 109.728 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.431 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . -173.89 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.346 -0.846 . . . . 4.9199999999999999 109.651 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.08 -179.91 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.735 -0.603 . . . . 4.54 109.479 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -66.88 150.27 49.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.265 -0.897 . . . . 5.2300000000000004 110.245 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 p -73.06 81.84 1.25 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.789 -0.57 . . . . 4.25 110.094 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.48 -45.15 3.58 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.171 -0.956 . . . . 1.8100000000000001 110.109 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.86 62.17 2.05 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.942 -1.263 . . . . 1.5800000000000001 109.942 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.44 67.74 0.69 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.689 -0.889 . . . . 1.8899999999999999 109.258 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -129.18 157.08 42.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.425 -0.797 . . . . 2.5899999999999999 109.902 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG23 ' HB2' ' A' ' 73' ' ' ALA . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 1.3700000000000001 109.283 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.2 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.79000000000000004 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.4700000000000002 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 1.3200000000000001 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 57.9 m -108.06 123.14 48.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 1.27 109.166 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 23' ' ' ASP . 19.8 tp -66.85 140.22 57.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.542 -0.724 . . . . 1.3400000000000001 110.004 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.9 p -126.81 45.06 2.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.706 -0.621 . . . . 1.4299999999999999 109.9 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.66 -65.18 0.08 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.308 -0.87 . . . . 1.8200000000000001 110.042 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.607 ' HB2' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -84.37 145.77 46.12 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.502 -0.749 . . . . 1.99 109.804 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.07 -25.02 9.16 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.897 2.398 . . . . 0.93999999999999995 111.329 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 118.43 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.417 -0.802 . . . . 2.3900000000000001 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.52 107.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.597 -0.519 . . . . 1.96 109.597 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.49 -46.31 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.551 2.168 . . . . 1.0800000000000001 110.615 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 52.4 p90 -138.97 166.29 24.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.78 109.838 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -146.09 128.48 15.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.582 -0.699 . . . . 1.78 109.518 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 1.51 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.52 109.7 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.5900000000000001 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 1.45 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.22 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.1899999999999999 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 2.04 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.407 HG23 ' HD2' ' A' ' 38' ' ' PRO . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.77 109.296 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.2 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.84999999999999998 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 1.3600000000000001 108.783 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 1.3300000000000001 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 1.3999999999999999 109.309 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 1.3600000000000001 109.709 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.9300000000000002 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 2.1200000000000001 110.225 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 1.3500000000000001 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 1.04 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.3100000000000001 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.97999999999999998 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.73999999999999999 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 3.1099999999999999 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 1.25 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.82999999999999996 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 1.3700000000000001 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.49 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.47 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 1.0700000000000001 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 1.29 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 1.1299999999999999 109.347 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 1.24 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 1.1100000000000001 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.5 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76000000000000001 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 1.3 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.65000000000000002 109.944 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 1.1899999999999999 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.27 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89000000000000001 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.25 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.644 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.3200000000000001 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 1.0600000000000001 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 1.2 109.958 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.92000000000000004 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.29 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.467 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 1.25 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 1.0900000000000001 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 1.4399999999999999 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.5299999999999998 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.81000000000000005 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77000000000000002 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.3400000000000001 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 1.3400000000000001 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 2.0499999999999998 109.478 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.604 ' HB3' HD13 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 1.3400000000000001 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 1.4399999999999999 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo -74.51 90.85 1.0 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.85999999999999999 110.289 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 71.97 128.2 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.243 0.544 . . . . 3.0299999999999998 109.756 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.69 111.17 22.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.582 -0.699 . . . . 1.53 109.744 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -57.93 3.13 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.008 -0.738 . . . . 2.8300000000000001 109.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.04 -23.27 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 3.3100000000000001 109.904 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.71 -153.88 17.1 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.192 -1.563 . . . . 1.8899999999999999 109.192 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.4 t60 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 117.743 -1.122 . . . . 3.25 109.812 179.727 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' HE2' ' HB3' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.472 -0.936 . . . . 5.8200000000000003 108.472 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.29 21.92 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.975 -0.75 . . . . 3.3999999999999999 108.975 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.03 77.92 0.4 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.965 -1.654 . . . . 4.0899999999999999 108.965 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.01 85.26 1.42 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.372 -1.491 . . . . 4.6200000000000001 109.372 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.425 ' HA ' ' N ' ' A' ' 1' ' ' MET . 17.0 p -82.71 133.51 35.15 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.402 -1.058 . . . . 4.9500000000000002 110.219 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.99 85.86 1.69 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 3.2200000000000002 110.098 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.14 -52.36 10.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.652 -0.655 . . . . 3.0600000000000001 109.744 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.1 p -109.46 127.54 54.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.539 -0.726 . . . . 3.25 109.379 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -100.08 160.85 14.0 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.705 0.764 . . . . 4.7199999999999998 111.265 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.26 3.24 23.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.885 -0.509 . . . . 4.3700000000000001 110.261 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.62 -56.66 12.23 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.872 -1.291 . . . . 3.5099999999999998 109.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.5 p -98.66 2.38 47.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.83 -0.806 . . . . 2.21 110.449 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -121.68 159.65 26.12 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -0.883 . . . . 2.4500000000000002 109.898 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 73' ' ' ALA . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 1.3400000000000001 109.88 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 1.3100000000000001 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 14' ' ' VAL . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.79000000000000004 110.013 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.55 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 1.3 110.077 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m -129.08 134.16 47.97 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 1.3500000000000001 109.026 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.71 123.19 18.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.533 -0.729 . . . . 1.3400000000000001 110.043 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.57 ' HB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -106.73 -30.02 9.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.82 -0.55 . . . . 1.27 110.029 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -40.13 75.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.43 -0.794 . . . . 1.3999999999999999 109.861 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -76.18 166.87 41.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.691 -0.631 . . . . 1.2 109.99 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 32.2 Cg_endo -74.81 -29.8 8.19 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.631 2.221 . . . . 1.1799999999999999 110.635 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 167.07 18.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.5 -0.75 . . . . 4.5700000000000003 109.817 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.09 72.57 71.67 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.77 . . . . 1.78 109.895 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.1 119.02 4.9 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.67 2.247 . . . . 0.73999999999999999 110.076 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -87.23 144.29 26.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.524 -0.735 . . . . 1.76 110.056 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt -131.73 111.38 11.61 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.95 109.14 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 1.3500000000000001 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.8300000000000001 109.527 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 1.1299999999999999 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 1.27 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.80000000000000004 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.6200000000000001 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 1.1699999999999999 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.56999999999999995 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.66000000000000003 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 1.1000000000000001 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 1.1699999999999999 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 1.24 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HG ' HD12 ' A' ' 59' ' ' ILE . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 1.3400000000000001 109.453 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.6200000000000001 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 2.1099999999999999 110.15 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 1.1000000000000001 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 1.1200000000000001 109.922 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.9099999999999999 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.1399999999999999 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.423 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.80000000000000004 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.71 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 47' ' ' ALA . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 1.3200000000000001 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.91000000000000003 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 1.3200000000000001 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.2 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.501 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.53 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 1.27 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 1.1399999999999999 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 43' ' ' LEU . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 1.1399999999999999 109.122 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.618 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 1.3 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 1.3100000000000001 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.84999999999999998 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.1800000000000002 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.69999999999999996 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 1.3200000000000001 108.946 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.618 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.52000000000000002 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' CG1' HD13 ' A' ' 76' ' ' ILE . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 1.0700000000000001 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.83999999999999997 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.56999999999999995 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 1.03 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.0800000000000001 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.54000000000000004 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 1.1499999999999999 110.213 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.6799999999999999 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.437 HD13 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 1.29 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.93999999999999995 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 1.48 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.7799999999999998 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 1.04 109.897 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.70999999999999996 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 1.1200000000000001 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 1.54 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.57 ' HD3' ' HB ' ' A' ' 21' ' ' THR . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.5 109.908 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 1.28 109.736 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.607 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 1.23 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -73.99 122.81 7.93 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.70999999999999996 109.688 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 70.55 143.18 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.251 0.548 . . . . 2.8399999999999999 109.587 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.3 112.9 6.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 1.3100000000000001 109.42 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.514 ' HB2' HD12 ' A' ' 87' ' ' ILE . 3.3 mtt180 -125.03 -49.71 1.71 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 4.5 110.607 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 t 70.03 78.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.318 -0.623 . . . . 1.8500000000000001 109.318 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.29 69.56 0.49 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.668 -1.373 . . . . 1.8400000000000001 109.668 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.823 -1.084 . . . . 2.1699999999999999 109.981 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HE1' ' HB2' ' A' ' 32' ' ' SER . 40.5 ttm . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.797 -0.445 . . . . 5.4800000000000004 109.797 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB3' HG21 ' A' ' 5' ' ' THR . 0.1 OUTLIER 57.66 84.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.552 -0.907 . . . . 4.5999999999999996 108.552 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.46 109.48 1.98 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.269 -1.132 . . . . 5.3300000000000001 110.269 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.93 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 6.6500000000000004 110.131 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 2' ' ' SER . 13.3 t -87.15 161.14 18.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.586 -0.949 . . . . 5.25 110.371 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.81 -37.51 35.01 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.647 -0.871 . . . . 4.5499999999999998 108.647 178.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.71 46.53 18.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.436 0.636 . . . . 3.6400000000000001 110.12 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -77.96 111.79 14.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 3.0099999999999998 109.532 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -77.48 -41.14 40.57 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.052 -0.721 . . . . 2.4700000000000002 109.052 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.33 152.11 27.63 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.443 -0.577 . . . . 1.8400000000000001 109.443 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.13 -60.82 4.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.612 -1.395 . . . . 1.3200000000000001 109.612 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.2 p -94.75 120.61 35.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.709 -0.877 . . . . 1.27 109.814 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -141.89 154.57 45.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.579 -0.701 . . . . 2.46 109.782 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.5 HG22 ' CE2' ' A' ' 16' ' ' PHE . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 1.25 109.603 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 1.28 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CE2' HG22 ' A' ' 14' ' ' VAL . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68000000000000005 109.967 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.8700000000000001 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 1.4199999999999999 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 m -126.42 147.21 49.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 1.3799999999999999 108.777 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.27 139.93 55.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.206 -0.934 . . . . 1.8500000000000001 109.67 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 87' ' ' ILE . 21.0 p -84.82 -46.36 11.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.669 -0.644 . . . . 1.3 110.131 -179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -55.0 5.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.557 -0.714 . . . . 1.6399999999999999 109.841 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' A' ' 20' ' ' LEU . 2.4 t70 -78.75 132.71 63.86 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.685 -0.635 . . . . 2.1299999999999999 110.104 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.0 94.85 1.06 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.715 2.277 . . . . 2.1000000000000001 109.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 124.54 47.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.618 -0.676 . . . . 2.5299999999999998 110.355 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -65.86 -55.84 20.57 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.455 -0.572 . . . . 2.21 109.455 179.254 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 35.9 Cg_endo -78.38 165.52 25.34 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 122.519 2.146 . . . . 1.3999999999999999 110.403 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -136.71 161.39 36.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.489 -0.757 . . . . 1.6100000000000001 110.104 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -80.36 119.48 23.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 1.52 109.912 -179.829 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 1.3700000000000001 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 1.27 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 1.1699999999999999 109.057 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 1.4099999999999999 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.68999999999999995 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.54 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 1.1599999999999999 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.52000000000000002 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.69999999999999996 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 1.49 108.547 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 1.1399999999999999 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.518 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 1.2 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 1.24 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.5299999999999998 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 2.0 110.124 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 18' ' ' ILE . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 1.1399999999999999 109.404 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 1.1699999999999999 109.978 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.90000000000000002 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.526 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 1.29 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 3.1099999999999999 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 1.23 109.46 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.411 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.69999999999999996 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 1.25 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.82999999999999996 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 89' ' ' ARG . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 1.3100000000000001 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 1.1200000000000001 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 1.1699999999999999 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 1.01 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 1.3700000000000001 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 65' ' ' VAL . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 1.2 110.22 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.1399999999999999 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HB ' HG22 ' A' ' 61' ' ' THR . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 1.3899999999999999 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.571 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.66000000000000003 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.479 HG11 HD11 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 1.46 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.1200000000000001 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.55000000000000004 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 1.01 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.3700000000000001 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.51000000000000001 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 1.27 110.371 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.41999999999999998 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 1.1399999999999999 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 HD11 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 1.22 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.76000000000000001 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 1.3700000000000001 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 3.2799999999999998 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.4 ' CD2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.4399999999999999 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64000000000000001 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.95999999999999996 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.3100000000000001 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 1.3300000000000001 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 2.2400000000000002 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 1.52 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.487 HG23 HG23 ' A' ' 21' ' ' THR . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 1.27 109.333 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.94 55.59 5.65 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.62 110.712 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 65.47 167.67 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.512 -0.742 . . . . 1.1599999999999999 110.356 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 t70 69.51 152.9 0.1 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.401 0.619 . . . . 1.0800000000000001 110.314 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.2 tpt85 -77.68 101.21 6.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 109.32 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.2 m -138.27 140.29 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.652 -0.655 . . . . 1.52 109.661 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.63 -70.05 1.36 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.558 -1.417 . . . . 1.6200000000000001 109.558 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.0 t60 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.852 -1.07 . . . . 1.6499999999999999 109.757 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.292 0.568 . . . . 7.0 109.765 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -95.85 -44.4 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.689 . . . . 4.2300000000000004 109.459 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' HA2' ' C ' ' A' ' 11' ' ' GLY . . . -108.13 80.45 0.27 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.844 -1.302 . . . . 4.0599999999999996 109.844 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.89 -66.08 0.02 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.847 -1.301 . . . . 4.1699999999999999 109.847 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -100.08 -15.41 18.22 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.685 -0.891 . . . . 4.7300000000000004 110.055 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 7' ' ' ALA . . . -88.67 97.93 11.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.228 -0.92 . . . . 2.6200000000000001 109.373 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' CB ' ' HB1' ' A' ' 10' ' ' ALA . . . 68.8 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.93 -0.767 . . . . 2.5499999999999998 108.93 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.1 p -69.43 -37.63 77.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 2.6600000000000001 111.688 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -105.5 -18.71 14.01 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.078 -1.013 . . . . 2.3999999999999999 111.518 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.566 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . . . -78.82 -58.71 3.1 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.063 . . . . 2.2999999999999998 109.526 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' C ' ' HA2' ' A' ' 3' ' ' GLY . . . 99.16 -117.31 5.83 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.994 -1.243 . . . . 1.45 109.994 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.494 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 48.0 p -77.19 -59.17 2.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.474 -1.015 . . . . 1.52 109.83 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -129.34 164.9 22.56 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.513 -0.742 . . . . 2.02 109.701 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.566 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 1.23 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 1.1299999999999999 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.78000000000000003 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.5600000000000001 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.659 HG23 ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 1.25 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 28' ' ' PHE . 73.6 p -116.4 138.53 51.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 1.3 109.401 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD22 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -68.3 125.58 26.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.316 -0.865 . . . . 1.28 108.903 179.543 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -85.05 -44.28 13.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 1.3999999999999999 110.904 -178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -45.45 66.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.422 -0.799 . . . . 1.6200000000000001 110.752 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.56 112.59 63.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.52 -0.738 . . . . 2.4199999999999999 110.142 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.68 -30.19 4.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.781 2.321 . . . . 1.72 110.599 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -37.15 85.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.517 -0.739 . . . . 3.04 109.913 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.74 132.87 95.35 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.521 -0.737 . . . . 2.04 109.881 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.48 160.59 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.0 2.467 . . . . 1.05 111.606 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CB ' HG23 ' A' ' 19' ' ' THR . 53.3 p90 -70.58 162.83 28.17 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.671 -0.643 . . . . 1.23 110.649 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.0 129.9 47.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.746 -0.596 . . . . 2.1899999999999999 109.684 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 1.3899999999999999 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 1.52 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 1.1399999999999999 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 1.29 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.77000000000000002 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.0800000000000001 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.5600000000000001 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 1.1000000000000001 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.55000000000000004 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.507 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.67000000000000004 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 1.2 108.899 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 1.04 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 1.21 109.299 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 1.3799999999999999 109.736 179.698 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 3.1899999999999999 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 2.1899999999999999 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.79000000000000004 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 1.1699999999999999 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.1299999999999999 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CD1' HD22 ' A' ' 20' ' ' LEU . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76000000000000001 110.791 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 2.1600000000000001 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 1.27 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.26 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 1.3999999999999999 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.51 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.6399999999999999 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 1.1399999999999999 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 1.1299999999999999 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 1.1000000000000001 109.369 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.457 HG21 HG23 ' A' ' 87' ' ' ILE . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 1.22 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.404 HG21 ' CG ' ' A' ' 80' ' ' HIS . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 1.21 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 2.2200000000000002 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91000000000000003 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 1.4299999999999999 108.933 179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.68999999999999995 109.88 -179.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 1.23 109.527 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.74 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.64000000000000001 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.89000000000000001 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.616 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 1.2 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.68000000000000005 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB2' HG23 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.72999999999999998 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.82999999999999996 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.1200000000000001 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.507 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 1.24 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 1.0700000000000001 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.78 109.982 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 2.1800000000000002 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.404 ' CG ' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.1799999999999999 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.81000000000000005 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 16' ' ' PHE . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 1.26 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.97 109.475 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 1.53 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.457 HG23 HG21 ' A' ' 60' ' ' ILE . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 1.22 108.814 179.293 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.13 102.18 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 1.05 110.554 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 101.37 3.93 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.229 -0.656 . . . . 2.7999999999999998 109.229 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -166.57 155.95 11.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.597 -0.689 . . . . 1.9399999999999999 109.71 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -46.23 72.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 3.1800000000000002 110.271 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 92' ' ' VAL . 7.6 p -100.31 130.39 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.474 -0.766 . . . . 2.77 110.251 -179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.23 51.06 14.52 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.996 -1.242 . . . . 3.1800000000000002 109.996 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 117.7 -1.143 . . . . 3.1200000000000001 110.389 179.856 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.919 0.866 . . . . 5.8099999999999996 110.561 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.89 171.76 19.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.332 -0.618 . . . . 6.3099999999999996 109.332 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.88 -34.44 10.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.845 -1.302 . . . . 4.8200000000000003 109.845 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.06 -68.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.892 -1.147 . . . . 3.6699999999999999 110.604 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 m -129.21 117.2 20.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.914 . . . . 3.9300000000000002 110.447 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.07 138.84 31.69 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.81 -0.811 . . . . 3.1899999999999999 108.81 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.4 -38.81 5.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.472 -0.768 . . . . 5.1500000000000004 111.399 -178.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.2 p -59.47 111.5 1.42 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.314 -0.866 . . . . 4.2699999999999996 108.823 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 m -121.43 132.44 54.74 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.563 -0.855 . . . . 3.7200000000000002 111.388 -178.213 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.81 -30.01 6.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.424 -0.954 . . . . 2.4700000000000002 108.424 178.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.75 -130.02 5.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.664 -1.774 . . . . 1.55 108.664 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.95 112.37 17.13 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.384 -0.969 . . . . 1.75 108.384 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt -121.94 156.12 34.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.387 -0.821 . . . . 2.5899999999999999 110.816 -178.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 1.1100000000000001 108.961 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 1.21 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.81000000000000005 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.8999999999999999 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 1.28 109.889 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m -116.15 122.4 44.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 1.3100000000000001 109.285 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.588 HD21 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -67.03 137.43 56.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.632 . . . . 1.1299999999999999 109.549 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -64.61 -51.71 61.24 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.555 -0.716 . . . . 1.1699999999999999 109.803 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -21.98 33.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.732 -0.605 . . . . 1.55 110.14 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 17.2 m-20 60.13 67.58 1.64 Allowed Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.687 -0.633 . . . . 0.79000000000000004 109.547 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' A' ' 23' ' ' ASP . 36.1 Cg_endo -78.46 87.85 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.964 2.443 . . . . 0.82999999999999996 110.053 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 77.61 -34.76 0.2 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.019 -0.426 . . . . 3.8500000000000001 110.76 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.22 133.57 22.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 2.02 109.898 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.73 -59.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.743 2.295 . . . . 0.64000000000000001 110.753 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -143.89 161.66 38.12 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -0.767 . . . . 1.23 110.347 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 128.4 36.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.653 -0.654 . . . . 2.2000000000000002 109.695 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 1.25 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 1.48 109.859 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 1.0700000000000001 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 1.22 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.55000000000000004 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91000000000000003 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 1.3500000000000001 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 1.1499999999999999 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.5 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.56000000000000005 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.524 HG22 ' HB2' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 1.6200000000000001 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 1.1100000000000001 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 1.1799999999999999 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 1.25 109.828 179.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.9900000000000002 110.108 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.21 109.926 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 1.25 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 1.1799999999999999 110.092 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76000000000000001 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.71999999999999997 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.505 ' CG ' HD22 ' A' ' 20' ' ' LEU . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.76000000000000001 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.8399999999999999 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 1.21 109.41 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.81000000000000005 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 44' ' ' LYS . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 1.3500000000000001 109.96 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.82999999999999996 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 1.3899999999999999 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 1.1399999999999999 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 1.1000000000000001 109.266 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 43' ' ' LEU . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 1.21 109.8 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.468 HG21 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 1.21 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 65' ' ' VAL . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 1.1200000000000001 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.5800000000000001 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.70999999999999996 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.589 ' HB ' HG23 ' A' ' 61' ' ' THR . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 1.27 108.92 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA2' HG21 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.40000000000000002 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.486 ' CG1' HD11 ' A' ' 76' ' ' ILE . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 1.05 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.59999999999999998 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.524 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.62 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 1.1899999999999999 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD12 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.1399999999999999 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.57999999999999996 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 1.02 110.336 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.52000000000000002 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.53 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.533 HG22 HD11 ' A' ' 76' ' ' ILE . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 1.0800000000000001 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 1.0600000000000001 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 1.47 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.73 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.447 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68000000000000005 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65000000000000002 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.98999999999999999 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 1.3500000000000001 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.6599999999999999 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.588 ' HB3' HD21 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 1.29 109.695 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 1.21 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.7 100.95 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.67000000000000004 110.431 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.4 141.34 0.05 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.465 0.65 . . . . 1.3500000000000001 110.582 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.31 -37.84 21.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.726 -0.609 . . . . 0.58999999999999997 109.413 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 60.36 55.41 3.54 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.569 0.7 . . . . 5.1500000000000004 110.081 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.3 m -130.4 42.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.085 -0.709 . . . . 1.4399999999999999 109.085 179.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.59 60.2 0.7 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.561 -1.416 . . . . 1.3 109.561 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.69 -0.888 . . . . 2.0 109.702 -179.892 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.983 -0.377 . . . . 4.1500000000000004 109.983 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 p -96.59 -48.32 5.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.675 . . . . 3.2999999999999998 109.738 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.9 104.22 0.77 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.619 -1.392 . . . . 3.2000000000000002 109.619 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.55 -75.45 0.42 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.798 -1.321 . . . . 3.5499999999999998 109.798 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -106.39 132.07 52.85 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.581 -0.953 . . . . 5.2000000000000002 109.347 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.03 48.33 23.27 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.455 0.645 . . . . 3.3300000000000001 109.594 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.43 128.11 34.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.48 -0.762 . . . . 1.8999999999999999 110.27 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.23 137.93 31.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.655 -0.653 . . . . 2.27 109.24 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.487 HG21 ' CG1' ' A' ' 14' ' ' VAL . 82.6 m -65.11 104.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.117 -0.698 . . . . 1.98 109.117 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.73 122.55 36.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 2.21 109.64 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.12 -114.92 2.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.07 -1.212 . . . . 1.46 110.07 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.85 -48.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.924 . . . . 1.9099999999999999 110.326 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt -114.29 166.22 11.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.422 -0.799 . . . . 2.3700000000000001 110.086 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.522 HG22 ' CE2' ' A' ' 16' ' ' PHE . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 1.1499999999999999 109.787 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 1.1799999999999999 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' HG22 ' A' ' 14' ' ' VAL . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.71999999999999997 110.167 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.9199999999999999 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.616 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 1.25 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -116.8 151.5 36.36 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 1.6699999999999999 109.256 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.1 tp -70.73 133.48 46.63 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.334 -0.854 . . . . 1.4399999999999999 109.947 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 p -90.37 -23.69 21.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.815 -0.553 . . . . 1.25 110.097 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -51.1 67.66 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 1.8100000000000001 110.069 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -138.93 152.54 70.47 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 1.4199999999999999 110.317 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.25 -6.55 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 123.018 2.479 . . . . 1.3 111.298 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -58.84 -58.81 6.96 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.357 -0.839 . . . . 3.96 109.692 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -65.58 123.8 85.56 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.606 -0.684 . . . . 1.8200000000000001 109.473 179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.49 -173.85 1.89 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.71 2.274 . . . . 1.03 111.495 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.74 160.31 31.91 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.514 0.673 . . . . 0.81999999999999995 110.293 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 122.24 37.93 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.5600000000000001 108.84 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 1.3 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 1.45 109.318 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 1.3799999999999999 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 1.3 109.412 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.68999999999999995 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 1.03 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.89000000000000001 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.54000000000000004 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.66000000000000003 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.69999999999999996 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.94999999999999996 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 1.23 109.359 179.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 1.23 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 3.0699999999999998 109.921 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.8500000000000001 109.53 179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 1.0 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 1.1299999999999999 109.626 179.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.73999999999999999 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.68999999999999995 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.68999999999999995 110.785 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 2.0600000000000001 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 1.24 109.521 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.67000000000000004 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 1.1799999999999999 110.161 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 1.29 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 HG21 ' HG2' ' A' ' 91' ' ' ARG . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 1.3 109.555 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.3999999999999999 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 1.1599999999999999 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 1.1699999999999999 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 1.27 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 80' ' ' HIS . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 1.3100000000000001 109.897 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89000000000000001 109.817 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.3600000000000001 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.71999999999999997 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' A' ' 61' ' ' THR . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 1.3799999999999999 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.57999999999999996 110.019 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' CD2' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 1.22 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.471 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.3700000000000001 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.64000000000000001 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 1.24 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.6100000000000001 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.57999999999999996 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.93999999999999995 110.326 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52000000000000002 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 2.0800000000000001 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 71' ' ' GLN . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 1.1899999999999999 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 1.3200000000000001 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 1.4299999999999999 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.9900000000000002 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.61 ' HB3' HG21 ' A' ' 61' ' ' THR . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.85999999999999999 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.68000000000000005 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 1.0600000000000001 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 1.45 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 2.29 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.616 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 1.3300000000000001 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.524 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 1.3200000000000001 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.96 123.84 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.97999999999999998 110.746 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 156.31 24.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.748 -0.595 . . . . 2.0800000000000001 110.199 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.97 148.97 48.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.554 . . . . 1.4299999999999999 110.24 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' HG2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -91.2 111.38 22.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.721 . . . . 3.5 109.167 179.555 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 m -131.62 -50.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.722 -0.612 . . . . 2.6000000000000001 109.424 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -155.83 59.06 0.37 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.904 -1.278 . . . . 2.0099999999999998 109.904 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 117.873 -1.06 . . . . 3.3700000000000001 109.81 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.391 0.615 . . . . 1.77 110.426 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 0.93 109.654 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.07 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.8 110.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 82' ' ' SER . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 2.69 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 0.71 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 178.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.42 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.08 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.2 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.05 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 0.98 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.16 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.42 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.48 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 0.97 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.79 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.66 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.03 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 0.75 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 0.67 109.315 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.62 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.38 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 31' ' ' LEU . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.4 109.921 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 0.73 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 0.79 109.783 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.599 ' CD2' HD13 ' A' ' 86' ' ' LEU . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.98 110.856 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.0 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 0.95 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.82 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 0.7 110.153 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.76 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 0.96 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 0.81 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 0.54 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 0.56 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 0.66 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.525 HG21 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 0.54 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.01 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 0.68 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.61 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 76' ' ' ILE . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 0.59 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.3 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 0.94 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 1.8 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 0.94 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 0.84 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.9 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 1.7 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.462 HG21 ' CE1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 0.69 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 0.95 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.12 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 1.61 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.19 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.8 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.03 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.63 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 18' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 0.66 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.59 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.97 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 0.74 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.12 110.849 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 2.6 109.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.96 109.959 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.02 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.75 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 2.61 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 86' ' ' LEU . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 0.67 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 0.96 109.131 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 0.95 109.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.07 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.23 109.536 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.15 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 0.94 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.08 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.19 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 0.97 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.88 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' CE1' HG21 ' A' ' 76' ' ' ILE . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.6 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 0.78 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 0.63 109.313 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 59' ' ' ILE . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 0.67 109.674 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.15 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 1.93 109.721 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.42 109.522 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 0.51 109.747 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.19 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.82 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 86' ' ' LEU . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 0.77 110.71 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 3.7 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG21 HD21 ' A' ' 86' ' ' LEU . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 0.83 109.018 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.07 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.21 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 1.58 110.321 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.616 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 1.52 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 0.8 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 0.68 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.48 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.527 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 0.72 110.046 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 84' ' ' LEU . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.62 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 1.61 111.207 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.95 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.7 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 0.63 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.47 110.069 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 76' ' ' ILE . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.41 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.97 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.7 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 0.89 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.67 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.83 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 0.75 110.38 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.85 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.62 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG21 ' CE1' ' A' ' 39' ' ' PHE . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 0.66 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.18 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.07 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 2.65 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' HG22 ' A' ' 67' ' ' VAL . 14.8 m80 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.85 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.05 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 61' ' ' THR . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 0.62 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.02 109.681 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.93 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 0.91 109.751 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.09 109.451 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 1.67 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 0.5 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 0.58 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.58 109.964 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 1.98 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 0.64 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.43 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.611 -0.514 . . . . 1.1 109.611 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.62 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.68 109.363 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 0.89 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.575 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 0.68 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.62 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.1 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 0.73 109.422 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.73 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.55 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 69' ' ' PRO . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 0.61 108.74 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.45 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 0.56 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.62 109.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 1.88 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' A' ' 31' ' ' LEU . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 0.94 110.118 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 0.45 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 0.49 110.214 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.96 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.58 110.764 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 2.65 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 0.61 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.58 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 0.63 110.077 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 0.65 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 0.59 109.793 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.47 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 0.5 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.52 109.096 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 85' ' ' ARG . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 0.6 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 0.54 109.699 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.0 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.9 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.69 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 0.67 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.56 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 0.54 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.95 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.56 110.316 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.06 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.649 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.73 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.53 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 0.49 110.003 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.47 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.25 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG11 ' A' ' 67' ' ' VAL . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 0.45 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.72 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 0.82 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 1.9 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.463 ' CE1' HG22 ' A' ' 67' ' ' VAL . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.68 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.58 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 0.66 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.603 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 1.95 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.07 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 0.79 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.7 110.48 179.645 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 1.51 109.805 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 0.72 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 0.71 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.7 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 2.88 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 0.58 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 179.45 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.617 -0.512 . . . . 1.26 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 0.84 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.05 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.13 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.6 109.646 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.57 110.734 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.86 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 0.86 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 0.65 109.433 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.66 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.73 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 0.89 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 0.62 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 0.58 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.563 HD12 HD12 ' A' ' 59' ' ' ILE . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.02 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.36 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.48 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 0.51 109.634 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.61 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 2.55 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 47' ' ' ALA . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 0.76 109.28 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.68 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 0.8 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 0.68 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 0.85 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 0.94 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 0.5 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.563 HD12 HD12 ' A' ' 43' ' ' LEU . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.56 109.523 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 0.58 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 62' ' ' ASN . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.62 109.861 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 61' ' ' THR . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.33 110.802 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.16 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.82 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 0.77 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.49 109.803 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.846 HG11 ' CE1' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 0.65 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.27 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 40' ' ' THR . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.73 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 0.82 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.6 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.7 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 0.53 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.67 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.05 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 0.6 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.88 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 0.99 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.47 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.846 ' CE1' HG11 ' A' ' 67' ' ' VAL . 4.4 m80 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.8 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 0.83 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.17 109.248 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 0.91 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.601 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.49 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.96 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.81 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo . . . . . 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.93 110.202 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.409 0.624 . . . . 2.76 110.224 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 0.54 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 0.77 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.63 109.703 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.01 108.933 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 0.54 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 179.706 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.155 0.502 . . . . 1.23 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 17' ' ' LYS . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 0.78 108.758 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.2 110.111 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 0.7 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 0.6 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.74 110.881 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.74 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.68 109.48 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.53 111.173 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.52 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.6 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 0.43 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.49 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 59' ' ' ILE . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 0.69 109.63 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.31 109.998 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.28 109.631 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 0.49 109.622 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 0.43 109.803 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.71 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.69 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 2.82 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG23 ' HB1' ' A' ' 47' ' ' ALA . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 0.7 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.74 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 0.78 110.018 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 0.93 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 0.93 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 0.63 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.39 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 43' ' ' LEU . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 0.46 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.708 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 0.59 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 0.56 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.45 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.05 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.74 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 0.68 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.708 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.52 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.483 HG22 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 0.55 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.84 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.55 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 0.67 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.556 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.4 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.47 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 0.57 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.53 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 0.91 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 0.52 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 0.82 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.9 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 3.53 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.72 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.58 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 0.68 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 0.83 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 1.61 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.628 HD12 HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.0 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 60' ' ' ILE . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 0.6 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo . . . . . 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.65 110.519 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.327 -0.619 . . . . 1.7 109.327 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 0.75 109.758 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 0.61 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.452 ' HB3' HD12 ' A' ' 84' ' ' LEU . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 0.93 109.832 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.45 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 0.56 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 0.68 108.782 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' CB ' ' A' ' 49' ' ' GLU . 2.5 tmtt? . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.259 0.552 . . . . 0.99 110.427 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 0.73 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 0.82 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 0.63 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 0.68 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.9 110.846 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.14 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 0.81 109.706 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.7 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.61 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 0.71 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.64 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 0.62 109.11 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 0.61 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 2.74 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 31' ' ' LEU . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 1.67 110.22 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.47 109.277 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 0.42 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.61 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.04 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 47' ' ' ALA . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 0.65 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.7 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 0.83 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.77 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 0.68 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.14 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 0.58 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 0.54 109.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.648 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 0.81 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.79 110.06 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.18 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.17 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.11 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.06 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.648 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.85 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.677 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 0.71 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.05 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 0.88 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HB2' HD11 ' A' ' 76' ' ' ILE . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.21 109.715 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.89 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 0.75 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.85 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.49 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 71' ' ' GLN . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 0.78 109.647 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 0.95 110.072 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.08 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 1.91 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.95 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.8 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 0.62 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 16' ' ' PHE . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 0.84 109.731 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.27 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 0.69 109.995 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 0.85 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.76 111.034 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mttm . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.098 0.475 . . . . 2.22 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 0.73 109.368 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 0.83 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.7 109.898 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.18 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 0.68 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 0.67 109.109 179.732 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.494 -0.558 . . . . 1.13 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 0.89 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.19 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 0.95 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 0.9 109.837 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 0.93 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.16 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.18 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 0.8 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.76 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 76' ' ' ILE . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.61 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 0.65 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 0.64 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 33' ' ' VAL . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 0.65 109.492 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 58' ' ' ALA . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 0.73 109.819 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 1.53 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.38 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 0.51 110.196 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.58 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.99 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.84 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.73 109.52 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.3 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 0.75 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.75 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 0.91 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 0.87 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 0.83 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.02 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 0.58 109.523 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 43' ' ' LEU . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.55 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.756 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 0.65 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 0.56 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.03 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.94 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 0.82 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.756 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.62 109.966 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 76' ' ' ILE . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 0.67 109.362 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.32 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.7 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 0.92 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.36 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.76 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 0.71 110.226 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.73 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.18 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 67' ' ' VAL . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 0.56 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.97 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 0.96 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.24 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.02 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 0.81 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.9 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 0.86 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 2.56 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 52' ' ' VAL . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.11 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.684 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo . . . . . 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.11 110.078 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.33 0.586 . . . . 2.04 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 0.88 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 0.86 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.77 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 1.91 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.65 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 0.64 108.749 179.108 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.3 mptt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.369 -0.604 . . . . 1.21 109.369 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.8 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.06 109.79 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 0.93 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.0 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.04 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.02 110.205 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.17 110.469 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.08 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.07 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.79 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 0.96 108.606 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 0.81 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 33' ' ' VAL . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 0.74 109.165 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 59' ' ' ILE . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 0.68 109.574 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.15 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.42 110.215 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.52 109.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 0.52 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.98 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.73 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 2.66 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 0.84 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.78 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 0.8 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 0.9 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.09 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.04 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 0.75 109.232 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 43' ' ' LEU . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 0.68 109.391 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.667 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 0.87 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.81 110.065 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.02 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.06 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.01 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.85 109.701 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG11 HD12 ' A' ' 76' ' ' ILE . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 0.78 109.446 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.16 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.96 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.16 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.57 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.15 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 0.89 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.9 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.67 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 HG11 ' A' ' 67' ' ' VAL . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.85 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.86 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.08 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 1.78 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' NE2' HG22 ' A' ' 67' ' ' VAL . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.29 110.138 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.85 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.67 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.9 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 0.73 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 2.97 109.92 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 0.91 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 0.88 109.068 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo . . . . . 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.84 110.655 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.301 0.572 . . . . 2.02 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 0.53 109.176 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 0.73 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.67 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.4 108.889 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 0.61 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 0.73 108.987 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 109.541 -0.54 . . . . 2.24 109.541 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 0.91 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 0.91 108.999 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.0 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 42' ' ' VAL . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 0.56 109.511 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.45 110.759 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.02 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 0.6 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.43 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.51 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 0.81 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 0.51 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 33' ' ' VAL . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 0.46 109.229 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 0.7 109.665 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 2.86 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.31 110.25 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 0.5 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 0.57 109.882 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.35 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.97 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' HD2' HD13 ' A' ' 86' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.68 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 2.92 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 0.75 109.041 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.9 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 0.78 109.713 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 0.98 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.05 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 0.79 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 0.57 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 0.47 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.7 109.388 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.56 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.18 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.14 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.77 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 0.72 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.54 109.812 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 80' ' ' HIS . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 0.44 109.385 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 0.9 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 40' ' ' THR . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.62 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.64 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.28 110.103 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.39 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 0.38 110.355 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.41 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 0.95 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 HG11 ' A' ' 67' ' ' VAL . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.5 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.58 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 0.54 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 1.72 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.68 110.06 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.61 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 0.95 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.22 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.603 HD12 HG21 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 0.81 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 0.75 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.06 110.12 179.124 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.274 0.559 . . . . 1.32 109.762 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 0.78 109.388 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 0.97 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.7 109.866 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.12 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.6 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.63 109.219 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.18 109.057 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.68 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.06 109.506 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 0.87 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 0.67 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.77 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.36 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 0.71 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.69 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.588 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.59 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.17 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.52 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 0.53 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 0.6 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 3.67 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 1.67 110.233 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 0.51 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 0.46 109.908 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.71 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 0.79 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.26 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG21 HD21 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 0.74 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.78 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 0.69 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 0.93 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 0.89 109.549 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 0.69 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 0.49 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 0.46 109.212 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.664 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 0.62 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 0.69 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 0.99 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 0.95 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.61 109.865 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 0.66 109.522 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.22 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.2 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.84 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 0.65 110.373 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.76 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 1.62 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.482 HG21 ' CE1' ' A' ' 39' ' ' PHE . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 0.68 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.94 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 0.96 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.12 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.01 110.451 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.8 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 0.95 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.91 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 0.95 109.822 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 1.97 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 0.78 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 0.7 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.88 110.884 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.637 . . . . 1.15 110.438 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 0.5 109.343 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.61 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.46 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.41 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.504 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 0.57 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 85' ' ' ARG . 13.6 t . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.409 -0.589 . . . . 1.18 109.409 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 0.63 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.14 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 0.94 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 0.67 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.77 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.8 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 0.76 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 0.7 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 0.97 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.61 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 0.76 108.704 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 0.67 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 0.58 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 0.64 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 3.95 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 1.66 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 0.55 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 0.56 109.55 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.97 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 0.91 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.18 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 0.8 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 0.9 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 0.74 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 0.94 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 1.47 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.57 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 0.44 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.44 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 0.59 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 0.56 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.22 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.36 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.85 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 0.82 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.6 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 0.53 109.571 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.72 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.601 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.59 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 0.89 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.15 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.72 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 0.5 110.145 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.47 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.59 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 39' ' ' PHE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 0.56 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.71 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.83 110.107 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.02 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.34 110.014 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.54 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 0.69 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.39 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 0.83 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' HG22 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.38 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.8 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 0.66 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.68 110.32 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 79.8 mttt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 1.97 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 0.76 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.62 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.75 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 1.63 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 0.86 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 0.58 108.553 179.531 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.252 0.549 . . . . 1.31 110.139 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 0.66 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.99 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.55 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 42' ' ' VAL . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 0.81 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.82 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.14 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.4 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 0.75 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.79 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.56 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 0.56 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 33' ' ' VAL . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 0.57 109.281 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 0.64 109.659 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 1.57 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 1.93 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.38 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 0.52 109.976 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.89 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.7 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.21 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 0.79 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.76 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 0.57 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.76 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 0.95 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 0.88 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.45 109.671 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.45 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.79 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.79 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.06 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 0.97 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 0.94 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.56 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 76' ' ' ILE . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 0.53 109.32 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.72 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.62 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 0.9 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 0.98 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.72 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 0.66 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.78 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 0.92 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 67' ' ' VAL . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 0.65 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 0.92 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.09 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 1.53 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.407 ' NE2' HG22 ' A' ' 67' ' ' VAL . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.39 110.101 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.84 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 0.95 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.63 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 0.98 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.49 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.95 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.621 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 0.69 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.621 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.82 110.321 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 19.6 mttt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.193 0.52 . . . . 1.44 109.756 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 0.6 109.391 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' OG ' ' A' ' 32' ' ' SER . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.81 109.943 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.68 109.978 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.16 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 0.66 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 0.71 109.582 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.23 0.538 . . . . 0.93 109.995 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 0.71 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 0.92 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.46 ' OG ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.05 109.316 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.81 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.89 110.731 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 0.92 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 0.8 109.09 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.79 111.418 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.58 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.06 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 0.66 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 0.62 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD12 HD12 ' A' ' 59' ' ' ILE . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.69 109.783 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.36 109.667 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.22 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 0.53 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 0.63 109.833 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.72 111.068 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 1.55 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 0.77 109.488 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 0.92 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 0.93 110.294 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.12 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.31 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 0.71 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 0.64 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 HD12 ' A' ' 43' ' ' LEU . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 0.52 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.644 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 0.79 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 0.72 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.07 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.17 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.89 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 0.83 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.644 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.65 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG11 HD12 ' A' ' 76' ' ' ILE . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 0.59 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.0 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.687 ' O ' HG23 ' A' ' 40' ' ' THR . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 0.86 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' HD11 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.36 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.72 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 0.59 110.216 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.6 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.575 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 1.63 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG11 ' A' ' 67' ' ' VAL . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 0.56 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.69 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 0.85 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.06 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.04 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.71 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 0.71 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 0.84 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 1.76 109.983 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 0.65 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.512 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 0.84 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo . . . . . 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.68 110.152 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.132 0.491 . . . . 1.35 109.909 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 0.71 109.303 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.09 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.66 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.4 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 0.61 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 0.57 108.982 179.342 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.627 -0.509 . . . . 1.03 109.627 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 0.74 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 0.98 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.3 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.65 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.83 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.92 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.96 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 0.68 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.55 111.418 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.54 109.705 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 0.52 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 0.61 109.293 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 59' ' ' ILE . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 0.58 109.559 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 2.85 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.545 ' CB ' HD21 ' A' ' 31' ' ' LEU . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.57 110.092 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 0.54 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 0.57 109.97 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.06 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 86' ' ' LEU . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.77 111.27 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.46 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 0.67 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.65 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 0.59 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 0.71 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 0.82 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.59 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 0.46 109.291 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 43' ' ' LEU . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 0.43 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.609 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 0.71 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.63 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 0.96 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.12 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.7 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 0.62 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.45 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 0.52 109.519 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.22 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.53 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 0.92 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.56 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.69 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 0.64 110.135 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.71 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.11 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.447 HG21 ' CE1' ' A' ' 39' ' ' PHE . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 0.54 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 0.87 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 0.86 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 1.66 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.32 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.66 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 0.71 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.99 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 0.91 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 1.82 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.636 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 0.72 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.548 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 0.77 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.78 109.573 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.418 0.628 . . . . 2.35 110.25 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 0.85 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 0.84 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.79 110.09 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 0.86 108.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.71 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.5 109.573 179.643 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.624 -0.51 . . . . 0.98 109.624 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 0.86 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.1 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 0.7 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 HG22 ' A' ' 42' ' ' VAL . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 0.75 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.79 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.44 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.54 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 0.77 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.83 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.69 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 0.87 108.705 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.68 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 33' ' ' VAL . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 0.75 109.18 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 2.68 109.846 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.525 ' HB3' HD21 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 1.58 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 0.48 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 0.55 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.6 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 3.62 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 86' ' ' LEU . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 0.71 108.947 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.89 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 0.87 110.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.17 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 0.87 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.94 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 0.57 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 43' ' ' LEU . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 0.55 108.99 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 0.66 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.69 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.52 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.43 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 0.89 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.63 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 80' ' ' HIS . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 0.66 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.12 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.86 110.145 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.11 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.98 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.8 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.92 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.56 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 67' ' ' VAL . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.78 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.03 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.17 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.27 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 67' ' ' VAL . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.07 110.688 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.86 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 0.8 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 0.84 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 1.71 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 0.82 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 0.77 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.68 110.572 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.284 0.564 . . . . 1.52 109.733 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 0.36 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 0.47 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.53 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.02 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 0.49 109.634 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 0.58 109.527 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.196 0.522 . . . . 1.52 109.602 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 0.71 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.16 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 0.56 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 0.57 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.47 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.71 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 0.94 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.51 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.52 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.52 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.59 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 0.45 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.571 HG22 HG21 ' A' ' 33' ' ' VAL . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 0.48 109.32 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 57' ' ' SER . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 0.67 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' THR . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 2.59 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 0.98 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 0.38 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 0.37 110.056 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.09 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.55 109.27 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.12 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 0.61 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.62 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 0.64 110.314 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 0.78 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 1.34 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 0.84 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 0.39 109.369 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.43 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 0.64 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 80' ' ' HIS . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 0.58 110.156 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 0.89 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.41 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.9 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 0.75 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.58 109.93 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 0.55 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.33 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.58 110.128 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 0.97 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.14 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.48 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 0.44 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.4 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 0.98 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.463 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 0.51 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.59 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 0.67 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 2.57 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 61' ' ' THR . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.36 110.618 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.5 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.01 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 0.65 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.77 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.75 109.997 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.631 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.61 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo . . . . . 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.61 110.672 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 1.82 109.601 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 0.46 109.465 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 0.61 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.54 110.196 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 2.75 108.679 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 0.56 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 0.47 108.73 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.083 0.468 . . . . 0.81 109.746 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG22 ' HG3' ' A' ' 17' ' ' LYS . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 0.61 109.291 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.08 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.0 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 42' ' ' VAL . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.52 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.41 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.97 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.5 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.41 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.54 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.57 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 0.42 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 33' ' ' VAL . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 0.41 109.319 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD12 HD12 ' A' ' 59' ' ' ILE . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 0.6 109.805 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.51 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.2 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 0.46 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 0.44 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.74 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.52 110.968 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.23 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 86' ' ' LEU . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 0.57 109.399 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.63 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 0.67 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.81 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 0.85 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 0.63 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 0.49 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.432 HD12 HD12 ' A' ' 43' ' ' LEU . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.45 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 0.6 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 0.51 109.331 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 0.66 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.54 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 76' ' ' ILE . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 0.54 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.39 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.59 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.03 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.06 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.43 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.38 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.43 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.33 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 67' ' ' VAL . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 0.49 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 0.8 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 0.73 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.06 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.29 110.252 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.6 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.61 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.32 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 0.95 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.45 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 0.71 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 0.71 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.77 110.412 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.0 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 0.69 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 0.78 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.64 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.11 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 0.65 109.85 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 0.69 109.202 179.56 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.53 -0.545 . . . . 1.17 109.53 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 0.76 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 0.83 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 0.94 109.601 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 0.58 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.6 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 0.65 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 0.58 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.53 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.56 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 0.63 108.513 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.51 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 0.52 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 0.53 109.905 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.49 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.88 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.49 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 0.41 109.993 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.49 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.32 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 86' ' ' LEU . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.53 111.133 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 2.68 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.069 HG21 HD21 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 0.59 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.6 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.64 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 0.6 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.68 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 0.8 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 0.73 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 0.35 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 0.54 109.426 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 66' ' ' GLY . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.62 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 0.57 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.0 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.36 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.74 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 0.65 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.45 110.002 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 0.53 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 0.87 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 0.98 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.23 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.58 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.59 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 1.61 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.431 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 0.61 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.9 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 0.94 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 2.56 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.85 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 0.89 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.31 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.88 110.199 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 2.46 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.069 HD21 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.9 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 0.54 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo . . . . . 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64 110.804 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.192 0.52 . . . . 2.09 109.902 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 0.87 109.283 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.01 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.69 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.02 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.61 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.425 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 57.9 m . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 0.85 109.166 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.518 -0.549 . . . . 1.25 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 0.89 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.0 109.7 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.25 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.98 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.15 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.19 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 1.66 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.17 109.296 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.11 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.465 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.8 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 69' ' ' PRO . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.94 108.783 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 33' ' ' VAL . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 0.8 109.309 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 59' ' ' ILE . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 0.73 109.709 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.47 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 1.64 110.225 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 0.62 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 0.5 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.31 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.98 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.56 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 2.66 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 0.54 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.75 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 0.8 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.01 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.02 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 0.75 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 0.62 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 43' ' ' LEU . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 0.44 109.347 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.739 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 0.59 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 0.58 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.34 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 0.72 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.56 109.944 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 0.51 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.07 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.02 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.22 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 0.97 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 0.84 109.958 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.83 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.11 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.465 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 0.58 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 0.9 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 0.86 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.07 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.73 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.04 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 0.75 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 19' ' ' THR . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 1.72 109.478 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 0.67 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.42 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 0.91 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.8 110.289 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.384 0.611 . . . . 2.03 109.898 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 0.67 109.88 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 0.84 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.7 110.013 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 0.7 110.077 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 0.67 109.026 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.34 109.14 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 0.74 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.17 109.527 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 0.76 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 0.7 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.71 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.25 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 0.59 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.52 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.55 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 0.54 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 0.52 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 0.55 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 0.58 109.453 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.15 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 31' ' ' LEU . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 1.62 110.15 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 0.51 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 0.51 109.922 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.91 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.14 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 86' ' ' LEU . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.66 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.12 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 0.72 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.81 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 0.73 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.07 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.36 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 0.91 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 0.39 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 0.47 109.122 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.697 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 0.62 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 0.61 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.85 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.18 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.68 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG11 ' HE1' ' A' ' 80' ' ' HIS . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 0.72 108.946 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.48 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 80' ' ' HIS . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 0.54 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.82 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.51 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.6 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.08 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.5 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 0.54 110.213 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.34 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 0.6 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.81 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 0.94 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.25 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' HG22 ' A' ' 67' ' ' VAL . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.93 109.897 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.71 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 0.81 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.93 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.04 109.908 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.61 109.736 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 0.55 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.651 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.62 109.688 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.406 0.622 . . . . 1.79 109.782 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.54 109.603 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 0.74 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68 109.967 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.39 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.577 HG21 HD12 ' A' ' 86' ' ' LEU . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 0.78 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 2.6 m . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 0.84 108.777 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.18 0.514 . . . . 0.92 109.912 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 0.83 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 0.83 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 0.85 109.057 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 0.72 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.62 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.08 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 0.56 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.45 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.56 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 0.74 108.547 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 0.42 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 0.47 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 0.53 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.04 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HB2' HD21 ' A' ' 31' ' ' LEU . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 1.58 110.124 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 0.47 109.404 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.47 109.978 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.9 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.54 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 0.89 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 2.64 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 0.61 109.46 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.62 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 0.55 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.68 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 0.71 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 0.59 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 0.46 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 0.54 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 0.76 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 0.73 110.22 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.14 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 0.88 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.58 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 0.75 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.04 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.52 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.69 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.16 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.43 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 0.48 110.371 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.42 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 0.93 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 0.5 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.61 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 0.8 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 2.82 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.442 ' NE2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.28 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.68 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.31 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 0.75 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 1.86 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.91 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 0.61 109.333 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.57 110.712 179.859 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.499 2.024 0 CA-C-O 121.278 0.561 . . . . 1.5 109.701 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.422 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 0.74 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 0.76 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.64 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.03 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 0.59 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.406 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 73.6 p . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 0.67 109.401 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.684 -0.487 . . . . 1.66 109.684 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 0.91 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 0.94 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 0.82 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 0.67 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.72 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.08 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.21 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 0.63 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.49 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.54 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 69' ' ' PRO . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 0.59 108.899 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 0.44 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 33' ' ' VAL . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 0.53 109.299 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 59' ' ' ILE . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 0.7 109.736 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 2.78 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 1.72 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.51 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 0.63 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.13 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' HD2' HD13 ' A' ' 86' ' ' LEU . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76 110.791 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 1.74 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 0.9 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.07 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 0.91 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.01 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.19 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.77 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 0.47 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 43' ' ' LEU . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.47 109.369 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.673 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 0.56 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 84' ' ' LEU . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 0.58 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 1.75 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 0.77 108.933 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.62 109.88 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 76' ' ' ILE . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 0.58 109.527 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.36 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.63 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.8 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.632 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 0.91 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.63 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.62 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.83 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.12 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 0.72 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 0.92 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.17 109.982 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 1.58 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.06 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.72 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 61' ' ' THR . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 0.58 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 19' ' ' THR . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.63 109.475 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 0.76 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 0.56 108.814 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 0.89 110.554 -179.484 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.492 0.663 . . . . 2.05 110.816 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 0.55 108.961 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 0.68 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.65 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.39 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.788 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.65 109.889 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 0.61 109.285 179.564 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.118 0.485 . . . . 1.6 109.695 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 0.67 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 0.85 109.859 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 0.71 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 0.65 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.48 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.97 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 0.55 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.44 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.43 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 0.86 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 0.43 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 0.52 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.58 109.828 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.48 110.108 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD21 ' A' ' 31' ' ' LEU . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.01 109.926 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 0.5 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 0.52 110.092 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.72 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.66 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.3 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.7 109.41 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.71 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 0.65 109.96 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.72 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 0.73 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 0.75 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 0.42 109.266 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 0.45 109.8 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 0.56 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 63' ' ' ASP . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.45 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.28 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 61' ' ' THR . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.71 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 0.51 108.92 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.33 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 80' ' ' HIS . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 0.36 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.49 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' O ' HG23 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.59 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 0.76 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.14 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.52 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 0.46 110.336 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.49 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.2 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 67' ' ' VAL . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 0.4 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 0.82 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 0.9 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.2 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.66 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 0.79 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.34 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 0.61 109.695 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 0.54 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.62 110.431 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.354 0.597 . . . . 1.9 110.086 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 0.48 109.787 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 0.55 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.63 110.167 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.52 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.63 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 0.92 109.256 179.42 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.03 108.84 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 0.74 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 0.88 109.318 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.91 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 42' ' ' VAL . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 0.64 109.412 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.6 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 0.58 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.5 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.48 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.54 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.49 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.43 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 33' ' ' VAL . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 0.45 109.359 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 0.6 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 2.53 109.921 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.38 109.53 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.46 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 0.39 109.626 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.74 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.63 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.56 110.785 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 1.65 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD21 ' A' ' 86' ' ' LEU . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.63 109.521 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.59 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 0.57 110.161 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 0.7 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 0.69 109.555 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.04 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 0.45 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 0.45 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.702 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 0.58 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 0.56 109.897 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89 109.817 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.36 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.72 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 0.73 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.51 110.019 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 0.53 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.12 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.56 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.87 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.61 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.52 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.44 110.326 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 1.6 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' PHE . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 0.57 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.97 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.84 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.59 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.86 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.67 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 0.77 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 0.86 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 1.9 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 0.77 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 0.71 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.86 110.746 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 8.87 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -102.84 123.25 46.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.672 -0.642 . . . . 6.88 109.337 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.13 25.17 32.21 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.301 -1.12 . . . . 5.64 110.301 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.73 61.07 0.5 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.862 -1.695 . . . . 4.48 108.862 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 p -97.6 124.48 41.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.793 -0.828 . . . . 3.38 109.517 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.34 83.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.235 -1.024 . . . . 3.65 108.235 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.8 147.77 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.504 -0.925 . . . . 2.79 108.504 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -82.97 111.75 19.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.431 -0.793 . . . . 2.41 109.866 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 m -125.18 112.21 16.18 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.573 -0.899 . . . . 2.46 108.573 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.71 -20.15 16.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.618 -0.676 . . . . 2.76 110.248 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.96 -89.92 0.19 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.073 -1.611 . . . . 2.02 109.073 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.33 93.89 7.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.817 . . . . 2.07 108.866 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -143.05 156.81 44.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.725 . . . . 1.77 110.426 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 0.93 109.654 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.07 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.8 110.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 2.69 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 0.71 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 28' ' ' PHE . 8.4 p -125.35 155.58 40.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -77.96 117.18 19.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.95 109.644 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.4 t -97.12 -29.4 13.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.746 -0.596 . . . . 1.03 110.077 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -76.28 -39.8 53.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.471 -0.768 . . . . 1.22 110.079 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.2 m-20 -83.74 166.03 36.39 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 1.28 110.051 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.6 Cg_endo -74.87 -31.17 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.543 2.162 . . . . 1.51 110.273 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 155.46 30.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.694 -0.628 . . . . 2.86 109.49 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.59 69.55 72.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.616 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 20' ' ' LEU . 33.8 Cg_endo -77.22 96.04 1.09 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.638 2.225 . . . . 1.08 109.615 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.633 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.3 p90 -56.8 147.49 23.06 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.555 0.693 . . . . 1.3 110.535 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -127.68 119.18 25.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.42 108.896 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.08 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.2 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.05 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 0.98 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.16 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.42 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.48 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 0.97 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.79 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.66 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.03 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 0.75 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 0.67 109.315 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.62 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.38 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 31' ' ' LEU . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.4 109.921 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 0.73 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 0.79 109.783 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.599 ' CD2' HD13 ' A' ' 86' ' ' LEU . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.98 110.856 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.0 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 0.95 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.82 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 0.7 110.153 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.76 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 0.96 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 0.81 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 0.54 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 0.56 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 0.66 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.525 HG21 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 0.54 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.01 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 0.68 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.61 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 76' ' ' ILE . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 0.59 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.3 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 0.94 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 1.8 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 0.94 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 0.84 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.9 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 1.7 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.462 HG21 ' CE1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 0.69 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 0.95 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.12 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 1.61 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.19 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.8 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.03 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.63 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 18' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 0.66 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.59 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.97 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 0.74 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo -75.14 133.09 15.96 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.12 110.849 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -76.44 124.76 28.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.856 -0.528 . . . . 1.51 109.87 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -41.46 9.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.719 -0.613 . . . . 3.0 109.858 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 171.7 7.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.571 -0.706 . . . . 5.0 109.837 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.87 111.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.675 -0.861 . . . . 1.92 108.675 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 94' ' ' HIS . . . 79.49 51.57 5.17 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.378 -1.889 . . . . 1.88 108.378 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 2.9 t-80 . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 117.681 -1.152 . . . . 2.11 110.028 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.019 -0.734 . . . . 5.58 109.019 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 p -94.3 79.64 3.95 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.595 0.712 . . . . 3.67 109.797 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 10' ' ' ALA . . . 60.95 58.57 13.02 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 111.613 -0.595 . . . . 2.13 111.613 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.33 -102.74 2.96 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.233 -0.984 . . . . 4.7 111.234 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 m -112.2 -70.4 0.81 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.59 -0.947 . . . . 5.71 111.379 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.04 -120.76 0.11 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.133 -0.979 . . . . 4.46 110.729 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 55.1 0.74 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.166 -0.959 . . . . 4.21 109.745 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.64 176.95 5.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.284 -0.885 . . . . 2.86 109.255 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -65.72 154.38 39.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.558 -0.714 . . . . 2.22 110.536 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.747 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . . . -74.1 103.68 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.542 -0.54 . . . . 1.56 109.542 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.84 94.36 0.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.928 -1.269 . . . . 1.11 109.928 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 p -85.49 97.79 10.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.935 . . . . 2.41 109.086 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -129.14 152.97 48.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.618 -0.676 . . . . 2.6 109.732 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.96 109.959 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.02 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.75 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 2.61 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 86' ' ' LEU . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 0.67 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -127.58 163.51 24.02 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 0.96 109.131 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.78 152.27 42.85 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 1.32 109.756 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.42 HG21 ' CG2' ' A' ' 87' ' ' ILE . 10.8 p -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.595 -0.69 . . . . 1.62 109.893 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.0 p -68.83 -47.12 66.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.507 -0.746 . . . . 2.01 109.967 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 4.6 p-10 -118.15 157.38 48.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.684 -0.635 . . . . 1.65 109.934 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' ASP . 33.7 Cg_endo -75.96 -38.6 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.638 2.226 . . . . 1.93 110.111 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.397 0.617 . . . . 1.69 110.447 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -61.56 -55.21 44.78 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.668 -0.645 . . . . 1.99 109.917 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -78.43 131.22 10.42 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 122.382 2.055 . . . . 1.52 110.552 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.58 148.86 27.77 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.564 -0.71 . . . . 1.36 109.727 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt -86.93 99.74 12.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 0.95 109.108 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.07 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.23 109.536 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.15 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 0.94 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.08 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.19 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 0.97 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.88 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' CE1' HG21 ' A' ' 76' ' ' ILE . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.6 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 0.78 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 0.63 109.313 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 59' ' ' ILE . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 0.67 109.674 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.15 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 1.93 109.721 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.42 109.522 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 0.51 109.747 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.19 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.82 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 86' ' ' LEU . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 0.77 110.71 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 3.7 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG21 HD21 ' A' ' 86' ' ' LEU . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 0.83 109.018 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.07 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.21 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 91' ' ' ARG . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 1.58 110.321 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.616 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 1.52 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 0.8 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 0.68 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.48 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 0.72 110.046 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 84' ' ' LEU . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.62 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 1.61 111.207 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.95 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.7 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 0.63 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.47 110.069 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 76' ' ' ILE . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.41 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.97 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.7 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 0.89 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.67 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.83 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 0.75 110.38 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.85 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.62 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG21 ' CE1' ' A' ' 39' ' ' PHE . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 0.66 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.18 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.07 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 2.65 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' HG22 ' A' ' 67' ' ' VAL . 14.8 m80 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.85 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.05 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 61' ' ' THR . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 0.62 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.02 109.681 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.93 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' CG2' HG21 ' A' ' 21' ' ' THR . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 0.91 109.751 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.12 94.84 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.09 109.451 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.64 130.39 52.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.755 -0.591 . . . . 2.98 110.066 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.28 146.85 52.93 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.072 -0.714 . . . . 1.81 109.072 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -95.63 116.34 28.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 1.93 109.783 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.58 83.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.067 -0.716 . . . . 3.39 109.067 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.84 49.1 0.87 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.407 -1.477 . . . . 4.87 109.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.66 -0.906 . . . . 6.21 110.176 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.845 -0.428 . . . . 4.79 109.845 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.29 139.59 32.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.697 -0.627 . . . . 2.47 109.638 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.96 -74.04 0.28 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.021 -1.631 . . . . 2.36 109.021 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.39 55.25 0.7 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.975 -1.65 . . . . 2.41 108.975 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 6' ' ' ALA . 5.1 t -143.03 -44.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.656 -0.908 . . . . 2.33 110.164 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 5' ' ' THR . . . -138.43 133.4 32.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.904 . . . . 1.79 110.353 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 12' ' ' SER . . . -90.33 103.18 15.89 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.966 -0.753 . . . . 1.59 108.966 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.7 m -128.43 -72.21 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.574 -0.703 . . . . 2.01 109.195 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -138.09 -62.83 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.041 -0.726 . . . . 1.86 109.041 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.68 130.69 38.23 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.921 -0.77 . . . . 2.21 108.921 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.25 58.98 9.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.686 -1.365 . . . . 1.39 109.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 1.3 m -82.38 -42.71 18.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.605 -0.938 . . . . 0.88 109.324 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -117.96 161.59 19.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 1.67 109.383 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 0.5 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 0.58 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.58 109.964 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 1.98 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 0.64 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m -110.26 128.73 55.67 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -66.38 111.64 3.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.453 -0.779 . . . . 1.3 109.3 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 t -93.46 -28.85 15.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 1.06 110.632 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 60.2 p -67.79 -41.63 82.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.303 -0.873 . . . . 1.2 109.735 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -100.94 124.47 41.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.707 -0.621 . . . . 1.57 109.407 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 161.17 29.24 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.783 2.322 . . . . 1.52 111.151 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.68 59.17 1.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.455 0.645 . . . . 3.28 109.94 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.5 9.54 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.411 -0.806 . . . . 0.98 109.964 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 156.69 33.7 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 123.0 2.467 . . . . 1.02 111.424 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -79.01 157.56 28.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.715 -0.616 . . . . 1.17 110.356 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 131.94 55.51 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.585 -0.697 . . . . 1.1 109.611 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.62 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.68 109.363 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 0.89 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.575 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 0.68 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.62 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.1 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 0.73 109.422 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.73 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.55 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 69' ' ' PRO . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 0.61 108.74 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.45 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 0.56 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.62 109.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 1.88 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' A' ' 31' ' ' LEU . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 0.94 110.118 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 0.45 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 0.49 110.214 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.96 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 20' ' ' LEU . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.58 110.764 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 2.65 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 0.61 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.58 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 0.63 110.077 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 0.65 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 90' ' ' ASP . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 0.59 109.793 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.47 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 0.5 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.52 109.096 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 85' ' ' ARG . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 0.6 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 0.54 109.699 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.0 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.9 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.69 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 0.67 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.56 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 0.54 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.95 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.56 110.316 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.06 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.649 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.73 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.53 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 0.49 110.003 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.47 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.25 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG11 ' A' ' 67' ' ' VAL . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 0.45 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.72 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 0.82 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 1.9 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.463 ' CE1' HG22 ' A' ' 67' ' ' VAL . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.68 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.58 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 0.66 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.603 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 1.95 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.07 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 0.79 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 35.5 Cg_endo -78.36 123.04 5.86 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.7 110.48 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -56.37 2.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 1.36 109.402 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 56' ' ' THR . 1.7 m-20 -135.3 164.82 26.85 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.62 -0.675 . . . . 1.49 109.867 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 128.3 53.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 2.87 109.29 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.3 m -88.05 -37.72 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.472 -0.768 . . . . 2.51 109.781 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.85 82.15 1.5 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.478 -1.449 . . . . 2.67 109.478 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.862 -1.066 . . . . 4.33 109.976 -179.734 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.926 0.393 . . . . 7.44 110.007 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 49.78 52.07 15.31 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.603 0.716 . . . . 5.03 110.144 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.97 30.86 7.25 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.913 -1.275 . . . . 2.49 109.913 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 5' ' ' THR . . . -99.82 -72.59 1.02 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.718 -1.753 . . . . 1.84 108.718 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 33' ' ' VAL . 99.6 m 67.91 130.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.335 0.588 . . . . 2.22 110.141 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 135.38 35.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.756 -0.59 . . . . 2.68 109.863 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.37 -41.64 72.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.637 -0.664 . . . . 2.01 109.424 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.3 m 53.24 59.42 4.42 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.334 0.587 . . . . 3.71 109.871 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p 43.08 54.09 4.99 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.238 0.542 . . . . 3.98 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . . . -129.61 109.89 11.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -0.769 . . . . 2.11 109.509 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.58 -52.29 8.57 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.739 -1.344 . . . . 1.43 109.739 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.2 p -82.62 135.7 34.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.745 -0.856 . . . . 1.05 109.897 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -131.47 150.5 52.13 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 1.51 109.805 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 0.72 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 0.71 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.7 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 2.88 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 0.58 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 14.0 t -121.62 143.39 49.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 86' ' ' LEU . 6.1 tp -67.6 136.24 54.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.432 -0.793 . . . . 1.07 110.053 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.2 p -107.35 -3.76 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.698 -0.626 . . . . 1.29 110.489 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -58.03 3.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 1.86 109.527 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -96.82 136.54 21.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.745 -0.597 . . . . 1.49 109.661 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 23' ' ' ASP . 35.4 Cg_endo -78.76 155.98 27.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.708 2.272 . . . . 0.96 110.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 57.77 0.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.431 0.634 . . . . 4.36 109.822 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 143.78 50.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.476 -0.765 . . . . 1.14 109.689 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.36 160.58 35.57 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.964 2.442 . . . . 0.69 111.256 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 43.1 p90 -99.32 161.37 13.65 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.84 110.203 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -117.39 135.43 53.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.564 -0.71 . . . . 1.26 109.617 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 0.84 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.05 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.13 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 5' ' ' THR . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.6 109.646 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.57 110.734 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.86 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 0.86 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 0.65 109.433 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.66 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.73 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 0.89 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 0.62 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 0.58 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.563 HD12 HD12 ' A' ' 59' ' ' ILE . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.02 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.36 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.48 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 0.51 109.634 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.61 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 2.55 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 47' ' ' ALA . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 0.76 109.28 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.68 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 0.8 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 0.68 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 0.85 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 0.94 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 0.5 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.563 HD12 HD12 ' A' ' 43' ' ' LEU . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.56 109.523 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 0.58 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 62' ' ' ASN . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.62 109.861 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 61' ' ' THR . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.33 110.802 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.16 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.82 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 0.77 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.49 109.803 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.846 HG11 ' CE1' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 0.65 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.27 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 40' ' ' THR . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.73 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 0.82 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.6 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.7 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 0.53 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.67 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.05 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 0.6 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.88 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 0.99 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.47 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.846 ' CE1' HG11 ' A' ' 67' ' ' VAL . 4.4 m80 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.8 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 0.83 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.17 109.248 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 0.91 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.601 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.49 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.96 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.81 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo -74.65 95.47 0.95 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.93 110.202 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -140.62 134.88 31.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.191 -0.67 . . . . 2.67 109.191 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -88.8 156.48 18.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.511 -0.743 . . . . 2.01 110.101 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.09 102.04 5.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.266 -0.642 . . . . 1.92 109.266 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.95 -63.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.704 -0.622 . . . . 2.86 109.349 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.03 -56.67 0.83 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.532 -1.427 . . . . 2.93 109.532 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.849 -1.072 . . . . 4.39 109.745 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 mtt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.568 -0.53 . . . . 3.99 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.28 96.46 7.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.535 0.683 . . . . 3.38 110.315 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.07 58.62 2.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.084 -2.406 . . . . 4.07 107.084 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.85 -69.61 2.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.46 -1.856 . . . . 4.72 108.46 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -155.0 49.05 0.56 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 108.439 -0.949 . . . . 5.47 108.439 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.73 99.86 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.693 -0.629 . . . . 2.76 109.72 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.94 98.81 1.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.434 0.635 . . . . 3.53 109.346 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -146.23 151.56 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.39 -0.596 . . . . 1.91 109.39 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.56 -44.7 73.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.74 -0.6 . . . . 1.82 109.736 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.5 -61.22 1.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.649 -0.657 . . . . 1.65 110.074 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.38 -99.67 1.22 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.213 -1.555 . . . . 1.21 109.213 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.53 129.18 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.658 -0.907 . . . . 1.11 109.122 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -140.87 155.34 46.34 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.505 -0.747 . . . . 2.76 110.224 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 0.54 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 0.77 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.63 109.703 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.01 108.933 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 0.54 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -111.83 133.94 53.71 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 22' ' ' SER . 5.5 tp -61.86 145.86 51.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.99 109.998 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 87' ' ' ILE . 5.2 p -70.56 -26.51 63.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.605 . . . . 1.03 110.245 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -62.41 -46.59 87.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 1.74 109.697 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.8 p30 -86.12 161.96 47.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.603 -0.686 . . . . 1.05 109.66 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 23' ' ' ASP . 34.0 Cg_endo -77.01 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.602 2.202 . . . . 1.22 110.602 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.73 73.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.52 -0.737 . . . . 1.18 109.769 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.695 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -145.96 -66.1 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.49 -0.756 . . . . 1.23 109.653 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.695 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.9 Cg_endo -79.51 86.44 1.68 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.082 1.855 . . . . 0.97 110.122 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -128.05 163.19 25.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.523 -0.736 . . . . 1.06 110.064 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.6 136.4 50.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.565 -0.709 . . . . 1.23 110.15 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 17' ' ' LYS . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 0.78 108.758 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.2 110.111 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 0.7 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 0.6 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.74 110.881 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.74 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.68 109.48 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.53 111.173 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.52 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.6 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 0.43 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.49 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 59' ' ' ILE . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 0.69 109.63 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.31 109.998 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.28 109.631 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 0.49 109.622 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 0.43 109.803 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.71 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.69 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 2.82 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG23 ' HB1' ' A' ' 47' ' ' ALA . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 0.7 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.74 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 0.78 110.018 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 0.93 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 0.93 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 0.63 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.39 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 43' ' ' LEU . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 0.46 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.708 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 0.59 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 0.56 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.45 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.05 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.74 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 0.68 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.708 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.52 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.483 HG22 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 0.55 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.84 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.55 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 0.67 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.556 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.4 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.47 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 0.57 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.53 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 0.91 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 0.52 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 0.82 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.9 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 3.53 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.72 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.58 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 0.68 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 0.83 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 1.61 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.628 HD12 HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.0 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.74 HD13 ' HB3' ' A' ' 94' ' ' HIS . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 0.6 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo -77.24 86.87 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.65 110.519 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 71.38 144.26 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.45 0.643 . . . . 1.35 110.547 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.63 179.81 4.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 0.7 109.477 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.57 22.38 12.86 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.504 -0.748 . . . . 2.96 110.594 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.06 53.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.268 -0.895 . . . . 1.2 109.175 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.95 -41.17 2.21 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.529 -1.429 . . . . 1.21 109.529 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.74 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.631 -0.923 . . . . 2.07 110.031 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.9 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 7.5 109.385 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.37 97.06 0.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.668 -0.864 . . . . 7.82 108.668 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.04 47.2 11.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 107.501 -2.24 . . . . 4.69 107.501 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 61.19 0.13 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.076 -2.01 . . . . 3.06 108.076 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 29.9 m -53.33 110.82 0.6 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.919 -0.754 . . . . 4.17 109.851 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 9' ' ' THR . . . -93.6 89.67 6.34 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.184 0.516 . . . . 3.19 110.397 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -46.98 7.97 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.447 -0.783 . . . . 5.08 109.064 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.7 p -95.07 -56.28 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.614 -0.884 . . . . 6.06 108.614 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.618 ' O ' ' HB1' ' A' ' 6' ' ' ALA . 40.0 p -82.99 175.0 10.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 4.42 109.402 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.63 -25.81 26.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.694 -0.854 . . . . 2.49 108.694 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.97 -85.08 0.3 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.496 -1.442 . . . . 2.08 109.496 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -97.13 138.91 33.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 122.06 -0.671 . . . . 1.34 109.203 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 146.28 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.625 -0.672 . . . . 1.7 109.327 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 0.75 109.758 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 0.61 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' HB3' HD12 ' A' ' 84' ' ' LEU . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 0.93 109.832 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.45 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 0.56 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 28' ' ' PHE . 38.3 m -121.51 111.94 17.89 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 0.68 108.782 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 23' ' ' ASP . 1.8 pt? -64.75 140.53 58.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.436 -0.79 . . . . 0.73 109.861 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.1 t -107.33 -1.93 21.15 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.673 -0.642 . . . . 0.95 110.69 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.3 -45.9 14.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.08 -1.013 . . . . 1.38 109.787 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.573 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.8 t70 -112.18 119.44 43.97 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.604 -0.685 . . . . 0.99 109.742 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.85 -30.69 3.57 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.88 2.386 . . . . 1.23 111.283 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -65.54 -42.98 91.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.773 . . . . 2.21 110.061 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 136.05 84.8 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.434 -0.791 . . . . 1.11 109.933 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.59 170.39 18.36 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.948 2.432 . . . . 0.79 111.369 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 19' ' ' THR . 41.8 p90 -76.98 163.0 27.11 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.636 -0.665 . . . . 0.96 109.895 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' CB ' ' A' ' 49' ' ' GLU . 2.5 tmtt? -119.67 137.6 53.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.99 110.427 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 0.73 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 0.82 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 0.63 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 0.68 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.9 110.846 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.14 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 0.81 109.706 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.7 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.61 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 0.71 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.64 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 0.62 109.11 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 0.61 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 2.74 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 31' ' ' LEU . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 1.67 110.22 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.47 109.277 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 0.42 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.61 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.04 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 47' ' ' ALA . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 0.65 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.7 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 0.83 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.77 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 0.68 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.14 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 0.58 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 0.54 109.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 0.81 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.79 110.06 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.18 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.17 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.11 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.06 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.648 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.85 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.677 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 0.71 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.05 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 0.88 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HB2' HD11 ' A' ' 76' ' ' ILE . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.21 109.715 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.89 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 0.75 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.85 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.49 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 71' ' ' GLN . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 0.78 109.647 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 0.95 110.072 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.08 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 1.91 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.95 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.8 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 0.62 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 16' ' ' PHE . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 0.84 109.731 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.27 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 0.69 109.995 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 0.85 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.749 ' HB2' ' HB2' ' A' ' 91' ' ' ARG . 36.4 Cg_endo -77.66 131.48 11.39 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.76 111.034 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -76.64 -57.8 3.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.259 -0.645 . . . . 1.86 109.259 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.93 78.25 1.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.125 -0.694 . . . . 1.65 109.125 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -151.62 156.23 40.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.532 -0.73 . . . . 2.3 109.833 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.9 -28.46 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 1.85 110.141 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.5 76.89 0.51 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.322 -1.511 . . . . 1.73 109.322 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.479 -0.772 . . . . 2.91 110.121 -179.707 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.263 0.554 . . . . 3.74 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 4.0 p -84.53 -53.94 5.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.649 -0.657 . . . . 2.3 109.507 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.66 130.7 9.97 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.543 -1.423 . . . . 3.93 109.543 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.74 -98.01 0.18 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.076 -1.209 . . . . 4.22 110.076 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 m -100.26 -58.57 1.88 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.869 -0.783 . . . . 5.22 108.958 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 147.43 36.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.84 -0.537 . . . . 4.23 109.802 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.56 34.51 1.17 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.167 -0.679 . . . . 3.57 109.167 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -103.61 137.93 40.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.334 -0.854 . . . . 4.96 109.749 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 8' ' ' THR . 20.7 m 73.89 135.28 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.515 0.674 . . . . 4.49 110.0 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.57 14.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 2.83 109.822 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.94 -76.75 1.16 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.19 -1.164 . . . . 1.44 110.19 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -138.25 108.11 6.31 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.46 -1.024 . . . . 1.6 110.26 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 2' ' ' SER . 2.0 mttm -119.12 159.77 23.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.724 -0.61 . . . . 2.22 109.788 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 0.73 109.368 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 0.83 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.7 109.898 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.18 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 0.68 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -133.08 141.97 48.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 0.67 109.109 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -60.08 115.76 3.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.459 -0.776 . . . . 1.03 109.597 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -72.55 -32.94 66.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.777 -0.577 . . . . 1.09 110.151 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.46 -51.08 21.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.446 -0.784 . . . . 1.71 109.672 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.48 105.35 1.83 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.621 -0.674 . . . . 2.75 109.865 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.56 138.63 17.45 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.796 2.331 . . . . 2.3 110.545 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.11 -64.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.657 . . . . 2.36 109.855 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.567 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -176.42 -58.22 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 109.389 -0.597 . . . . 2.12 109.389 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -77.81 124.6 6.93 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 C-N-CA 122.344 2.03 . . . . 1.55 110.188 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -92.88 151.47 19.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.57 -0.706 . . . . 1.47 109.807 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 99.39 10.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 1.13 109.494 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 0.89 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.19 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 0.95 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 0.9 109.837 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 0.93 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.16 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.18 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 0.8 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.76 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 76' ' ' ILE . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.61 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 0.65 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 0.64 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 33' ' ' VAL . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 0.65 109.492 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 58' ' ' ALA . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 0.73 109.819 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 1.53 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.38 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 0.51 110.196 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.58 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.99 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.84 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' CD1' HD23 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.73 109.52 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.3 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 0.75 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.75 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 0.91 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 0.87 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 0.83 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.02 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 0.58 109.523 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 43' ' ' LEU . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.55 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.756 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 0.65 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 0.56 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.03 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.94 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 0.82 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.756 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.62 109.966 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 76' ' ' ILE . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 0.67 109.362 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.32 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.7 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 0.92 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.36 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.76 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 0.71 110.226 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.73 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.18 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 67' ' ' VAL . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 0.56 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.97 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 0.96 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.24 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.02 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 0.81 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.9 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 0.86 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 2.56 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 52' ' ' VAL . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.11 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.684 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo -75.8 75.08 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.11 110.078 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.46 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.358 0.599 . . . . 1.72 110.095 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.06 -47.2 75.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.591 -0.693 . . . . 1.64 109.399 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -91.65 -153.38 0.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.258 -0.645 . . . . 3.21 109.258 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.06 156.51 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.26 -0.9 . . . . 2.17 110.102 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.0 89.28 0.32 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.901 -1.279 . . . . 1.4 109.901 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.858 -1.068 . . . . 3.26 109.777 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.66 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 1.1 mtt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.341 0.591 . . . . 4.95 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -110.57 101.0 9.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.161 -0.962 . . . . 6.24 110.495 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.9 -82.23 0.33 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.365 -0.921 . . . . 8.6 111.116 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.96 -98.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.936 0 O-C-N 122.085 -0.656 . . . . 8.47 111.835 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.21 146.93 23.65 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.446 -1.032 . . . . 7.35 110.975 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 1' ' ' MET . . . -121.73 43.29 2.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.164 -1.421 . . . . 5.63 107.164 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.15 85.62 2.39 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.864 -0.607 . . . . 3.79 111.701 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 43.0 m -70.36 -43.02 71.04 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.515 -1.291 . . . . 2.72 107.515 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.463 HG21 ' OE2' ' A' ' 35' ' ' GLU . 5.5 m 43.08 68.22 0.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.537 0.684 . . . . 1.47 110.448 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.83 -31.65 25.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 1.33 109.904 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -68.51 1.63 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.913 -1.275 . . . . 1.28 109.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 p -81.6 140.67 34.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.535 -0.979 . . . . 1.08 109.75 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -131.19 159.55 37.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.562 -0.711 . . . . 2.04 110.037 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 0.88 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 0.86 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.77 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 1.91 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.65 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m -113.43 134.31 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 0.64 108.749 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -67.63 128.46 36.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.366 -0.834 . . . . 1.15 109.891 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 p -85.22 -39.21 18.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.664 -0.647 . . . . 1.28 109.586 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -71.69 -35.65 70.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.638 -0.664 . . . . 1.91 110.317 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.1 t70 -106.29 115.6 60.7 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 2.07 110.035 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.28 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.849 2.366 . . . . 1.9 110.591 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -63.63 -49.68 72.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.626 -0.671 . . . . 3.16 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 2.8 mm? -55.65 118.17 18.45 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.859 -0.526 . . . . 1.56 109.911 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.43 166.58 27.21 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.701 2.267 . . . . 0.95 111.183 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -62.92 155.49 27.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.722 -0.611 . . . . 0.72 110.485 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.3 mptt -119.16 132.5 55.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.651 -0.656 . . . . 1.21 109.369 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.8 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.06 109.79 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 0.93 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.0 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.04 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' OE2' HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.02 110.205 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 8' ' ' THR . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.17 110.469 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.08 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.07 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.79 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 0.96 108.606 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 0.81 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 33' ' ' VAL . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 0.74 109.165 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 59' ' ' ILE . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 0.68 109.574 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.15 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.42 110.215 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.52 109.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 0.52 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.98 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.683 ' CD1' HD12 ' A' ' 20' ' ' LEU . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.73 110.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 2.66 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 0.84 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.78 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 0.8 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 0.9 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.09 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.04 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' A' ' 89' ' ' ARG . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 0.75 109.232 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 43' ' ' LEU . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 0.68 109.391 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.667 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 0.87 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.81 110.065 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.02 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.06 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.01 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.85 109.701 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG11 HD12 ' A' ' 76' ' ' ILE . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 0.78 109.446 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.16 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.96 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.16 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.57 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.15 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 0.89 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.9 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.67 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 HG11 ' A' ' 67' ' ' VAL . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.85 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.86 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.08 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 1.78 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' NE2' HG22 ' A' ' 67' ' ' VAL . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.29 110.138 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.85 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.67 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.9 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 0.73 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 2.97 109.92 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 0.91 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 0.88 109.068 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo -75.6 116.79 4.57 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.84 110.655 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 52.1 mtp180 -71.57 -52.38 18.45 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.77 -0.581 . . . . 2.96 109.882 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 63.9 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.356 0.598 . . . . 1.8 110.353 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 ttm105 -86.88 -56.08 3.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.523 -0.736 . . . . 5.64 109.878 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.1 130.45 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.292 -0.88 . . . . 2.59 110.009 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.36 58.13 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.766 -1.333 . . . . 2.28 109.766 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.794 -1.098 . . . . 3.36 109.703 179.738 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 14' ' ' VAL . 4.3 tpt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.082 0.468 . . . . 1.64 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 -55.83 1.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.749 -0.594 . . . . 0.72 109.528 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.8 69.19 0.72 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.502 -1.439 . . . . 0.74 109.502 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.21 -76.66 0.05 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.106 -1.198 . . . . 0.95 110.106 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -105.81 -64.19 1.18 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.917 . . . . 1.39 109.697 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.74 111.14 21.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.585 -0.697 . . . . 1.06 109.783 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.02 -46.11 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.69 -0.631 . . . . 1.22 109.642 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 p -80.52 95.08 6.38 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.672 -0.642 . . . . 1.48 109.471 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.31 131.08 14.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.529 -0.732 . . . . 1.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.13 109.38 20.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 1.19 109.598 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.04 71.26 1.16 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.834 -1.306 . . . . 0.98 109.834 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.25 142.91 42.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.693 -0.886 . . . . 0.95 109.639 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.29 171.49 8.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.68 -0.637 . . . . 2.02 110.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 0.53 109.176 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 0.73 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.67 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HE3' ' CG ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.4 108.889 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 0.61 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m -118.79 134.19 55.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 0.73 108.987 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 86' ' ' LEU . 7.5 tp -73.56 114.89 12.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 1.12 109.527 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 t -82.1 -24.28 35.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.72 -0.613 . . . . 0.84 109.915 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.26 -49.07 53.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.533 -0.73 . . . . 1.43 109.628 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.597 ' HB3' HD23 ' A' ' 20' ' ' LEU . 9.2 t70 -103.9 120.02 52.6 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.547 -0.721 . . . . 1.1 109.63 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.79 -30.61 4.6 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.72 2.28 . . . . 0.89 110.968 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -44.54 95.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.556 -0.715 . . . . 1.95 109.465 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD22 ' HD1' ' A' ' 50' ' ' PHE . 1.1 mt -68.2 121.9 82.05 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.486 -0.759 . . . . 1.25 109.627 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.14 174.85 11.55 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.79 2.326 . . . . 1.04 111.235 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 44.5 p90 -71.87 161.55 30.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 1.35 109.793 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? -137.83 143.5 41.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.53 -0.731 . . . . 2.24 109.541 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 0.91 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 0.91 108.999 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.0 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 42' ' ' VAL . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 0.56 109.511 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.45 110.759 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.02 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 0.6 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.43 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.51 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 0.81 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 0.51 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 33' ' ' VAL . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 0.46 109.229 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 0.7 109.665 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 2.86 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.31 110.25 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 0.5 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 0.57 109.882 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.35 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.97 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.68 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 2.92 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 0.75 109.041 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.9 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 0.78 109.713 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 0.98 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.05 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 0.79 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 0.57 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 0.47 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.7 109.388 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.56 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.18 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.14 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.77 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 0.72 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.54 109.812 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 80' ' ' HIS . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 0.44 109.385 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 0.9 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 40' ' ' THR . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.62 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.64 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.28 110.103 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.39 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 0.38 110.355 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.41 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 0.95 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 HG11 ' A' ' 67' ' ' VAL . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.5 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.58 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 0.54 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 1.72 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.68 110.06 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.61 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 0.95 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.22 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.693 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 0.81 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 0.75 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.95 83.67 2.21 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.06 110.12 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.443 ' NH2' ' HD3' ' A' ' 91' ' ' ARG . 26.9 ttp180 -92.49 104.35 16.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.901 -0.777 . . . . 3.12 108.901 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.92 112.31 23.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.513 -0.742 . . . . 1.94 109.502 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HD3' ' NH2' ' A' ' 89' ' ' ARG . 2.0 ptt-85 -128.63 150.29 50.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 3.24 109.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.7 t 57.41 89.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.644 -0.502 . . . . 3.02 109.644 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.14 100.09 0.09 OUTLIER Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.376 -1.49 . . . . 4.38 109.376 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.653 -1.165 . . . . 7.05 109.576 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.445 0.641 . . . . 3.75 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -105.27 130.55 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.83 -0.544 . . . . 3.94 109.614 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.25 80.17 0.66 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.922 -1.271 . . . . 4.62 109.922 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.99 -81.62 0.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.154 -1.178 . . . . 4.95 110.154 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.7 p -109.94 107.26 17.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.823 -0.81 . . . . 4.58 109.916 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.21 107.08 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.107 -1.442 . . . . 3.77 107.107 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.74 112.62 24.44 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.404 0.621 . . . . 3.61 110.653 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -102.42 113.67 27.2 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.847 -1.168 . . . . 2.68 107.847 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.1 m -69.23 104.94 2.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.683 -0.635 . . . . 2.95 109.821 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HB1' ' OE1' ' A' ' 35' ' ' GLU . . . -150.29 126.81 10.84 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.169 -0.678 . . . . 1.2 109.169 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.62 -99.4 0.05 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.529 -1.428 . . . . 1.18 109.529 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -63.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.767 -0.843 . . . . 1.63 109.346 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt -140.32 149.52 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 1.32 109.762 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 0.78 109.388 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 0.97 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.7 109.866 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.12 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.6 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -119.75 143.48 47.78 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.63 109.219 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 119.33 11.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.358 -0.838 . . . . 0.83 109.897 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -98.44 -27.98 13.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.619 . . . . 1.06 110.189 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -40.52 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.414 -0.804 . . . . 1.17 109.738 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -72.81 166.49 42.49 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.659 -0.651 . . . . 1.2 109.809 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.0 Cg_endo -74.85 -27.44 10.31 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.535 2.157 . . . . 1.2 110.509 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.61 -173.92 4.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.67 . . . . 4.06 109.74 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 70.86 13.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.201 -0.666 . . . . 1.48 109.201 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HG2' ' HE1' ' A' ' 50' ' ' PHE . 34.3 Cg_endo -77.25 96.15 1.09 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.615 2.21 . . . . 0.66 109.95 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -69.49 152.8 44.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.553 0.692 . . . . 1.04 110.597 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.75 124.31 23.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.18 109.057 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.68 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.06 109.506 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 0.87 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 0.67 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.77 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' OE1' ' HB1' ' A' ' 10' ' ' ALA . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.36 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 0.71 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.69 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.588 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.59 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.17 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.52 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 0.53 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 0.6 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 3.67 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 1.67 110.233 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 0.51 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 0.46 109.908 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.71 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 0.79 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.26 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG21 HD21 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 0.74 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.78 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 0.69 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 0.93 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' A' ' 90' ' ' ASP . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 0.89 109.549 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 0.69 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 0.49 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 0.46 109.212 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.664 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 0.62 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 0.69 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 0.99 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 0.95 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.61 109.865 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 0.66 109.522 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.22 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.2 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.84 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 0.65 110.373 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.76 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 1.62 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.482 HG21 ' CE1' ' A' ' 39' ' ' PHE . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 0.68 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.94 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 0.96 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.12 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.01 110.451 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.8 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 0.95 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.91 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 0.95 109.822 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 1.97 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 0.78 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 0.7 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.89 90.49 1.07 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.88 110.884 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.412 ' HG2' HG12 ' A' ' 87' ' ' ILE . 23.4 mmm-85 -105.24 106.24 16.64 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.106 -0.702 . . . . 3.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -72.12 -19.38 61.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.725 -0.609 . . . . 3.17 110.918 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -179.55 4.4 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.327 -0.858 . . . . 6.59 110.523 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.8 -17.68 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.8 -0.563 . . . . 3.86 109.607 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.21 -70.36 0.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.74 -1.344 . . . . 2.7 109.74 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.892 -0.769 . . . . 2.82 109.511 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.98 -0.378 . . . . 3.9 109.98 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -105.26 121.8 44.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.532 -0.73 . . . . 2.37 109.433 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.1 -70.21 0.67 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.162 -1.575 . . . . 2.87 109.162 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.29 -92.25 0.09 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.673 -1.371 . . . . 2.41 109.673 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.669 ' HB ' ' CD1' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -103.36 -40.57 6.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.885 -0.774 . . . . 2.47 109.114 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . 70.82 100.19 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.319 0.581 . . . . 1.43 109.715 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.908 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -102.36 118.61 37.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.77 . . . . 1.41 109.621 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLY . 85.1 m -79.64 115.75 19.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.949 -0.76 . . . . 1.34 108.949 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.6 m -95.04 -54.04 3.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.609 -0.682 . . . . 1.08 109.464 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.04 -57.14 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.612 -0.68 . . . . 1.22 109.809 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -134.54 -74.16 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.557 -1.417 . . . . 1.19 109.557 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.61 40.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.775 -0.838 . . . . 1.27 109.474 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 166.32 33.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.403 -0.81 . . . . 1.15 110.438 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 0.5 109.343 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.61 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.46 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.41 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.504 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 0.57 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 13.6 t -113.27 151.79 30.64 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.91 131.65 45.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.412 -0.805 . . . . 1.04 110.105 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 85' ' ' ARG . 36.4 p -85.2 -42.84 14.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.675 -0.641 . . . . 0.79 109.541 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -41.36 95.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.708 -0.62 . . . . 1.29 109.612 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.813 ' HB3' HD13 ' A' ' 26' ' ' LEU . 1.2 m-20 -76.11 158.11 82.45 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.682 -0.636 . . . . 1.66 109.626 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.71 98.39 1.21 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.68 2.254 . . . . 1.95 110.448 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 -88.04 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.053 -0.404 . . . . 2.63 109.978 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD13 ' HB3' ' A' ' 23' ' ' ASP . 1.2 mp 66.25 163.39 0.13 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.616 -0.677 . . . . 1.51 110.183 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.65 133.9 14.63 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.666 2.244 . . . . 1.07 110.652 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.615 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 28.7 p90 -86.93 154.27 20.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.707 -0.621 . . . . 1.01 110.119 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 132.93 42.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.623 -0.673 . . . . 1.18 109.409 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 0.63 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.14 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 0.94 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 0.67 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.77 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.8 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 0.76 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 0.7 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 0.97 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.61 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 0.76 108.704 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 0.67 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 0.58 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 0.64 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 3.95 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 1.66 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 0.55 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 0.56 109.55 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.97 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD1' HD12 ' A' ' 20' ' ' LEU . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 0.91 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.18 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 0.8 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 0.9 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 0.74 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 0.94 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 1.47 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.57 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 0.44 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.44 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 0.59 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 0.56 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.22 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.36 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.85 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 0.82 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.6 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 0.53 109.571 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.72 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.601 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.59 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 0.89 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.15 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.72 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 0.5 110.145 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.47 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.59 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 39' ' ' PHE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 0.56 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.71 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.908 ' HG ' ' HB2' ' A' ' 7' ' ' ALA . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.83 110.107 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.02 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.34 110.014 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.54 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 0.69 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.39 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 0.83 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' HG22 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.38 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.8 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 0.66 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo -75.58 77.32 3.35 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.68 110.32 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -84.98 101.14 12.13 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.48 108.899 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -154.74 176.51 12.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.547 -0.721 . . . . 1.65 109.997 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.7 -65.58 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 4.9 109.433 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.96 153.0 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.526 -0.733 . . . . 4.14 110.357 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.4 -77.77 0.37 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.199 -1.56 . . . . 3.9 109.199 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 34.9 p-80 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.376 -0.821 . . . . 3.93 109.256 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 2' ' ' SER . 1.7 ptt? . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 110.022 -0.362 . . . . 5.29 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.523 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER -104.2 -41.42 5.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 4.01 109.471 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.38 -82.52 1.6 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.112 -1.195 . . . . 2.78 110.112 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.77 92.88 0.72 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.063 -1.215 . . . . 2.55 110.063 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.6 m -93.09 116.05 28.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.709 -0.848 . . . . 2.46 108.709 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 130.51 36.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.451 -0.781 . . . . 1.83 109.804 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 122.65 25.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 1.67 109.696 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -89.58 120.29 30.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.597 -0.69 . . . . 2.15 109.25 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 m -91.17 123.78 34.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.51 -0.744 . . . . 2.09 109.554 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 -48.34 17.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.604 -0.685 . . . . 1.96 109.664 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.31 80.28 0.09 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.306 -1.118 . . . . 1.65 110.306 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -92.89 124.67 37.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.557 -0.966 . . . . 1.17 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 79.8 mttt -134.55 158.07 44.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.506 -0.746 . . . . 1.97 110.325 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 0.76 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.62 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.75 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 1.63 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 0.86 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 25' ' ' LYS . 27.2 m -122.91 125.26 45.0 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 0.58 108.553 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -55.38 137.91 46.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.561 -0.712 . . . . 1.16 110.078 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 p -62.53 -44.63 95.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.794 -0.566 . . . . 0.83 109.969 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -65.26 -43.88 89.86 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.646 -0.659 . . . . 1.13 109.592 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.3 m-20 -71.71 160.58 82.21 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.721 -0.612 . . . . 1.18 109.644 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.43 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.647 2.231 . . . . 0.81 110.475 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 19' ' ' THR . 7.5 mttp -84.73 -25.91 28.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 3.14 110.952 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.57 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -52.75 -56.52 22.32 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.454 -0.779 . . . . 1.69 110.88 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.8 Cg_endo -80.1 110.55 2.54 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.511 2.141 . . . . 0.85 110.801 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.49 159.81 43.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.532 -0.73 . . . . 0.97 109.705 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.35 138.69 48.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.31 110.139 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 0.66 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.99 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.55 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 42' ' ' VAL . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 0.81 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.82 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.14 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.4 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 0.75 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.79 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.56 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 0.56 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 33' ' ' VAL . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 0.57 109.281 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 0.64 109.659 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 1.57 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 1.93 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.38 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 0.52 109.976 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.89 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.7 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.21 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 0.79 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.76 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 0.57 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.76 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 0.95 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 0.88 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.45 109.671 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.45 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.79 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.79 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.06 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 0.97 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 0.94 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.56 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 76' ' ' ILE . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 0.53 109.32 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.72 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.62 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 0.9 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 0.98 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.72 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 0.66 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.78 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 0.92 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 67' ' ' VAL . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 0.65 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 0.92 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.09 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 1.53 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.407 ' NE2' HG22 ' A' ' 67' ' ' VAL . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.39 110.101 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.84 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 0.95 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.63 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 0.98 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.49 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.95 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.621 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 0.69 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.621 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo -76.4 69.65 6.5 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.82 110.321 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -91.91 115.19 27.85 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.663 -0.865 . . . . 1.69 108.663 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.12 134.37 42.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.734 -0.604 . . . . 2.34 110.735 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.3 107.08 8.29 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.533 -0.914 . . . . 1.6 108.533 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 93' ' ' GLY . 68.1 t -95.9 -103.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.618 -0.676 . . . . 2.57 109.182 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 92' ' ' VAL . . . -91.87 -28.93 12.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 4.43 109.452 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.682 -0.893 . . . . 7.83 109.911 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.475 0.655 . . . . 9.16 109.569 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 m -71.01 110.95 6.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 5.86 109.051 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.27 -157.36 1.01 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.398 -1.081 . . . . 4.43 110.398 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.57 87.95 0.35 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.726 -1.349 . . . . 3.04 109.726 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -54.21 -29.93 48.0 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.813 -0.816 . . . . 3.53 109.599 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.16 72.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.698 -1.223 . . . . 2.24 107.698 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.13 80.39 5.48 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.738 -0.601 . . . . 1.94 109.572 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 42.36 55.34 4.07 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.492 0.663 . . . . 2.75 109.844 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 m -118.75 97.84 5.92 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.56 139.69 49.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 1.23 110.007 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.04 -73.55 0.22 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.478 -1.449 . . . . 1.04 109.478 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.89 115.42 22.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.792 -0.828 . . . . 1.56 109.282 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 19.6 mttt -133.41 153.12 51.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.611 -0.681 . . . . 1.44 109.756 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 0.6 109.391 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' OG ' ' A' ' 32' ' ' SER . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.81 109.943 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.68 109.978 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.16 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 0.66 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -107.28 147.12 30.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 0.71 109.582 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.09 137.87 56.7 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.492 -0.755 . . . . 1.18 110.182 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 85' ' ' ARG . 28.5 p -98.96 52.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.284 -0.636 . . . . 1.24 109.284 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.58 -54.89 0.17 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 1.9 109.686 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.2 152.67 65.19 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.64 -0.662 . . . . 1.97 109.9 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.94 -17.01 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.77 2.313 . . . . 2.29 110.937 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -56.4 -52.55 64.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.544 -0.722 . . . . 2.72 109.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -62.28 126.11 87.11 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.538 -0.541 . . . . 1.49 109.538 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.39 141.55 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.678 2.252 . . . . 1.04 110.825 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -65.75 157.09 31.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.776 -0.578 . . . . 1.06 110.055 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? -106.05 129.58 54.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.556 -0.715 . . . . 0.93 109.995 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 0.71 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 0.92 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.46 ' OG ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.05 109.316 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.81 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.89 110.731 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 0.92 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 0.8 109.09 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.79 111.418 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.58 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.06 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 0.66 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 0.62 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD12 HD12 ' A' ' 59' ' ' ILE . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.69 109.783 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.36 109.667 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.22 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 0.53 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 0.63 109.833 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.72 111.068 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 1.55 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 0.77 109.488 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 0.92 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 0.93 110.294 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.12 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.31 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 0.71 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 0.64 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 HD12 ' A' ' 43' ' ' LEU . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 0.52 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 0.79 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 0.72 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.07 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.17 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.89 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 0.83 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.644 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.65 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG11 HD12 ' A' ' 76' ' ' ILE . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 0.59 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.0 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.687 ' O ' HG23 ' A' ' 40' ' ' THR . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 0.86 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' HD11 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.36 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.72 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 0.59 110.216 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.6 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.575 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 1.63 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG11 ' A' ' 67' ' ' VAL . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 0.56 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.69 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 0.85 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.06 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.04 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.71 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 0.71 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 0.84 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.514 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 1.76 109.983 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 0.65 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.512 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 0.84 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo -75.57 88.63 1.27 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.68 110.152 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 90.53 5.4 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.63 . . . . 1.74 109.572 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -114.29 -53.23 2.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.23 109.43 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -102.05 -173.37 2.33 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.731 -0.605 . . . . 2.3 109.988 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.45 -45.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.42 -0.8 . . . . 2.18 109.683 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.49 36.12 4.6 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.86 -1.296 . . . . 2.18 109.86 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.959 -1.02 . . . . 1.47 109.491 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.947 -0.39 . . . . 4.77 109.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.22 100.03 11.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.338 -0.851 . . . . 4.99 110.397 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.53 120.54 2.19 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.219 -1.152 . . . . 4.1 110.219 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.37 68.93 0.54 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.979 -1.648 . . . . 3.8 108.979 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -66.88 112.39 4.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.811 -0.817 . . . . 3.6 109.555 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.17 -39.65 13.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.844 -0.798 . . . . 2.4 108.844 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.16 98.32 5.61 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.375 -0.602 . . . . 2.31 109.375 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.4 m -96.15 -50.02 5.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.724 -0.843 . . . . 2.38 108.724 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -88.07 178.93 6.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.916 -0.772 . . . . 2.11 108.916 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.14 138.24 43.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.229 -0.92 . . . . 3.51 109.276 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -107.25 3.0 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.666 -1.373 . . . . 1.99 109.666 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -162.36 152.92 17.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.907 . . . . 1.81 110.171 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -126.0 149.09 49.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.747 -0.596 . . . . 1.35 109.909 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 0.71 109.303 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.09 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.66 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.4 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 0.61 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p -113.14 128.13 56.4 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 0.57 108.982 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 86' ' ' LEU . 12.4 tp -67.58 130.58 43.48 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.54 -0.725 . . . . 0.9 109.975 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 p -74.95 -38.77 61.64 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.803 -0.561 . . . . 0.9 109.757 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -91.7 57.8 3.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.598 -0.688 . . . . 1.14 109.485 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -148.47 139.02 13.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.397 -0.814 . . . . 1.2 109.503 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.53 161.7 33.96 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.559 2.173 . . . . 1.57 111.164 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 65.4 -154.74 0.27 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.942 -0.474 . . . . 3.54 109.832 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.98 74.71 48.45 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.109 -0.994 . . . . 1.88 110.362 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 37.0 Cg_endo -82.3 130.96 6.46 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 122.973 2.449 . . . . 1.43 110.186 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -137.97 154.53 49.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 1.43 110.354 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 121.07 34.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 1.03 109.627 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 0.74 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 0.98 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.3 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.65 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.83 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.92 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.96 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 0.68 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.55 111.418 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.54 109.705 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 0.52 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 0.61 109.293 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 59' ' ' ILE . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 0.58 109.559 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 2.85 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.545 ' CB ' HD21 ' A' ' 31' ' ' LEU . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.57 110.092 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 0.54 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 0.57 109.97 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.06 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 86' ' ' LEU . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.77 111.27 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.46 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 0.67 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.65 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 0.59 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 0.71 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 0.82 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.59 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 90' ' ' ASP . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 0.46 109.291 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 43' ' ' LEU . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 0.43 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.609 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 0.71 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.63 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 0.96 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.12 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.7 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 0.62 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.45 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 0.52 109.519 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.22 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.53 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 0.92 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.56 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.69 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 0.64 110.135 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.71 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.11 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.447 HG21 ' CE1' ' A' ' 39' ' ' PHE . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 0.54 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 0.87 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 0.86 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 1.66 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.32 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.66 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 0.71 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.99 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 0.91 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 1.82 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 0.72 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.548 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 0.77 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.44 59.99 6.31 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.78 109.573 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.96 113.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 2.66 109.605 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -76.51 113.43 14.12 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.707 -0.849 . . . . 1.08 108.707 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 164.72 33.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.536 -0.728 . . . . 3.34 110.586 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 -53.84 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.788 -0.57 . . . . 1.34 110.584 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.18 -66.91 1.42 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.441 -1.064 . . . . 1.66 110.441 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.644 -0.915 . . . . 3.8 109.93 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.151 0.5 . . . . 4.87 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -150.53 -54.93 0.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.525 -0.546 . . . . 6.01 109.525 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.57 -92.66 0.57 Allowed Glycine 0 N--CA 1.501 2.982 0 N-CA-C 108.982 -1.647 . . . . 6.07 108.982 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.03 88.44 0.78 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.665 -1.774 . . . . 6.26 108.665 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.91 163.56 25.03 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.569 -0.96 . . . . 4.6 109.933 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 5' ' ' THR . . . -68.91 122.97 19.74 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.792 -0.568 . . . . 3.41 110.66 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 106.59 6.79 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.99 -1.115 . . . . 2.94 107.99 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.17 160.02 14.65 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.667 0.746 . . . . 2.23 111.418 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 m -104.69 -2.15 25.35 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.746 -0.596 . . . . 2.85 109.774 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.27 -57.59 2.22 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.297 -0.877 . . . . 1.67 109.854 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.59 63.46 0.27 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.259 -1.136 . . . . 1.05 110.259 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.43 132.04 14.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.91 . . . . 1.27 109.325 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt -116.76 153.85 31.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.631 -0.668 . . . . 2.35 110.25 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 0.85 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 0.84 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.79 110.09 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 0.86 108.428 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.71 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -118.74 154.05 33.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.5 109.573 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 20' ' ' LEU . 12.5 tp -64.32 135.38 56.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.372 -0.83 . . . . 0.94 109.894 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 85' ' ' ARG . 2.9 m -104.32 -49.9 3.47 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.709 -0.619 . . . . 0.84 110.055 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -52.34 64.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.694 -0.628 . . . . 1.34 110.14 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.79 146.85 34.61 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.624 -0.672 . . . . 2.14 110.203 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.99 -16.97 13.97 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.665 2.243 . . . . 1.23 109.786 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.243 0.544 . . . . 3.29 110.424 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.34 124.74 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 122.136 -0.353 . . . . 1.82 110.741 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.74 165.21 30.65 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.917 2.411 . . . . 0.94 111.156 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.7 p90 -69.44 158.88 34.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.625 -0.672 . . . . 0.78 110.39 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -121.24 135.67 55.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.671 -0.643 . . . . 0.98 109.624 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 0.86 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.1 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 0.7 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 HG22 ' A' ' 42' ' ' VAL . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 0.75 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.79 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.44 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.54 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 0.77 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.83 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.69 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 0.87 108.705 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.68 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 33' ' ' VAL . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 0.75 109.18 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 2.68 109.846 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.525 ' HB3' HD21 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 1.58 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 0.48 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 0.55 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.6 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 3.62 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 86' ' ' LEU . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 0.71 108.947 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.89 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 0.87 110.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.17 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 0.87 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.94 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 0.57 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 43' ' ' LEU . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 0.55 108.99 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 0.66 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.69 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.52 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.43 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 0.89 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.63 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 80' ' ' HIS . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 0.66 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.12 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.86 110.145 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.11 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.98 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.8 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.92 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.56 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 67' ' ' VAL . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.78 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.03 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.17 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.27 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 67' ' ' VAL . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.07 110.688 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.86 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 0.8 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 0.84 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 1.71 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 0.82 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 0.77 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo -75.85 123.85 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.68 110.572 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -89.13 147.15 24.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.766 -0.584 . . . . 1.36 109.572 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.83 56.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 2.04 108.84 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 -58.38 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.257 -0.646 . . . . 2.44 109.257 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.49 -57.29 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.592 . . . . 2.23 109.4 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.34 -115.7 0.93 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.691 -1.364 . . . . 1.4 109.691 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.719 -1.134 . . . . 1.87 110.282 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttm . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.603 0.716 . . . . 4.08 110.342 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.06 174.23 10.85 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.361 -0.607 . . . . 5.01 109.361 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.06 -98.24 1.83 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.676 -1.37 . . . . 2.8 109.676 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.98 -126.85 2.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.47 -1.452 . . . . 1.27 109.47 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.7 p -114.88 140.41 48.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.919 . . . . 1.53 109.35 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.84 125.75 35.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.891 -0.781 . . . . 1.16 108.891 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.32 110.76 20.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.99 109.871 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.9 m -99.87 96.0 7.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.053 -0.721 . . . . 0.94 109.053 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.547 -0.721 . . . . 0.81 109.78 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.22 143.27 34.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.668 -0.645 . . . . 1.01 109.777 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.49 -77.17 0.38 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.48 -1.448 . . . . 0.73 109.48 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 p -88.19 -52.68 5.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.729 -0.865 . . . . 0.78 109.458 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -136.99 153.92 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.586 -0.696 . . . . 1.52 109.733 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 0.36 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 0.47 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.53 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.02 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 0.49 109.634 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 26.5 p -116.54 134.38 54.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 0.58 109.527 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 23' ' ' ASP . 26.9 tp -85.12 117.52 24.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.549 -0.719 . . . . 0.72 109.8 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 t -110.5 -10.94 14.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.695 -0.628 . . . . 1.12 110.435 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -56.53 3.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.159 -0.963 . . . . 1.26 109.786 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.735 ' HB2' HD21 ' A' ' 20' ' ' LEU . 6.8 m-20 -97.53 152.74 38.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.581 -0.7 . . . . 1.42 110.077 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.87 -29.15 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.696 2.264 . . . . 1.16 110.774 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 133.17 48.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.635 -0.666 . . . . 3.69 109.956 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER 65.39 106.35 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.98 -0.45 . . . . 0.93 109.821 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' HD2' HD13 ' A' ' 26' ' ' LEU . 33.7 Cg_endo -75.41 -46.8 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.641 2.227 . . . . 0.72 110.955 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 47.8 p90 -150.95 163.73 38.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.435 -0.79 . . . . 1.26 110.114 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -145.38 131.08 18.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.651 -0.655 . . . . 1.52 109.602 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 0.71 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.16 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 0.56 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 0.57 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.47 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.71 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 0.94 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.51 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.52 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.52 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.59 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 0.45 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.571 HG22 HG21 ' A' ' 33' ' ' VAL . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 0.48 109.32 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 57' ' ' SER . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 0.67 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' THR . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 2.59 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 0.98 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 0.38 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 0.37 110.056 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.09 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.55 109.27 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.12 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 0.61 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.62 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 0.64 110.314 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 0.78 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 1.34 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 0.84 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 0.39 109.369 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.43 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 0.64 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 80' ' ' HIS . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 0.58 110.156 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 0.89 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.41 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.9 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 0.75 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.58 109.93 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 0.55 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.33 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.58 110.128 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 0.97 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.14 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.48 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 0.44 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.4 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 0.98 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.463 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 0.51 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.59 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 0.67 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 2.57 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 61' ' ' THR . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.36 110.618 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.5 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.01 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 0.65 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.77 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.75 109.997 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.631 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.61 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo -74.34 95.6 0.93 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.61 110.672 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 89.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.524 0.678 . . . . 1.54 109.718 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 1.2 p-10 -90.78 156.98 17.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.605 -0.685 . . . . 1.26 110.313 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -97.95 103.94 15.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.821 -0.549 . . . . 3.19 109.531 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 92' ' ' VAL . 8.2 p -144.01 99.18 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.563 -0.71 . . . . 3.21 110.382 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.54 -83.14 0.08 OUTLIER Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.458 -1.057 . . . . 2.79 110.458 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 14.9 m80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 117.452 -1.261 . . . . 5.53 109.724 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.502 -0.555 . . . . 3.36 109.502 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -89.13 127.92 35.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 2.84 109.819 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.87 76.15 1.17 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.76 -1.336 . . . . 3.47 109.76 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.66 -94.81 0.27 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.176 -1.569 . . . . 3.75 109.176 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 8' ' ' THR . 20.4 p -104.34 86.68 2.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.821 . . . . 3.52 109.743 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 1' ' ' MET . . . -75.75 129.93 37.84 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.39 -0.818 . . . . 2.17 109.526 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 49.33 72.72 0.28 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.449 -0.945 . . . . 2.97 108.449 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 5' ' ' THR . 97.0 m -128.31 149.06 50.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.66 -0.65 . . . . 3.18 110.511 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -117.68 139.14 51.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 4.01 109.077 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.99 102.65 15.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 2.16 110.195 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.39 78.02 2.05 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.619 -1.392 . . . . 1.1 109.619 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.9 -62.65 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.688 -0.89 . . . . 1.36 109.01 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt -139.13 151.05 46.35 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 1.82 109.601 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 0.46 109.465 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 0.61 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.54 110.196 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 2.75 108.679 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 0.56 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m -114.04 129.2 56.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 0.47 108.73 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -64.19 109.57 1.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.449 -0.782 . . . . 0.67 109.584 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -76.81 -28.03 55.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.616 -0.678 . . . . 0.74 109.752 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.68 -36.08 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.449 -0.782 . . . . 1.16 109.712 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 109.65 58.12 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 1.49 109.919 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.12 -25.5 8.61 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.773 2.316 . . . . 0.78 110.901 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -48.32 76.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.568 -0.708 . . . . 2.63 109.737 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.74 130.33 88.8 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.09 109.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.19 175.6 11.15 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.049 2.499 . . . . 0.68 111.283 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -76.32 163.85 26.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.588 -0.695 . . . . 0.68 110.396 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt -128.38 133.89 48.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.516 -0.74 . . . . 0.81 109.746 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG22 ' HG3' ' A' ' 17' ' ' LYS . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 0.61 109.291 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.08 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.0 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 42' ' ' VAL . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.52 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.41 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.97 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.5 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.41 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.54 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.57 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 0.42 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 33' ' ' VAL . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 0.41 109.319 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD12 HD12 ' A' ' 59' ' ' ILE . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 0.6 109.805 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.51 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.2 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 0.46 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 0.44 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.74 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 20' ' ' LEU . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.52 110.968 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.23 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 86' ' ' LEU . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 0.57 109.399 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.63 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 0.67 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.81 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 0.85 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 0.63 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 0.49 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.432 HD12 HD12 ' A' ' 43' ' ' LEU . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.45 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 0.6 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 0.51 109.331 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 0.66 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.54 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 76' ' ' ILE . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 0.54 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.39 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.59 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.03 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.06 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.43 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.38 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.43 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.33 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 67' ' ' VAL . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 0.49 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 0.8 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 0.73 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.06 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.29 110.252 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.6 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.61 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.32 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 0.95 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.45 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 0.71 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 0.71 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo -76.12 121.24 6.05 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.77 110.412 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 130.21 35.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.453 -0.573 . . . . 0.98 109.453 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.41 103.35 9.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.868 -0.79 . . . . 1.16 108.868 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.04 -68.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.677 -0.639 . . . . 2.69 109.293 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.3 t -128.7 117.81 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 4.78 109.402 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.45 -72.29 1.31 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.56 -1.416 . . . . 3.89 109.56 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.884 . . . . 3.16 109.92 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.175 0.512 . . . . 4.77 109.829 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -89.67 -39.28 13.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.566 -0.709 . . . . 3.2 109.724 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 32' ' ' SER . . . -175.0 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.955 -1.258 . . . . 1.86 109.955 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.64 70.2 0.22 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -161.21 117.34 2.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.802 -0.822 . . . . 2.36 109.227 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.55 -55.93 3.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.473 -0.767 . . . . 2.93 109.614 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.25 -58.8 0.84 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.313 -0.625 . . . . 3.69 109.313 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -109.82 -49.21 3.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.551 -0.718 . . . . 3.52 109.403 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -159.68 146.5 16.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.698 . . . . 2.59 109.63 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.42 140.9 49.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.686 -0.634 . . . . 2.01 109.379 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.18 47.45 3.12 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.994 -1.242 . . . . 1.76 109.994 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.47 -54.12 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.644 -0.915 . . . . 1.52 109.407 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -138.25 166.51 24.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 0.69 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 0.78 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.64 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.11 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 0.65 109.85 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 29.2 m -103.81 131.83 50.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 0.69 109.202 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -65.35 125.75 26.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.559 -0.713 . . . . 0.95 109.784 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.2 p -83.87 -41.95 16.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.703 -0.623 . . . . 0.8 109.768 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -61.98 -36.97 83.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.592 -0.693 . . . . 1.05 109.916 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.8 139.71 97.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.68 -0.638 . . . . 1.03 109.902 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.27 -29.79 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.532 2.155 . . . . 0.87 110.486 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -26.12 51.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.572 -0.705 . . . . 3.12 109.95 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 62.61 65.25 1.5 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.692 -0.63 . . . . 1.24 109.318 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.65 111.49 3.26 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.046 2.497 . . . . 0.63 110.6 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 43.7 p90 -83.06 154.65 24.29 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.713 -0.617 . . . . 0.97 110.064 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -134.83 134.46 40.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.712 -0.617 . . . . 1.17 109.53 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 0.76 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 0.83 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.426 ' OG ' ' HA3' ' A' ' 3' ' ' GLY . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 0.94 109.601 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 0.58 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.6 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 0.65 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 0.58 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.53 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.56 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 0.63 108.513 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.51 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 0.52 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 0.53 109.905 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.49 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.88 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.49 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 0.41 109.993 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.49 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.32 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 20' ' ' LEU . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.53 111.133 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 2.68 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.069 HG21 HD21 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 0.59 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.6 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.64 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 0.6 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.68 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 0.8 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 0.73 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 0.35 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 0.54 109.426 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 66' ' ' GLY . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.62 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 0.57 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.0 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.36 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.74 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 0.65 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.45 110.002 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 0.53 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 0.87 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 0.98 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.23 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.58 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.59 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 1.61 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.431 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 0.61 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.9 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 0.94 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 2.56 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.85 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 0.89 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.31 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.88 110.199 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 2.46 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.069 HD21 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.9 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 0.54 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo -74.45 108.19 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64 110.804 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -83.38 87.26 6.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 1.24 109.627 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -132.19 -50.87 0.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 1.36 109.415 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -53.03 3.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.689 -0.632 . . . . 3.72 109.424 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -90.5 156.85 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.765 -0.584 . . . . 1.42 110.218 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.06 65.2 2.92 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.417 -1.473 . . . . 1.02 109.417 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.803 -1.094 . . . . 1.78 109.832 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 6' ' ' ALA . 4.9 mtm . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.658 -0.497 . . . . 3.53 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -124.98 124.82 42.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.74 . . . . 4.73 109.842 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.25 -98.3 0.5 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.554 -1.418 . . . . 3.48 109.554 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.32 -64.64 1.07 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.668 -1.373 . . . . 3.28 109.668 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 10.0 t -152.98 171.92 17.61 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.691 -0.888 . . . . 4.87 109.728 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . -173.89 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.346 -0.846 . . . . 4.92 109.651 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.08 -179.91 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.735 -0.603 . . . . 3.85 109.479 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -66.88 150.27 49.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.265 -0.897 . . . . 4.87 110.245 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.403 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 26.4 p -73.06 81.84 1.25 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.789 -0.57 . . . . 3.96 110.094 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.48 -45.15 3.58 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.171 -0.956 . . . . 1.58 110.109 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.86 62.17 2.05 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.942 -1.263 . . . . 1.42 109.942 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.44 67.74 0.69 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.689 -0.889 . . . . 1.57 109.258 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -129.18 157.08 42.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.425 -0.797 . . . . 2.09 109.902 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 0.87 109.283 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.01 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.69 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.02 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.61 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.425 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 57.9 m -108.06 123.14 48.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 0.85 109.166 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 23' ' ' ASP . 19.8 tp -66.85 140.22 57.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.542 -0.724 . . . . 0.66 110.004 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.9 p -126.81 45.06 2.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.706 -0.621 . . . . 0.96 109.9 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.66 -65.18 0.08 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.308 -0.87 . . . . 1.37 110.042 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -84.37 145.77 46.12 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.502 -0.749 . . . . 1.99 109.804 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.07 -25.02 9.16 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.897 2.398 . . . . 0.84 111.329 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 118.43 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.417 -0.802 . . . . 1.9 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.52 107.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.597 -0.519 . . . . 1.42 109.597 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.49 -46.31 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.551 2.168 . . . . 0.94 110.615 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 52.4 p90 -138.97 166.29 24.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.51 109.838 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -146.09 128.48 15.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.582 -0.699 . . . . 1.25 109.518 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 0.89 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.0 109.7 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.25 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.98 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.15 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.19 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 1.66 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.17 109.296 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.11 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.465 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.8 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 69' ' ' PRO . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.94 108.783 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 33' ' ' VAL . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 0.8 109.309 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 59' ' ' ILE . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 0.73 109.709 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.47 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 1.64 110.225 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 0.62 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 0.5 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.31 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.98 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.56 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 2.66 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 0.54 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.75 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 0.8 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.01 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.02 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 0.75 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 0.62 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 43' ' ' LEU . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 0.44 109.347 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.739 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 0.59 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 0.58 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.34 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 0.72 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.56 109.944 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 0.51 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.07 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.02 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.22 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 0.97 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 0.84 109.958 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.83 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.11 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.465 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 0.58 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 0.9 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 0.86 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.07 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.73 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.04 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 0.75 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 19' ' ' THR . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 1.72 109.478 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 0.67 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 0.91 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo -74.51 90.85 1.0 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.8 110.289 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 71.97 128.2 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.243 0.544 . . . . 2.62 109.756 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.69 111.17 22.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.582 -0.699 . . . . 1.53 109.744 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -57.93 3.13 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.008 -0.738 . . . . 2.55 109.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.04 -23.27 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 2.94 109.904 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.71 -153.88 17.1 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.192 -1.563 . . . . 1.75 109.192 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.4 t60 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 117.743 -1.122 . . . . 3.02 109.812 179.727 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.685 ' H1 ' ' HA ' ' A' ' 5' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.472 -0.936 . . . . 5.37 108.472 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.29 21.92 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.975 -0.75 . . . . 3.12 108.975 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.03 77.92 0.4 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.965 -1.654 . . . . 4.09 108.965 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.01 85.26 1.42 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.372 -1.491 . . . . 3.92 109.372 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.685 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 17.0 p -82.71 133.51 35.15 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.402 -1.058 . . . . 4.47 110.219 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.99 85.86 1.69 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 2.95 110.098 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.14 -52.36 10.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.652 -0.655 . . . . 3.06 109.744 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.1 p -109.46 127.54 54.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.539 -0.726 . . . . 3.25 109.379 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -100.08 160.85 14.0 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.705 0.764 . . . . 4.5 111.265 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.26 3.24 23.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.885 -0.509 . . . . 4.34 110.261 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.62 -56.66 12.23 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.872 -1.291 . . . . 2.96 109.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.5 p -98.66 2.38 47.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.83 -0.806 . . . . 1.86 110.449 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -121.68 159.65 26.12 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -0.883 . . . . 2.03 109.898 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 0.67 109.88 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 0.84 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.7 110.013 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 0.7 110.077 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m -129.08 134.16 47.97 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 0.67 109.026 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.71 123.19 18.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.533 -0.729 . . . . 0.63 110.043 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -106.73 -30.02 9.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.82 -0.55 . . . . 0.8 110.029 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -40.13 75.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.43 -0.794 . . . . 1.11 109.861 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -76.18 166.87 41.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.691 -0.631 . . . . 1.2 109.99 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 32.2 Cg_endo -74.81 -29.8 8.19 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.631 2.221 . . . . 1.03 110.635 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 167.07 18.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.5 -0.75 . . . . 4.14 109.817 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.09 72.57 71.67 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.77 . . . . 1.22 109.895 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.1 119.02 4.9 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.67 2.247 . . . . 0.74 110.076 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -87.23 144.29 26.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.524 -0.735 . . . . 1.5 110.056 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt -131.73 111.38 11.61 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.34 109.14 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 0.74 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.17 109.527 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 0.76 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 0.7 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.71 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.25 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 0.59 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.52 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.55 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 0.54 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 0.52 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 0.55 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 0.58 109.453 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.15 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 31' ' ' LEU . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 1.62 110.15 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 0.51 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 0.51 109.922 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.91 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.14 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 86' ' ' LEU . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.66 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.12 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 0.72 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.81 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 0.73 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.07 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.36 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 0.91 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 0.39 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 0.47 109.122 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.697 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 0.62 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 0.61 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.85 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.18 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.68 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG11 ' HE1' ' A' ' 80' ' ' HIS . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 0.72 108.946 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.48 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 80' ' ' HIS . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 0.54 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.82 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.51 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.6 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.08 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.5 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 0.54 110.213 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.34 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 0.6 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.81 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 0.94 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.25 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' HG22 ' A' ' 67' ' ' VAL . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.93 109.897 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.71 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 0.81 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.93 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.588 ' HD3' ' HB ' ' A' ' 21' ' ' THR . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.04 109.908 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.61 109.736 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 0.55 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.651 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -73.99 122.81 7.93 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.62 109.688 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 70.55 143.18 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.251 0.548 . . . . 2.31 109.587 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.3 112.9 6.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 1.31 109.42 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -125.03 -49.71 1.71 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 3.75 110.607 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 t 70.03 78.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.318 -0.623 . . . . 1.38 109.318 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.29 69.56 0.49 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.668 -1.373 . . . . 1.54 109.668 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.823 -1.084 . . . . 1.7 109.981 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.797 -0.445 . . . . 5.02 109.797 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.66 84.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.552 -0.907 . . . . 4.6 108.552 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.46 109.48 1.98 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.269 -1.132 . . . . 5.33 110.269 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.93 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 6.11 110.131 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 t -87.15 161.14 18.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.586 -0.949 . . . . 5.25 110.371 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.81 -37.51 35.01 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.647 -0.871 . . . . 4.36 108.647 178.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.71 46.53 18.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.436 0.636 . . . . 3.3 110.12 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -77.96 111.79 14.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 2.67 109.532 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -77.48 -41.14 40.57 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.052 -0.721 . . . . 2.04 109.052 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.33 152.11 27.63 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.443 -0.577 . . . . 1.26 109.443 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.13 -60.82 4.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.612 -1.395 . . . . 1.17 109.612 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.2 p -94.75 120.61 35.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.709 -0.877 . . . . 0.95 109.814 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -141.89 154.57 45.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.579 -0.701 . . . . 1.79 109.782 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.54 109.603 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 0.74 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68 109.967 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.39 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.577 HG21 HD12 ' A' ' 86' ' ' LEU . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 0.78 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 2.6 m -126.42 147.21 49.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 0.84 108.777 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.27 139.93 55.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.206 -0.934 . . . . 1.31 109.67 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -84.82 -46.36 11.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.669 -0.644 . . . . 0.99 110.131 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -55.0 5.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.557 -0.714 . . . . 1.38 109.841 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 20' ' ' LEU . 2.4 t70 -78.75 132.71 63.86 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.685 -0.635 . . . . 2.13 110.104 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.0 94.85 1.06 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.715 2.277 . . . . 1.84 109.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 124.54 47.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.618 -0.676 . . . . 1.86 110.355 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -65.86 -55.84 20.57 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.455 -0.572 . . . . 1.71 109.455 179.254 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 35.9 Cg_endo -78.38 165.52 25.34 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 122.519 2.146 . . . . 1.23 110.403 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -136.71 161.39 36.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.489 -0.757 . . . . 1.38 110.104 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -80.36 119.48 23.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.92 109.912 -179.829 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 0.83 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 0.83 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 0.85 109.057 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 0.72 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.62 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.08 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 0.56 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.45 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.56 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 0.74 108.547 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 0.42 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 0.47 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 0.53 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.04 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HB2' HD21 ' A' ' 31' ' ' LEU . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 1.58 110.124 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 0.47 109.404 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.47 109.978 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.9 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.54 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 0.89 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 2.64 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 0.61 109.46 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.62 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 0.55 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.68 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 89' ' ' ARG . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 0.71 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 0.59 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 0.46 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 0.54 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 0.76 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 0.73 110.22 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.14 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 0.88 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.58 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 0.75 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.04 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.52 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.69 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.16 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.43 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 0.48 110.371 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.42 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 0.93 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 0.5 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.61 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 0.8 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 2.82 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.442 ' NE2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.28 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.68 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.31 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 0.75 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 1.86 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.91 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 0.61 109.333 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.94 55.59 5.65 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.57 110.712 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 65.47 167.67 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.512 -0.742 . . . . 0.96 110.356 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 t70 69.51 152.9 0.1 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.401 0.619 . . . . 1.08 110.314 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.2 tpt85 -77.68 101.21 6.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.431 -0.793 . . . . 1.39 109.32 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.2 m -138.27 140.29 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.652 -0.655 . . . . 1.11 109.661 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.63 -70.05 1.36 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.558 -1.417 . . . . 1.62 109.558 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.0 t60 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.852 -1.07 . . . . 1.56 109.757 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 4' ' ' GLY . 24.3 ttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.292 0.568 . . . . 6.77 109.765 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -95.85 -44.4 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.689 . . . . 3.86 109.459 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 11' ' ' GLY . . . -108.13 80.45 0.27 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.844 -1.302 . . . . 4.06 109.844 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . -144.89 -66.08 0.02 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.847 -1.301 . . . . 3.94 109.847 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -100.08 -15.41 18.22 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.685 -0.891 . . . . 4.44 110.055 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 7' ' ' ALA . . . -88.67 97.93 11.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.228 -0.92 . . . . 2.28 109.373 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . . . 68.8 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.93 -0.767 . . . . 2.25 108.93 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.1 p -69.43 -37.63 77.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 2.27 111.688 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -105.5 -18.71 14.01 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.078 -1.013 . . . . 2.4 111.518 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.674 ' HB3' ' CB ' ' A' ' 7' ' ' ALA . . . -78.82 -58.71 3.1 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.063 . . . . 2.04 109.526 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' C ' ' HA2' ' A' ' 3' ' ' GLY . . . 99.16 -117.31 5.83 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.994 -1.243 . . . . 1.37 109.994 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 48.0 p -77.19 -59.17 2.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.474 -1.015 . . . . 1.24 109.83 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -129.34 164.9 22.56 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.513 -0.742 . . . . 1.5 109.701 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG12 ' CB ' ' A' ' 10' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 0.74 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 0.76 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.64 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.03 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 0.59 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 28' ' ' PHE . 73.6 p -116.4 138.53 51.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 0.67 109.401 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD23 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -68.3 125.58 26.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.316 -0.865 . . . . 0.69 108.903 179.543 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.545 HG22 ' NH2' ' A' ' 85' ' ' ARG . 29.2 p -85.05 -44.28 13.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 0.72 110.904 -178.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -45.45 66.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.422 -0.799 . . . . 1.31 110.752 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.559 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -99.56 112.59 63.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.52 -0.738 . . . . 2.42 110.142 -179.439 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.68 -30.19 4.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.781 2.321 . . . . 1.58 110.599 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -37.15 85.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.517 -0.739 . . . . 2.5 109.913 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.74 132.87 95.35 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.521 -0.737 . . . . 1.35 109.881 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.48 160.59 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.0 2.467 . . . . 0.97 111.606 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.686 ' HB3' HG22 ' A' ' 19' ' ' THR . 53.3 p90 -70.58 162.83 28.17 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.671 -0.643 . . . . 1.08 110.649 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.0 129.9 47.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.746 -0.596 . . . . 1.66 109.684 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 0.91 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 0.94 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 0.82 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 0.67 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.72 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.08 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.21 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 0.63 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.49 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.54 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 69' ' ' PRO . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 0.59 108.899 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 0.44 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 33' ' ' VAL . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 0.53 109.299 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 59' ' ' ILE . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 0.7 109.736 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 2.78 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 1.72 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.51 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 0.63 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.13 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD1' HD23 ' A' ' 20' ' ' LEU . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76 110.791 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 1.74 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 0.9 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.07 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 0.91 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.01 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.19 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.77 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 0.47 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 43' ' ' LEU . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.47 109.369 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.673 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 0.56 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 84' ' ' LEU . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 0.58 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 1.75 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 0.77 108.933 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.62 109.88 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 76' ' ' ILE . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 0.58 109.527 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.36 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.63 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.8 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.632 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 0.91 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.63 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.62 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.83 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.12 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 0.72 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 0.92 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.17 109.982 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 1.58 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.06 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.72 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 61' ' ' THR . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 0.58 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 21' ' ' THR . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.63 109.475 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.676 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 0.76 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 0.56 108.814 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.13 102.18 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 0.89 110.554 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 101.37 3.93 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.229 -0.656 . . . . 2.47 109.229 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -166.57 155.95 11.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.597 -0.689 . . . . 1.51 109.71 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -46.23 72.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 2.86 110.271 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.31 130.39 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.474 -0.766 . . . . 2.37 110.251 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.23 51.06 14.52 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.996 -1.242 . . . . 2.69 109.996 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 117.7 -1.143 . . . . 2.92 110.389 179.856 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.919 0.866 . . . . 5.48 110.561 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.89 171.76 19.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.332 -0.618 . . . . 5.93 109.332 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.88 -34.44 10.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.845 -1.302 . . . . 4.27 109.845 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.06 -68.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.892 -1.147 . . . . 3.5 110.604 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 m -129.21 117.2 20.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.914 . . . . 3.41 110.447 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.07 138.84 31.69 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.81 -0.811 . . . . 2.93 108.81 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.4 -38.81 5.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.472 -0.768 . . . . 4.77 111.399 -178.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.2 p -59.47 111.5 1.42 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.314 -0.866 . . . . 3.76 108.823 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 m -121.43 132.44 54.74 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.563 -0.855 . . . . 3.2 111.388 -178.213 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.81 -30.01 6.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.424 -0.954 . . . . 1.94 108.424 178.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.75 -130.02 5.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.664 -1.774 . . . . 1.55 108.664 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.95 112.37 17.13 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.384 -0.969 . . . . 1.44 108.384 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt -121.94 156.12 34.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.387 -0.821 . . . . 2.05 110.816 -178.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 0.55 108.961 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 0.68 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.65 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.39 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.788 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.65 109.889 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m -116.15 122.4 44.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 0.61 109.285 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -67.03 137.43 56.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.632 . . . . 0.54 109.549 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -64.61 -51.71 61.24 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.555 -0.716 . . . . 0.58 109.803 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -21.98 33.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.732 -0.605 . . . . 1.2 110.14 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 17.2 m-20 60.13 67.58 1.64 Allowed Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.687 -0.633 . . . . 0.79 109.547 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 23' ' ' ASP . 36.1 Cg_endo -78.46 87.85 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.964 2.443 . . . . 0.82 110.053 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 77.61 -34.76 0.2 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.019 -0.426 . . . . 3.51 110.76 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.22 133.57 22.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 1.54 109.898 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.73 -59.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.743 2.295 . . . . 0.57 110.753 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -143.89 161.66 38.12 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -0.767 . . . . 1.03 110.347 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 128.4 36.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.653 -0.654 . . . . 1.6 109.695 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 0.67 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 0.85 109.859 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 0.71 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 0.65 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.48 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.97 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 0.55 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.44 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.43 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 0.86 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 0.43 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 0.52 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.58 109.828 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.48 110.108 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD21 ' A' ' 31' ' ' LEU . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.01 109.926 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 0.5 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 0.52 110.092 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.72 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CG ' HD23 ' A' ' 20' ' ' LEU . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.66 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.3 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.7 109.41 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.71 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 0.65 109.96 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.72 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 0.73 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 0.75 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB1' ' OD2' ' A' ' 90' ' ' ASP . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 0.42 109.266 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 0.45 109.8 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 0.56 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 63' ' ' ASP . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.45 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.28 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 61' ' ' THR . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.71 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 0.51 108.92 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.33 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 80' ' ' HIS . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 0.36 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.49 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' O ' HG23 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.59 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 0.76 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.14 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.52 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 0.46 110.336 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.49 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.2 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 67' ' ' VAL . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 0.4 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 0.82 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 0.9 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.2 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.66 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 0.79 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.34 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.857 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 0.61 109.695 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 0.54 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.7 100.95 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.62 110.431 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.4 141.34 0.05 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.465 0.65 . . . . 1.19 110.582 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -84.31 -37.84 21.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.726 -0.609 . . . . 0.59 109.413 179.626 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 60.36 55.41 3.54 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.569 0.7 . . . . 4.39 110.081 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 90' ' ' ASP . 9.3 m -130.4 42.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.085 -0.709 . . . . 1.44 109.085 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.59 60.2 0.7 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.561 -1.416 . . . . 1.24 109.561 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.1 m80 . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.69 -0.888 . . . . 1.53 109.702 -179.892 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.983 -0.377 . . . . 3.77 109.983 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 p -96.59 -48.32 5.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.675 . . . . 2.88 109.738 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.9 104.22 0.77 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.619 -1.392 . . . . 3.2 109.619 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.55 -75.45 0.42 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.798 -1.321 . . . . 3.47 109.798 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -106.39 132.07 52.85 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.581 -0.953 . . . . 4.79 109.347 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.03 48.33 23.27 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.455 0.645 . . . . 3.06 109.594 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.43 128.11 34.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.48 -0.762 . . . . 1.73 110.27 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.23 137.93 31.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.655 -0.653 . . . . 1.63 109.24 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 m -65.11 104.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.117 -0.698 . . . . 1.49 109.117 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.73 122.55 36.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 1.9 109.64 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.12 -114.92 2.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.07 -1.212 . . . . 1.46 110.07 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.85 -48.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.924 . . . . 1.62 110.326 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt -114.29 166.22 11.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.422 -0.799 . . . . 1.9 110.086 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 0.48 109.787 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 0.55 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.63 110.167 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.52 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.63 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -116.8 151.5 36.36 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 0.92 109.256 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 26' ' ' LEU . 12.1 tp -70.73 133.48 46.63 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.334 -0.854 . . . . 0.92 109.947 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 p -90.37 -23.69 21.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.815 -0.553 . . . . 1.1 110.097 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -51.1 67.66 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 1.49 110.069 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -138.93 152.54 70.47 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 1.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.25 -6.55 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 123.018 2.479 . . . . 1.21 111.298 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -58.84 -58.81 6.96 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.357 -0.839 . . . . 3.41 109.692 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' CD1' HD22 ' A' ' 20' ' ' LEU . 2.0 mt -65.58 123.8 85.56 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.606 -0.684 . . . . 1.25 109.473 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.49 -173.85 1.89 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.71 2.274 . . . . 0.91 111.495 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.74 160.31 31.91 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.514 0.673 . . . . 0.71 110.293 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 122.24 37.93 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.03 108.84 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 0.74 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 0.88 109.318 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.91 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 42' ' ' VAL . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 0.64 109.412 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.6 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 0.58 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.5 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.48 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.54 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.49 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.43 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 33' ' ' VAL . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 0.45 109.359 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 0.6 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 2.53 109.921 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.38 109.53 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.46 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 0.39 109.626 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.74 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.63 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.56 110.785 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 1.65 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD21 ' A' ' 86' ' ' LEU . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.63 109.521 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.59 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 0.57 110.161 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 0.7 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 0.69 109.555 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.04 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 0.45 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 0.45 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.702 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 0.58 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 0.56 109.897 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89 109.817 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.36 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.72 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 0.73 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.51 110.019 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 0.53 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.12 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.56 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.87 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.61 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.52 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.44 110.326 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 1.6 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' PHE . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 0.57 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.97 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.84 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.59 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.86 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.67 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 0.77 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 0.86 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 1.9 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 0.77 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 0.71 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.96 123.84 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.86 110.746 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 156.31 24.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.748 -0.595 . . . . 1.75 110.199 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.97 148.97 48.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.554 . . . . 1.35 110.24 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 111.38 22.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.721 . . . . 2.95 109.167 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 93' ' ' GLY . 3.1 m -131.62 -50.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.722 -0.612 . . . . 2.25 109.424 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 92' ' ' VAL . . . -155.83 59.06 0.37 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.904 -1.278 . . . . 2.01 109.904 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 117.873 -1.06 . . . . 3.37 109.81 -179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.391 0.615 . . . . 1.77 110.426 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 0.93 109.654 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.07 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.8 110.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 82' ' ' SER . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 2.69 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 0.71 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 178.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.42 108.896 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.08 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.2 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.05 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 0.98 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.16 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.42 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.48 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 0.97 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.79 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.66 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.03 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 0.75 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 0.67 109.315 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.62 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.38 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 31' ' ' LEU . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.4 109.921 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 0.73 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 0.79 109.783 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.599 ' CD2' HD13 ' A' ' 86' ' ' LEU . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.98 110.856 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.0 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 0.95 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.82 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 0.7 110.153 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.76 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 0.96 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 0.81 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 0.54 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 0.56 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 0.66 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.525 HG21 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 0.54 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.01 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 0.68 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.61 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 76' ' ' ILE . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 0.59 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.3 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 0.94 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 1.8 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 0.94 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 0.84 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.9 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 1.7 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.462 HG21 ' CE1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 0.69 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 0.95 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.12 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 1.61 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.19 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.8 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.03 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.63 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 18' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 0.66 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.59 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.97 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 0.74 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo . . . . . 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.12 110.849 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 2.6 109.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.96 109.959 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.02 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.75 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 2.61 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 86' ' ' LEU . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 0.67 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 0.96 109.131 179.511 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 0.95 109.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.07 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.23 109.536 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.15 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 0.94 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.08 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.19 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 0.97 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.88 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' CE1' HG21 ' A' ' 76' ' ' ILE . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.6 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 0.78 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 0.63 109.313 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 59' ' ' ILE . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 0.67 109.674 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.15 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 1.93 109.721 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.42 109.522 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 0.51 109.747 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.19 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.82 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 86' ' ' LEU . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 0.77 110.71 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 3.7 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.573 HG21 HD21 ' A' ' 86' ' ' LEU . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 0.83 109.018 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.07 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.21 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 1.58 110.321 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.616 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 1.52 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 0.8 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 0.68 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.48 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.527 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 0.72 110.046 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 84' ' ' LEU . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.62 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 1.61 111.207 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.95 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.7 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 0.63 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.47 110.069 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 80' ' ' HIS . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.41 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.97 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.7 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 0.89 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.67 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.83 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 0.75 110.38 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.85 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.62 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG21 ' CE1' ' A' ' 39' ' ' PHE . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 0.66 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.18 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.07 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 2.65 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.517 ' CE1' HG22 ' A' ' 67' ' ' VAL . 41.6 m-70 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.85 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.05 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 61' ' ' THR . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 0.62 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.02 109.681 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.93 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 0.91 109.751 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.09 109.451 179.205 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 1.67 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 0.5 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 0.58 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.58 109.964 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 1.98 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 0.64 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.43 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 109.611 -0.514 . . . . 1.1 109.611 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.62 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.68 109.363 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 0.89 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.575 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 0.68 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.62 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.1 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 0.73 109.422 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.73 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.55 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 69' ' ' PRO . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 0.61 108.74 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.45 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 0.56 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.62 109.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 1.88 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' A' ' 31' ' ' LEU . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 0.94 110.118 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 0.45 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 0.49 110.214 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.96 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.58 110.764 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 2.65 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 0.61 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.58 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 0.63 110.077 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 0.65 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 0.59 109.793 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.47 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 0.5 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.52 109.096 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 85' ' ' ARG . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 0.6 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 0.54 109.699 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.0 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.9 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.69 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 0.67 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.56 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 0.54 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.95 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.56 110.316 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.06 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.649 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.73 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.53 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 0.49 110.003 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.47 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.25 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG11 ' A' ' 67' ' ' VAL . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 0.45 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.72 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 0.82 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 1.9 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.463 ' CE1' HG22 ' A' ' 67' ' ' VAL . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.68 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.58 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 0.66 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.603 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 1.95 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.07 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 0.79 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.7 110.48 179.645 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 1.51 109.805 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 0.72 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 0.71 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.7 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 2.88 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 0.58 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 179.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.617 -0.512 . . . . 1.26 109.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 0.84 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.05 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.13 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.6 109.646 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.57 110.734 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.86 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 0.86 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 0.65 109.433 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.66 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.73 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 0.89 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 0.62 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 0.58 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.563 HD12 HD12 ' A' ' 59' ' ' ILE . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.02 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.36 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.48 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 0.51 109.634 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.61 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 2.55 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 47' ' ' ALA . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 0.76 109.28 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.68 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 0.8 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 0.68 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 0.85 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 0.94 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 0.5 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.563 HD12 HD12 ' A' ' 43' ' ' LEU . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.56 109.523 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 0.58 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 62' ' ' ASN . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.62 109.861 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 61' ' ' THR . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.33 110.802 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.16 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.82 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 0.77 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.49 109.803 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG11 ' NE2' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 0.65 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.27 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 40' ' ' THR . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.73 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 0.82 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.6 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.7 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 0.53 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.67 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.05 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 0.6 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.88 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 0.99 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.47 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.646 ' NE2' HG11 ' A' ' 67' ' ' VAL . 6.9 m-70 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.8 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 0.83 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.17 109.248 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 0.91 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.601 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.49 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.96 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.81 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo . . . . . 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.93 110.202 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 CA-C-O 121.409 0.624 . . . . 2.76 110.224 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 0.54 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 0.77 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.63 109.703 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.01 108.933 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 0.54 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 179.706 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 CA-C-O 121.155 0.502 . . . . 1.23 110.15 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 17' ' ' LYS . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 0.78 108.758 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.2 110.111 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 0.7 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 0.6 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.74 110.881 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.74 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.68 109.48 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.53 111.173 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.52 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.6 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 0.43 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.49 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 59' ' ' ILE . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 0.69 109.63 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.31 109.998 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.28 109.631 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 0.49 109.622 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 0.43 109.803 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.71 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.69 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 2.82 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.544 HG23 ' HB1' ' A' ' 47' ' ' ALA . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 0.7 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.74 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 0.78 110.018 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 0.93 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 0.93 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 0.63 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.39 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 43' ' ' LEU . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 0.46 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.708 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 0.59 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 0.56 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.45 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.05 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.74 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 0.68 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.708 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.52 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.483 HG22 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 0.55 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.84 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.55 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 0.67 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.556 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.4 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.47 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 0.57 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.53 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 0.91 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 0.52 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 0.82 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.9 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 3.53 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.72 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.58 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 0.68 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 0.83 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 1.61 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.628 HD12 HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.0 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 60' ' ' ILE . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 0.6 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo . . . . . 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.65 110.519 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 N-CA-C 109.327 -0.619 . . . . 1.7 109.327 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 0.75 109.758 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 0.61 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.452 ' HB3' HD12 ' A' ' 84' ' ' LEU . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 0.93 109.832 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.45 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 0.56 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 0.68 108.782 179.735 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' CB ' ' A' ' 49' ' ' GLU . 2.5 tmtt? . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.259 0.552 . . . . 0.99 110.427 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 0.73 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 0.82 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 0.63 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 0.68 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.9 110.846 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.14 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 0.81 109.706 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.7 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.61 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 0.71 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.64 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 0.62 109.11 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 0.61 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 2.74 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 31' ' ' LEU . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 1.67 110.22 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.47 109.277 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 0.42 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.406 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.61 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.04 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 47' ' ' ALA . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 0.65 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.7 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 0.83 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.77 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 0.68 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.14 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 0.58 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 0.54 109.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.648 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 0.81 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.79 110.06 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.18 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.17 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.11 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.06 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.648 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.85 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.677 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 0.71 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.05 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 0.88 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HB2' HD11 ' A' ' 76' ' ' ILE . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.21 109.715 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.89 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 0.75 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.85 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.49 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 71' ' ' GLN . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 0.78 109.647 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 0.95 110.072 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.08 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 1.91 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.95 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.8 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 0.62 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 16' ' ' PHE . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 0.84 109.731 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.27 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 0.69 109.995 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 0.85 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.76 111.034 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mttm . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.098 0.475 . . . . 2.22 109.788 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 0.73 109.368 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 0.83 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.7 109.898 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.18 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 0.68 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 0.67 109.109 179.732 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 109.494 -0.558 . . . . 1.13 109.494 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 0.89 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.19 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 0.95 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 0.9 109.837 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 0.93 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.16 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.18 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 0.8 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.76 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 76' ' ' ILE . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.61 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 0.65 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 0.64 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 33' ' ' VAL . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 0.65 109.492 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 58' ' ' ALA . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 0.73 109.819 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 1.53 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.38 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 0.51 110.196 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.58 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.99 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.84 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.73 109.52 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.3 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 0.75 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.75 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 0.91 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 0.87 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 0.83 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.02 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 0.58 109.523 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 43' ' ' LEU . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.55 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.756 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 0.65 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 0.56 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.03 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.94 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 0.82 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.756 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.62 109.966 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 76' ' ' ILE . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 0.67 109.362 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.32 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.7 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 0.92 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.36 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.76 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 0.71 110.226 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.73 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.18 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 67' ' ' VAL . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 0.56 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.97 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 0.96 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.24 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.02 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 0.81 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.9 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 0.86 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 2.56 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 52' ' ' VAL . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.11 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.684 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo . . . . . 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.11 110.078 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.33 0.586 . . . . 2.04 110.037 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 0.88 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 0.86 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.77 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 1.91 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.65 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 0.64 108.749 179.108 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.3 mptt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.369 -0.604 . . . . 1.21 109.369 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.8 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.06 109.79 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 0.93 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.0 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.04 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.02 110.205 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.17 110.469 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.08 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.07 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.79 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 0.96 108.606 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 0.81 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 33' ' ' VAL . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 0.74 109.165 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 59' ' ' ILE . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 0.68 109.574 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.15 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.42 110.215 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.52 109.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 0.52 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.98 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.73 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 2.66 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 0.84 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.78 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 0.8 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 0.9 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.09 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.04 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 0.75 109.232 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 43' ' ' LEU . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 0.68 109.391 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.667 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 0.87 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.81 110.065 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.02 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.06 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.01 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.85 109.701 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 HG11 HD12 ' A' ' 76' ' ' ILE . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 0.78 109.446 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.16 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.96 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.16 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.57 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.15 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 0.89 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.9 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.67 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 HG11 ' A' ' 67' ' ' VAL . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.85 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.86 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.08 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 1.78 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' NE2' HG22 ' A' ' 67' ' ' VAL . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.29 110.138 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.85 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.67 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.9 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 0.73 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 2.97 109.92 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 0.91 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 0.88 109.068 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo . . . . . 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.84 110.655 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.301 0.572 . . . . 2.02 110.136 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 0.53 109.176 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 0.73 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.67 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.4 108.889 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 0.61 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 0.73 108.987 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? . . . . . 0 N--CA 1.498 1.959 0 N-CA-C 109.541 -0.54 . . . . 2.24 109.541 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 0.91 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 0.91 108.999 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.0 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 42' ' ' VAL . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 0.56 109.511 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.45 110.759 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.02 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 0.6 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.43 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.51 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 0.81 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 0.51 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 33' ' ' VAL . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 0.46 109.229 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 0.7 109.665 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 2.86 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.31 110.25 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 0.5 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 0.57 109.882 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.35 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.97 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' HD2' HD13 ' A' ' 86' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.68 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 2.92 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 0.75 109.041 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.9 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 0.78 109.713 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 0.98 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.05 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 0.79 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 0.57 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 0.47 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.7 109.388 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.56 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.18 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.14 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.77 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 0.72 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.54 109.812 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 80' ' ' HIS . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 0.44 109.385 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 0.9 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 40' ' ' THR . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.62 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.64 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.28 110.103 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.39 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 0.38 110.355 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.41 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 0.95 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 HG11 ' A' ' 67' ' ' VAL . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.5 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.58 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 0.54 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 1.72 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.68 110.06 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.61 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 0.95 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.22 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.603 HD12 HG21 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 0.81 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 0.75 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.06 110.12 179.124 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.274 0.559 . . . . 1.32 109.762 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 0.78 109.388 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 0.97 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.7 109.866 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.12 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.6 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.63 109.219 179.515 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.18 109.057 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.68 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.06 109.506 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 0.87 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 0.67 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.77 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.36 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 0.71 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.69 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.588 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.59 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.17 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.52 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 0.53 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 0.6 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 3.67 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 1.67 110.233 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 0.51 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 0.46 109.908 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.71 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 0.79 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.26 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG21 HD21 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 0.74 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.78 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 0.69 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 0.93 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 0.89 109.549 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 0.69 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 0.49 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 0.46 109.212 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.664 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 0.62 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 0.69 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 0.99 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 0.95 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.61 109.865 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 0.66 109.522 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.22 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.2 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.84 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 0.65 110.373 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.76 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 1.62 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.482 HG21 ' CE1' ' A' ' 39' ' ' PHE . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 0.68 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.94 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 0.96 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.12 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.01 110.451 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.8 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 0.95 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.91 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 0.95 109.822 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 1.97 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 0.78 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 0.7 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.88 110.884 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.439 0.637 . . . . 1.15 110.438 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 0.5 109.343 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.61 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.46 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.41 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.504 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 0.57 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.471 HG22 ' HG3' ' A' ' 85' ' ' ARG . 13.6 t . . . . . 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.409 -0.589 . . . . 1.18 109.409 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 0.63 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.14 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 0.94 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 0.67 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.77 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.8 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 0.76 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 0.7 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 0.97 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.61 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 0.76 108.704 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 0.67 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 0.58 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 0.64 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 3.95 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 1.66 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 0.55 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 0.56 109.55 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.97 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 0.91 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.18 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 0.8 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 0.9 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 0.74 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 0.94 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 1.47 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.57 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 0.44 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.44 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 0.59 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 0.56 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.22 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.36 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.85 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 0.82 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.6 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 0.53 109.571 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.72 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.601 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.59 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 0.89 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.15 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.72 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 0.5 110.145 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.47 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.59 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 39' ' ' PHE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 0.56 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.71 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.83 110.107 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.02 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.34 110.014 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.54 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 0.69 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.39 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 0.83 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' HG22 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.38 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.8 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 0.66 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo . . . . . 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.68 110.32 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 79.8 mttt . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 1.97 110.325 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 0.76 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.62 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.75 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 1.63 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 0.86 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 0.58 108.553 179.531 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 121.252 0.549 . . . . 1.31 110.139 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 0.66 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.99 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.55 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 42' ' ' VAL . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 0.81 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.82 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.14 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.4 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 0.75 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.79 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.56 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 0.56 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 33' ' ' VAL . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 0.57 109.281 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 0.64 109.659 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 1.57 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 1.93 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.38 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 0.52 109.976 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.89 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.7 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.21 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 0.79 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.76 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 0.57 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.76 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 0.95 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 0.88 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.45 109.671 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.45 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.79 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.79 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.06 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 0.97 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 0.94 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.56 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 76' ' ' ILE . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 0.53 109.32 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.72 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.62 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 0.9 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 0.98 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.72 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 0.66 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.78 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 0.92 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 67' ' ' VAL . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 0.65 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 0.92 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.09 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 1.53 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.407 ' NE2' HG22 ' A' ' 67' ' ' VAL . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.39 110.101 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.84 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 0.95 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.63 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 0.98 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.49 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.95 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.621 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 0.69 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.621 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo . . . . . 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.82 110.321 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 19.6 mttt . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.193 0.52 . . . . 1.44 109.756 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 0.6 109.391 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' OG ' ' A' ' 32' ' ' SER . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.81 109.943 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.68 109.978 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.16 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 0.66 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 0.71 109.582 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.23 0.538 . . . . 0.93 109.995 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 0.71 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 0.92 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.46 ' OG ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.05 109.316 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.81 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.89 110.731 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 0.92 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 0.8 109.09 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.79 111.418 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.58 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.06 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 0.66 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 0.62 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD12 HD12 ' A' ' 59' ' ' ILE . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.69 109.783 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.36 109.667 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.22 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 0.53 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 0.63 109.833 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.72 111.068 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 1.55 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 0.77 109.488 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 0.92 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 0.93 110.294 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.12 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.31 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 0.71 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 0.64 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 HD12 ' A' ' 43' ' ' LEU . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 0.52 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.644 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 0.79 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 0.72 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.07 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.17 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.89 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 0.83 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.644 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.65 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.505 HG11 HD12 ' A' ' 76' ' ' ILE . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 0.59 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.0 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.687 ' O ' HG23 ' A' ' 40' ' ' THR . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 0.86 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' HD11 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.36 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.72 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 0.59 110.216 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.6 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.575 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 1.63 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG11 ' A' ' 67' ' ' VAL . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 0.56 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.69 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 0.85 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.06 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.04 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.71 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 0.71 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 0.84 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 1.76 109.983 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 0.65 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.512 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 0.84 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo . . . . . 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.68 110.152 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.132 0.491 . . . . 1.35 109.909 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 0.71 109.303 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.09 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.66 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.4 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 0.61 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 0.57 108.982 179.342 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.627 -0.509 . . . . 1.03 109.627 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 0.74 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 0.98 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.3 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.65 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.83 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.92 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.96 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 0.68 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.55 111.418 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.54 109.705 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 0.52 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 0.61 109.293 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 59' ' ' ILE . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 0.58 109.559 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 2.85 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.545 ' CB ' HD21 ' A' ' 31' ' ' LEU . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.57 110.092 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 0.54 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 0.57 109.97 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.06 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 86' ' ' LEU . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.77 111.27 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.46 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 0.67 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.65 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 0.59 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 0.71 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 0.82 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.59 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 0.46 109.291 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 43' ' ' LEU . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 0.43 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.609 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 0.71 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.63 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 0.96 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.12 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.7 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 0.62 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.45 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 0.52 109.519 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.22 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.53 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 0.92 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.56 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.69 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 0.64 110.135 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.71 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.11 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.447 HG21 ' CE1' ' A' ' 39' ' ' PHE . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 0.54 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 0.87 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 0.86 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 1.66 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.32 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.66 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 0.71 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.99 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 0.91 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 1.82 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.636 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 0.72 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.548 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 0.77 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.78 109.573 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.418 0.628 . . . . 2.35 110.25 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 0.85 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 0.84 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.79 110.09 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 0.86 108.428 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.71 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.5 109.573 179.643 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 109.624 -0.51 . . . . 0.98 109.624 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 0.86 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.1 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 0.7 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 HG22 ' A' ' 42' ' ' VAL . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 0.75 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.79 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.44 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.54 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 0.77 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.83 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.69 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 0.87 108.705 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.68 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 33' ' ' VAL . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 0.75 109.18 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 2.68 109.846 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.525 ' HB3' HD21 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 1.58 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 0.48 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 0.55 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.6 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 3.62 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 86' ' ' LEU . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 0.71 108.947 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.89 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 0.87 110.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.17 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 0.87 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.94 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 0.57 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 43' ' ' LEU . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 0.55 108.99 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 0.66 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.69 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.52 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.43 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 0.89 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.63 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 80' ' ' HIS . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 0.66 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.12 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.86 110.145 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.11 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.98 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.8 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.92 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.56 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 67' ' ' VAL . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.78 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.03 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.17 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.27 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 67' ' ' VAL . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.07 110.688 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.86 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 0.8 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 0.84 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 1.71 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 0.82 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 0.77 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo . . . . . 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.68 110.572 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.284 0.564 . . . . 1.52 109.733 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 0.36 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 0.47 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.53 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.02 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 0.49 109.634 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 0.58 109.527 179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.196 0.522 . . . . 1.52 109.602 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 0.71 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.16 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 0.56 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 0.57 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.47 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.71 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 0.94 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.51 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.52 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.52 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.59 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 0.45 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.571 HG22 HG21 ' A' ' 33' ' ' VAL . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 0.48 109.32 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 57' ' ' SER . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 0.67 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' THR . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 2.59 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 0.98 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 0.38 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 0.37 110.056 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.09 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.55 109.27 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.12 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 0.61 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.62 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 0.64 110.314 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 0.78 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 1.34 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 0.84 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 0.39 109.369 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.43 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 0.64 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 80' ' ' HIS . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 0.58 110.156 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 0.89 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.41 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.9 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 0.75 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.58 109.93 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 0.55 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.33 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.58 110.128 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 0.97 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.14 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.48 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 0.44 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.4 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 0.98 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.463 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 0.51 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.59 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 0.67 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 2.57 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 61' ' ' THR . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.36 110.618 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.5 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.01 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 0.65 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.77 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.75 109.997 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.631 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.61 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo . . . . . 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.61 110.672 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 1.82 109.601 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 0.46 109.465 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 0.61 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.54 110.196 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 2.75 108.679 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 0.56 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 0.47 108.73 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.083 0.468 . . . . 0.81 109.746 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG22 ' HG3' ' A' ' 17' ' ' LYS . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 0.61 109.291 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.08 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.0 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 42' ' ' VAL . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.52 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.41 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.97 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.5 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.41 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.54 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.57 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 0.42 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 33' ' ' VAL . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 0.41 109.319 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD12 HD12 ' A' ' 59' ' ' ILE . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 0.6 109.805 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.51 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.2 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 0.46 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 0.44 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.74 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.52 110.968 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.23 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 86' ' ' LEU . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 0.57 109.399 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.63 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 0.67 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.81 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 0.85 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 0.63 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 0.49 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.432 HD12 HD12 ' A' ' 43' ' ' LEU . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.45 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 0.6 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 0.51 109.331 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 0.66 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.54 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 76' ' ' ILE . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 0.54 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.39 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.59 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.03 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.06 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.43 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.38 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.43 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.33 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 67' ' ' VAL . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 0.49 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 0.8 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 0.73 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.06 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.29 110.252 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.6 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.61 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.32 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 0.95 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.45 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 0.71 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 0.71 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo . . . . . 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.77 110.412 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.0 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 0.69 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 0.78 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.64 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.11 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 0.65 109.85 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 0.69 109.202 179.56 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 109.53 -0.545 . . . . 1.17 109.53 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 0.76 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 0.83 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 0.94 109.601 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 0.58 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.6 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 0.65 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 0.58 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.53 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.56 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 0.63 108.513 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.51 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 0.52 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 0.53 109.905 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.49 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.88 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.49 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 0.41 109.993 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.49 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.32 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CD2' HD13 ' A' ' 86' ' ' LEU . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.53 111.133 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 2.68 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.069 HG21 HD21 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 0.59 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.6 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.64 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 0.6 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.68 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 0.8 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 0.73 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 0.35 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 0.54 109.426 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 66' ' ' GLY . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.62 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 0.57 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.0 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.36 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.74 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 0.65 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.45 110.002 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 0.53 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 0.87 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 0.98 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.23 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.58 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.59 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 1.61 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.431 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 0.61 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.9 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 0.94 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 2.56 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.85 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 0.89 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.31 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.88 110.199 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 2.46 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.069 HD21 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.9 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 0.54 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo . . . . . 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64 110.804 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.192 0.52 . . . . 2.09 109.902 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 0.87 109.283 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.01 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.69 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.02 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.61 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.425 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 57.9 m . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 0.85 109.166 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.518 -0.549 . . . . 1.25 109.518 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 0.89 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.0 109.7 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.25 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.98 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.15 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.19 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 1.66 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.17 109.296 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.11 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.465 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.8 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 69' ' ' PRO . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.94 108.783 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 33' ' ' VAL . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 0.8 109.309 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 59' ' ' ILE . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 0.73 109.709 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.47 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 1.64 110.225 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 0.62 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 0.5 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.31 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.98 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.56 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 2.66 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 0.54 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.75 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 0.8 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.01 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.02 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 0.75 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 0.62 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 43' ' ' LEU . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 0.44 109.347 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.739 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 0.59 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 0.58 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.34 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 0.72 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.56 109.944 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 0.51 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.07 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.02 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.22 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 0.97 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 0.84 109.958 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.83 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.11 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.465 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 0.58 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 0.9 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 0.86 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.07 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.73 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.04 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 0.75 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 19' ' ' THR . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 1.72 109.478 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 0.67 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.42 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 0.91 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.8 110.289 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.384 0.611 . . . . 2.03 109.898 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 0.67 109.88 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 0.84 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.7 110.013 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.552 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 0.7 110.077 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 0.67 109.026 179.444 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.34 109.14 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 0.74 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.17 109.527 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 0.76 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 0.7 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.71 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.25 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 0.59 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.52 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.55 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 0.54 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 0.52 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 0.55 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 0.58 109.453 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.15 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 31' ' ' LEU . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 1.62 110.15 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 0.51 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 0.51 109.922 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.91 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.14 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 86' ' ' LEU . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.66 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.12 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 0.72 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.81 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 0.73 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.07 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.36 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 0.91 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 0.39 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 0.47 109.122 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.697 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 0.62 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 0.61 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.85 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.18 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.68 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 HG11 ' HE1' ' A' ' 80' ' ' HIS . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 0.72 108.946 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.48 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 80' ' ' HIS . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 0.54 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.82 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.51 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.6 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.08 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.5 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 0.54 110.213 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.34 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 0.6 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.81 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 0.94 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.25 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' HG22 ' A' ' 67' ' ' VAL . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.93 109.897 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.71 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 0.81 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.93 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.404 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.04 109.908 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.61 109.736 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 0.55 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.651 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.62 109.688 179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.903 0 CA-C-O 121.406 0.622 . . . . 1.79 109.782 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.54 109.603 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 0.74 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68 109.967 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.39 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.577 HG21 HD12 ' A' ' 86' ' ' LEU . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 0.78 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 2.6 m . . . . . 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 0.84 108.777 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.18 0.514 . . . . 0.92 109.912 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 0.83 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 0.83 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 0.85 109.057 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 0.72 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.62 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.08 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 0.56 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.45 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.56 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 0.74 108.547 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 0.42 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 0.47 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 0.53 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.04 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HB2' HD21 ' A' ' 31' ' ' LEU . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 1.58 110.124 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 0.47 109.404 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.47 109.978 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.9 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.54 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 0.89 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 2.64 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 0.61 109.46 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.62 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 0.55 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.68 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.44 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 0.71 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 0.59 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 0.46 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 0.54 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 0.76 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 0.73 110.22 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.14 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 0.88 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.58 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 0.75 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.04 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.52 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.69 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.16 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.43 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 0.48 110.371 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.42 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 0.93 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 0.5 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.61 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 0.8 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 2.82 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.442 ' NE2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.28 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.68 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.31 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 0.75 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 1.86 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.91 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 0.61 109.333 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.57 110.712 179.859 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.499 2.024 0 CA-C-O 121.278 0.561 . . . . 1.5 109.701 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.422 HG21 ' HB1' ' A' ' 73' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 0.74 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 0.76 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.64 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.03 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 0.59 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.406 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 73.6 p . . . . . 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 0.67 109.401 179.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 109.684 -0.487 . . . . 1.66 109.684 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 0.91 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 0.94 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 0.82 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 0.67 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.72 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.08 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.21 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 0.63 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.49 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.54 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 69' ' ' PRO . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 0.59 108.899 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 0.44 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 33' ' ' VAL . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 0.53 109.299 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 59' ' ' ILE . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 0.7 109.736 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 2.78 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 1.72 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.51 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 0.63 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.13 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' HD2' HD13 ' A' ' 86' ' ' LEU . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76 110.791 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 1.74 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 0.9 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.07 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 0.91 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.01 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.19 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.77 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 0.47 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 43' ' ' LEU . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.47 109.369 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.673 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 0.56 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 84' ' ' LEU . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 0.58 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 1.75 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 0.77 108.933 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.62 109.88 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 76' ' ' ILE . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 0.58 109.527 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.36 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.63 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.8 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.632 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 0.91 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.63 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.62 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.83 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.12 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 0.72 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 0.92 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.17 109.982 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 1.58 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.06 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.72 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 61' ' ' THR . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 0.58 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.406 ' HA ' ' H ' ' A' ' 19' ' ' THR . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.63 109.475 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 0.76 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 0.56 108.814 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo . . . . . 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 0.89 110.554 -179.484 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.492 0.663 . . . . 2.05 110.816 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 0.55 108.961 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 0.68 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.65 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.39 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.788 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.65 109.889 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 0.61 109.285 179.564 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 121.118 0.485 . . . . 1.6 109.695 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 0.67 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 0.85 109.859 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 0.71 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 0.65 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.48 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.97 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 0.55 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.44 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.43 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 0.86 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 0.43 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 0.52 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.58 109.828 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.48 110.108 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD21 ' A' ' 31' ' ' LEU . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.01 109.926 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 0.5 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 0.52 110.092 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.72 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' LYS . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.66 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.3 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.7 109.41 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.71 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 0.65 109.96 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.72 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 0.73 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 0.75 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 0.42 109.266 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 0.45 109.8 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 0.56 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 63' ' ' ASP . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.45 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.28 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 61' ' ' THR . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.71 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 0.51 108.92 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.33 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 80' ' ' HIS . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 0.36 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.49 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' O ' HG23 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.59 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 0.76 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.489 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.14 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.52 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 0.46 110.336 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.49 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.2 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 67' ' ' VAL . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 0.4 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 0.82 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 0.9 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.2 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.66 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 0.79 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.34 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 0.61 109.695 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 0.54 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo . . . . . 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.62 110.431 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.354 0.597 . . . . 1.9 110.086 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 0.48 109.787 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 0.55 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.63 110.167 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.52 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.63 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 0.92 109.256 179.42 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.03 108.84 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 0.74 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 0.88 109.318 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.91 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 42' ' ' VAL . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 0.64 109.412 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.6 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 0.58 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.5 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.48 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.54 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.49 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.43 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 33' ' ' VAL . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 0.45 109.359 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 0.6 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 2.53 109.921 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.38 109.53 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.46 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 0.39 109.626 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.74 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.63 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.56 110.785 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 1.65 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD21 ' A' ' 86' ' ' LEU . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.63 109.521 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.59 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 0.57 110.161 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 0.7 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 0.69 109.555 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.04 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 0.45 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 0.45 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.702 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 0.58 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 0.56 109.897 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89 109.817 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.36 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.72 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 0.73 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.51 110.019 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 0.53 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.12 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.56 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.87 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.61 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.52 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.44 110.326 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 1.6 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' PHE . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 0.57 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.97 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.84 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.59 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.86 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.67 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 0.77 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 0.86 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 1.9 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 0.77 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 0.71 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo . . . . . 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.86 110.746 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.454 0.645 . . . . 8.87 110.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m -102.84 123.25 46.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.672 -0.642 . . . . 6.88 109.337 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.13 25.17 32.21 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.301 -1.12 . . . . 5.64 110.301 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.73 61.07 0.5 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.862 -1.695 . . . . 4.48 108.862 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 p -97.6 124.48 41.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.793 -0.828 . . . . 3.38 109.517 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.34 83.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.235 -1.024 . . . . 3.65 108.235 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.8 147.77 24.26 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.504 -0.925 . . . . 2.79 108.504 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -82.97 111.75 19.12 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.431 -0.793 . . . . 2.41 109.866 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 m -125.18 112.21 16.18 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.573 -0.899 . . . . 2.46 108.573 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -99.71 -20.15 16.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.618 -0.676 . . . . 2.76 110.248 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 139.96 -89.92 0.19 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.073 -1.611 . . . . 2.02 109.073 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.33 93.89 7.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.817 . . . . 2.07 108.866 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -143.05 156.81 44.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.725 . . . . 1.77 110.426 -179.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 m -108.29 140.16 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.755 -0.591 . . . . 0.93 109.654 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 38.6 m -99.15 136.34 39.25 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.467 -0.771 . . . . 1.07 109.766 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.38 146.25 42.62 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.694 -0.629 . . . . 0.8 110.058 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.633 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 11.0 tttt -127.98 107.55 9.93 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.729 -0.841 . . . . 2.69 108.729 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 46' ' ' ALA . 3.3 mp -114.37 132.51 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.459 -0.776 . . . . 0.71 110.549 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.461 HG22 ' HA ' ' A' ' 28' ' ' PHE . 8.4 p -125.35 155.58 40.08 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.957 -0.757 . . . . 0.86 108.957 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.511 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -77.96 117.18 19.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 0.95 109.644 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.4 t -97.12 -29.4 13.63 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.746 -0.596 . . . . 1.03 110.077 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.3 p -76.28 -39.8 53.34 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.471 -0.768 . . . . 1.22 110.079 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.49 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.2 m-20 -83.74 166.03 36.39 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 1.28 110.051 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.6 Cg_endo -74.87 -31.17 6.65 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.543 2.162 . . . . 1.51 110.273 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.17 155.46 30.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.694 -0.628 . . . . 2.86 109.49 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.59 69.55 72.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.457 -0.777 . . . . 1.21 109.616 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 20' ' ' LEU . 33.8 Cg_endo -77.22 96.04 1.09 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 C-N-CA 122.638 2.225 . . . . 1.08 109.615 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.633 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.3 p90 -56.8 147.49 23.06 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.555 0.693 . . . . 1.3 110.535 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -127.68 119.18 25.29 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.896 -0.779 . . . . 1.42 108.896 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.4 t -98.24 117.74 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.6 -0.688 . . . . 1.08 109.21 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.25 104.81 11.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.774 -0.579 . . . . 1.2 109.674 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 m -100.0 101.17 12.19 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.571 -0.706 . . . . 1.05 109.328 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -135.43 157.92 75.52 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.72 -0.613 . . . . 0.98 109.418 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.4 Cg_endo -74.2 160.05 43.04 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.594 2.196 . . . . 1.16 110.675 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -25.91 60.67 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.708 -0.62 . . . . 1.42 110.517 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.63 -41.0 94.01 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.504 -0.748 . . . . 1.48 109.645 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 m -64.28 126.77 91.08 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 109.114 -0.699 . . . . 0.97 109.114 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -77.61 163.81 28.93 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.737 2.291 . . . . 0.79 111.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 2.2 t80 -66.05 -18.38 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.575 -0.703 . . . . 0.66 109.978 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -61.33 -46.87 88.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.5 -0.926 . . . . 1.03 108.5 178.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.35 72.89 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.212 -0.662 . . . . 0.75 109.212 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -59.73 -49.56 83.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.664 -0.647 . . . . 0.67 109.315 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.647 HD13 HG12 ' A' ' 59' ' ' ILE . 13.9 tp -61.78 -34.31 75.66 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.3 -0.63 . . . . 0.62 109.3 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -54.0 46.98 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.582 -0.699 . . . . 3.38 109.536 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 31' ' ' LEU . 31.8 m-85 -58.61 -41.44 85.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.641 -0.662 . . . . 1.4 109.921 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.51 -49.0 73.05 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.602 -0.686 . . . . 0.73 109.286 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -59.99 -32.85 71.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.801 -0.562 . . . . 0.79 109.783 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -44.29 95.79 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 109.233 -0.654 . . . . 1.24 109.233 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -39.85 75.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.65 -0.656 . . . . 1.26 109.309 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.599 ' CD2' HD13 ' A' ' 86' ' ' LEU . 44.9 m-85 -73.3 -10.99 60.33 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.702 -0.624 . . . . 0.98 110.856 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.92 40.41 3.04 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.491 -0.755 . . . . 3.0 109.976 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 86' ' ' LEU . 21.8 m -133.71 159.83 70.95 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.44 -0.788 . . . . 0.95 109.497 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.3 Cg_endo -75.85 123.55 7.49 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 C-N-CA 122.613 2.208 . . . . 0.82 110.859 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.47 62.76 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.972 -0.455 . . . . 0.7 110.153 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.64 89.22 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.76 110.073 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -107.74 34.89 3.32 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.601 -0.687 . . . . 0.96 109.863 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.5 t -134.82 146.96 49.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.253 -0.904 . . . . 0.81 109.793 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -117.37 169.15 9.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.442 -0.577 . . . . 0.54 109.442 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.647 HG12 HD13 ' A' ' 43' ' ' LEU . 23.3 mm -122.29 113.05 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.577 -0.702 . . . . 0.56 109.53 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.06 172.66 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.402 -0.812 . . . . 0.66 108.935 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.525 HG21 ' CE1' ' A' ' 80' ' ' HIS . 77.8 p -106.43 169.62 8.41 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -0.898 . . . . 0.54 110.096 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -64.98 -25.28 67.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.713 -0.617 . . . . 1.01 109.847 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -79.32 -50.35 11.01 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.575 -0.703 . . . . 1.3 109.374 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.17 52.65 0.04 OUTLIER Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.89 -1.284 . . . . 0.77 109.89 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.3 t -126.7 119.41 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.669 -0.9 . . . . 0.68 109.005 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.21 85.32 1.02 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.206 -1.157 . . . . 0.61 110.206 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 76' ' ' ILE . 42.2 t -74.64 138.05 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.832 -0.804 . . . . 0.59 109.246 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -104.67 158.49 31.88 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.5 -0.75 . . . . 1.3 110.084 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -78.01 67.05 8.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 123.042 2.495 . . . . 0.68 109.914 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.96 -41.72 0.91 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.642 -0.661 . . . . 0.94 110.116 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 7.9 mt-30 -74.82 160.58 80.46 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.556 -0.715 . . . . 1.8 110.102 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.53 160.39 31.83 Favored 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.758 2.305 . . . . 0.94 110.583 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.1 77.22 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.563 -0.711 . . . . 0.84 110.14 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.13 99.28 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.035 -1.226 . . . . 0.9 110.035 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.7 t30 -70.85 -39.37 72.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.654 -0.909 . . . . 1.7 110.013 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.462 HG21 ' CE1' ' A' ' 39' ' ' PHE . 37.6 mm -62.2 -45.58 98.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.531 -0.731 . . . . 0.69 109.36 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.59 -37.9 83.25 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.603 -0.685 . . . . 0.95 109.481 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.77 -37.41 84.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.569 -0.707 . . . . 1.12 109.925 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.21 -58.01 3.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.686 -0.634 . . . . 1.61 110.181 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.525 ' CE1' HG21 ' A' ' 61' ' ' THR . 98.9 m-70 -109.32 -57.13 2.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.484 -0.76 . . . . 1.19 109.928 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.37 -109.12 1.62 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.624 -1.391 . . . . 0.8 109.624 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' LYS . 55.8 p -113.86 0.47 14.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.81 -0.818 . . . . 1.03 110.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.96 95.04 8.41 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.106 -0.996 . . . . 1.63 109.396 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' HB2' HG13 ' A' ' 18' ' ' ILE . 63.5 mt -136.12 167.16 21.78 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.474 0.654 . . . . 0.66 110.171 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.98 149.49 29.66 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 109.182 -0.673 . . . . 1.59 109.182 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -101.13 131.95 46.82 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.405 -0.81 . . . . 0.97 110.271 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.6 tt -142.71 131.87 11.85 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.083 -0.71 . . . . 0.74 109.083 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.2 Cg_endo -75.14 133.09 15.96 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.583 2.188 . . . . 1.12 110.849 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -76.44 124.76 28.05 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.856 -0.528 . . . . 1.51 109.87 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.93 -41.46 9.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.719 -0.613 . . . . 3.0 109.858 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.42 171.7 7.21 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.571 -0.706 . . . . 5.0 109.837 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.0 t -61.87 111.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.675 -0.861 . . . . 1.92 108.675 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 94' ' ' HIS . . . 79.49 51.57 5.17 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 108.378 -1.889 . . . . 1.88 108.378 -178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.417 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 2.9 t-80 . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 117.681 -1.152 . . . . 2.11 110.028 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.019 -0.734 . . . . 5.58 109.019 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 p -94.3 79.64 3.95 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.595 0.712 . . . . 3.67 109.797 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 10' ' ' ALA . . . 60.95 58.57 13.02 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 111.613 -0.595 . . . . 2.13 111.613 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.33 -102.74 2.96 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 120.233 -0.984 . . . . 4.7 111.234 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 m -112.2 -70.4 0.81 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.59 -0.947 . . . . 5.71 111.379 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.04 -120.76 0.11 Allowed 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.133 -0.979 . . . . 4.46 110.729 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.8 55.1 0.74 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.166 -0.959 . . . . 4.21 109.745 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.64 176.95 5.15 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.284 -0.885 . . . . 2.86 109.255 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.3 t -65.72 154.38 39.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.558 -0.714 . . . . 2.22 110.536 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.747 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . . . -74.1 103.68 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.542 -0.54 . . . . 1.56 109.542 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -126.84 94.36 0.41 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.928 -1.269 . . . . 1.11 109.928 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.9 p -85.49 97.79 10.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.611 -0.935 . . . . 2.41 109.086 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -129.14 152.97 48.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.618 -0.676 . . . . 2.6 109.732 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.08 122.53 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.462 -0.774 . . . . 0.96 109.959 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.4 t -100.9 148.21 25.25 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.639 -0.663 . . . . 1.02 109.465 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -127.57 136.34 51.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.419 -0.801 . . . . 0.75 110.229 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -107.91 103.29 12.5 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.53 -0.545 . . . . 2.61 109.53 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 86' ' ' LEU . 3.6 mp -100.77 126.9 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.169 -0.957 . . . . 0.67 110.037 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.0 t -127.58 163.51 24.02 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.131 -0.692 . . . . 0.96 109.131 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.78 152.27 42.85 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.442 -0.786 . . . . 1.32 109.756 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.42 HG21 ' CG2' ' A' ' 87' ' ' ILE . 10.8 p -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.595 -0.69 . . . . 1.62 109.893 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 56.0 p -68.83 -47.12 66.83 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.507 -0.746 . . . . 2.01 109.967 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 4.6 p-10 -118.15 157.38 48.98 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.684 -0.635 . . . . 1.65 109.934 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 23' ' ' ASP . 33.7 Cg_endo -75.96 -38.6 1.16 Allowed 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.638 2.226 . . . . 1.93 110.111 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 124.74 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.397 0.617 . . . . 1.69 110.447 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.525 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -61.56 -55.21 44.78 Favored Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.668 -0.645 . . . . 1.99 109.917 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -78.43 131.22 10.42 Favored 'Trans proline' 0 C--N 1.322 -0.862 0 C-N-CA 122.382 2.055 . . . . 1.52 110.552 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -106.58 148.86 27.77 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.564 -0.71 . . . . 1.36 109.727 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 13.4 mptt -86.93 99.74 12.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.108 -0.701 . . . . 0.95 109.108 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -99.14 119.7 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.593 -0.692 . . . . 1.07 109.264 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.3 109.64 18.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.66 -0.65 . . . . 1.23 109.536 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -98.59 110.23 22.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.642 -0.661 . . . . 1.15 109.283 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.8 m -137.89 159.62 67.89 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.814 -0.554 . . . . 0.94 109.628 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.1 161.91 37.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.649 2.232 . . . . 1.08 110.457 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.02 -29.72 68.68 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.648 -0.657 . . . . 1.24 109.984 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.2 p -60.91 -38.13 84.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 1.19 109.925 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.6 m -64.24 124.93 87.11 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.563 -0.711 . . . . 0.97 109.208 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.5 Cg_endo -78.48 162.87 27.51 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.742 2.294 . . . . 0.88 111.231 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' CE1' HG21 ' A' ' 76' ' ' ILE . 5.1 t80 -66.39 -16.44 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.545 -0.722 . . . . 0.6 109.704 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 20.3 p -60.22 -45.38 93.41 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.284 -0.885 . . . . 0.78 108.632 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.51 56.17 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.439 HG22 HG21 ' A' ' 33' ' ' VAL . 82.3 t -61.69 -51.01 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.605 -0.684 . . . . 0.63 109.313 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HD12 ' A' ' 59' ' ' ILE . 2.5 tt -64.58 -36.71 85.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.755 -0.591 . . . . 0.67 109.674 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.0 OUTLIER -61.59 -46.2 90.87 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.343 -0.614 . . . . 3.15 109.343 179.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.53 -43.19 81.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.856 -0.528 . . . . 1.93 109.721 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.23 93.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.677 -0.64 . . . . 0.42 109.522 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.31 -38.74 92.13 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.782 -0.574 . . . . 0.51 109.747 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -45.52 92.02 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.73 -0.606 . . . . 1.19 109.414 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.1 mp0 -73.07 -31.35 64.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.775 -0.578 . . . . 0.82 109.658 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 86' ' ' LEU . 2.4 m-85 -79.28 0.38 28.99 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.55 -0.719 . . . . 0.77 110.71 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.2 mttm 62.86 40.17 9.92 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.34 -0.85 . . . . 3.7 110.402 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.573 HG21 HD21 ' A' ' 86' ' ' LEU . 16.2 m -133.91 155.24 80.42 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.505 -0.747 . . . . 0.83 109.018 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.616 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 33.6 Cg_endo -76.17 130.35 12.05 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 C-N-CA 122.508 2.138 . . . . 1.07 110.902 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.34 -29.51 70.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.487 . . . . 1.21 109.781 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 91' ' ' ARG . . . -72.94 -12.1 60.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.68 -0.637 . . . . 1.58 110.321 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.616 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.4 m -136.4 48.92 2.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.313 -0.867 . . . . 1.52 108.705 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.9 p -149.39 151.12 33.53 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.435 -0.791 . . . . 0.8 110.147 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.26 162.97 35.03 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.722 -0.611 . . . . 0.68 109.359 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 24.7 mt -124.23 122.84 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.324 -0.86 . . . . 0.48 109.447 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -100.4 171.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.517 -0.739 . . . . 0.72 110.046 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 84' ' ' LEU . 13.4 m -109.12 158.29 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.453 -0.779 . . . . 0.62 109.745 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.9 -27.92 20.88 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.788 -0.57 . . . . 1.61 111.207 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.61 -38.87 38.83 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.289 -0.882 . . . . 0.95 109.853 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.98 47.81 0.16 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.847 -1.301 . . . . 0.7 109.847 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -121.43 120.19 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.712 -0.875 . . . . 0.63 108.755 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.527 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.41 85.71 0.61 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.069 -1.212 . . . . 0.47 110.069 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 80' ' ' HIS . 18.4 t -65.5 129.8 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.971 -0.723 . . . . 0.41 109.462 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 71.8 m-80 -112.22 162.21 22.44 Favored Pre-proline 0 N--CA 1.495 1.815 0 O-C-N 121.817 -0.552 . . . . 0.97 109.779 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.3 Cg_endo -77.79 67.45 7.95 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 123.045 2.497 . . . . 0.7 109.92 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -135.52 -42.69 0.69 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.636 -0.665 . . . . 0.89 110.185 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -82.36 161.96 57.86 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.543 -0.723 . . . . 1.67 109.844 -179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -76.85 152.82 32.74 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.67 2.247 . . . . 0.83 110.548 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.22 -38.77 63.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.761 -0.587 . . . . 0.75 110.38 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.05 -48.15 87.34 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.817 -1.313 . . . . 0.85 109.817 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -68.63 -37.72 79.95 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.639 -0.918 . . . . 1.62 109.91 179.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG21 ' CE1' ' A' ' 39' ' ' PHE . 29.9 mm -60.2 -41.48 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.71 -0.619 . . . . 0.66 109.456 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -72.95 -39.5 66.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.627 -0.671 . . . . 1.18 109.931 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.8 mt -67.41 -37.02 82.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.49 -0.756 . . . . 1.07 110.578 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -87.72 -59.41 2.25 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.44 -0.788 . . . . 2.65 110.727 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.517 ' CE1' HG22 ' A' ' 67' ' ' VAL . 41.6 m-70 -85.4 -61.16 1.83 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.718 -0.614 . . . . 0.92 110.115 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.19 -126.48 5.22 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.778 -1.329 . . . . 0.85 109.778 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.2 p -124.2 -50.87 1.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.795 -0.827 . . . . 1.05 110.203 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.77 111.25 2.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 1.26 110.148 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 61' ' ' THR . 8.0 mt -134.7 171.68 14.02 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.315 -0.624 . . . . 0.62 109.315 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -129.46 150.29 50.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.774 . . . . 1.02 109.681 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -103.29 130.24 50.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.455 -0.778 . . . . 0.93 109.806 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 ' CG2' HG21 ' A' ' 21' ' ' THR . 3.3 pt -131.49 150.88 77.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.761 -0.587 . . . . 0.91 109.751 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.12 94.84 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 122.569 2.179 . . . . 1.09 109.451 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.64 130.39 52.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.755 -0.591 . . . . 2.98 110.066 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.28 146.85 52.93 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.072 -0.714 . . . . 1.81 109.072 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -95.63 116.34 28.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.537 -0.727 . . . . 1.93 109.783 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.58 83.5 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.067 -0.716 . . . . 3.39 109.067 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.84 49.1 0.87 Allowed Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.407 -1.477 . . . . 4.87 109.407 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.66 -0.906 . . . . 6.21 110.176 -179.74 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 109.845 -0.428 . . . . 4.79 109.845 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.29 139.59 32.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.697 -0.627 . . . . 2.47 109.638 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.96 -74.04 0.28 Allowed Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.021 -1.631 . . . . 2.36 109.021 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.39 55.25 0.7 Allowed Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.975 -1.65 . . . . 2.41 108.975 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 6' ' ' ALA . 5.1 t -143.03 -44.62 0.3 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.656 -0.908 . . . . 2.33 110.164 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 5' ' ' THR . . . -138.43 133.4 32.76 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.904 . . . . 1.79 110.353 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' A' ' 12' ' ' SER . . . -90.33 103.18 15.89 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.966 -0.753 . . . . 1.59 108.966 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 93.7 m -128.43 -72.21 0.62 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.574 -0.703 . . . . 2.01 109.195 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.4 m -138.09 -62.83 0.58 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.041 -0.726 . . . . 1.86 109.041 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.68 130.69 38.23 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.921 -0.77 . . . . 2.21 108.921 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.25 58.98 9.62 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.686 -1.365 . . . . 1.39 109.686 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 1.3 m -82.38 -42.71 18.31 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.605 -0.938 . . . . 0.88 109.324 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -117.96 161.59 19.54 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.383 -0.599 . . . . 1.67 109.383 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.1 m -112.19 131.44 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.561 -0.712 . . . . 0.5 109.726 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 m -103.33 143.09 33.13 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 0.58 109.501 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.15 138.43 52.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.543 -0.723 . . . . 0.58 109.964 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -111.8 102.95 11.19 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.887 -0.783 . . . . 1.98 108.887 179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 86' ' ' LEU . 2.7 mp -102.72 121.27 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.591 -0.693 . . . . 0.64 109.882 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.4 m -110.26 128.73 55.67 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -66.38 111.64 3.63 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.453 -0.779 . . . . 1.3 109.3 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 t -93.46 -28.85 15.87 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.63 -0.669 . . . . 1.06 110.632 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 60.2 p -67.79 -41.63 82.91 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.303 -0.873 . . . . 1.2 109.735 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -100.94 124.47 41.71 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.707 -0.621 . . . . 1.57 109.407 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 161.17 29.24 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 122.783 2.322 . . . . 1.52 111.151 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.68 59.17 1.49 Allowed 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.455 0.645 . . . . 3.28 109.94 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.25 134.5 9.54 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.411 -0.806 . . . . 0.98 109.964 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.16 156.69 33.7 Favored 'Trans proline' 0 N--CA 1.484 0.935 0 C-N-CA 123.0 2.467 . . . . 1.02 111.424 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -79.01 157.56 28.07 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.715 -0.616 . . . . 1.17 110.356 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.88 131.94 55.51 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.585 -0.697 . . . . 1.1 109.611 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.69 122.85 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.62 109.317 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -115.51 107.58 15.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.635 -0.666 . . . . 0.68 109.363 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.24 104.14 15.17 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.64 -0.662 . . . . 0.89 109.493 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.575 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -136.95 159.48 69.93 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.718 -0.614 . . . . 0.68 109.492 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.7 Cg_endo -75.88 156.49 39.13 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 122.624 2.216 . . . . 0.62 110.758 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.4 -22.37 61.31 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.667 -0.645 . . . . 1.27 110.606 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -41.29 94.82 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.41 -0.806 . . . . 1.1 110.046 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.1 p -68.35 135.11 91.03 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.423 -0.798 . . . . 0.73 109.422 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.84 163.26 26.22 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.786 2.324 . . . . 0.73 111.188 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.8 t80 -65.44 -19.19 65.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.628 -0.67 . . . . 0.55 109.768 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 69' ' ' PRO . 23.6 p -61.67 -44.6 96.65 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.74 -0.837 . . . . 0.61 108.74 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.06 -38.5 66.44 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.247 -0.649 . . . . 0.45 109.247 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.575 HG22 HG21 ' A' ' 33' ' ' VAL . 94.6 t -61.97 -47.12 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.648 -0.658 . . . . 0.56 109.249 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -65.35 -35.76 81.95 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.841 -0.537 . . . . 0.62 109.78 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -65.04 -50.47 66.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.631 -0.668 . . . . 1.88 109.663 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' HB3' HD11 ' A' ' 31' ' ' LEU . 2.3 t80 -62.27 -40.43 96.21 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.775 -0.578 . . . . 0.94 110.118 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.16 -47.14 75.01 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.554 -0.716 . . . . 0.45 110.065 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.08 -37.75 86.56 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.67 -0.643 . . . . 0.49 110.214 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -45.57 93.19 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 0.87 109.845 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.51 -28.64 62.01 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.604 -0.685 . . . . 0.96 109.827 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 20' ' ' LEU . 2.4 m-85 -80.85 1.97 28.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.527 -0.733 . . . . 0.58 110.764 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 62.93 42.53 7.51 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.431 -0.793 . . . . 2.65 110.314 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 86' ' ' LEU . 14.3 m -138.12 157.37 73.01 Favored Pre-proline 0 N--CA 1.499 1.985 0 N-CA-C 109.06 -0.718 . . . . 0.61 109.06 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -74.59 119.92 5.95 Favored 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 122.463 2.109 . . . . 0.58 110.82 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 47' ' ' ALA . . . -73.28 -32.8 64.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 122.071 -0.393 . . . . 0.63 110.077 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.12 -30.82 71.29 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.781 -0.575 . . . . 0.65 110.488 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 90' ' ' ASP . 30.6 p -121.42 49.57 1.5 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.835 . . . . 0.59 109.793 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 93.0 p -147.62 146.06 29.21 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.355 -0.841 . . . . 0.47 110.017 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -124.14 168.46 12.87 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.219 0.533 . . . . 0.5 109.636 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 mt -126.01 121.02 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.52 109.096 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 85' ' ' ARG . 2.5 pt -98.46 173.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.509 -0.745 . . . . 0.6 109.574 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.4 p -100.89 173.16 6.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.334 -0.854 . . . . 0.54 109.699 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -69.86 -22.21 63.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.546 -0.721 . . . . 1.0 109.997 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -83.48 -54.57 4.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.507 -0.745 . . . . 0.9 109.485 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 150.59 54.75 0.01 OUTLIER Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.948 -1.261 . . . . 0.69 109.948 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 60.8 t -128.47 121.86 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.696 -0.885 . . . . 0.67 109.026 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.594 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -78.18 88.71 1.09 Allowed Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.043 -1.223 . . . . 0.56 110.043 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.463 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.6 t -71.61 128.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.86 -0.788 . . . . 0.54 109.299 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -110.4 161.7 23.52 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.802 -0.562 . . . . 0.95 109.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.13 62.88 8.15 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.947 2.431 . . . . 0.56 110.316 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.62 -13.25 4.81 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.42 -0.8 . . . . 1.06 110.924 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.649 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.2 pm0 -116.49 165.83 14.13 Favored Pre-proline 0 N--CA 1.501 2.091 0 O-C-N 121.195 -0.941 . . . . 0.73 109.774 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.4 Cg_endo -76.21 156.93 37.8 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 C-N-CA 122.644 2.229 . . . . 0.53 111.056 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.8 76.44 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.79 -0.569 . . . . 0.49 110.003 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.73 -44.76 91.52 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.563 -1.415 . . . . 0.47 109.563 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -69.33 -34.28 74.41 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.734 -0.863 . . . . 1.25 109.71 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG11 ' A' ' 67' ' ' VAL . 19.9 mm -61.1 -43.37 96.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.59 -0.694 . . . . 0.45 109.492 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -74.39 -38.08 63.23 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.686 -0.633 . . . . 0.72 109.917 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 mt -65.97 -38.83 89.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.559 -0.713 . . . . 0.82 110.46 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -55.29 3.63 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 1.9 110.657 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.463 ' CE1' HG22 ' A' ' 67' ' ' VAL . 61.1 m-70 -88.93 -65.08 1.05 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.485 -0.759 . . . . 0.68 110.334 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.34 -122.72 4.71 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.674 -1.37 . . . . 0.69 109.674 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 t -119.59 -41.78 2.68 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.618 -0.931 . . . . 0.58 110.325 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.2 106.43 0.37 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.6 -0.688 . . . . 1.3 110.026 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.5 mt -138.37 172.13 13.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.764 -0.585 . . . . 0.66 110.114 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.603 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.1 mtt180 -141.57 156.26 45.71 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.694 -0.629 . . . . 1.95 109.621 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.94 123.7 49.5 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 1.07 109.998 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.528 HG12 HG23 ' A' ' 60' ' ' ILE . 1.6 pt -127.01 155.11 76.34 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.668 -0.645 . . . . 0.79 110.114 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 35.5 Cg_endo -78.36 123.04 5.86 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.89 2.393 . . . . 0.7 110.48 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 -56.37 2.94 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.605 -0.684 . . . . 1.36 109.402 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.401 ' O ' ' HB ' ' A' ' 56' ' ' THR . 1.7 m-20 -135.3 164.82 26.85 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.62 -0.675 . . . . 1.49 109.867 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.61 128.3 53.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.609 -0.682 . . . . 2.87 109.29 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.3 m -88.05 -37.72 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.472 -0.768 . . . . 2.51 109.781 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.85 82.15 1.5 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.478 -1.449 . . . . 2.67 109.478 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.5 m80 . . . . . 0 N--CA 1.498 1.958 0 CA-C-O 117.862 -1.066 . . . . 4.33 109.976 -179.734 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.926 0.393 . . . . 7.44 110.007 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 49.78 52.07 15.31 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 121.603 0.716 . . . . 5.03 110.144 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 96.97 30.86 7.25 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.913 -1.275 . . . . 2.49 109.913 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 5' ' ' THR . . . -99.82 -72.59 1.02 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.718 -1.753 . . . . 1.84 108.718 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.572 HG21 ' HA ' ' A' ' 33' ' ' VAL . 99.6 m 67.91 130.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.335 0.588 . . . . 2.22 110.141 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 135.38 35.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.756 -0.59 . . . . 2.68 109.863 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.37 -41.64 72.85 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.637 -0.664 . . . . 2.01 109.424 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.3 m 53.24 59.42 4.42 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.334 0.587 . . . . 3.71 109.871 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.5 p 43.08 54.09 4.99 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.238 0.542 . . . . 3.98 110.551 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 34' ' ' PRO . . . -129.61 109.89 11.37 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.47 -0.769 . . . . 2.11 109.509 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.58 -52.29 8.57 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.739 -1.344 . . . . 1.43 109.739 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.2 p -82.62 135.7 34.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.745 -0.856 . . . . 1.05 109.897 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -131.47 150.5 52.13 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.238 0.542 . . . . 1.51 109.805 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -103.47 130.87 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.76 -0.588 . . . . 0.72 109.442 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.7 p -99.04 143.48 29.27 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.689 -0.632 . . . . 0.71 109.82 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -128.34 136.5 51.04 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.538 -0.726 . . . . 0.7 109.892 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.47 115.31 29.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.713 -0.847 . . . . 2.88 108.713 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.572 HG21 HD12 ' A' ' 86' ' ' LEU . 3.1 mp -123.79 128.5 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.685 -0.634 . . . . 0.58 109.812 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 14.0 t -121.62 143.39 49.34 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' HB3' ' A' ' 86' ' ' LEU . 6.1 tp -67.6 136.24 54.15 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.432 -0.793 . . . . 1.07 110.053 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.2 p -107.35 -3.76 19.29 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.698 -0.626 . . . . 1.29 110.489 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.89 -58.03 3.52 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 1.86 109.527 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -96.82 136.54 21.61 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.745 -0.597 . . . . 1.49 109.661 -179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 23' ' ' ASP . 35.4 Cg_endo -78.76 155.98 27.36 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.708 2.272 . . . . 0.96 110.757 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.26 57.77 0.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.431 0.634 . . . . 4.36 109.822 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.01 143.78 50.41 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.476 -0.765 . . . . 1.14 109.689 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.36 160.58 35.57 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 C-N-CA 122.964 2.442 . . . . 0.69 111.256 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 43.1 p90 -99.32 161.37 13.65 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.619 -0.676 . . . . 0.84 110.203 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -117.39 135.43 53.88 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.564 -0.71 . . . . 1.26 109.617 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.71 122.86 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.576 -0.702 . . . . 0.84 109.208 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.06 119.98 40.3 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.565 -0.71 . . . . 1.05 109.719 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.89 118.3 36.63 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.716 -0.615 . . . . 1.13 109.379 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 5' ' ' THR . 22.2 m -135.71 154.41 78.04 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.654 -0.654 . . . . 0.6 109.646 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 35.1 Cg_endo -76.48 151.89 33.5 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.762 2.308 . . . . 0.57 110.734 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 82.73 0.1 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.688 0.756 . . . . 0.86 109.128 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.77 -38.8 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.96 -0.755 . . . . 0.86 108.96 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.0 p -63.28 139.08 97.51 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.753 -0.592 . . . . 0.65 109.433 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.38 157.5 32.99 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.686 2.257 . . . . 0.66 111.234 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 1.1 t80 -66.12 -17.66 64.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.689 -0.632 . . . . 0.73 109.792 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -62.15 -45.23 94.33 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.602 -0.888 . . . . 0.89 108.602 178.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.11 -42.75 62.6 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.542 -0.54 . . . . 0.62 109.542 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.41 -48.75 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.607 -0.683 . . . . 0.58 109.236 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.563 HD12 HD12 ' A' ' 59' ' ' ILE . 4.9 tt -65.27 -35.66 81.72 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.727 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.9 -44.96 95.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.758 -0.589 . . . . 2.02 109.741 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -68.42 -43.44 77.19 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.553 . . . . 1.36 110.092 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.58 -45.5 86.75 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.578 -0.701 . . . . 0.48 110.05 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.56 -46.83 86.56 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.619 -0.676 . . . . 0.51 109.634 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -35.79 80.52 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.683 -0.636 . . . . 1.0 109.761 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -61.85 -34.76 76.56 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.674 -0.641 . . . . 0.91 109.504 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -83.21 -83.26 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.534 -0.913 . . . . 0.61 108.534 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 174.83 33.59 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 2.55 110.518 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG23 ' HB1' ' A' ' 47' ' ' ALA . 4.4 m -134.36 152.7 78.53 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.24 -0.912 . . . . 0.76 109.28 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.51 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 35.1 Cg_endo -77.0 136.39 16.42 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.57 2.18 . . . . 0.68 110.885 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -60.8 -36.3 78.66 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.754 -0.591 . . . . 0.8 110.163 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.66 -35.15 75.52 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.619 -0.675 . . . . 0.68 109.788 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 13.9 m -111.99 43.65 1.54 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.551 -0.718 . . . . 0.85 109.309 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 m -142.74 149.94 39.41 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.261 -0.9 . . . . 0.94 110.354 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -140.1 166.16 25.4 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.933 -0.766 . . . . 0.5 108.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.563 HD12 HD12 ' A' ' 43' ' ' LEU . 11.7 mt -124.89 138.94 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.3 -0.875 . . . . 0.56 109.523 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.64 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -114.24 166.71 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.492 -0.755 . . . . 0.58 109.584 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 62' ' ' ASN . 24.0 m -101.15 160.85 14.04 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.62 109.861 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.403 ' N ' HG22 ' A' ' 61' ' ' THR . 3.9 t30 -57.64 -25.79 60.66 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.748 -0.595 . . . . 1.33 110.802 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.24 -44.73 21.21 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.282 -0.886 . . . . 1.16 109.622 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.52 51.45 0.06 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.782 -1.327 . . . . 0.82 109.782 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.71 111.75 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.746 -0.855 . . . . 0.77 108.957 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.64 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.96 83.26 0.83 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.803 -1.319 . . . . 0.49 109.803 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG11 ' NE2' ' A' ' 80' ' ' HIS . 28.0 m -73.55 141.02 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.835 -0.803 . . . . 0.65 109.95 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.459 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 2.7 m120 -101.75 165.17 14.47 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.774 -0.579 . . . . 1.27 109.792 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.659 ' O ' HG23 ' A' ' 40' ' ' THR . 34.8 Cg_endo -76.92 63.89 7.62 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 122.858 2.372 . . . . 0.73 110.246 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -142.34 31.14 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.566 -0.709 . . . . 0.82 109.839 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.48 ' HB2' HD11 ' A' ' 76' ' ' ILE . 16.0 mt-30 -135.97 160.29 67.86 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.402 -0.811 . . . . 1.6 109.477 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.66 146.58 27.07 Favored 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 122.462 2.108 . . . . 0.7 110.49 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.92 -41.98 71.67 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.725 -0.61 . . . . 0.53 110.208 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.13 -44.14 94.92 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.035 -1.226 . . . . 0.67 110.035 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.516 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 22.0 t-20 -67.86 -39.31 83.77 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.586 -0.949 . . . . 1.05 110.088 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 71' ' ' GLN . 37.5 mm -60.87 -40.81 86.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.556 -0.715 . . . . 0.6 109.371 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -73.3 -39.11 65.58 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 0.88 109.635 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.67 -33.76 76.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.435 -0.791 . . . . 0.99 110.221 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -86.69 -55.87 3.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.585 -0.697 . . . . 2.47 110.377 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.646 ' NE2' HG11 ' A' ' 67' ' ' VAL . 6.9 m-70 -98.01 -56.72 2.41 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.607 -0.683 . . . . 0.8 110.141 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.49 -102.79 2.15 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.545 -1.422 . . . . 0.79 109.545 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.77 40.71 3.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.671 -0.899 . . . . 0.83 109.747 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 2.5 mm-40 -136.41 86.47 2.22 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.413 -0.805 . . . . 1.17 109.248 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mt -134.43 167.4 20.83 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.655 -0.653 . . . . 0.91 110.132 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.601 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.5 mtm-85 -134.15 149.93 51.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.559 -0.713 . . . . 1.49 109.583 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -102.72 132.02 49.16 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.96 110.063 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.624 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -139.15 135.87 17.69 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.018 -0.734 . . . . 0.81 109.018 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo -74.65 95.47 0.95 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.297 1.998 . . . . 0.93 110.202 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -140.62 134.88 31.11 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.191 -0.67 . . . . 2.67 109.191 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -88.8 156.48 18.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.511 -0.743 . . . . 2.01 110.101 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.09 102.04 5.55 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.266 -0.642 . . . . 1.92 109.266 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.95 -63.59 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.704 -0.622 . . . . 2.86 109.349 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.03 -56.67 0.83 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.532 -1.427 . . . . 2.93 109.532 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.7 t60 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.849 -1.072 . . . . 4.39 109.745 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 mtt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.568 -0.53 . . . . 3.99 109.568 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.28 96.46 7.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.535 0.683 . . . . 3.38 110.315 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.07 58.62 2.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 107.084 -2.406 . . . . 4.07 107.084 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.85 -69.61 2.17 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.46 -1.856 . . . . 4.72 108.46 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -155.0 49.05 0.56 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 108.439 -0.949 . . . . 5.47 108.439 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.73 99.86 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.693 -0.629 . . . . 2.76 109.72 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.94 98.81 1.66 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.434 0.635 . . . . 3.53 109.346 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.9 t -146.23 151.56 37.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.39 -0.596 . . . . 1.91 109.39 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -68.56 -44.7 73.93 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.74 -0.6 . . . . 1.82 109.736 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -128.5 -61.22 1.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.649 -0.657 . . . . 1.65 110.074 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.38 -99.67 1.22 Allowed Glycine 0 N--CA 1.496 2.661 0 N-CA-C 109.213 -1.555 . . . . 1.21 109.213 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -101.53 129.18 47.56 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.658 -0.907 . . . . 1.11 109.122 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -140.87 155.34 46.34 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.505 -0.747 . . . . 2.76 110.224 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -110.17 140.49 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.726 -0.609 . . . . 0.54 109.498 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.9 m -104.53 134.17 48.16 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.604 -0.685 . . . . 0.77 109.473 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -119.85 142.82 48.3 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.613 -0.679 . . . . 0.63 109.703 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -119.48 108.8 14.98 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.933 -0.766 . . . . 3.01 108.933 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG21 HD12 ' A' ' 86' ' ' LEU . 3.7 mp -103.71 116.35 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.672 -0.642 . . . . 0.54 109.572 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.4 m -111.83 133.94 53.71 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.862 -0.792 . . . . 0.52 108.862 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 22' ' ' SER . 5.5 tp -61.86 145.86 51.44 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.492 -0.755 . . . . 0.99 109.998 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.498 HG21 HG22 ' A' ' 87' ' ' ILE . 5.2 p -70.56 -26.51 63.58 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.605 . . . . 1.03 110.245 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -62.41 -46.59 87.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.539 -0.726 . . . . 1.74 109.697 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 1.8 p30 -86.12 161.96 47.88 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.603 -0.686 . . . . 1.05 109.66 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 23' ' ' ASP . 34.0 Cg_endo -77.01 -69.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.602 2.202 . . . . 1.22 110.602 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.73 73.48 0.12 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.52 -0.737 . . . . 1.18 109.769 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.695 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -145.96 -66.1 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.49 -0.756 . . . . 1.23 109.653 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.695 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.9 Cg_endo -79.51 86.44 1.68 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.082 1.855 . . . . 0.97 110.122 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -128.05 163.19 25.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.523 -0.736 . . . . 1.06 110.064 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.6 136.4 50.86 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.565 -0.709 . . . . 1.23 110.15 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 17' ' ' LYS . 46.0 t -107.06 124.6 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.758 -0.83 . . . . 0.78 108.758 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.36 119.35 34.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.501 -0.75 . . . . 1.2 110.111 -179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 m -109.09 113.27 25.99 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.991 -0.744 . . . . 0.7 108.991 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -133.39 156.13 80.05 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.696 -0.627 . . . . 0.6 109.598 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -75.49 152.05 38.07 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.619 2.213 . . . . 0.74 110.881 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.72 83.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.707 0.765 . . . . 0.91 109.159 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.8 p -179.13 -39.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.006 -0.738 . . . . 0.74 109.006 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 30.6 p -64.01 140.07 97.8 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.696 -0.627 . . . . 0.68 109.48 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.0 Cg_endo -77.72 154.7 30.74 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 122.7 2.266 . . . . 0.53 111.173 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.499 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.3 t80 -65.19 -19.32 65.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.673 -0.642 . . . . 0.52 109.703 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.3 p -61.11 -43.85 98.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.295 -0.878 . . . . 0.6 108.775 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.37 -39.14 62.92 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.392 -0.596 . . . . 0.43 109.392 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -61.37 -49.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.591 -0.693 . . . . 0.49 109.232 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD12 HD12 ' A' ' 59' ' ' ILE . 2.9 tt -63.35 -35.42 80.32 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.796 -0.565 . . . . 0.69 109.63 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -62.65 -46.3 88.84 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.762 -0.586 . . . . 2.31 109.998 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.563 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.1 t80 -66.35 -44.57 82.9 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.678 -0.639 . . . . 1.28 109.631 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.36 -46.45 90.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.66 -0.65 . . . . 0.49 109.622 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.544 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.87 -36.58 83.83 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.684 -0.635 . . . . 0.43 109.803 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -45.41 92.23 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.696 -0.628 . . . . 0.89 109.567 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.24 -27.94 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.71 109.86 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -82.69 0.54 42.88 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.437 -0.789 . . . . 0.69 111.073 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.2 mptt 66.23 35.56 5.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.313 -0.867 . . . . 2.82 110.078 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.544 HG23 ' HB1' ' A' ' 47' ' ' ALA . 13.9 m -131.1 154.9 82.13 Favored Pre-proline 0 N--CA 1.497 1.925 0 O-C-N 121.373 -0.829 . . . . 0.7 109.651 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.75 128.23 10.0 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.704 2.269 . . . . 0.74 110.581 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.37 -34.45 78.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.863 -0.523 . . . . 0.78 110.018 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.02 -38.7 87.02 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.654 -0.654 . . . . 0.93 109.917 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.3 m -107.9 38.47 2.17 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.573 -0.704 . . . . 0.93 109.409 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -135.17 154.77 51.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.888 . . . . 0.63 110.149 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -147.02 169.29 19.52 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.212 -0.662 . . . . 0.39 109.212 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.427 HD12 HD12 ' A' ' 43' ' ' LEU . 23.0 mt -130.59 124.84 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -0.898 . . . . 0.46 109.707 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.708 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -104.65 171.41 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.53 -0.731 . . . . 0.59 109.413 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.7 p -100.29 170.55 8.36 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.329 -0.857 . . . . 0.56 109.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.2 -24.04 64.9 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.624 -0.672 . . . . 1.45 110.019 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.39 -51.56 9.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 2.05 109.448 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.85 49.93 0.03 OUTLIER Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.724 -1.35 . . . . 0.74 109.724 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -122.53 118.16 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.762 -0.846 . . . . 0.68 108.858 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.708 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -76.55 87.53 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.952 -1.259 . . . . 0.52 109.952 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.483 HG22 ' CE1' ' A' ' 80' ' ' HIS . 21.2 t -69.31 130.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.973 -0.722 . . . . 0.55 109.443 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -111.26 163.06 18.31 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.755 -0.591 . . . . 0.84 109.658 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.6 Cg_endo -78.18 64.84 8.44 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 122.985 2.457 . . . . 0.55 110.471 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.35 34.32 1.19 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.52 -0.737 . . . . 0.67 109.796 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.556 ' HG3' HD11 ' A' ' 76' ' ' ILE . 2.4 pt20 -155.55 162.9 26.35 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.238 -0.914 . . . . 1.4 109.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.35 153.61 35.63 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 122.685 2.257 . . . . 0.47 111.186 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.58 85.76 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.89 -0.506 . . . . 0.57 109.905 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.0 91.6 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.796 -1.322 . . . . 0.53 109.796 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -69.57 -34.53 74.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.682 -0.893 . . . . 0.91 110.008 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.556 HD11 ' HG3' ' A' ' 71' ' ' GLN . 18.0 mm -60.71 -43.89 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.649 -0.657 . . . . 0.52 109.415 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -75.65 -38.59 58.72 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.645 -0.659 . . . . 0.82 110.099 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.8 mt -65.42 -35.78 81.96 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.549 -0.719 . . . . 0.9 110.694 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.84 -56.41 2.78 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.612 -0.68 . . . . 3.53 110.72 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.483 ' CE1' HG22 ' A' ' 67' ' ' VAL . 40.3 m-70 -85.73 -58.31 2.71 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.495 -0.753 . . . . 0.72 110.314 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.87 -132.25 9.33 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.798 -1.321 . . . . 0.58 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.3 p -115.36 -43.65 3.04 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.746 -0.855 . . . . 0.68 110.41 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.01 108.21 1.17 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.485 -0.76 . . . . 1.76 110.15 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 mt -138.43 169.58 17.54 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.822 -0.549 . . . . 0.83 109.638 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.4 mtp85 -132.84 159.81 38.74 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.601 -0.687 . . . . 1.61 109.655 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.628 HD12 HG21 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.44 129.99 55.25 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 1.0 109.857 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.74 HD13 ' HB3' ' A' ' 94' ' ' HIS . 3.5 pt -128.59 158.75 70.96 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.725 -0.61 . . . . 0.6 109.564 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 35.7 Cg_endo -77.24 86.87 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.621 2.214 . . . . 0.65 110.519 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 71.38 144.26 0.06 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.45 0.643 . . . . 1.35 110.547 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.63 179.81 4.56 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 0.7 109.477 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 61.57 22.38 12.86 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.504 -0.748 . . . . 2.96 110.594 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.06 53.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.268 -0.895 . . . . 1.2 109.175 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.95 -41.17 2.21 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.529 -1.429 . . . . 1.21 109.529 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.74 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.631 -0.923 . . . . 2.07 110.031 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' THR . 4.9 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.385 -0.598 . . . . 7.5 109.385 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.37 97.06 0.06 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.668 -0.864 . . . . 7.82 108.668 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.04 47.2 11.67 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 107.501 -2.24 . . . . 4.69 107.501 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.81 61.19 0.13 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.076 -2.01 . . . . 3.06 108.076 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 29.9 m -53.33 110.82 0.6 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.919 -0.754 . . . . 4.17 109.851 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 9' ' ' THR . . . -93.6 89.67 6.34 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.184 0.516 . . . . 3.19 110.397 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -46.98 7.97 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.447 -0.783 . . . . 5.08 109.064 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.7 p -95.07 -56.28 2.79 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.614 -0.884 . . . . 6.06 108.614 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.618 ' O ' ' HB1' ' A' ' 6' ' ' ALA . 40.0 p -82.99 175.0 10.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.605 -0.684 . . . . 4.42 109.402 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.63 -25.81 26.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.694 -0.854 . . . . 2.49 108.694 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.97 -85.08 0.3 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.496 -1.442 . . . . 2.08 109.496 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -97.13 138.91 33.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 122.06 -0.671 . . . . 1.34 109.203 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 146.28 47.09 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.625 -0.672 . . . . 1.7 109.327 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.5 m -98.24 126.25 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.683 -0.636 . . . . 0.75 109.758 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.0 m -107.48 132.32 53.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.736 -0.602 . . . . 0.61 109.454 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' HB3' HD12 ' A' ' 84' ' ' LEU . 6.3 m-85 -120.48 132.34 55.16 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.596 -0.69 . . . . 0.93 109.832 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 99.94 9.47 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.791 -0.818 . . . . 1.45 108.791 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.6 mp -91.32 134.15 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.53 -0.731 . . . . 0.56 109.664 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.463 HG23 ' HB3' ' A' ' 28' ' ' PHE . 38.3 m -121.51 111.94 17.89 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.782 -0.822 . . . . 0.68 108.782 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.573 HD11 ' HB3' ' A' ' 23' ' ' ASP . 1.8 pt? -64.75 140.53 58.88 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.436 -0.79 . . . . 0.73 109.861 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.1 t -107.33 -1.93 21.15 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.673 -0.642 . . . . 0.95 110.69 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.3 -45.9 14.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.08 -1.013 . . . . 1.38 109.787 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.573 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.8 t70 -112.18 119.44 43.97 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.604 -0.685 . . . . 0.99 109.742 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.85 -30.69 3.57 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.88 2.386 . . . . 1.23 111.283 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -65.54 -42.98 91.31 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.462 -0.773 . . . . 2.21 110.061 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.1 136.05 84.8 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.434 -0.791 . . . . 1.11 109.933 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.59 170.39 18.36 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 122.948 2.432 . . . . 0.79 111.369 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' HB3' HG23 ' A' ' 19' ' ' THR . 41.8 p90 -76.98 163.0 27.11 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.636 -0.665 . . . . 0.96 109.895 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HG3' ' CB ' ' A' ' 49' ' ' GLU . 2.5 tmtt? -119.67 137.6 53.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.474 -0.766 . . . . 0.99 110.427 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.5 t -106.36 134.83 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.887 -0.783 . . . . 0.73 108.887 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.1 112.52 16.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.576 -0.703 . . . . 0.82 109.858 -179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.8 p -102.16 111.29 23.51 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.171 -0.678 . . . . 0.63 109.171 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.4 m -138.51 156.92 73.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.634 -0.666 . . . . 0.68 110.014 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.89 155.7 34.45 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.797 2.332 . . . . 0.9 110.846 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -65.05 83.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.721 0.772 . . . . 1.14 109.119 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.8 p -179.78 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.1 p -61.25 140.81 94.39 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.541 -0.724 . . . . 0.81 109.706 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.84 150.67 27.29 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.721 2.281 . . . . 0.7 111.079 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.3 t80 -66.42 -18.3 65.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.623 -0.673 . . . . 0.61 109.813 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 p -61.36 -44.38 97.27 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.769 -0.826 . . . . 0.71 108.769 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.57 -39.27 62.36 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.365 -0.606 . . . . 0.64 109.365 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.8 t -60.95 -50.88 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 109.11 -0.7 . . . . 0.62 109.11 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 tt -62.25 -35.36 78.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.769 -0.582 . . . . 0.61 109.65 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -50.78 66.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.68 -0.637 . . . . 2.74 109.798 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.507 ' CB ' HD21 ' A' ' 31' ' ' LEU . 4.3 m-85 -59.06 -43.21 91.69 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.656 -0.653 . . . . 1.67 110.22 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -65.27 -46.03 82.1 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.648 -0.657 . . . . 0.47 109.277 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.561 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.07 -30.66 71.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.77 -0.581 . . . . 0.42 110.137 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -49.5 77.4 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.598 -0.689 . . . . 1.6 109.63 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 0.7 OUTLIER -69.29 -39.15 78.51 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.674 -0.641 . . . . 0.88 109.627 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.5 ' CD2' HD13 ' A' ' 86' ' ' LEU . 22.2 m-85 -67.47 -18.17 64.97 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.763 -0.586 . . . . 0.61 110.581 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER 76.45 33.7 0.51 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.753 -0.592 . . . . 2.04 109.961 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.561 HG23 ' HB1' ' A' ' 47' ' ' ALA . 12.8 m -123.07 156.01 63.43 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.42 -0.8 . . . . 0.65 109.608 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.92 123.7 6.96 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.586 2.191 . . . . 0.7 110.247 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.81 -29.39 68.55 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.955 -0.466 . . . . 0.83 110.215 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.11 83.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.68 -0.637 . . . . 0.77 110.237 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.6 p -114.0 46.39 1.33 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.565 -0.709 . . . . 0.68 109.752 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.09 160.36 38.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.444 -0.785 . . . . 1.14 110.12 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -144.74 162.45 36.69 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.282 -0.636 . . . . 0.58 109.282 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 mt -131.24 121.33 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.4 -0.812 . . . . 0.54 109.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.55 168.58 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.551 -0.718 . . . . 0.81 109.205 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -112.22 170.83 7.89 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.79 110.06 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -64.97 -19.34 65.92 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.608 -0.683 . . . . 1.18 110.619 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.07 -25.22 43.13 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.353 -0.842 . . . . 1.17 110.106 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.92 47.75 0.93 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.62 -1.392 . . . . 1.11 109.62 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 30.9 t -130.13 127.17 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.805 -0.82 . . . . 1.06 108.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.648 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.42 87.8 1.02 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.652 -1.379 . . . . 0.85 109.652 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.677 HG22 ' CE1' ' A' ' 80' ' ' HIS . 10.3 t -64.93 128.98 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.919 -0.754 . . . . 0.71 109.423 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.1 m-80 -104.68 161.04 24.0 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.856 -0.527 . . . . 1.05 109.671 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.38 63.37 7.83 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 122.81 2.34 . . . . 0.67 110.14 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.8 31.06 0.45 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.616 -0.678 . . . . 0.88 109.832 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' HB2' HD11 ' A' ' 76' ' ' ILE . 30.5 mt-30 -137.49 155.7 75.29 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.472 -0.768 . . . . 1.21 109.715 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.4 Cg_endo -76.79 146.55 26.61 Favored 'Trans proline' 0 C--N 1.315 -1.229 0 C-N-CA 122.653 2.235 . . . . 0.89 110.392 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.01 62.9 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.761 -0.587 . . . . 0.75 110.388 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.34 -46.77 93.34 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.95 -1.26 . . . . 0.85 109.95 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 13.8 t-20 -67.97 -34.88 77.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.63 -0.923 . . . . 1.49 110.078 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 71' ' ' GLN . 33.1 mm -59.73 -41.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.604 -0.685 . . . . 0.78 109.647 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -76.9 -39.5 50.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.63 -0.669 . . . . 0.95 110.072 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.9 mt -67.62 -38.93 84.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.553 -0.717 . . . . 1.08 110.642 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -52.69 5.22 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.505 -0.747 . . . . 1.91 110.886 -179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.677 ' CE1' HG22 ' A' ' 67' ' ' VAL . 49.0 m-70 -93.33 -62.81 1.3 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.714 . . . . 0.95 110.332 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.75 -135.38 8.24 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.853 -1.299 . . . . 0.8 109.853 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.4 p -113.63 -46.35 3.05 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.69 -0.888 . . . . 0.62 110.164 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 112.92 3.6 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.487 -0.758 . . . . 1.01 109.862 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 16' ' ' PHE . 2.7 mt -135.69 161.19 36.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.256 0.55 . . . . 0.84 109.731 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.0 146.01 49.62 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.028 -0.73 . . . . 1.27 109.028 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.5 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -105.47 129.19 53.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.2 -0.937 . . . . 0.69 109.995 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -131.98 125.09 19.98 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.063 -0.717 . . . . 0.85 109.063 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.749 ' HB2' ' HB2' ' A' ' 91' ' ' ARG . 36.4 Cg_endo -77.66 131.48 11.39 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 122.695 2.263 . . . . 0.76 111.034 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.0 mtt180 -76.64 -57.8 3.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.259 -0.645 . . . . 1.86 109.259 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.93 78.25 1.17 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.125 -0.694 . . . . 1.65 109.125 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -151.62 156.23 40.02 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.532 -0.73 . . . . 2.3 109.833 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.5 m -76.9 -28.46 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.533 -0.729 . . . . 1.85 110.141 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 119.5 76.89 0.51 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.322 -1.511 . . . . 1.73 109.322 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.479 -0.772 . . . . 2.91 110.121 -179.707 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.263 0.554 . . . . 3.74 109.911 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' HB2' ' HE2' ' A' ' 13' ' ' LYS . 4.0 p -84.53 -53.94 5.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.649 -0.657 . . . . 2.3 109.507 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -110.66 130.7 9.97 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.543 -1.423 . . . . 3.93 109.543 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.74 -98.01 0.18 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.076 -1.209 . . . . 4.22 110.076 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 m -100.26 -58.57 1.88 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.869 -0.783 . . . . 5.22 108.958 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.45 147.43 36.5 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.84 -0.537 . . . . 4.23 109.802 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.56 34.51 1.17 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.167 -0.679 . . . . 3.57 109.167 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.459 ' O ' ' HB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER -103.61 137.93 40.99 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.334 -0.854 . . . . 4.96 109.749 -179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 8' ' ' THR . 20.7 m 73.89 135.28 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.515 0.674 . . . . 4.49 110.0 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.57 14.61 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.631 -0.668 . . . . 2.83 109.822 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.94 -76.75 1.16 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.19 -1.164 . . . . 1.44 110.19 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m -138.25 108.11 6.31 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.46 -1.024 . . . . 1.6 110.26 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 2' ' ' SER . 2.0 mttm -119.12 159.77 23.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.724 -0.61 . . . . 2.22 109.788 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 27.3 m -103.99 137.87 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.566 -0.709 . . . . 0.73 109.368 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.2 p -98.95 146.01 26.45 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 0.83 110.053 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -129.96 145.5 51.64 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.647 -0.658 . . . . 0.7 109.898 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.63 104.42 7.19 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.801 -0.814 . . . . 1.18 108.801 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.1 mp -101.62 133.92 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.681 -0.637 . . . . 0.68 109.901 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -133.08 141.97 48.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.109 -0.7 . . . . 0.67 109.109 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -60.08 115.76 3.69 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.459 -0.776 . . . . 1.03 109.597 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -72.55 -32.94 66.47 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.777 -0.577 . . . . 1.09 110.151 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.46 -51.08 21.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.446 -0.784 . . . . 1.71 109.672 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.48 105.35 1.83 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.621 -0.674 . . . . 2.75 109.865 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.56 138.63 17.45 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.796 2.331 . . . . 2.3 110.545 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.11 -64.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.649 -0.657 . . . . 2.36 109.855 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.567 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -176.42 -58.22 0.0 OUTLIER Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 109.389 -0.597 . . . . 2.12 109.389 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.0 Cg_endo -77.81 124.6 6.93 Favored 'Trans proline' 0 C--N 1.325 -0.679 0 C-N-CA 122.344 2.03 . . . . 1.55 110.188 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -92.88 151.47 19.95 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.57 -0.706 . . . . 1.47 109.807 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.4 99.39 10.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.62 -0.675 . . . . 1.13 109.494 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.33 119.68 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.918 -0.771 . . . . 0.89 108.918 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.69 121.51 39.4 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.669 -0.645 . . . . 1.19 110.05 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.22 106.35 16.83 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.141 -0.688 . . . . 0.95 109.141 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -134.72 156.12 78.89 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.62 -0.675 . . . . 0.9 109.837 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.66 164.87 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.716 2.278 . . . . 0.93 110.779 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.5 OUTLIER -56.64 -33.83 66.69 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.747 -0.595 . . . . 1.16 110.237 -179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.29 -42.47 70.08 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.655 -0.653 . . . . 1.18 110.23 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.3 m -67.98 124.91 90.67 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.578 -0.701 . . . . 0.8 109.197 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.95 164.95 24.72 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.87 2.38 . . . . 0.76 111.575 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.524 ' CE1' HG21 ' A' ' 76' ' ' ILE . 3.8 t80 -66.81 -16.57 64.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.647 -0.658 . . . . 0.61 109.878 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.5 p -61.29 -44.35 97.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.331 -0.856 . . . . 0.65 108.799 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.52 -38.61 54.87 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.249 -0.649 . . . . 0.64 109.249 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 33' ' ' VAL . 86.7 t -61.39 -45.29 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.722 -0.611 . . . . 0.65 109.492 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 58' ' ' ALA . 2.2 tt -68.86 -36.48 78.18 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.729 -0.607 . . . . 0.73 109.819 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 4.0 mttt -60.78 -43.52 97.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.742 -0.599 . . . . 1.53 109.811 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.72 -44.32 64.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.631 -0.668 . . . . 1.38 109.785 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.495 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -60.89 -46.64 89.82 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.566 -0.709 . . . . 0.51 110.196 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -68.35 -44.41 75.33 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.655 -0.653 . . . . 0.58 110.005 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -44.84 92.77 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.684 -0.635 . . . . 0.99 110.138 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 -29.47 68.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.62 -0.675 . . . . 0.84 110.563 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' CD1' HD23 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -80.31 -81.97 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.299 -0.876 . . . . 0.73 109.52 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.7 pttt 175.14 36.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.683 -0.635 . . . . 1.3 110.305 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.3 m -145.93 154.31 50.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.98 -1.075 . . . . 0.75 110.485 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.09 131.83 11.18 Favored 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.992 2.461 . . . . 0.75 110.476 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -57.34 -34.17 68.51 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.768 -0.583 . . . . 0.91 110.272 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.98 97.87 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.6 -0.688 . . . . 0.87 110.054 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -110.39 42.51 1.55 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.563 -0.711 . . . . 0.83 109.625 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -142.13 154.64 45.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.252 -0.905 . . . . 1.02 110.04 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.552 ' HA ' HD11 ' A' ' 43' ' ' LEU . . . -146.89 170.85 16.2 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.523 -0.547 . . . . 0.58 109.523 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 HD12 HD12 ' A' ' 43' ' ' LEU . 16.1 mt -128.22 121.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.55 109.39 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.756 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.9 pt -98.76 176.08 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.528 -0.733 . . . . 0.65 109.507 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 76.6 p -105.13 171.61 7.23 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.348 -0.845 . . . . 0.56 110.001 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -67.01 -24.79 66.05 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.655 -0.653 . . . . 1.03 109.957 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -80.42 -49.59 11.24 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 1.22 109.548 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.76 52.74 0.03 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.969 -1.252 . . . . 0.94 109.969 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 54.2 t -126.51 117.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.711 -0.876 . . . . 0.82 108.958 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.756 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.63 87.32 0.73 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.966 -1.254 . . . . 0.62 109.966 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 76' ' ' ILE . 24.3 t -71.64 127.9 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.873 -0.781 . . . . 0.67 109.362 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 25.2 m-20 -103.47 163.6 17.12 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.731 -0.606 . . . . 1.32 109.897 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.49 66.81 7.93 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.916 2.411 . . . . 0.7 109.977 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.72 -39.82 1.1 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.656 -0.652 . . . . 0.92 110.252 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.8 mt-30 -82.6 161.84 57.63 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.503 -0.748 . . . . 1.36 110.068 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 36.1 Cg_endo -77.88 157.97 31.15 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 C-N-CA 122.828 2.352 . . . . 0.76 110.55 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -56.29 -38.97 71.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.632 -0.668 . . . . 0.71 110.226 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.508 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.88 -45.79 94.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.076 -1.209 . . . . 0.73 110.076 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -71.52 -38.16 71.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.682 -0.893 . . . . 1.18 110.207 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 67' ' ' VAL . 37.0 mm -61.95 -44.44 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.417 -0.802 . . . . 0.56 109.494 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -73.77 -38.91 64.52 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 0.97 109.727 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.8 tp -67.35 -39.79 85.78 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.694 -0.629 . . . . 0.96 110.282 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.65 -56.37 3.63 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.389 -0.819 . . . . 2.24 110.373 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -90.9 -65.28 1.03 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.514 -0.741 . . . . 1.02 110.137 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.32 -136.43 8.8 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.018 -1.233 . . . . 0.76 110.018 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.2 p -108.83 -45.63 3.78 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.739 -0.859 . . . . 0.81 110.335 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.18 108.87 0.85 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 0.9 110.008 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.6 mt -136.87 166.08 24.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.773 -0.579 . . . . 0.86 109.68 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -121.86 159.29 27.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.517 -0.739 . . . . 2.56 109.756 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD21 HG21 ' A' ' 52' ' ' VAL . 1.7 tp -108.1 117.86 35.23 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.553 -0.717 . . . . 1.11 109.761 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.684 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.9 tt -118.62 143.83 34.19 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.088 -0.708 . . . . 0.86 109.088 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.4 Cg_endo -75.8 75.08 4.17 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.307 2.004 . . . . 1.11 110.078 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.46 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.358 0.599 . . . . 1.72 110.095 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.06 -47.2 75.09 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.591 -0.693 . . . . 1.64 109.399 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -91.65 -153.38 0.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.258 -0.645 . . . . 3.21 109.258 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.9 m -54.06 156.51 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.26 -0.9 . . . . 2.17 110.102 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.0 89.28 0.32 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.901 -1.279 . . . . 1.4 109.901 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 117.858 -1.068 . . . . 3.26 109.777 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.66 ' HB3' ' HA ' ' A' ' 6' ' ' ALA . 1.1 mtt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.341 0.591 . . . . 4.95 109.413 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -110.57 101.0 9.71 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.161 -0.962 . . . . 6.24 110.495 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.9 -82.23 0.33 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.365 -0.921 . . . . 8.6 111.116 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.96 -98.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.936 0 O-C-N 122.085 -0.656 . . . . 8.47 111.835 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.21 146.93 23.65 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.446 -1.032 . . . . 7.35 110.975 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 1' ' ' MET . . . -121.73 43.29 2.88 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.164 -1.421 . . . . 5.63 107.164 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.15 85.62 2.39 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.864 -0.607 . . . . 3.79 111.701 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 36' ' ' SER . 43.0 m -70.36 -43.02 71.04 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.515 -1.291 . . . . 2.72 107.515 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.463 HG21 ' OE2' ' A' ' 35' ' ' GLU . 5.5 m 43.08 68.22 0.53 Allowed 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.537 0.684 . . . . 1.47 110.448 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.83 -31.65 25.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.426 -0.796 . . . . 1.33 109.904 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.58 -68.51 1.63 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.913 -1.275 . . . . 1.28 109.913 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 71.5 p -81.6 140.67 34.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.535 -0.979 . . . . 1.08 109.75 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -131.19 159.55 37.42 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.562 -0.711 . . . . 2.04 110.037 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -113.38 132.52 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.531 -0.731 . . . . 0.88 109.639 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.3 m -100.56 144.62 29.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.619 -0.675 . . . . 0.86 109.589 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -127.17 139.82 52.68 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.596 -0.69 . . . . 0.77 110.111 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.32 107.25 14.16 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.304 -0.999 . . . . 1.91 108.304 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -111.85 125.62 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.588 -0.695 . . . . 0.65 110.378 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.1 m -113.43 134.31 54.72 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.749 -0.834 . . . . 0.64 108.749 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.683 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -67.63 128.46 36.54 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.366 -0.834 . . . . 1.15 109.891 -179.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.8 p -85.22 -39.21 18.05 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.664 -0.647 . . . . 1.28 109.586 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.1 m -71.69 -35.65 70.34 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.638 -0.664 . . . . 1.91 110.317 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' H ' HD22 ' A' ' 20' ' ' LEU . 1.1 t70 -106.29 115.6 60.7 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.482 -0.761 . . . . 2.07 110.035 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.28 1.51 Allowed 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 122.849 2.366 . . . . 1.9 110.591 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -63.63 -49.68 72.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.626 -0.671 . . . . 3.16 109.727 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 2.8 mm? -55.65 118.17 18.45 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.859 -0.526 . . . . 1.56 109.911 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' HD13 ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.43 166.58 27.21 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 C-N-CA 122.701 2.267 . . . . 0.95 111.183 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -62.92 155.49 27.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.722 -0.611 . . . . 0.72 110.485 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.3 mptt -119.16 132.5 55.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.651 -0.656 . . . . 1.21 109.369 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.03 123.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.8 109.16 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -118.03 113.17 21.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.664 -0.648 . . . . 1.06 109.79 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.0 p -100.7 107.6 19.25 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.193 -0.669 . . . . 0.93 109.193 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.0 m -137.22 159.53 69.33 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.7 -0.625 . . . . 1.0 109.643 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -76.2 158.84 37.35 Favored 'Trans proline' 0 C--N 1.316 -1.159 0 C-N-CA 122.546 2.164 . . . . 1.04 110.339 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' OE2' HG21 ' A' ' 9' ' ' THR . 0.8 OUTLIER -60.92 -20.57 62.31 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.515 -0.74 . . . . 1.02 110.205 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.65 ' HB3' ' HA ' ' A' ' 8' ' ' THR . 16.4 p -63.05 -39.09 93.7 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.435 -0.791 . . . . 1.17 110.469 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 51.4 p -69.74 130.14 90.56 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.475 -0.766 . . . . 1.08 109.603 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.7 Cg_endo -77.88 166.45 25.15 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.737 2.291 . . . . 1.07 111.059 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.566 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.6 t80 -65.52 -17.09 64.3 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.639 -0.663 . . . . 0.79 110.016 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -62.05 -45.05 95.27 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.269 -0.894 . . . . 0.96 108.606 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.42 -38.08 63.15 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.296 -0.631 . . . . 0.81 109.296 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 HG21 ' A' ' 33' ' ' VAL . 99.0 t -62.1 -49.44 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.165 -0.68 . . . . 0.74 109.165 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD12 HD12 ' A' ' 59' ' ' ILE . 1.1 tt -62.81 -37.6 87.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.779 -0.575 . . . . 0.68 109.574 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -61.91 -50.9 70.34 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.717 -0.614 . . . . 3.15 109.914 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.6 -42.37 98.77 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.664 -0.648 . . . . 2.42 110.215 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -64.54 -45.01 88.98 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.592 -0.693 . . . . 0.52 109.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.44 86.77 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.659 -0.65 . . . . 0.52 109.873 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.98 -43.26 95.24 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.633 -0.667 . . . . 0.98 109.473 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 39.3 mt-10 -68.87 -35.28 76.72 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.575 -0.703 . . . . 1.45 109.48 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.683 ' CD1' HD12 ' A' ' 20' ' ' LEU . 6.7 m-85 -78.53 -1.78 35.55 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.666 -0.646 . . . . 0.73 110.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.76 39.28 2.72 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.465 -0.772 . . . . 2.66 110.123 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 22.4 m -135.71 157.96 75.13 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.379 -0.826 . . . . 0.84 109.434 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 57' ' ' SER . 33.6 Cg_endo -76.11 124.42 7.9 Favored 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.567 2.178 . . . . 0.78 110.618 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -25.45 54.07 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.863 -0.523 . . . . 0.8 110.44 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.57 92.12 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.541 -0.724 . . . . 0.9 110.344 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.7 t -111.47 39.43 2.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.45 -0.781 . . . . 1.09 110.229 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.543 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -132.32 161.1 34.37 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.215 -0.928 . . . . 1.04 110.197 179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' A' ' 89' ' ' ARG . . . -140.4 164.54 29.83 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.232 -0.655 . . . . 0.75 109.232 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.419 HD12 HD12 ' A' ' 43' ' ' LEU . 14.3 mt -126.64 123.0 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.337 -0.852 . . . . 0.68 109.391 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.667 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.79 170.48 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.524 -0.735 . . . . 0.87 109.436 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.8 t -113.53 171.68 7.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.367 -0.833 . . . . 0.81 110.065 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 8.7 p-10 -65.13 -19.53 66.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.667 -0.646 . . . . 1.02 110.685 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.59 -25.03 41.64 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.411 -0.806 . . . . 1.28 110.118 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 107.82 47.3 0.97 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.648 -1.381 . . . . 1.06 109.648 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -129.92 127.61 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.676 -0.897 . . . . 1.01 109.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.667 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.32 87.1 1.01 Allowed Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.701 -1.36 . . . . 0.85 109.701 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 HG11 HD12 ' A' ' 76' ' ' ILE . 21.4 t -66.0 131.62 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.89 -0.771 . . . . 0.78 109.446 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -107.69 161.49 23.0 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.725 -0.61 . . . . 1.16 109.957 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.5 Cg_endo -77.85 68.51 7.71 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.025 2.483 . . . . 0.96 109.74 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.84 -43.4 0.74 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.638 -0.664 . . . . 1.16 110.087 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt-30 -80.55 161.79 63.09 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.522 -0.736 . . . . 1.57 110.057 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -76.81 156.89 35.2 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 122.776 2.318 . . . . 1.15 110.885 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.26 69.12 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.669 -0.645 . . . . 0.89 110.234 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.98 -47.28 91.5 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 109.98 -1.248 . . . . 0.9 109.98 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.436 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -67.61 -38.69 84.32 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.628 -0.925 . . . . 1.67 110.014 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 HG11 ' A' ' 67' ' ' VAL . 41.8 mm -61.36 -43.82 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.661 -0.649 . . . . 0.85 109.535 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -71.95 -35.87 69.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.609 -0.682 . . . . 0.86 109.856 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.7 mt -67.6 -39.86 84.79 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.486 -0.759 . . . . 1.08 110.383 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -81.47 -53.64 6.12 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.594 -0.691 . . . . 1.78 110.484 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' NE2' HG22 ' A' ' 67' ' ' VAL . 78.2 m-70 -100.6 -63.42 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.508 -0.745 . . . . 1.29 110.138 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.64 -125.9 6.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.777 -1.329 . . . . 0.85 109.777 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.23 -31.08 9.27 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.689 -0.889 . . . . 0.67 110.185 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.5 OUTLIER -62.81 99.27 0.15 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 1.9 110.007 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.9 mt -136.75 168.27 19.85 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.04 -0.726 . . . . 0.73 109.04 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' HG13 ' A' ' 60' ' ' ILE . 46.9 mtt-85 -145.9 149.48 34.31 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.249 -0.907 . . . . 2.97 109.92 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -100.24 127.57 46.5 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.604 -0.685 . . . . 0.91 110.279 -179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.1 tt -130.29 127.48 22.52 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.068 -0.716 . . . . 0.88 109.068 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.2 Cg_endo -75.6 116.79 4.57 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.561 2.174 . . . . 0.84 110.655 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 52.1 mtp180 -71.57 -52.38 18.45 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.77 -0.581 . . . . 2.96 109.882 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 10.8 t70 63.9 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 121.356 0.598 . . . . 1.8 110.353 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 ttm105 -86.88 -56.08 3.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.523 -0.736 . . . . 5.64 109.878 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.1 130.45 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.292 -0.88 . . . . 2.59 110.009 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.36 58.13 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.766 -1.333 . . . . 2.28 109.766 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 117.794 -1.098 . . . . 3.36 109.703 179.738 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 14' ' ' VAL . 4.3 tpt . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.082 0.468 . . . . 1.64 109.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.07 -55.83 1.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.749 -0.594 . . . . 0.72 109.528 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -97.8 69.19 0.72 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.502 -1.439 . . . . 0.74 109.502 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.21 -76.66 0.05 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.106 -1.198 . . . . 0.95 110.106 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.7 m -105.81 -64.19 1.18 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.642 -0.917 . . . . 1.39 109.697 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.74 111.14 21.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.585 -0.697 . . . . 1.06 109.783 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.02 -46.11 15.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.69 -0.631 . . . . 1.22 109.642 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.2 p -80.52 95.08 6.38 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.672 -0.642 . . . . 1.48 109.471 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.31 131.08 14.1 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.529 -0.732 . . . . 1.0 109.355 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.13 109.38 20.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.672 -0.642 . . . . 1.19 109.598 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.04 71.26 1.16 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.834 -1.306 . . . . 0.98 109.834 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.25 142.91 42.01 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.693 -0.886 . . . . 0.95 109.639 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.29 171.49 8.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.68 -0.637 . . . . 2.02 110.136 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 12.3 m -103.72 130.89 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 109.176 -0.676 . . . . 0.53 109.176 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.3 p -98.26 148.16 23.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.575 -0.703 . . . . 0.73 109.901 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.94 139.7 50.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.527 -0.733 . . . . 0.67 109.932 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' HE3' ' CG ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -112.8 104.6 12.62 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.889 -0.782 . . . . 2.4 108.889 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.603 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -110.46 127.62 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.445 -0.785 . . . . 0.61 110.038 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.503 ' HB ' ' HE ' ' A' ' 85' ' ' ARG . 6.9 m -118.79 134.19 55.32 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.987 -0.746 . . . . 0.73 108.987 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 86' ' ' LEU . 7.5 tp -73.56 114.89 12.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.45 -0.781 . . . . 1.12 109.527 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.6 t -82.1 -24.28 35.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.72 -0.613 . . . . 0.84 109.915 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.26 -49.07 53.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.533 -0.73 . . . . 1.43 109.628 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.597 ' HB3' HD23 ' A' ' 20' ' ' LEU . 9.2 t70 -103.9 120.02 52.6 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.547 -0.721 . . . . 1.1 109.63 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.79 -30.61 4.6 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.72 2.28 . . . . 0.89 110.968 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -44.54 95.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.556 -0.715 . . . . 1.95 109.465 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.454 HD22 ' HD1' ' A' ' 50' ' ' PHE . 1.1 mt -68.2 121.9 82.05 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.486 -0.759 . . . . 1.25 109.627 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.14 174.85 11.55 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 122.79 2.326 . . . . 1.04 111.235 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CG ' ' HE3' ' A' ' 17' ' ' LYS . 44.5 p90 -71.87 161.55 30.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.654 -0.654 . . . . 1.35 109.793 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 4.5 mtmp? -137.83 143.5 41.03 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.53 -0.731 . . . . 2.24 109.541 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -100.97 128.62 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.587 -0.695 . . . . 0.91 110.003 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 113.25 25.43 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.999 -0.741 . . . . 0.91 108.999 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.4 m -99.12 110.56 23.12 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 1.0 109.682 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 42' ' ' VAL . 24.0 m -140.5 156.36 69.46 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.635 -0.665 . . . . 0.56 109.511 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.2 Cg_endo -75.37 162.11 36.67 Favored 'Trans proline' 0 C--N 1.315 -1.194 0 C-N-CA 122.623 2.216 . . . . 0.45 110.759 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.19 -31.59 70.27 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.701 -0.624 . . . . 0.78 109.912 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -38.76 81.4 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.653 -0.654 . . . . 1.02 109.728 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -64.76 124.12 85.41 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 109.119 -0.697 . . . . 0.6 109.119 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -77.95 164.5 27.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 C-N-CA 122.759 2.306 . . . . 0.43 111.102 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.574 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.5 t80 -65.01 -18.99 65.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.625 -0.672 . . . . 0.51 109.882 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -58.94 -47.73 84.04 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.261 -0.899 . . . . 0.81 108.63 178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -38.34 65.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.834 -0.541 . . . . 0.51 109.716 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 33' ' ' VAL . 74.2 t -60.43 -52.32 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.519 -0.738 . . . . 0.46 109.229 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 tt -64.58 -34.83 79.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.783 -0.573 . . . . 0.7 109.665 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 40' ' ' THR . 0.3 OUTLIER -64.72 -46.67 81.3 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.67 -0.644 . . . . 2.86 109.513 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.65 -42.56 82.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.727 -0.608 . . . . 1.31 110.25 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.97 86.99 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 0.5 109.743 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.53 -35.54 80.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.694 -0.629 . . . . 0.57 109.882 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -47.06 86.69 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.617 -0.677 . . . . 1.35 109.831 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.2 mp0 -75.06 -27.67 60.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.97 109.816 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 2.1 m-85 -79.05 -0.42 31.32 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.517 -0.739 . . . . 0.68 110.404 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.3 mttp 63.56 38.01 9.97 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.431 -0.793 . . . . 2.92 109.881 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.0 m -133.55 154.78 80.93 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 109.041 -0.725 . . . . 0.75 109.041 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.33 121.05 6.22 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.513 2.142 . . . . 0.9 110.928 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.48 -33.89 67.29 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.713 -0.477 . . . . 0.78 109.713 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.7 -35.16 73.95 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.807 -0.558 . . . . 0.98 109.959 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -113.43 45.63 1.38 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.453 -0.78 . . . . 1.05 109.332 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 m -148.07 153.66 39.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.419 -0.801 . . . . 0.79 110.175 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.08 169.5 17.52 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.192 -0.67 . . . . 0.57 109.192 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.1 123.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.378 -0.827 . . . . 0.47 109.308 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.597 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.46 174.03 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.668 -0.645 . . . . 0.7 109.388 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 m -107.73 157.75 17.85 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.56 109.495 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -26.15 53.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.633 -0.667 . . . . 1.18 111.081 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -79.19 -45.17 20.42 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.244 -0.91 . . . . 1.14 109.549 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 138.44 55.41 0.05 OUTLIER Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.86 -1.296 . . . . 0.77 109.86 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.5 t -131.52 118.16 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.679 -0.895 . . . . 0.72 109.06 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.02 87.41 0.56 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.812 -1.315 . . . . 0.54 109.812 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 80' ' ' HIS . 16.3 t -68.48 129.69 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.842 -0.799 . . . . 0.44 109.385 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -104.09 160.02 27.42 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.795 -0.565 . . . . 0.9 109.888 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 40' ' ' THR . 36.3 Cg_endo -78.17 65.81 8.38 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.956 2.438 . . . . 0.62 109.837 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.8 -48.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.64 109.923 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.46 156.6 81.62 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.631 -0.668 . . . . 1.28 110.103 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.5 Cg_endo -77.29 154.43 32.17 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.781 2.32 . . . . 0.39 110.549 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.72 65.63 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.7 -0.625 . . . . 0.38 110.355 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.92 -48.83 79.8 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.964 -1.254 . . . . 0.41 109.964 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -69.71 -34.61 74.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.679 -0.895 . . . . 0.95 110.163 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.441 HD12 HG11 ' A' ' 67' ' ' VAL . 25.2 mm -60.17 -42.59 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.561 -0.712 . . . . 0.5 109.623 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -76.28 -41.51 48.6 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.58 109.779 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.0 mt -62.55 -36.58 83.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.425 -0.797 . . . . 0.54 110.018 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -87.87 -54.26 4.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.618 -0.676 . . . . 1.72 110.658 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.7 m-70 -94.19 -62.31 1.36 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.614 -0.679 . . . . 0.68 110.06 -178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 124.5 -128.88 6.92 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.543 -1.423 . . . . 0.68 109.543 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.37 -33.56 5.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.728 -0.866 . . . . 1.26 110.463 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -70.63 107.17 3.78 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.194 -0.941 . . . . 1.61 110.374 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.25 166.5 24.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.8 -0.563 . . . . 0.95 110.042 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.503 ' HE ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -129.49 149.12 51.4 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.557 -0.715 . . . . 2.22 109.605 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.693 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -105.1 121.13 43.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.334 -0.854 . . . . 0.81 109.235 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.2 pt -119.94 149.16 48.24 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.544 -0.722 . . . . 0.75 110.571 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -78.95 83.67 2.21 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 122.862 2.374 . . . . 1.06 110.12 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.443 ' NH2' ' HD3' ' A' ' 91' ' ' ARG . 26.9 ttp180 -92.49 104.35 16.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.901 -0.777 . . . . 3.12 108.901 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.92 112.31 23.15 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.513 -0.742 . . . . 1.94 109.502 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HD3' ' NH2' ' A' ' 89' ' ' ARG . 2.0 ptt-85 -128.63 150.29 50.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.726 -0.609 . . . . 3.24 109.908 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.7 t 57.41 89.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 109.644 -0.502 . . . . 3.02 109.644 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -56.14 100.09 0.09 OUTLIER Glycine 0 N--CA 1.498 2.818 0 N-CA-C 109.376 -1.49 . . . . 4.38 109.376 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 117.653 -1.165 . . . . 7.05 109.576 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.445 0.641 . . . . 3.75 109.525 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -105.27 130.55 53.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.83 -0.544 . . . . 3.94 109.614 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 119.25 80.17 0.66 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.922 -1.271 . . . . 4.62 109.922 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.99 -81.62 0.29 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.154 -1.178 . . . . 4.95 110.154 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 54.7 p -109.94 107.26 17.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.823 -0.81 . . . . 4.58 109.916 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.21 107.08 5.33 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.107 -1.442 . . . . 3.77 107.107 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -97.74 112.62 24.44 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.404 0.621 . . . . 3.61 110.653 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -102.42 113.67 27.2 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.847 -1.168 . . . . 2.68 107.847 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.1 m -69.23 104.94 2.34 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.683 -0.635 . . . . 2.95 109.821 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HB1' ' OE1' ' A' ' 35' ' ' GLU . . . -150.29 126.81 10.84 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.169 -0.678 . . . . 1.2 109.169 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.62 -99.4 0.05 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.529 -1.428 . . . . 1.18 109.529 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.11 -63.48 0.76 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.767 -0.843 . . . . 1.63 109.346 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 7.4 mtmt -140.32 149.52 42.85 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.654 -0.654 . . . . 1.32 109.762 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.8 m -109.14 138.58 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.709 -0.62 . . . . 0.78 109.388 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.4 p -100.3 146.47 26.9 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.648 -0.658 . . . . 0.97 109.856 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -129.49 139.07 51.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.521 -0.737 . . . . 0.7 109.866 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 103.45 10.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.677 -0.86 . . . . 1.12 108.677 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.0 mp -111.05 122.93 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.537 -0.727 . . . . 0.6 110.088 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -119.75 143.48 47.78 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.219 -0.66 . . . . 0.63 109.219 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 119.33 11.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.358 -0.838 . . . . 0.83 109.897 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.5 t -98.44 -27.98 13.83 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.709 -0.619 . . . . 1.06 110.189 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.16 -40.52 86.66 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.414 -0.804 . . . . 1.17 109.738 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 1.0 OUTLIER -72.81 166.49 42.49 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.659 -0.651 . . . . 1.2 109.809 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 33.0 Cg_endo -74.85 -27.44 10.31 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.535 2.157 . . . . 1.2 110.509 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -86.61 -173.92 4.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.629 -0.67 . . . . 4.06 109.74 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 70.86 13.8 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 109.201 -0.666 . . . . 1.48 109.201 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HG2' ' HE1' ' A' ' 50' ' ' PHE . 34.3 Cg_endo -77.25 96.15 1.09 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 122.615 2.21 . . . . 0.66 109.95 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -69.49 152.8 44.41 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.553 0.692 . . . . 1.04 110.597 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HD2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.75 124.31 23.61 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.057 -0.72 . . . . 1.18 109.057 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -98.57 119.2 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.68 109.49 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -116.03 113.59 23.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.723 -0.61 . . . . 1.06 109.506 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 t -102.18 111.17 23.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.64 -0.662 . . . . 0.87 109.482 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.548 HG21 HG22 ' A' ' 42' ' ' VAL . 19.2 m -137.08 158.21 73.1 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.337 -0.616 . . . . 0.67 109.337 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.3 Cg_endo -74.35 159.71 43.1 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 C-N-CA 122.438 2.092 . . . . 0.77 110.651 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' OE1' ' HB1' ' A' ' 10' ' ' ALA . 1.6 mp0 -59.34 -30.62 68.51 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.75 -0.594 . . . . 1.02 110.035 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -38.54 89.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.681 -0.637 . . . . 1.36 109.879 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.7 m -63.12 124.81 85.28 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 121.654 -0.654 . . . . 0.71 109.35 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.24 164.54 26.67 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.761 2.308 . . . . 0.69 111.167 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.588 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.9 t80 -65.57 -18.18 65.13 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.651 -0.656 . . . . 0.59 109.794 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.27 -46.95 88.06 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.524 -0.917 . . . . 1.17 108.524 178.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.33 -37.66 66.04 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.52 109.571 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 33' ' ' VAL . 70.7 t -61.54 -54.18 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 N-CA-C 109.013 -0.736 . . . . 0.53 109.013 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 tt -61.09 -34.6 75.19 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.103 -0.703 . . . . 0.6 109.103 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.71 -53.16 60.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.759 -0.588 . . . . 3.67 109.707 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -63.75 -43.72 95.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.878 -0.514 . . . . 1.67 110.233 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.92 79.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.684 -0.635 . . . . 0.51 109.686 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.04 87.88 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.718 -0.614 . . . . 0.46 109.908 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 -47.0 87.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.612 -0.68 . . . . 1.05 109.609 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 29' ' ' LYS . 1.2 mp0 -71.95 -33.67 68.39 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.607 -0.683 . . . . 0.71 109.584 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 5.0 m-85 -73.7 -6.46 46.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.64 -0.662 . . . . 0.79 110.439 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.1 tttt 69.44 38.28 1.83 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.462 -0.774 . . . . 2.26 110.25 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG21 HD21 ' A' ' 86' ' ' LEU . 15.4 m -134.98 157.05 77.87 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.425 -0.797 . . . . 0.74 109.271 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.73 123.2 7.31 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.591 2.194 . . . . 0.78 110.77 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.25 -31.6 69.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.916 -0.49 . . . . 0.69 110.086 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.13 78.43 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.65 -0.656 . . . . 0.93 109.904 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' A' ' 90' ' ' ASP . 36.5 p -114.73 46.74 1.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.596 -0.69 . . . . 0.89 109.549 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -139.97 156.83 46.46 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.475 -0.766 . . . . 0.69 109.898 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.79 166.51 24.44 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.825 -0.547 . . . . 0.49 109.567 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.19 121.27 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.444 -0.785 . . . . 0.46 109.212 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.664 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.68 172.2 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.523 -0.735 . . . . 0.62 109.559 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.2 m -101.99 154.86 18.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.382 -0.824 . . . . 0.69 109.492 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -56.0 -25.71 45.47 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.694 -0.629 . . . . 0.99 110.561 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.25 -49.46 12.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.291 -0.881 . . . . 1.3 109.552 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.59 56.51 0.02 OUTLIER Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.006 -1.237 . . . . 0.89 110.006 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.1 t -132.38 117.54 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.663 -0.904 . . . . 0.95 109.071 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.664 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -73.46 86.37 0.61 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.865 -1.294 . . . . 0.61 109.865 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 t -71.09 130.35 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.947 -0.737 . . . . 0.66 109.522 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -107.58 160.02 28.16 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.716 -0.615 . . . . 0.89 109.756 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.1 Cg_endo -77.87 65.52 8.24 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.891 2.394 . . . . 0.81 109.906 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.7 -22.41 1.25 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.539 -0.725 . . . . 1.22 111.093 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.534 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 5.1 mt-30 -96.14 163.22 21.39 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.125 -0.984 . . . . 1.2 110.115 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 71' ' ' GLN . 34.8 Cg_endo -76.73 152.41 32.9 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 122.724 2.283 . . . . 0.84 110.596 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.03 -40.23 69.99 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.672 -0.642 . . . . 0.65 110.373 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.99 -47.26 91.63 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.944 -1.262 . . . . 0.76 109.944 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.8 t30 -69.11 -37.57 78.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.642 -0.916 . . . . 1.62 110.047 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.482 HG21 ' CE1' ' A' ' 39' ' ' PHE . 24.4 mm -61.84 -41.6 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.567 -0.708 . . . . 0.68 109.429 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -73.86 -39.39 64.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.603 -0.686 . . . . 0.94 109.69 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.8 mt -65.18 -33.46 76.07 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.423 -0.798 . . . . 0.96 110.205 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -90.88 -58.88 2.33 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.541 -0.724 . . . . 3.12 111.059 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -90.53 -50.73 5.77 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.699 -0.626 . . . . 1.01 110.451 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.81 -128.44 9.45 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.946 -1.261 . . . . 0.8 109.946 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.02 -34.95 6.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.715 -0.874 . . . . 0.95 110.285 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.18 101.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.434 -0.791 . . . . 1.91 109.997 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 mt -140.25 169.37 17.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.697 -0.627 . . . . 0.95 109.822 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HB2' HG13 ' A' ' 60' ' ' ILE . 1.8 mtt180 -138.2 158.65 43.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.567 -0.708 . . . . 1.97 109.71 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -106.72 126.7 52.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.547 -0.721 . . . . 0.78 109.906 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.552 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.5 tt -132.05 131.17 22.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 N-CA-C 109.135 -0.691 . . . . 0.7 109.135 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.89 90.49 1.07 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.547 2.165 . . . . 0.88 110.884 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.412 ' HG2' HG12 ' A' ' 87' ' ' ILE . 23.4 mmm-85 -105.24 106.24 16.64 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.106 -0.702 . . . . 3.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.587 ' HA ' ' HB ' ' A' ' 56' ' ' THR . 0.1 OUTLIER -72.12 -19.38 61.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.725 -0.609 . . . . 3.17 110.918 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.63 -179.55 4.4 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.327 -0.858 . . . . 6.59 110.523 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -86.8 -17.68 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.8 -0.563 . . . . 3.86 109.607 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.21 -70.36 0.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.74 -1.344 . . . . 2.7 109.74 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.892 -0.769 . . . . 2.82 109.511 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.98 -0.378 . . . . 3.9 109.98 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 p -105.26 121.8 44.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.532 -0.73 . . . . 2.37 109.433 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.1 -70.21 0.67 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.162 -1.575 . . . . 2.87 109.162 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.29 -92.25 0.09 OUTLIER Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.673 -1.371 . . . . 2.41 109.673 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.669 ' HB ' ' CD1' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -103.36 -40.57 6.33 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.885 -0.774 . . . . 2.47 109.114 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . 70.82 100.19 0.06 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.319 0.581 . . . . 1.43 109.715 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.908 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -102.36 118.61 37.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.467 -0.77 . . . . 1.41 109.621 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLY . 85.1 m -79.64 115.75 19.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.949 -0.76 . . . . 1.34 108.949 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 89.6 m -95.04 -54.04 3.59 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.609 -0.682 . . . . 1.08 109.464 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.04 -57.14 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.612 -0.68 . . . . 1.22 109.809 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' THR . . . -134.54 -74.16 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.557 -1.417 . . . . 1.19 109.557 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.61 40.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.775 -0.838 . . . . 1.27 109.474 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.84 166.32 33.72 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.403 -0.81 . . . . 1.15 110.438 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.05 130.74 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.343 -0.614 . . . . 0.5 109.343 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.6 t -100.08 149.15 23.79 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.652 -0.655 . . . . 0.61 109.766 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -136.98 134.71 36.96 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.445 -0.784 . . . . 0.46 110.131 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -108.14 115.34 29.94 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.13 -1.063 . . . . 1.41 108.13 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.504 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -119.7 120.35 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.563 -0.711 . . . . 0.57 109.822 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 13.6 t -113.27 151.79 30.64 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.046 -0.724 . . . . 0.53 109.046 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.91 131.65 45.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.412 -0.805 . . . . 1.04 110.105 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 85' ' ' ARG . 36.4 p -85.2 -42.84 14.34 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.675 -0.641 . . . . 0.79 109.541 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.7 -41.36 95.02 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.708 -0.62 . . . . 1.29 109.612 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.813 ' HB3' HD13 ' A' ' 26' ' ' LEU . 1.2 m-20 -76.11 158.11 82.45 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.682 -0.636 . . . . 1.66 109.626 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.71 98.39 1.21 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.68 2.254 . . . . 1.95 110.448 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.1 -88.04 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 O-C-N 122.053 -0.404 . . . . 2.63 109.978 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.813 HD13 ' HB3' ' A' ' 23' ' ' ASP . 1.2 mp 66.25 163.39 0.13 Allowed Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.616 -0.677 . . . . 1.51 110.183 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.65 133.9 14.63 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.666 2.244 . . . . 1.07 110.652 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.615 ' HB3' ' HB ' ' A' ' 19' ' ' THR . 28.7 p90 -86.93 154.27 20.95 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.707 -0.621 . . . . 1.01 110.119 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.68 132.93 42.87 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.623 -0.673 . . . . 1.18 109.409 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.98 115.72 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.7 -0.852 . . . . 0.63 108.7 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -112.32 111.13 21.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.661 -0.65 . . . . 1.14 110.014 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 m -104.37 114.63 28.98 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.104 -0.702 . . . . 0.94 109.104 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 16.0 m -129.92 158.37 74.05 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.671 -0.643 . . . . 0.67 109.466 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -74.92 149.56 37.25 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.451 2.1 . . . . 0.77 110.725 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.65 82.78 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.821 0.82 . . . . 0.8 109.398 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.58 -39.61 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.935 -0.765 . . . . 0.76 108.935 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.6 p -63.92 138.38 97.38 Favored Pre-proline 0 N--CA 1.496 1.854 0 N-CA-C 109.365 -0.605 . . . . 0.7 109.365 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.6 Cg_endo -77.71 159.1 31.76 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 122.692 2.261 . . . . 0.97 111.368 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 8.3 t80 -65.11 -18.63 65.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.695 -0.628 . . . . 0.61 109.77 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 69' ' ' PRO . 21.9 p -60.94 -43.08 99.19 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.704 -0.85 . . . . 0.76 108.704 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.88 -39.85 55.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.34 -0.615 . . . . 0.67 109.34 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.0 t -60.59 -51.31 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.057 -0.72 . . . . 0.58 109.057 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.95 -35.15 77.58 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.786 -0.571 . . . . 0.64 109.505 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -61.37 -49.41 77.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.8 -0.563 . . . . 3.95 109.517 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 31' ' ' LEU . 7.2 m-85 -63.48 -44.13 95.27 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.906 -0.496 . . . . 1.66 110.048 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.36 89.24 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.616 -0.678 . . . . 0.55 109.579 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.39 -39.97 89.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.644 -0.66 . . . . 0.56 109.55 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.39 -43.36 96.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.729 -0.607 . . . . 1.26 109.555 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.78 -27.36 63.86 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.628 -0.67 . . . . 0.97 109.784 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CD1' HD12 ' A' ' 20' ' ' LEU . 4.8 m-85 -87.24 3.47 46.49 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.559 -0.713 . . . . 0.91 110.796 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 2.4 mttp 63.82 35.9 10.79 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.393 -0.817 . . . . 3.18 109.974 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG21 HD21 ' A' ' 86' ' ' LEU . 17.9 m -132.83 158.37 75.97 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.48 -0.763 . . . . 0.8 109.544 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 33.8 Cg_endo -76.17 125.94 8.88 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.611 2.207 . . . . 0.9 110.728 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -73.51 -33.5 64.81 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.909 -0.494 . . . . 0.74 110.169 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.66 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.642 -0.661 . . . . 0.94 110.46 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.41 24.31 13.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.382 -0.824 . . . . 1.47 110.348 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -136.24 154.13 51.0 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.124 -0.985 . . . . 0.57 110.204 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.16 172.71 11.16 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.315 -0.624 . . . . 0.44 109.315 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 mt -126.51 121.74 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.435 -0.791 . . . . 0.44 109.29 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.654 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 172.13 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.604 -0.685 . . . . 0.59 109.354 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 m -99.14 157.78 16.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.491 -0.756 . . . . 0.56 109.165 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 83' ' ' GLU . 0.6 OUTLIER -57.63 -26.37 61.49 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.586 -0.696 . . . . 1.22 110.254 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.42 -51.24 9.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.428 -0.795 . . . . 1.36 109.447 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.73 56.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.106 -1.198 . . . . 0.85 110.106 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 21.2 t -129.87 120.23 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.641 -0.917 . . . . 0.82 109.003 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.65 89.05 0.74 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.014 -1.234 . . . . 0.6 110.014 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -74.22 132.58 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 122.003 -0.704 . . . . 0.53 109.571 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 65.7 m-80 -113.32 161.42 27.17 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.784 -0.573 . . . . 0.72 109.583 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.601 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.3 Cg_endo -77.88 63.09 8.06 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 122.848 2.365 . . . . 0.59 110.464 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.52 -3.99 4.8 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.332 -0.855 . . . . 0.89 111.039 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 4.0 pt20 -125.31 165.13 27.98 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.988 -1.07 . . . . 1.15 109.814 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 34.2 Cg_endo -75.79 160.39 37.58 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 122.642 2.228 . . . . 0.72 111.259 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.74 82.12 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.872 -0.517 . . . . 0.5 110.145 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.74 -42.01 96.19 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.585 -1.406 . . . . 0.47 109.585 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 1.7 t30 -70.16 -34.71 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.849 -0.795 . . . . 1.59 109.748 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 39' ' ' PHE . 18.7 mm -59.95 -44.15 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.712 -0.617 . . . . 0.56 109.477 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -71.27 -38.46 71.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.693 -0.629 . . . . 0.71 110.127 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.908 ' HG ' ' HB2' ' A' ' 7' ' ' ALA . 24.6 mt -66.9 -40.62 87.76 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.423 -0.798 . . . . 0.83 110.107 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -78.21 -53.86 6.88 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.631 -0.668 . . . . 2.02 110.803 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -106.04 -59.88 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.519 -0.738 . . . . 1.34 110.014 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.07 -128.37 6.62 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.751 -1.34 . . . . 0.54 109.751 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.6 p -106.82 -34.26 7.31 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.835 -0.803 . . . . 0.69 110.17 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -66.05 107.3 1.85 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.47 -0.769 . . . . 1.39 110.059 -179.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.2 mt -138.36 172.53 12.77 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.298 0.571 . . . . 0.83 109.576 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HG3' HG22 ' A' ' 19' ' ' THR . 1.5 mtt-85 -142.83 151.93 41.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 2.38 109.911 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -102.28 116.16 32.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 0.8 109.777 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.65 HG13 ' HD2' ' A' ' 88' ' ' PRO . 17.1 tt -116.69 135.41 22.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.342 -0.614 . . . . 0.66 109.342 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.65 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.5 Cg_endo -75.58 77.32 3.35 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.495 2.13 . . . . 0.68 110.32 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -84.98 101.14 12.13 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.48 108.899 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -154.74 176.51 12.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.547 -0.721 . . . . 1.65 109.997 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.7 -65.58 0.99 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.651 -0.656 . . . . 4.9 109.433 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.96 153.0 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.526 -0.733 . . . . 4.14 110.357 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.4 -77.77 0.37 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.199 -1.56 . . . . 3.9 109.199 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.42 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 34.9 p-80 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 118.376 -0.821 . . . . 3.93 109.256 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' HG3' ' N ' ' A' ' 2' ' ' SER . 1.7 ptt? . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 110.022 -0.362 . . . . 5.29 110.022 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.523 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER -104.2 -41.42 5.81 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 4.01 109.471 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.38 -82.52 1.6 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.112 -1.195 . . . . 2.78 110.112 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.77 92.88 0.72 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.063 -1.215 . . . . 2.55 110.063 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.6 m -93.09 116.05 28.67 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.709 -0.848 . . . . 2.46 108.709 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.8 130.51 36.04 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.451 -0.781 . . . . 1.83 109.804 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.28 122.65 25.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.619 -0.676 . . . . 1.67 109.696 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 92.1 m -89.58 120.29 30.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.597 -0.69 . . . . 2.15 109.25 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 48.3 m -91.17 123.78 34.88 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.51 -0.744 . . . . 2.09 109.554 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.65 -48.34 17.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.604 -0.685 . . . . 1.96 109.664 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.31 80.28 0.09 OUTLIER Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.306 -1.118 . . . . 1.65 110.306 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -92.89 124.67 37.04 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.557 -0.966 . . . . 1.17 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 79.8 mttt -134.55 158.07 44.92 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.506 -0.746 . . . . 1.97 110.325 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 10.9 m -113.04 138.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.782 -0.574 . . . . 0.76 109.732 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.82 148.39 24.48 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.677 -0.639 . . . . 1.62 109.618 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -133.54 140.74 47.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.58 -0.7 . . . . 0.75 109.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -118.25 102.05 8.67 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.435 -0.95 . . . . 1.63 108.435 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.716 HG21 HD12 ' A' ' 86' ' ' LEU . 4.0 mp -98.1 125.05 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.642 -0.661 . . . . 0.86 109.56 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 25' ' ' LYS . 27.2 m -122.91 125.26 45.0 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.553 -0.906 . . . . 0.58 108.553 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -55.38 137.91 46.96 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.561 -0.712 . . . . 1.16 110.078 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 p -62.53 -44.63 95.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.794 -0.566 . . . . 0.83 109.969 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m -65.26 -43.88 89.86 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.646 -0.659 . . . . 1.13 109.592 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.3 m-20 -71.71 160.58 82.21 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.721 -0.612 . . . . 1.18 109.644 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.43 -167.9 0.51 Allowed 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.647 2.231 . . . . 0.81 110.475 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' HA ' HG21 ' A' ' 19' ' ' THR . 7.5 mttp -84.73 -25.91 28.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.508 -0.745 . . . . 3.14 110.952 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.57 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -52.75 -56.52 22.32 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.454 -0.779 . . . . 1.69 110.88 -179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 36.8 Cg_endo -80.1 110.55 2.54 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.511 2.141 . . . . 0.85 110.801 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -147.49 159.81 43.31 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.532 -0.73 . . . . 0.97 109.705 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.35 138.69 48.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.59 -0.694 . . . . 1.31 110.139 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -107.75 126.19 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.013 -0.736 . . . . 0.66 109.013 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.55 114.09 22.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.662 -0.649 . . . . 0.99 109.61 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -104.96 111.12 23.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.145 -0.687 . . . . 1.55 109.145 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.479 HG21 HG22 ' A' ' 42' ' ' VAL . 13.3 m -140.67 158.48 65.57 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.603 -0.686 . . . . 0.81 109.564 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.4 Cg_endo -75.51 161.18 37.64 Favored 'Trans proline' 0 C--N 1.316 -1.169 0 C-N-CA 122.517 2.145 . . . . 0.82 110.412 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.88 -28.52 66.23 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.693 -0.629 . . . . 1.14 110.14 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -40.35 95.04 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.607 -0.683 . . . . 1.4 109.876 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -63.87 124.41 84.93 Favored Pre-proline 0 N--CA 1.499 2.016 0 N-CA-C 109.236 -0.653 . . . . 0.75 109.236 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.0 Cg_endo -77.82 164.0 28.19 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 122.77 2.313 . . . . 0.79 111.498 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 7.0 t80 -65.8 -16.56 63.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.757 -0.589 . . . . 0.56 109.895 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 22.8 p -60.44 -46.65 89.27 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.549 -0.908 . . . . 0.7 108.549 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -38.75 62.68 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.4 -0.592 . . . . 0.56 109.4 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 33' ' ' VAL . 61.4 t -60.47 -46.58 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 109.281 -0.637 . . . . 0.57 109.281 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.3 -38.59 85.24 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.667 -0.645 . . . . 0.64 109.659 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.32 -44.51 95.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.735 -0.603 . . . . 1.57 109.627 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -72.11 -40.71 67.96 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.736 -0.602 . . . . 1.93 110.057 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.65 -49.63 75.76 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.54 -0.725 . . . . 0.38 109.982 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -65.39 -41.42 93.71 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.569 -0.707 . . . . 0.52 109.976 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -67.24 -40.26 86.3 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 2.89 109.758 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.658 ' HB3' ' HG2' ' A' ' 29' ' ' LYS . 16.0 mt-10 -64.25 -33.52 76.01 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.712 -0.617 . . . . 1.04 110.489 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.13 -83.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.7 109.389 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.11 37.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.807 -0.558 . . . . 3.21 110.105 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG21 HD21 ' A' ' 86' ' ' LEU . 12.3 m -142.18 155.16 65.08 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.061 -1.025 . . . . 0.79 109.966 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 128.09 9.37 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.753 2.302 . . . . 0.76 110.461 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -68.09 -27.93 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.745 -0.597 . . . . 0.57 110.386 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.91 72.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.574 -0.704 . . . . 0.76 110.2 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -120.97 47.39 1.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.504 -0.748 . . . . 0.95 109.667 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -143.8 157.46 44.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.4 -0.812 . . . . 0.88 110.039 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -136.96 170.85 15.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.45 109.671 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.52 118.38 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.415 -0.803 . . . . 0.45 108.943 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -97.52 172.69 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.79 109.394 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.0 m -103.03 154.63 19.05 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.446 -0.784 . . . . 0.79 109.342 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -56.21 -24.7 43.74 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.683 -0.636 . . . . 1.06 110.592 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.3 -48.3 14.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.371 -0.831 . . . . 1.97 109.4 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.83 54.79 0.03 OUTLIER Glycine 0 N--CA 1.496 2.68 0 N-CA-C 110.019 -1.232 . . . . 0.97 110.019 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 t -130.84 119.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.94 . . . . 0.94 109.165 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.78 86.51 0.75 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.129 -1.188 . . . . 0.56 110.129 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 76' ' ' ILE . 16.4 t -71.17 129.35 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.888 -0.772 . . . . 0.53 109.32 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.9 m-80 -108.73 161.96 21.71 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.738 -0.601 . . . . 0.72 109.898 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.9 Cg_endo -77.72 65.73 8.14 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 122.987 2.458 . . . . 0.62 110.012 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.44 -39.18 0.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.679 -0.638 . . . . 0.9 110.19 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -83.0 160.0 61.53 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.418 -0.801 . . . . 0.98 110.186 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.17 158.52 33.7 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.957 2.438 . . . . 0.72 110.734 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.426 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -55.48 -39.77 70.82 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.63 -0.668 . . . . 0.66 110.206 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.84 -46.87 93.36 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.008 -1.237 . . . . 0.78 110.008 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.426 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 23.3 t-20 -68.74 -38.12 79.93 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.633 -0.922 . . . . 0.92 109.956 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 67' ' ' VAL . 32.4 mm -61.19 -43.42 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.497 -0.752 . . . . 0.65 109.578 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -72.07 -35.75 69.35 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.674 -0.642 . . . . 0.92 109.67 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.63 -37.54 76.84 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.518 -0.739 . . . . 1.09 110.498 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 -52.57 5.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.477 -0.765 . . . . 1.53 110.539 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.407 ' NE2' HG22 ' A' ' 67' ' ' VAL . 37.1 m-70 -98.55 -60.34 1.57 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.535 -0.728 . . . . 1.39 110.101 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 123.52 -126.57 6.28 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.678 -1.369 . . . . 0.84 109.678 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 62.9 p -114.74 -44.46 3.06 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.718 -0.872 . . . . 0.95 110.051 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.51 107.32 0.66 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.74 . . . . 1.63 109.922 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.09 167.54 21.83 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.805 -0.559 . . . . 0.98 109.793 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' HG13 ' A' ' 60' ' ' ILE . 4.6 mtt-85 -126.63 152.49 46.6 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.642 -0.662 . . . . 1.49 109.885 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.716 HD12 HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -104.15 129.25 51.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 0.95 109.38 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.621 HG13 ' HD2' ' A' ' 88' ' ' PRO . 14.2 tt -130.66 134.38 25.95 Favored Pre-proline 0 N--CA 1.497 1.88 0 N-CA-C 109.282 -0.636 . . . . 0.69 109.282 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.621 ' HD2' HG13 ' A' ' 87' ' ' ILE . 35.6 Cg_endo -76.4 69.65 6.5 Favored 'Trans proline' 0 C--N 1.318 -1.032 0 C-N-CA 122.458 2.106 . . . . 0.82 110.321 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -91.91 115.19 27.85 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.663 -0.865 . . . . 1.69 108.663 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.12 134.37 42.87 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.734 -0.604 . . . . 2.34 110.735 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -76.3 107.08 8.29 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.533 -0.914 . . . . 1.6 108.533 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 93' ' ' GLY . 68.1 t -95.9 -103.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.618 -0.676 . . . . 2.57 109.182 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.501 ' N ' HG12 ' A' ' 92' ' ' VAL . . . -91.87 -28.93 12.54 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.452 -1.459 . . . . 4.43 109.452 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.682 -0.893 . . . . 7.83 109.911 179.916 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.475 0.655 . . . . 9.16 109.569 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.1 m -71.01 110.95 6.02 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.051 -0.722 . . . . 5.86 109.051 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.27 -157.36 1.01 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.398 -1.081 . . . . 4.43 110.398 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.57 87.95 0.35 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.726 -1.349 . . . . 3.04 109.726 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -54.21 -29.93 48.0 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.813 -0.816 . . . . 3.53 109.599 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.16 72.46 0.99 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.698 -1.223 . . . . 2.24 107.698 178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.13 80.39 5.48 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.738 -0.601 . . . . 1.94 109.572 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.8 p 42.36 55.34 4.07 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.492 0.663 . . . . 2.75 109.844 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 m -118.75 97.84 5.92 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.893 -0.78 . . . . 1.19 108.893 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.56 139.69 49.28 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.607 -0.683 . . . . 1.23 110.007 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.04 -73.55 0.22 Allowed Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.478 -1.449 . . . . 1.04 109.478 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.89 115.42 22.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.792 -0.828 . . . . 1.56 109.282 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 19.6 mttt -133.41 153.12 51.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.611 -0.681 . . . . 1.44 109.756 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 m -108.53 132.46 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.672 -0.642 . . . . 0.6 109.391 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' OG ' ' A' ' 32' ' ' SER . 24.6 p -98.73 141.15 31.9 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.692 -0.63 . . . . 0.81 109.943 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -124.42 140.64 52.76 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.68 109.978 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -124.75 113.65 18.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.977 -0.749 . . . . 3.16 108.977 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.6 mp -110.76 119.81 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.579 -0.701 . . . . 0.66 109.521 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 m -107.28 147.12 30.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.672 -0.643 . . . . 0.71 109.582 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.09 137.87 56.7 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.492 -0.755 . . . . 1.18 110.182 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 85' ' ' ARG . 28.5 p -98.96 52.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.284 -0.636 . . . . 1.24 109.284 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.58 -54.89 0.17 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.401 -0.812 . . . . 1.9 109.686 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.2 152.67 65.19 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.64 -0.662 . . . . 1.97 109.9 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.94 -17.01 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.77 2.313 . . . . 2.29 110.937 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -56.4 -52.55 64.2 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.544 -0.722 . . . . 2.72 109.909 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -62.28 126.11 87.11 Favored Pre-proline 0 N--CA 1.497 1.914 0 N-CA-C 109.538 -0.541 . . . . 1.49 109.538 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.39 141.55 20.32 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 122.678 2.252 . . . . 1.04 110.825 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -65.75 157.09 31.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.776 -0.578 . . . . 1.06 110.055 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HG3' ' HB3' ' A' ' 49' ' ' GLU . 1.9 tmtt? -106.05 129.58 54.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.556 -0.715 . . . . 0.93 109.995 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.3 126.0 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.877 -0.786 . . . . 0.71 108.877 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -120.52 117.49 27.77 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.589 -0.695 . . . . 0.92 110.036 -179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.46 ' OG ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -108.73 108.06 18.75 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 1.05 109.316 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.66 157.15 76.83 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.81 109.573 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 34.9 Cg_endo -75.99 159.79 37.43 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 122.599 2.2 . . . . 0.89 110.731 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 83.49 0.07 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.686 0.755 . . . . 1.02 109.029 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 p 178.56 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.424 -0.584 . . . . 0.92 109.424 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.4 m -63.47 130.42 94.29 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 109.09 -0.708 . . . . 0.8 109.09 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -75.45 155.69 40.91 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.542 2.161 . . . . 0.79 111.418 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.629 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.7 t80 -65.0 -16.92 63.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.771 -0.581 . . . . 0.58 110.093 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -60.47 -47.33 86.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.182 -0.949 . . . . 1.06 108.484 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.08 -40.56 64.93 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.436 -0.579 . . . . 0.66 109.436 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.3 t -58.85 -49.96 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.206 -0.664 . . . . 0.62 109.206 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD12 HD12 ' A' ' 59' ' ' ILE . 2.6 tt -63.51 -33.69 76.15 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.695 -0.628 . . . . 0.69 109.783 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -49.64 72.79 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 2.36 109.667 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.8 m-85 -62.87 -43.97 97.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.599 -0.688 . . . . 1.22 109.782 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -61.86 -41.11 97.45 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.637 -0.664 . . . . 0.53 109.602 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.78 -31.73 70.96 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.698 -0.626 . . . . 0.63 109.833 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -51.19 70.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.62 -0.675 . . . . 1.22 109.725 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.6 OUTLIER -69.39 -32.65 71.82 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.7 -0.625 . . . . 0.87 109.645 179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.451 ' HA ' HD21 ' A' ' 26' ' ' LEU . 3.7 m-85 -76.5 -6.53 52.2 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.639 -0.663 . . . . 0.72 111.068 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.0 37.53 6.77 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.391 -0.818 . . . . 1.55 109.963 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.7 m -131.36 156.81 79.62 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.36 -0.837 . . . . 0.77 109.488 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.73 124.1 7.32 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.654 2.236 . . . . 0.92 110.764 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.72 -29.22 65.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.933 -0.479 . . . . 0.93 110.294 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.58 -42.12 98.4 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.496 -0.752 . . . . 1.12 110.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -111.54 42.9 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.548 -0.72 . . . . 1.31 109.74 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.7 t -140.4 147.57 39.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.413 -0.804 . . . . 0.71 109.727 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.05 170.5 13.91 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.87 -0.519 . . . . 0.64 109.635 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.401 HD12 HD12 ' A' ' 43' ' ' LEU . 17.9 mt -127.72 121.19 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.812 -0.81 . . . . 0.52 108.812 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.45 171.24 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.495 -0.753 . . . . 0.79 109.558 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.4 m -103.06 158.0 16.6 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.405 -0.81 . . . . 0.72 109.351 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -57.3 -24.78 57.19 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.655 -0.653 . . . . 1.07 110.608 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.18 -47.33 16.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.436 -0.79 . . . . 1.17 109.463 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 140.28 54.04 0.04 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.104 -1.198 . . . . 0.89 110.104 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.1 t -130.15 119.93 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.714 -0.874 . . . . 0.83 109.022 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.644 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.51 88.55 0.72 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.987 -1.245 . . . . 0.65 109.987 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.505 HG11 HD12 ' A' ' 76' ' ' ILE . 12.4 t -71.2 129.85 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.999 -0.707 . . . . 0.59 109.358 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 66.0 m-80 -101.84 159.32 29.75 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.728 -0.608 . . . . 1.0 109.838 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.687 ' O ' HG23 ' A' ' 40' ' ' THR . 35.9 Cg_endo -77.4 66.0 7.95 Favored 'Trans proline' 0 C--N 1.318 -1.079 0 C-N-CA 122.893 2.395 . . . . 0.78 110.039 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.75 -48.38 0.38 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.556 -0.715 . . . . 0.86 110.343 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.431 ' HB2' HD11 ' A' ' 76' ' ' ILE . 10.1 mt-30 -63.11 156.13 69.76 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 121.561 -0.712 . . . . 1.36 110.468 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.9 Cg_endo -77.74 156.88 31.6 Favored 'Trans proline' 0 C--N 1.319 -1.002 0 C-N-CA 122.852 2.368 . . . . 0.72 110.643 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.36 -43.47 79.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.711 -0.618 . . . . 0.59 110.216 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.01 -45.86 85.95 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.036 -1.225 . . . . 0.6 110.036 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.575 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 2.1 t30 -72.54 -37.94 68.15 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.63 -0.923 . . . . 1.63 110.258 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG11 ' A' ' 67' ' ' VAL . 22.7 mm -60.77 -40.85 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.546 -0.721 . . . . 0.56 109.489 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -75.25 -37.73 60.88 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.705 -0.622 . . . . 0.69 109.831 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.23 -37.58 85.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.634 -0.666 . . . . 0.85 110.3 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.29 -54.41 4.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.551 -0.718 . . . . 3.06 110.444 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.475 ' CE1' HG22 ' A' ' 67' ' ' VAL . 51.5 m-70 -94.47 -58.69 2.13 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.54 -0.725 . . . . 1.04 110.324 -178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.11 -127.4 7.63 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.745 -1.342 . . . . 0.71 109.745 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 t -110.78 -39.79 4.74 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.655 -0.909 . . . . 0.71 110.224 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.89 103.95 0.4 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.516 -0.74 . . . . 2.46 110.135 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mt -138.96 171.57 14.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.731 -0.606 . . . . 0.84 109.635 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.514 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 4.8 mtp180 -139.51 155.3 47.62 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.52 -0.737 . . . . 1.76 109.983 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -106.85 130.24 54.57 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.499 -0.751 . . . . 0.65 110.091 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.512 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.3 tt -131.79 130.85 22.4 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 109.063 -0.717 . . . . 0.84 109.063 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.512 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.4 Cg_endo -75.57 88.63 1.27 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 C-N-CA 122.466 2.111 . . . . 0.68 110.152 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 90.53 5.4 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.422 0.63 . . . . 1.74 109.572 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -114.29 -53.23 2.68 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.23 109.43 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -102.05 -173.37 2.33 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.731 -0.605 . . . . 2.3 109.988 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.45 -45.6 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.42 -0.8 . . . . 2.18 109.683 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -104.49 36.12 4.6 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 109.86 -1.296 . . . . 2.18 109.86 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 . . . . . 0 N--CA 1.496 1.855 0 CA-C-O 117.959 -1.02 . . . . 1.47 109.491 179.949 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.947 -0.39 . . . . 4.77 109.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.22 100.03 11.5 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.338 -0.851 . . . . 4.99 110.397 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.53 120.54 2.19 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 110.219 -1.152 . . . . 4.1 110.219 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.37 68.93 0.54 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 108.979 -1.648 . . . . 3.8 108.979 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -66.88 112.39 4.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.811 -0.817 . . . . 3.6 109.555 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.17 -39.65 13.42 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.844 -0.798 . . . . 2.4 108.844 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -125.16 98.32 5.61 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.375 -0.602 . . . . 2.31 109.375 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.4 m -96.15 -50.02 5.0 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.724 -0.843 . . . . 2.38 108.724 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -88.07 178.93 6.51 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.916 -0.772 . . . . 2.11 108.916 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.14 138.24 43.72 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.229 -0.92 . . . . 3.51 109.276 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.37 -107.25 3.0 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.666 -1.373 . . . . 1.99 109.666 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.3 p -162.36 152.92 17.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.658 -0.907 . . . . 1.81 110.171 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -126.0 149.09 49.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.747 -0.596 . . . . 1.35 109.909 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -99.01 125.1 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.628 -0.67 . . . . 0.71 109.303 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 p -98.92 140.14 33.52 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.676 -0.64 . . . . 1.09 109.357 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.37 133.96 54.05 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.482 -0.761 . . . . 0.66 110.154 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -113.88 109.81 19.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.806 -0.813 . . . . 2.4 108.806 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.636 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -116.44 127.73 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.385 -0.822 . . . . 0.61 109.959 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.6 p -113.14 128.13 56.4 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.982 -0.747 . . . . 0.57 108.982 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.697 HD12 ' HB3' ' A' ' 86' ' ' LEU . 12.4 tp -67.58 130.58 43.48 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.54 -0.725 . . . . 0.9 109.975 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.3 p -74.95 -38.77 61.64 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.803 -0.561 . . . . 0.9 109.757 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -91.7 57.8 3.33 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.598 -0.688 . . . . 1.14 109.485 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -148.47 139.02 13.24 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.397 -0.814 . . . . 1.2 109.503 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.53 161.7 33.96 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.559 2.173 . . . . 1.57 111.164 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 65.4 -154.74 0.27 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.942 -0.474 . . . . 3.54 109.832 -179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.98 74.71 48.45 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.109 -0.994 . . . . 1.88 110.362 -179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.487 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 37.0 Cg_endo -82.3 130.96 6.46 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 C-N-CA 122.973 2.449 . . . . 1.43 110.186 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -137.97 154.53 49.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.366 -0.834 . . . . 1.43 110.354 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.36 121.07 34.86 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.646 -0.659 . . . . 1.03 109.627 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.91 119.94 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.777 -0.823 . . . . 0.74 108.777 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.545 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -117.23 109.62 17.1 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.555 -0.716 . . . . 0.98 109.971 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.49 111.78 24.07 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.162 -0.681 . . . . 1.3 109.162 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 10.7 m -137.89 158.71 70.92 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.639 -0.663 . . . . 0.65 109.784 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 35.0 Cg_endo -76.73 153.77 34.01 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.801 2.334 . . . . 0.83 110.805 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 83.53 0.08 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.782 0.801 . . . . 0.92 109.139 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.2 p -179.99 -38.51 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.96 108.999 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 20.2 p -60.78 140.1 93.27 Favored Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.74 -0.6 . . . . 0.68 109.518 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' THR . 36.4 Cg_endo -77.99 153.3 28.79 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.685 2.257 . . . . 0.55 111.418 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 3.1 t80 -66.48 -17.38 64.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.682 -0.636 . . . . 0.54 109.705 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.9 OUTLIER -61.85 -45.95 91.55 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.591 -0.892 . . . . 1.01 108.591 178.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.54 -39.91 67.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.448 -0.575 . . . . 0.52 109.448 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.5 t -61.18 -50.12 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.6 -0.687 . . . . 0.61 109.293 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 59' ' ' ILE . 3.6 tt -62.67 -35.08 78.52 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.78 -0.575 . . . . 0.58 109.559 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.61 -49.4 73.46 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.783 -0.573 . . . . 2.85 109.878 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.545 ' CB ' HD21 ' A' ' 31' ' ' LEU . 3.1 m-85 -61.41 -42.94 99.54 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.636 -0.665 . . . . 1.57 110.092 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.19 89.39 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.605 -0.684 . . . . 0.54 109.549 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -66.13 -36.39 83.03 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 0.57 109.97 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -43.96 97.82 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.624 -0.673 . . . . 2.06 109.59 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.97 -41.07 91.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 1.21 109.405 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 86' ' ' LEU . 26.3 m-85 -76.5 -7.35 54.95 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.814 -0.554 . . . . 0.77 111.27 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.98 32.55 3.03 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.511 -0.743 . . . . 2.46 110.331 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.449 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 28.6 m -120.18 158.02 51.73 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.507 -0.746 . . . . 0.67 109.035 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 52' ' ' VAL . 32.7 Cg_endo -76.12 121.23 6.04 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.544 2.163 . . . . 0.65 110.791 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.47 75.81 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.023 -0.423 . . . . 0.59 110.115 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.43 -26.57 66.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.633 -0.667 . . . . 0.71 110.241 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.2 m -110.8 19.53 18.49 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.478 -0.764 . . . . 0.82 110.116 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 81.3 p -137.68 150.96 47.76 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.037 -1.039 . . . . 0.59 110.298 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 90' ' ' ASP . . . -127.93 170.79 12.44 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.291 -0.633 . . . . 0.46 109.291 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 43' ' ' LEU . 13.2 mt -117.38 120.84 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 108.949 -0.76 . . . . 0.43 108.949 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.609 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.24 170.53 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.461 -0.774 . . . . 0.71 109.749 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.3 m -101.83 155.78 17.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.435 -0.791 . . . . 0.63 109.402 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -56.88 -24.59 52.94 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.615 -0.678 . . . . 0.96 110.322 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.37 -48.53 13.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.437 -0.789 . . . . 1.12 109.395 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.6 54.4 0.03 OUTLIER Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.171 -1.172 . . . . 0.7 110.171 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 47.6 t -130.23 117.47 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.668 -0.901 . . . . 0.62 109.102 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.609 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.65 87.73 0.84 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.735 -1.346 . . . . 0.45 109.735 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.1 t -72.44 128.72 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.867 -0.784 . . . . 0.52 109.519 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -99.61 159.82 28.99 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.685 -0.634 . . . . 1.22 109.628 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.489 ' O ' HG23 ' A' ' 40' ' ' THR . 35.7 Cg_endo -78.03 65.86 8.3 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.775 2.317 . . . . 0.53 109.738 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.69 18.33 1.3 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.549 -0.719 . . . . 0.92 110.618 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.4 ' HB2' HD11 ' A' ' 76' ' ' ILE . 32.7 mt-30 -128.72 161.92 54.56 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.124 -0.985 . . . . 1.56 109.641 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 34.7 Cg_endo -76.97 145.24 24.79 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 122.548 2.166 . . . . 0.69 110.486 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.12 -40.5 67.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.744 -0.597 . . . . 0.64 110.135 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.3 -46.38 91.81 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.005 -1.238 . . . . 0.71 110.005 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 8.5 t30 -70.14 -36.28 74.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.603 -0.94 . . . . 1.11 110.143 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.447 HG21 ' CE1' ' A' ' 39' ' ' PHE . 30.5 mm -60.49 -43.22 93.79 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.537 -0.727 . . . . 0.54 109.518 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.34 -37.87 65.96 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.706 -0.621 . . . . 0.87 109.901 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 50.6 mt -68.45 -39.14 81.59 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.541 -0.725 . . . . 0.86 110.399 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE2' ' CE1' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -81.39 -47.55 13.1 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.627 -0.67 . . . . 1.66 110.595 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HE2' ' A' ' 79' ' ' LYS . 76.9 m-70 -106.54 -65.27 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.47 -0.769 . . . . 1.32 110.065 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 128.09 -119.99 3.29 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.029 -1.229 . . . . 0.66 110.029 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -118.61 -45.65 2.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.71 -0.877 . . . . 0.71 110.293 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.01 106.84 0.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.556 -0.715 . . . . 0.99 110.178 -179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -141.28 170.17 16.22 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.303 0.573 . . . . 0.91 109.808 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.524 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -129.58 158.79 38.32 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.595 -0.691 . . . . 1.82 109.43 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HB3' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -115.64 122.13 44.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.45 -0.781 . . . . 0.72 109.584 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.548 HG13 ' HD2' ' A' ' 88' ' ' PRO . 16.0 tt -119.73 136.75 24.98 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 109.118 -0.697 . . . . 0.77 109.118 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.548 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.44 59.99 6.31 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.439 2.092 . . . . 0.78 109.573 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -167.96 113.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.594 -0.691 . . . . 2.66 109.605 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.692 ' HA ' ' HB2' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -76.51 113.43 14.12 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.707 -0.849 . . . . 1.08 108.707 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 164.72 33.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.536 -0.728 . . . . 3.34 110.586 -179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.88 -53.84 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.788 -0.57 . . . . 1.34 110.584 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.18 -66.91 1.42 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.441 -1.064 . . . . 1.66 110.441 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.499 1.989 0 O-C-N 121.644 -0.915 . . . . 3.8 109.93 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.151 0.5 . . . . 4.87 109.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -150.53 -54.93 0.16 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.525 -0.546 . . . . 6.01 109.525 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.57 -92.66 0.57 Allowed Glycine 0 N--CA 1.501 2.982 0 N-CA-C 108.982 -1.647 . . . . 6.07 108.982 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.03 88.44 0.78 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.665 -1.774 . . . . 6.26 108.665 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 6' ' ' ALA . 0.9 OUTLIER -128.91 163.56 25.03 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.569 -0.96 . . . . 4.6 109.933 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.467 ' N ' ' CG2' ' A' ' 5' ' ' THR . . . -68.91 122.97 19.74 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.792 -0.568 . . . . 3.41 110.66 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.19 106.59 6.79 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.99 -1.115 . . . . 2.94 107.99 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.17 160.02 14.65 Favored 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.667 0.746 . . . . 2.23 111.418 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 m -104.69 -2.15 25.35 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.746 -0.596 . . . . 2.85 109.774 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.27 -57.59 2.22 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.297 -0.877 . . . . 1.67 109.854 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.59 63.46 0.27 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.259 -1.136 . . . . 1.05 110.259 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.43 132.04 14.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.653 -0.91 . . . . 1.27 109.325 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 2.6 mttt -116.76 153.85 31.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.631 -0.668 . . . . 2.35 110.25 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -110.75 129.79 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 109.198 -0.667 . . . . 0.85 109.198 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 13.5 t -99.26 151.4 21.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.546 -0.721 . . . . 0.84 109.74 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.45 134.31 44.92 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.543 -0.723 . . . . 0.79 110.09 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -109.77 105.77 15.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.428 -0.952 . . . . 0.86 108.428 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.3 mp -113.78 129.51 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.71 110.295 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.2 t -118.74 154.05 33.41 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.68 -0.638 . . . . 0.5 109.573 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' HA ' HD12 ' A' ' 20' ' ' LEU . 12.5 tp -64.32 135.38 56.13 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.372 -0.83 . . . . 0.94 109.894 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 85' ' ' ARG . 2.9 m -104.32 -49.9 3.47 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.709 -0.619 . . . . 0.84 110.055 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -52.34 64.64 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.694 -0.628 . . . . 1.34 110.14 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.79 146.85 34.61 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.624 -0.672 . . . . 2.14 110.203 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.99 -16.97 13.97 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.665 2.243 . . . . 1.23 109.786 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -72.12 171.4 12.03 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.243 0.544 . . . . 3.29 110.424 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.34 124.74 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 122.136 -0.353 . . . . 1.82 110.741 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -75.74 165.21 30.65 Favored 'Trans proline' 0 C--N 1.318 -1.045 0 C-N-CA 122.917 2.411 . . . . 0.94 111.156 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . 52.7 p90 -69.44 158.88 34.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.625 -0.672 . . . . 0.78 110.39 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -121.24 135.67 55.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.671 -0.643 . . . . 0.98 109.624 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.65 124.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 109.136 -0.69 . . . . 0.86 109.136 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.68 112.29 23.23 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.505 -0.747 . . . . 1.1 109.858 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.6 p -101.7 111.87 24.27 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.115 -0.698 . . . . 0.7 109.115 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 HG22 ' A' ' 42' ' ' VAL . 15.7 m -141.86 158.46 62.26 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.741 -0.599 . . . . 0.75 109.472 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.7 Cg_endo -74.45 159.18 43.54 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 122.572 2.181 . . . . 0.79 110.831 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -58.4 -26.19 62.96 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.664 -0.647 . . . . 1.44 110.272 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.442 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 2.1 m -63.84 -38.32 90.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.488 -0.757 . . . . 1.54 109.744 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 98.0 m -64.54 126.57 90.96 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.55 -0.719 . . . . 0.77 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.8 Cg_endo -78.21 162.07 28.74 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.767 2.311 . . . . 0.83 111.31 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HG13 ' A' ' 76' ' ' ILE . 6.8 t80 -65.84 -18.72 65.53 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.696 -0.627 . . . . 0.69 109.859 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 69' ' ' PRO . 19.2 p -60.64 -43.93 96.97 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.705 -0.85 . . . . 0.87 108.705 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.31 -37.18 57.78 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.68 109.473 179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 33' ' ' VAL . 89.2 t -61.76 -52.23 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.486 HD12 HD12 ' A' ' 59' ' ' ILE . 1.6 tt -62.32 -35.53 79.35 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.18 -0.674 . . . . 0.75 109.18 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -52.28 65.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.763 -0.586 . . . . 2.68 109.846 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.525 ' HB3' HD21 ' A' ' 31' ' ' LEU . 5.2 t80 -64.54 -43.08 95.12 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.637 -0.664 . . . . 1.58 110.143 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.13 91.42 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.74 -0.6 . . . . 0.48 110.037 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.12 -41.67 97.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.586 -0.697 . . . . 0.55 109.878 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.91 -40.86 94.73 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.515 -0.741 . . . . 1.0 109.696 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -69.39 -34.41 74.49 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.594 -0.691 . . . . 0.65 109.538 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.91 -1.7 48.73 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.637 -0.664 . . . . 0.6 110.512 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.44 35.93 3.15 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.436 -0.79 . . . . 3.62 110.331 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 86' ' ' LEU . 13.8 m -129.42 152.95 80.43 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.452 -0.78 . . . . 0.71 108.947 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' SER . 31.6 Cg_endo -74.0 116.93 4.82 Favored 'Trans proline' 0 C--N 1.319 -0.991 0 C-N-CA 122.374 2.049 . . . . 0.89 111.465 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.2 -30.48 71.62 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 116.225 -0.443 . . . . 0.87 110.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.27 -39.3 82.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.684 -0.635 . . . . 1.17 109.802 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.8 m -115.5 45.42 1.68 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.576 -0.702 . . . . 0.87 109.653 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 3.4 t -135.23 158.86 43.29 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.94 109.902 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.48 163.48 32.82 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.826 -0.546 . . . . 0.57 109.696 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.486 HD12 HD12 ' A' ' 43' ' ' LEU . 25.9 mt -127.91 120.32 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.483 -0.761 . . . . 0.55 108.99 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.49 170.14 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.476 -0.765 . . . . 0.66 109.446 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.7 m -104.25 160.5 14.82 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.449 -0.782 . . . . 0.69 109.822 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -56.56 -26.46 55.12 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.621 -0.675 . . . . 1.52 110.77 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.06 -44.16 22.71 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.219 -0.926 . . . . 1.43 109.742 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.18 50.3 0.07 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.929 -1.268 . . . . 1.0 109.929 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 117.77 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.708 -0.878 . . . . 0.89 108.956 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.643 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -72.67 86.85 0.53 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.846 -1.302 . . . . 0.63 109.846 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG22 ' CE1' ' A' ' 80' ' ' HIS . 14.9 t -69.36 131.13 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.883 -0.775 . . . . 0.66 109.37 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -114.64 162.81 21.71 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.707 -0.621 . . . . 1.12 109.672 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' THR . 36.2 Cg_endo -78.47 63.03 8.37 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.755 2.303 . . . . 0.86 110.145 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.46 12.99 3.24 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.373 -0.829 . . . . 1.55 110.598 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.636 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -140.52 164.51 36.33 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.288 -0.882 . . . . 1.11 109.491 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.636 ' HD2' ' HB2' ' A' ' 71' ' ' GLN . 33.8 Cg_endo -75.37 153.16 39.87 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 122.639 2.226 . . . . 0.98 111.1 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.57 -37.43 75.74 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.792 -0.568 . . . . 0.8 110.184 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.78 -44.45 91.82 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.643 -1.383 . . . . 0.92 109.643 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.61 -34.76 74.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.721 -0.87 . . . . 1.56 109.515 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 67' ' ' VAL . 25.1 mm -61.54 -44.26 98.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.686 -0.634 . . . . 0.78 109.354 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -73.54 -41.35 63.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.657 -0.652 . . . . 1.03 109.707 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.5 mt -62.11 -37.43 85.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.421 -0.799 . . . . 1.17 110.251 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.48 -57.68 2.69 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.476 -0.765 . . . . 2.27 111.059 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CE1' HG22 ' A' ' 67' ' ' VAL . 53.4 m-70 -88.49 -56.36 3.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.426 -0.796 . . . . 1.07 110.688 -178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 114.37 -127.62 7.83 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.601 -1.4 . . . . 0.86 109.601 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -114.91 -40.83 3.45 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.666 -0.902 . . . . 0.8 110.026 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -59.73 105.02 0.33 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.531 -0.731 . . . . 0.93 109.862 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.11 169.69 17.35 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.351 0.596 . . . . 0.84 109.92 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HB2' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -134.01 149.34 51.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.691 -0.631 . . . . 1.71 109.714 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.34 119.82 40.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.462 -0.774 . . . . 0.82 109.723 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG13 ' HD2' ' A' ' 88' ' ' PRO . 7.8 tt -122.19 128.98 25.29 Favored Pre-proline 0 N--CA 1.494 1.775 0 N-CA-C 109.091 -0.707 . . . . 0.77 109.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.5 Cg_endo -75.85 123.85 7.68 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 122.508 2.139 . . . . 0.68 110.572 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.3 ttp-105 -89.13 147.15 24.36 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.766 -0.584 . . . . 1.36 109.572 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.83 56.76 1.65 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.84 -0.8 . . . . 2.04 108.84 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 -58.38 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.257 -0.646 . . . . 2.44 109.257 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.0 t -79.49 -57.29 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.4 -0.592 . . . . 2.23 109.4 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.34 -115.7 0.93 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.691 -1.364 . . . . 1.4 109.691 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 117.719 -1.134 . . . . 1.87 110.282 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ttm . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.603 0.716 . . . . 4.08 110.342 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.06 174.23 10.85 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.361 -0.607 . . . . 5.01 109.361 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.06 -98.24 1.83 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.676 -1.37 . . . . 2.8 109.676 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.98 -126.85 2.26 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.47 -1.452 . . . . 1.27 109.47 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.7 p -114.88 140.41 48.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.638 -0.919 . . . . 1.53 109.35 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.84 125.75 35.44 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.891 -0.781 . . . . 1.16 108.891 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.32 110.76 20.45 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.99 109.871 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 61.9 m -99.87 96.0 7.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.053 -0.721 . . . . 0.94 109.053 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 p -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.547 -0.721 . . . . 0.81 109.78 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.22 143.27 34.08 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.668 -0.645 . . . . 1.01 109.777 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 125.49 -77.17 0.38 Allowed Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.48 -1.448 . . . . 0.73 109.48 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.2 p -88.19 -52.68 5.1 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.729 -0.865 . . . . 0.78 109.458 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -136.99 153.92 50.55 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.586 -0.696 . . . . 1.52 109.733 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -112.31 122.46 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.722 -0.611 . . . . 0.36 109.377 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -102.78 135.23 44.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.675 -0.641 . . . . 0.47 109.568 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -117.97 131.44 56.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 0.53 109.876 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.55 100.38 10.05 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.713 -0.847 . . . . 1.02 108.713 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.2 142.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.644 -0.66 . . . . 0.49 109.634 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 26.5 p -116.54 134.38 54.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.579 -0.701 . . . . 0.58 109.527 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 23' ' ' ASP . 26.9 tp -85.12 117.52 24.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.549 -0.719 . . . . 0.72 109.8 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 t -110.5 -10.94 14.53 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.695 -0.628 . . . . 1.12 110.435 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.92 -56.53 3.64 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.159 -0.963 . . . . 1.26 109.786 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.735 ' HB2' HD21 ' A' ' 20' ' ' LEU . 6.8 m-20 -97.53 152.74 38.35 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.581 -0.7 . . . . 1.42 110.077 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.87 -29.15 5.61 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 122.696 2.264 . . . . 1.16 110.774 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 133.17 48.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.635 -0.666 . . . . 3.69 109.956 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER 65.39 106.35 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 121.98 -0.45 . . . . 0.93 109.821 179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' HD2' HD13 ' A' ' 26' ' ' LEU . 33.7 Cg_endo -75.41 -46.8 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.641 2.227 . . . . 0.72 110.955 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 47.8 p90 -150.95 163.73 38.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.435 -0.79 . . . . 1.26 110.114 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -145.38 131.08 18.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.651 -0.655 . . . . 1.52 109.602 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.2 t -103.49 122.94 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.588 -0.695 . . . . 0.71 109.25 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.02 115.56 27.03 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.583 -0.698 . . . . 1.16 109.674 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p -101.4 117.25 34.57 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.705 -0.622 . . . . 0.56 109.459 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.571 HG21 HG22 ' A' ' 42' ' ' VAL . 15.4 m -142.36 159.6 57.52 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.633 -0.667 . . . . 0.57 109.481 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.0 Cg_endo -75.7 160.48 37.81 Favored 'Trans proline' 0 C--N 1.315 -1.184 0 C-N-CA 122.414 2.076 . . . . 0.47 110.534 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.77 -29.55 68.27 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.67 -0.644 . . . . 0.71 110.13 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -39.3 89.64 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.56 -0.713 . . . . 0.94 109.858 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 m -63.03 126.48 89.08 Favored Pre-proline 0 N--CA 1.499 2.004 0 N-CA-C 109.116 -0.698 . . . . 0.51 109.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -78.32 161.45 28.79 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.809 2.339 . . . . 0.52 111.346 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.463 ' CD1' HG13 ' A' ' 76' ' ' ILE . 5.3 t80 -63.96 -19.07 64.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.726 -0.609 . . . . 0.52 109.732 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 21.2 p -59.15 -47.02 86.83 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.34 -0.85 . . . . 0.59 108.816 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.49 -39.02 62.72 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.907 -0.495 . . . . 0.45 109.685 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.571 HG22 HG21 ' A' ' 33' ' ' VAL . 97.3 t -60.3 -51.62 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.61 -0.681 . . . . 0.48 109.32 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 57' ' ' SER . 3.3 tt -66.12 -35.71 81.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.781 -0.575 . . . . 0.67 109.681 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 40' ' ' THR . 4.6 ttpt -61.58 -49.74 75.42 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.571 -0.706 . . . . 2.59 109.656 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -66.85 -41.88 86.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.925 -0.484 . . . . 0.98 110.539 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.62 -44.04 95.1 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.422 -0.798 . . . . 0.38 110.111 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.83 -46.91 79.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.615 -0.678 . . . . 0.37 110.056 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -39.86 90.65 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.629 -0.669 . . . . 0.87 109.965 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -69.46 -27.26 65.08 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.542 -0.723 . . . . 1.09 110.293 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 2.3 m-85 -83.58 -83.17 0.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.55 109.27 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.32 35.77 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.68 -0.638 . . . . 2.12 110.236 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.493 HG23 ' HB1' ' A' ' 47' ' ' ALA . 3.6 m -141.99 157.34 64.28 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.137 -0.977 . . . . 0.61 109.832 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.25 132.39 12.5 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.784 2.323 . . . . 0.62 110.684 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 -30.85 71.89 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.771 -0.581 . . . . 0.64 110.314 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.66 84.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.567 -0.708 . . . . 0.78 110.064 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.99 47.84 1.5 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.556 -0.715 . . . . 1.34 109.358 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -121.17 161.52 21.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.347 -0.845 . . . . 0.84 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -157.86 153.87 27.05 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.369 -0.604 . . . . 0.39 109.369 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.485 ' CG2' ' HB3' ' A' ' 84' ' ' LEU . 15.8 mt -122.59 121.7 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.322 -0.861 . . . . 0.43 109.548 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.655 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.4 pt -99.1 171.23 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.517 -0.739 . . . . 0.64 109.958 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.445 HG21 ' ND1' ' A' ' 80' ' ' HIS . 65.2 p -105.5 175.79 5.38 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.792 . . . . 0.58 110.156 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -70.03 -24.66 63.31 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.647 -0.658 . . . . 0.89 110.177 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 -42.17 26.27 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.393 -0.817 . . . . 1.41 109.449 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 132.79 46.75 0.11 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.809 -1.317 . . . . 0.9 109.809 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.9 t -119.46 117.04 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.721 -0.87 . . . . 0.75 108.917 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.09 85.24 0.8 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.93 -1.268 . . . . 0.58 109.93 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.9 t -64.98 127.21 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.995 -0.709 . . . . 0.55 109.203 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.51 161.87 21.55 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 1.33 109.917 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.4 Cg_endo -77.72 64.29 8.12 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.912 2.408 . . . . 0.58 110.128 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.59 -23.07 2.63 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.63 -0.669 . . . . 0.97 110.787 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.551 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 2.8 mt-30 -99.72 162.95 19.48 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.172 -0.955 . . . . 1.14 110.116 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.2 Cg_endo -77.6 155.08 31.42 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 122.785 2.323 . . . . 0.48 110.466 179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.49 -39.66 70.74 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.668 -0.645 . . . . 0.44 110.125 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.53 -46.83 92.64 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.937 -1.265 . . . . 0.4 109.937 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -69.18 -38.86 78.89 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.652 -0.911 . . . . 0.98 110.049 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.463 HG13 ' CD1' ' A' ' 39' ' ' PHE . 35.9 mm -60.04 -42.15 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.654 -0.654 . . . . 0.51 109.532 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -72.89 -36.62 67.37 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.7 -0.625 . . . . 0.59 110.143 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.24 -35.49 71.47 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.535 -0.728 . . . . 0.67 110.776 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.81 -52.68 5.35 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.459 -0.775 . . . . 2.57 110.61 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.445 ' ND1' HG21 ' A' ' 61' ' ' THR . 83.9 m-70 -96.26 -65.25 0.98 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.599 -0.688 . . . . 1.36 110.618 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.12 -120.09 2.15 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.944 -1.262 . . . . 0.57 109.944 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 p -128.3 -49.3 1.3 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.662 -0.905 . . . . 0.5 110.414 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.24 113.65 2.48 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.538 -0.726 . . . . 1.01 110.089 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 59' ' ' ILE . 15.6 mt -138.85 170.99 14.99 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.868 -0.52 . . . . 0.65 109.947 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.43 146.27 47.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.53 -0.731 . . . . 0.77 109.435 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.47 133.65 47.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.43 -0.794 . . . . 0.75 109.997 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.631 HG13 ' HD2' ' A' ' 88' ' ' PRO . 9.9 tt -148.79 135.18 10.13 Favored Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.999 -0.741 . . . . 0.61 108.999 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.631 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.2 Cg_endo -74.34 95.6 0.93 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 122.388 2.059 . . . . 0.61 110.672 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 89.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.524 0.678 . . . . 1.54 109.718 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' HB3' ' CG2' ' A' ' 87' ' ' ILE . 1.2 p-10 -90.78 156.98 17.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.605 -0.685 . . . . 1.26 110.313 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -97.95 103.94 15.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.821 -0.549 . . . . 3.19 109.531 179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 92' ' ' VAL . 8.2 p -144.01 99.18 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.563 -0.71 . . . . 3.21 110.382 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.54 -83.14 0.08 OUTLIER Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.458 -1.057 . . . . 2.79 110.458 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 14.9 m80 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 117.452 -1.261 . . . . 5.53 109.724 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 N-CA-C 109.502 -0.555 . . . . 3.36 109.502 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -89.13 127.92 35.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.543 -0.723 . . . . 2.84 109.819 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.87 76.15 1.17 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.76 -1.336 . . . . 3.47 109.76 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.66 -94.81 0.27 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.176 -1.569 . . . . 3.75 109.176 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.475 ' HB ' ' OG1' ' A' ' 8' ' ' THR . 20.4 p -104.34 86.68 2.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.804 -0.821 . . . . 3.52 109.743 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 1' ' ' MET . . . -75.75 129.93 37.84 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.39 -0.818 . . . . 2.17 109.526 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 49.33 72.72 0.28 Allowed 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.449 -0.945 . . . . 2.97 108.449 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.475 ' OG1' ' HB ' ' A' ' 5' ' ' THR . 97.0 m -128.31 149.06 50.66 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.66 -0.65 . . . . 3.18 110.511 -177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.4 m -117.68 139.14 51.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.077 -0.712 . . . . 4.01 109.077 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.99 102.65 15.29 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.392 -0.817 . . . . 2.16 110.195 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.39 78.02 2.05 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.619 -1.392 . . . . 1.1 109.619 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.9 -62.65 1.28 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.688 -0.89 . . . . 1.36 109.01 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 3.0 mtmt -139.13 151.05 46.35 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.375 0.607 . . . . 1.82 109.601 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 m -113.51 134.94 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.741 -0.6 . . . . 0.46 109.465 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 11.8 t -100.77 153.0 19.83 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.433 -0.792 . . . . 0.61 110.203 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -134.88 139.08 44.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.471 -0.768 . . . . 0.54 110.196 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.45 ' HG3' HG22 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -117.0 105.04 11.88 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.679 -0.86 . . . . 2.75 108.679 178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 86' ' ' LEU . 3.3 mp -104.91 120.68 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.655 -0.653 . . . . 0.56 109.83 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.0 m -114.04 129.2 56.62 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.73 -0.841 . . . . 0.47 108.73 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -64.19 109.57 1.91 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.449 -0.782 . . . . 0.67 109.584 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -76.81 -28.03 55.43 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.616 -0.678 . . . . 0.74 109.752 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.68 -36.08 32.86 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.449 -0.782 . . . . 1.16 109.712 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.49 109.65 58.12 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 1.49 109.919 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.12 -25.5 8.61 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.773 2.316 . . . . 0.78 110.901 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -48.32 76.85 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.568 -0.708 . . . . 2.63 109.737 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.74 130.33 88.8 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.09 109.849 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.19 175.6 11.15 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 123.049 2.499 . . . . 0.68 111.283 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -76.32 163.85 26.6 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.588 -0.695 . . . . 0.68 110.396 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 49' ' ' GLU . 2.1 mptt -128.38 133.89 48.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.516 -0.74 . . . . 0.81 109.746 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG22 ' HG3' ' A' ' 17' ' ' LYS . 45.1 t -99.8 127.41 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.614 -0.679 . . . . 0.61 109.291 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -120.94 109.76 15.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.635 -0.666 . . . . 1.08 109.628 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.46 110.05 21.98 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.611 -0.68 . . . . 1.0 109.343 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 42' ' ' VAL . 14.9 m -139.71 159.1 66.5 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.684 -0.635 . . . . 0.52 109.654 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 33.2 Cg_endo -73.96 159.54 44.59 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.572 2.181 . . . . 0.41 110.707 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.51 -29.17 66.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.79 -0.569 . . . . 0.66 110.422 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.49 -40.04 89.91 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.694 . . . . 0.97 110.052 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.9 m -64.17 126.7 90.83 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.535 -0.728 . . . . 0.5 109.232 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.62 165.5 24.86 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.842 2.361 . . . . 0.41 111.341 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.5 t80 -66.78 -17.41 64.86 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.705 -0.622 . . . . 0.54 109.874 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.6 p -61.1 -44.89 96.66 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.283 -0.885 . . . . 0.57 108.788 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.86 -37.62 58.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.335 -0.617 . . . . 0.42 109.335 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG22 HG21 ' A' ' 33' ' ' VAL . 94.2 t -61.58 -48.93 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.682 -0.636 . . . . 0.41 109.319 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD12 HD12 ' A' ' 59' ' ' ILE . 3.4 tt -65.18 -35.32 80.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.746 -0.596 . . . . 0.6 109.805 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -63.69 -50.88 67.45 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.639 -0.663 . . . . 2.51 109.941 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.2 t80 -61.93 -44.48 96.68 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.654 -0.654 . . . . 1.2 109.693 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.592 -0.692 . . . . 0.46 109.717 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.06 88.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.645 -0.66 . . . . 0.44 109.881 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.602 -0.686 . . . . 1.0 109.597 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 29' ' ' LYS . 1.3 mp0 -73.1 -26.21 61.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.689 -0.632 . . . . 0.74 110.018 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.572 ' CD1' HD12 ' A' ' 20' ' ' LEU . 4.3 m-85 -85.34 2.07 45.8 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.512 -0.742 . . . . 0.52 110.968 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mptt 63.01 35.68 12.98 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.376 -0.827 . . . . 2.23 110.03 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 86' ' ' LEU . 19.9 m -132.44 155.43 81.27 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.425 -0.797 . . . . 0.57 109.399 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.8 126.28 8.7 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.654 2.236 . . . . 0.63 110.719 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -67.27 -35.78 80.23 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.852 -0.53 . . . . 0.67 109.993 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.15 -35.45 80.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.651 -0.656 . . . . 0.81 110.048 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 m -111.01 42.11 1.69 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.523 -0.736 . . . . 0.85 109.616 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -150.23 148.61 29.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.357 -0.839 . . . . 0.63 110.07 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.89 172.79 11.64 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.262 0.553 . . . . 0.49 109.545 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.432 HD12 HD12 ' A' ' 43' ' ' LEU . 25.0 mt -128.53 122.42 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.495 -0.753 . . . . 0.45 109.094 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.595 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.7 pt -98.51 173.9 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.458 -0.776 . . . . 0.6 109.498 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 29.7 m -105.71 155.31 19.38 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.462 -0.774 . . . . 0.51 109.331 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -54.29 -25.53 24.21 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.731 -0.606 . . . . 0.75 110.8 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -78.97 -50.64 10.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.348 -0.845 . . . . 0.91 109.477 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 144.15 54.69 0.03 OUTLIER Glycine 0 N--CA 1.497 2.715 0 N-CA-C 110.097 -1.201 . . . . 0.68 110.097 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.45 121.47 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.669 -0.901 . . . . 0.66 109.066 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.595 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.34 88.97 0.81 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.9 -1.28 . . . . 0.54 109.9 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 76' ' ' ILE . 20.4 t -73.06 130.51 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.881 -0.776 . . . . 0.54 109.368 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 38.5 m-20 -109.09 162.53 19.74 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.703 -0.623 . . . . 1.39 109.747 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.6 Cg_endo -77.38 64.79 8.0 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.963 2.442 . . . . 0.59 110.133 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.02 -31.13 1.3 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.612 -0.68 . . . . 1.03 110.64 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 8.3 mt-30 -91.26 162.37 32.38 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.243 -0.911 . . . . 1.06 110.332 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.67 155.1 31.15 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.812 2.341 . . . . 0.43 110.479 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.24 -40.07 70.48 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.616 -0.678 . . . . 0.38 110.351 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.89 -46.63 93.31 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 110.004 -1.238 . . . . 0.43 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 5.3 t30 -69.57 -37.83 77.16 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.604 -0.939 . . . . 1.33 109.91 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 67' ' ' VAL . 34.1 mm -61.75 -42.75 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.631 -0.668 . . . . 0.49 109.447 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -72.69 -37.78 67.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.622 -0.674 . . . . 0.8 109.856 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.8 mt -66.58 -37.41 84.86 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.508 -0.745 . . . . 0.73 110.258 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -85.27 -56.92 3.3 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.518 -0.739 . . . . 2.06 110.645 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -95.15 -58.14 2.23 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.617 -0.677 . . . . 1.29 110.252 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.14 -128.76 7.9 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.986 -1.245 . . . . 0.6 109.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.4 p -111.82 -39.88 4.43 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.752 -0.852 . . . . 0.61 110.459 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.77 103.84 0.38 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.538 -0.726 . . . . 1.32 110.179 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.86 170.96 14.91 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.294 0.568 . . . . 0.95 109.803 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -133.99 160.99 36.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.53 -0.731 . . . . 1.45 109.672 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -107.71 130.77 54.91 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.424 -0.798 . . . . 0.71 109.87 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.584 HG13 ' HD2' ' A' ' 88' ' ' PRO . 10.4 tt -126.14 131.42 23.96 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 109.417 -0.586 . . . . 0.71 109.417 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 87' ' ' ILE . 32.8 Cg_endo -76.12 121.24 6.05 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.489 2.126 . . . . 0.77 110.412 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 130.21 35.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.453 -0.573 . . . . 0.98 109.453 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.41 103.35 9.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.868 -0.79 . . . . 1.16 108.868 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.04 -68.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.677 -0.639 . . . . 2.69 109.293 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.3 t -128.7 117.81 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.604 -0.685 . . . . 4.78 109.402 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.45 -72.29 1.31 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.56 -1.416 . . . . 3.89 109.56 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.884 . . . . 3.16 109.92 -179.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.175 0.512 . . . . 4.77 109.829 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -89.67 -39.28 13.3 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.566 -0.709 . . . . 3.2 109.724 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.426 ' HA3' ' OG ' ' A' ' 32' ' ' SER . . . -175.0 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.955 -1.258 . . . . 1.86 109.955 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.64 70.2 0.22 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.049 -1.22 . . . . 2.1 110.049 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 t -161.21 117.34 2.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.802 -0.822 . . . . 2.36 109.227 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.55 -55.93 3.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.473 -0.767 . . . . 2.93 109.614 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.25 -58.8 0.84 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.313 -0.625 . . . . 3.69 109.313 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.8 p -109.82 -49.21 3.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.551 -0.718 . . . . 3.52 109.403 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -159.68 146.5 16.46 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.698 . . . . 2.59 109.63 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -131.42 140.9 49.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.686 -0.634 . . . . 2.01 109.379 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.18 47.45 3.12 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.994 -1.242 . . . . 1.76 109.994 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.47 -54.12 2.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.644 -0.915 . . . . 1.52 109.407 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.5 mttt -138.25 166.51 24.0 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.485 0.66 . . . . 2.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.6 m -118.91 121.9 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.577 -0.897 . . . . 0.69 108.577 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 p -98.1 141.46 31.01 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.632 -0.668 . . . . 0.78 110.03 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -125.11 137.57 54.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.763 -0.586 . . . . 0.64 109.844 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -110.23 111.2 22.36 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.876 -0.787 . . . . 2.11 108.876 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.409 HD13 ' HB2' ' A' ' 46' ' ' ALA . 2.9 mp -114.34 110.03 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.58 -0.7 . . . . 0.65 109.85 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 29.2 m -103.81 131.83 50.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.202 -0.666 . . . . 0.69 109.202 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.7 HD12 ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -65.35 125.75 26.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.559 -0.713 . . . . 0.95 109.784 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.2 p -83.87 -41.95 16.91 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.703 -0.623 . . . . 0.8 109.768 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 m -61.98 -36.97 83.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.592 -0.693 . . . . 1.05 109.916 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.8 139.71 97.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.68 -0.638 . . . . 1.03 109.902 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -75.27 -29.79 7.45 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.532 2.155 . . . . 0.87 110.486 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 -26.12 51.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.572 -0.705 . . . . 3.12 109.95 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' N ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER 62.61 65.25 1.5 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.692 -0.63 . . . . 1.24 109.318 -179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 26' ' ' LEU . 34.9 Cg_endo -76.65 111.49 3.26 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 C-N-CA 123.046 2.497 . . . . 0.63 110.6 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 43.7 p90 -83.06 154.65 24.29 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.713 -0.617 . . . . 0.97 110.064 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -134.83 134.46 40.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.712 -0.617 . . . . 1.17 109.53 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.1 t -101.17 119.64 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.691 -0.63 . . . . 0.76 109.553 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.06 110.19 19.2 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.733 -0.604 . . . . 0.83 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.426 ' OG ' ' HA3' ' A' ' 3' ' ' GLY . 5.3 t -102.49 120.8 41.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.564 -0.71 . . . . 0.94 109.601 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 13.9 m -138.7 158.62 69.84 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.711 -0.618 . . . . 0.58 109.411 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.8 Cg_endo -76.8 150.27 30.49 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.504 2.136 . . . . 0.6 110.675 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.91 83.29 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.753 0.787 . . . . 1.0 108.97 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 p -179.17 -39.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.941 -0.763 . . . . 0.65 108.941 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.0 p -67.12 136.87 94.14 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.703 -0.623 . . . . 0.58 109.325 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.2 Cg_endo -77.67 161.84 30.52 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.702 2.268 . . . . 0.53 111.289 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.49 -16.84 64.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.657 -0.652 . . . . 0.56 109.698 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.2 p -61.91 -44.56 96.53 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.513 -0.921 . . . . 0.63 108.513 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.72 -39.54 61.83 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.517 -0.549 . . . . 0.51 109.517 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.08 -51.73 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.607 -0.683 . . . . 0.52 109.172 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.45 -34.55 74.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.811 -0.556 . . . . 0.53 109.905 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.82 -44.46 77.22 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.653 -0.654 . . . . 3.49 109.739 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.49 -42.59 99.02 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.677 -0.639 . . . . 1.88 109.974 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.409 ' HB2' HD13 ' A' ' 18' ' ' ILE . . . -68.93 -44.78 72.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.702 . . . . 0.49 109.4 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -63.28 -34.35 77.49 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.764 -0.585 . . . . 0.41 109.993 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.609 -0.682 . . . . 2.49 109.691 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.41 -40.56 85.58 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.678 -0.639 . . . . 1.32 109.509 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CD1' HD12 ' A' ' 20' ' ' LEU . 17.2 m-85 -72.02 -8.37 54.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.877 -0.514 . . . . 0.53 111.133 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.82 41.53 2.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.384 -0.823 . . . . 2.68 109.722 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.069 HG21 HD21 ' A' ' 86' ' ' LEU . 29.8 m -132.46 161.27 64.22 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.477 -0.764 . . . . 0.59 109.605 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.6 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.6 Cg_endo -77.34 131.75 11.93 Favored 'Trans proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.674 2.249 . . . . 0.64 110.393 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.18 -35.86 58.95 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.542 -0.724 . . . . 0.6 110.226 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.96 -35.86 69.68 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.565 -0.709 . . . . 0.68 110.411 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.6 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 9.7 m -87.34 -43.3 12.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.558 -0.714 . . . . 0.8 110.315 -179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -78.83 156.34 28.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.526 -0.734 . . . . 0.73 110.419 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -129.31 170.79 13.19 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.355 -0.609 . . . . 0.35 109.355 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.8 mt -122.85 120.04 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.301 -0.874 . . . . 0.54 109.426 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.775 HG22 ' HA2' ' A' ' 66' ' ' GLY . 2.0 pt -98.53 174.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.481 -0.762 . . . . 0.62 109.66 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 77.3 p -101.83 172.29 7.02 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.43 -0.794 . . . . 0.57 109.764 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -66.4 -25.08 66.6 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.569 -0.707 . . . . 1.0 109.739 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -56.09 4.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.534 -0.729 . . . . 2.36 109.418 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.44 52.54 0.02 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.844 -1.303 . . . . 0.74 109.844 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 61.7 t -124.61 119.25 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.699 -0.883 . . . . 0.65 108.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.775 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -74.4 85.37 0.72 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.002 -1.239 . . . . 0.45 110.002 -179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.66 133.63 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.939 -0.742 . . . . 0.53 109.573 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -109.17 162.5 19.88 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.817 -0.552 . . . . 0.87 109.638 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.65 64.71 8.13 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.95 2.433 . . . . 0.56 110.218 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.06 -32.91 1.79 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.564 -0.71 . . . . 0.98 110.54 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt-30 -85.99 161.64 49.23 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.356 -0.84 . . . . 1.23 110.247 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' HG2' ' HB2' ' A' ' 75' ' ' ASN . 35.4 Cg_endo -78.03 155.93 30.13 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 122.869 2.379 . . . . 0.58 110.613 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.01 -42.01 75.77 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.636 -0.665 . . . . 0.59 110.313 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.75 -43.27 94.61 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 110.074 -1.21 . . . . 0.67 110.074 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.6 OUTLIER -71.16 -38.69 72.2 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.666 -0.902 . . . . 1.61 110.02 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.431 HG13 ' CD1' ' A' ' 39' ' ' PHE . 34.0 mm -61.2 -41.55 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.585 -0.697 . . . . 0.61 109.528 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -74.67 -34.95 62.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.617 -0.677 . . . . 0.9 109.888 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.91 -34.55 78.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.484 -0.76 . . . . 0.94 110.579 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.3 -51.9 4.93 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.541 -0.725 . . . . 2.56 110.487 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -95.75 -56.71 2.58 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.487 -0.758 . . . . 0.85 110.068 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.75 -111.65 4.21 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.39 -1.484 . . . . 0.78 109.39 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.7 34.52 5.16 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.779 -0.836 . . . . 0.89 109.889 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 84.69 2.28 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.25 -0.906 . . . . 2.31 109.286 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.8 mt -132.79 172.82 12.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.562 -0.711 . . . . 0.88 110.199 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -150.97 156.61 41.53 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.603 -0.685 . . . . 2.46 109.483 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.069 HD21 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -102.84 123.8 47.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.403 -0.81 . . . . 0.9 109.885 -179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.551 HG13 ' HD2' ' A' ' 88' ' ' PRO . 8.8 tt -138.86 135.16 17.46 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 109.158 -0.682 . . . . 0.54 109.158 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.551 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.9 Cg_endo -74.45 108.19 2.63 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 122.519 2.146 . . . . 0.64 110.804 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.6 ttt180 -83.38 87.26 6.97 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.734 -0.604 . . . . 1.24 109.627 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -132.19 -50.87 0.95 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.58 -0.7 . . . . 1.36 109.415 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 -53.03 3.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.689 -0.632 . . . . 3.72 109.424 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -90.5 156.85 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.765 -0.584 . . . . 1.42 110.218 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.06 65.2 2.92 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.417 -1.473 . . . . 1.02 109.417 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.446 ' HB3' HD13 ' A' ' 87' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 117.803 -1.094 . . . . 1.78 109.832 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 6' ' ' ALA . 4.9 mtm . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.658 -0.497 . . . . 3.53 109.658 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 p -124.98 124.82 42.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.74 . . . . 4.73 109.842 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.25 -98.3 0.5 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.554 -1.418 . . . . 3.48 109.554 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.32 -64.64 1.07 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.668 -1.373 . . . . 3.28 109.668 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 10.0 t -152.98 171.92 17.61 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.691 -0.888 . . . . 4.87 109.728 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' N ' ' HG2' ' A' ' 1' ' ' MET . . . -173.89 -55.12 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.346 -0.846 . . . . 4.92 109.651 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -109.08 -179.91 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.735 -0.603 . . . . 3.85 109.479 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -66.88 150.27 49.42 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.265 -0.897 . . . . 4.87 110.245 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.403 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 26.4 p -73.06 81.84 1.25 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.789 -0.57 . . . . 3.96 110.094 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -110.48 -45.15 3.58 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.171 -0.956 . . . . 1.58 110.109 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.86 62.17 2.05 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.942 -1.263 . . . . 1.42 109.942 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.44 67.74 0.69 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.689 -0.889 . . . . 1.57 109.258 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -129.18 157.08 42.81 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.425 -0.797 . . . . 2.09 109.902 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.76 123.84 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.612 -0.68 . . . . 0.87 109.283 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.8 m -98.73 138.67 35.56 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.52 -0.737 . . . . 1.01 109.396 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -122.78 134.29 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.591 -0.693 . . . . 0.69 110.181 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -108.68 102.1 11.18 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.648 -0.871 . . . . 2.02 108.648 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.2 mp -104.67 128.96 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.564 -0.71 . . . . 0.61 110.014 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.425 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 57.9 m -108.06 123.14 48.24 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.166 -0.679 . . . . 0.85 109.166 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 23' ' ' ASP . 19.8 tp -66.85 140.22 57.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.542 -0.724 . . . . 0.66 110.004 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.9 p -126.81 45.06 2.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.706 -0.621 . . . . 0.96 109.9 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.66 -65.18 0.08 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.308 -0.87 . . . . 1.37 110.042 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.65 ' HB2' HD21 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -84.37 145.77 46.12 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.502 -0.749 . . . . 1.99 109.804 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.07 -25.02 9.16 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.897 2.398 . . . . 0.84 111.329 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.76 118.43 10.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.417 -0.802 . . . . 1.9 109.565 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.52 107.86 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 109.597 -0.519 . . . . 1.42 109.597 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.49 -46.31 0.22 Allowed 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.551 2.168 . . . . 0.94 110.615 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 52.4 p90 -138.97 166.29 24.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.587 -0.695 . . . . 1.51 109.838 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -146.09 128.48 15.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.582 -0.699 . . . . 1.25 109.518 -179.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.2 t -102.37 122.31 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 109.159 -0.682 . . . . 0.89 109.159 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.537 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -113.61 114.46 26.48 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.644 -0.66 . . . . 1.0 109.7 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.61 105.0 14.92 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.148 -0.686 . . . . 1.25 109.148 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.2 m -135.42 160.07 69.28 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.543 -0.723 . . . . 0.98 109.705 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.8 Cg_endo -74.62 163.74 35.27 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.585 2.19 . . . . 1.15 110.561 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.72 -29.57 69.44 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.58 -0.7 . . . . 1.19 110.121 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.68 -38.2 84.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.607 -0.683 . . . . 1.66 109.868 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.1 m -63.57 125.37 87.3 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.584 -0.697 . . . . 1.17 109.296 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.1 Cg_endo -78.07 159.4 30.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 122.734 2.289 . . . . 1.11 111.241 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.465 ' CD1' HG13 ' A' ' 76' ' ' ILE . 4.4 t80 -64.53 -19.53 65.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.639 -0.663 . . . . 0.8 109.894 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.415 HG22 ' HB2' ' A' ' 69' ' ' PRO . 20.9 p -60.38 -45.07 94.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.94 108.783 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.19 -37.5 63.91 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 33' ' ' VAL . 90.9 t -62.28 -50.21 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.636 -0.665 . . . . 0.8 109.309 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 59' ' ' ILE . 1.5 tt -63.13 -36.31 83.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.647 -0.658 . . . . 0.73 109.709 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -65.06 -51.14 63.21 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.608 -0.683 . . . . 2.47 109.665 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' HB3' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.59 -42.58 97.02 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.559 -0.713 . . . . 1.64 110.225 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.29 76.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.514 -0.742 . . . . 0.62 109.869 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.731 -0.606 . . . . 0.5 110.129 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -46.49 89.5 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.538 -0.726 . . . . 1.31 109.757 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.19 -27.51 61.68 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.683 -0.636 . . . . 0.98 110.01 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 3.0 m-85 -79.52 -4.42 51.29 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.423 -0.798 . . . . 0.56 110.708 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.32 37.81 1.52 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.406 -0.809 . . . . 2.66 109.945 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.95 156.53 75.78 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.395 -0.815 . . . . 0.54 109.317 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.75 123.33 7.39 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 122.582 2.188 . . . . 0.75 110.815 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.32 74.0 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.934 -0.479 . . . . 0.8 110.397 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.9 82.42 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.657 -0.652 . . . . 1.01 110.191 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -103.12 4.67 37.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.519 -0.738 . . . . 1.02 110.609 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 2.1 m -102.45 156.19 17.77 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.139 -0.976 . . . . 0.75 110.432 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -137.06 149.12 47.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.923 -0.769 . . . . 0.62 108.923 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD12 ' A' ' 43' ' ' LEU . 29.8 mt -110.9 115.09 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.298 -0.876 . . . . 0.44 109.347 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.739 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.74 168.09 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.64 -0.662 . . . . 0.59 109.656 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.4 p -96.62 169.91 9.56 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.425 -0.797 . . . . 0.58 110.033 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.64 -23.8 65.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.598 -0.689 . . . . 1.34 109.911 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.05 -48.13 12.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.553 -0.717 . . . . 1.22 109.807 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 142.7 56.55 0.03 OUTLIER Glycine 0 N--CA 1.497 2.707 0 N-CA-C 110.107 -1.197 . . . . 0.76 110.107 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -131.61 118.46 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.667 -0.901 . . . . 0.72 108.981 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.739 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.71 87.92 0.84 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.944 -1.262 . . . . 0.56 109.944 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.7 t -73.93 132.6 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.856 -0.79 . . . . 0.51 109.572 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.483 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 60.1 m-80 -112.62 162.79 19.94 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.834 -0.541 . . . . 1.07 109.742 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 36.1 Cg_endo -77.74 62.79 7.92 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.792 2.328 . . . . 0.89 110.387 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.66 -14.65 6.74 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.536 -0.727 . . . . 1.02 110.712 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.658 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 1.7 pt20 -115.49 166.21 12.59 Favored Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.172 -0.955 . . . . 1.22 109.844 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.8 Cg_endo -76.47 160.39 35.34 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.642 2.228 . . . . 0.97 111.083 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.78 82.37 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.691 -0.63 . . . . 0.84 109.958 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.64 -43.51 91.28 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.743 -1.343 . . . . 0.83 109.743 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -70.0 -34.7 73.65 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.698 -0.883 . . . . 1.11 109.689 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.465 HG13 ' CD1' ' A' ' 39' ' ' PHE . 15.2 mm -61.43 -45.14 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.622 -0.674 . . . . 0.58 109.492 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -72.1 -39.16 69.13 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.702 -0.624 . . . . 0.9 109.598 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.29 -34.81 79.22 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.643 -0.661 . . . . 0.86 110.419 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tttt -90.79 -58.39 2.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.437 -0.79 . . . . 2.07 110.483 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -92.92 -58.92 2.18 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.534 -0.729 . . . . 0.73 110.404 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.09 -112.85 2.3 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.766 -1.334 . . . . 0.77 109.766 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -123.75 -43.14 2.15 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.744 -0.856 . . . . 1.04 110.328 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.7 105.79 0.24 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.62 -0.675 . . . . 1.22 110.2 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.4 mt -139.55 171.13 14.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.782 -0.574 . . . . 0.75 109.713 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 19' ' ' THR . 2.6 mtp180 -143.49 141.08 30.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.438 -0.789 . . . . 1.72 109.478 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' HD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -103.91 129.41 51.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.324 -0.86 . . . . 0.67 109.927 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 HG13 ' HD2' ' A' ' 88' ' ' PRO . 6.2 tt -140.53 131.6 13.91 Favored Pre-proline 0 N--CA 1.496 1.858 0 N-CA-C 108.822 -0.807 . . . . 0.91 108.822 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 57' ' ' SER . 33.6 Cg_endo -74.51 90.85 1.0 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 122.49 2.127 . . . . 0.8 110.289 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? 71.97 128.2 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.243 0.544 . . . . 2.62 109.756 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.69 111.17 22.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.582 -0.699 . . . . 1.53 109.744 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -57.93 3.13 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.008 -0.738 . . . . 2.55 109.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.04 -23.27 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.689 -0.632 . . . . 2.94 109.904 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.71 -153.88 17.1 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.192 -1.563 . . . . 1.75 109.192 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.4 t60 . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 117.743 -1.122 . . . . 3.02 109.812 179.727 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.685 ' H1 ' ' HA ' ' A' ' 5' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.472 -0.936 . . . . 5.37 108.472 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.29 21.92 4.51 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 108.975 -0.75 . . . . 3.12 108.975 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 123.03 77.92 0.4 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.965 -1.654 . . . . 4.09 108.965 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.01 85.26 1.42 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.372 -1.491 . . . . 3.92 109.372 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.685 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 17.0 p -82.71 133.51 35.15 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.402 -1.058 . . . . 4.47 110.219 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.99 85.86 1.69 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 2.95 110.098 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.14 -52.36 10.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.652 -0.655 . . . . 3.06 109.744 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.1 p -109.46 127.54 54.49 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.539 -0.726 . . . . 3.25 109.379 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -100.08 160.85 14.0 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.705 0.764 . . . . 4.5 111.265 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -108.26 3.24 23.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.885 -0.509 . . . . 4.34 110.261 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.62 -56.66 12.23 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.872 -1.291 . . . . 2.96 109.872 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 91.5 p -98.66 2.38 47.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.83 -0.806 . . . . 1.86 110.449 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -121.68 159.65 26.12 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.287 -0.883 . . . . 2.03 109.898 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -113.28 131.6 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.465 -0.772 . . . . 0.67 109.88 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.4 t -100.54 154.37 18.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.445 -0.784 . . . . 0.84 109.815 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -133.85 137.74 45.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.498 -0.751 . . . . 0.7 110.013 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 109.67 17.98 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.363 -0.977 . . . . 1.1 108.363 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.552 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -114.21 125.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.544 -0.723 . . . . 0.7 110.077 -179.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 88.2 m -129.08 134.16 47.97 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.026 -0.731 . . . . 0.67 109.026 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.71 123.19 18.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.533 -0.729 . . . . 0.63 110.043 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.588 ' HB ' ' HD3' ' A' ' 85' ' ' ARG . 10.1 t -106.73 -30.02 9.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.82 -0.55 . . . . 0.8 110.029 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -40.13 75.95 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.43 -0.794 . . . . 1.11 109.861 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -76.18 166.87 41.58 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.691 -0.631 . . . . 1.2 109.99 -179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 32.2 Cg_endo -74.81 -29.8 8.19 Favored 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 122.631 2.221 . . . . 1.03 110.635 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.74 167.07 18.53 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.5 -0.75 . . . . 4.14 109.817 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.09 72.57 71.67 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.467 -0.77 . . . . 1.22 109.895 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.1 119.02 4.9 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.67 2.247 . . . . 0.74 110.076 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -87.23 144.29 26.89 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.524 -0.735 . . . . 1.5 110.056 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 6.6 tptt -131.73 111.38 11.61 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.14 -0.689 . . . . 1.34 109.14 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.22 117.89 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 109.148 -0.686 . . . . 0.74 109.148 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.544 HD21 ' CB ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -118.54 110.67 17.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.715 -0.616 . . . . 1.17 109.527 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -102.73 102.87 13.06 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.686 -0.634 . . . . 0.76 109.592 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 14.2 m -136.72 160.42 66.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 0.7 109.672 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.9 Cg_endo -75.63 164.49 32.12 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 122.512 2.141 . . . . 0.71 110.607 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -25.01 64.36 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.605 -0.685 . . . . 1.03 110.571 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.49 -40.25 90.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.452 -0.78 . . . . 1.25 109.911 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.1 m -66.78 124.82 89.54 Favored Pre-proline 0 N--CA 1.497 1.901 0 N-CA-C 109.092 -0.707 . . . . 0.59 109.092 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -77.78 164.22 28.08 Favored 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 122.72 2.28 . . . . 0.52 111.297 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.525 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.9 t80 -66.75 -16.75 64.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.578 -0.701 . . . . 0.55 109.791 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.1 p -61.36 -43.9 98.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.318 -0.863 . . . . 0.54 108.721 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.41 -39.19 54.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.333 -0.617 . . . . 0.52 109.333 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -60.27 -51.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.088 -0.708 . . . . 0.55 109.088 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.21 -32.94 74.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.453 -0.573 . . . . 0.58 109.453 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -53.17 59.15 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.698 -0.626 . . . . 2.15 109.588 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.544 ' CB ' HD21 ' A' ' 31' ' ' LEU . 11.7 m-85 -61.69 -41.76 98.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.653 -0.654 . . . . 1.62 110.15 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . . . -63.3 -41.93 98.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.633 -0.667 . . . . 0.51 109.618 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.9 -33.0 71.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.762 -0.586 . . . . 0.51 109.922 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.78 -49.52 76.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.616 -0.677 . . . . 1.91 109.64 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.2 -30.74 68.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.706 -0.621 . . . . 1.14 109.508 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 86' ' ' LEU . 3.5 m-85 -78.86 -8.4 58.79 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.684 -0.635 . . . . 0.66 110.893 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.42 37.74 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 3.12 110.066 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 53' ' ' PRO . 16.1 m -132.98 158.76 75.04 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.478 -0.764 . . . . 0.72 109.177 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.518 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.2 Cg_endo -77.46 125.36 7.61 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.519 2.146 . . . . 0.81 110.435 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.82 74.2 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.864 -0.523 . . . . 0.73 110.44 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.61 70.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 1.07 110.578 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 4.6 m -102.83 -5.97 23.04 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.471 -0.768 . . . . 1.36 110.627 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.7 m -105.44 155.29 19.29 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.164 -0.96 . . . . 0.91 110.316 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -132.19 165.7 23.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.776 -0.578 . . . . 0.39 109.52 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.32 118.35 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.294 -0.879 . . . . 0.47 109.122 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.697 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.3 pt -98.46 169.38 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.612 -0.68 . . . . 0.62 109.476 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.4 m -98.3 158.31 15.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.47 -0.769 . . . . 0.61 109.552 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -59.94 -24.56 64.45 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.582 -0.699 . . . . 0.85 110.032 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -47.91 15.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.488 -0.758 . . . . 2.18 109.353 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 141.13 58.76 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.796 -1.321 . . . . 0.68 109.796 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 HG11 ' HE1' ' A' ' 80' ' ' HIS . 23.7 t -134.07 119.91 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.849 . . . . 0.72 108.946 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.697 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.32 87.62 0.8 Allowed Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.129 -1.188 . . . . 0.48 110.129 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 80' ' ' HIS . 11.4 t -72.92 131.42 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.987 -0.714 . . . . 0.54 109.454 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -110.85 161.34 25.3 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.823 -0.548 . . . . 0.82 109.758 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 36.0 Cg_endo -77.75 65.55 8.18 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.872 2.381 . . . . 0.51 109.733 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.12 -41.84 0.81 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.622 -0.674 . . . . 0.6 110.209 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -79.99 160.31 68.99 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.525 -0.735 . . . . 1.08 109.975 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.621 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.1 Cg_endo -77.14 157.99 33.83 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 122.778 2.319 . . . . 0.5 110.584 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.66 -39.04 70.37 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.662 -0.649 . . . . 0.54 110.213 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.74 -46.34 94.2 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.05 -1.22 . . . . 0.63 110.05 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.52 -38.41 77.53 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.653 -0.91 . . . . 1.34 109.936 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.461 HD12 ' CG1' ' A' ' 67' ' ' VAL . 36.4 mm -62.36 -43.99 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.594 -0.691 . . . . 0.6 109.583 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -71.05 -36.28 72.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.652 -0.655 . . . . 0.81 109.782 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -66.06 -33.95 76.97 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.384 -0.823 . . . . 0.94 110.178 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -58.53 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.423 -0.798 . . . . 3.25 110.994 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CE1' HG22 ' A' ' 67' ' ' VAL . 25.6 m-70 -91.95 -51.25 5.3 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.497 -0.752 . . . . 0.93 109.897 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.4 -124.82 8.05 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.779 -1.329 . . . . 0.71 109.779 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 t -110.03 -38.2 5.39 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.797 -0.825 . . . . 0.81 110.155 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -60.44 101.37 0.13 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.488 -0.757 . . . . 1.25 109.835 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mt -138.85 164.61 29.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.681 -0.637 . . . . 0.93 109.867 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.588 ' HD3' ' HB ' ' A' ' 21' ' ' THR . 1.6 mtp180 -136.17 150.4 49.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.461 -0.774 . . . . 2.04 109.908 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.612 HD13 ' CD2' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -98.7 142.87 29.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.523 -0.736 . . . . 0.61 109.736 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.651 HG13 ' HD2' ' A' ' 88' ' ' PRO . 13.1 tt -155.73 141.18 12.54 Favored Pre-proline 0 N--CA 1.496 1.862 0 N-CA-C 109.018 -0.734 . . . . 0.55 109.018 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.651 ' HD2' HG13 ' A' ' 87' ' ' ILE . 34.7 Cg_endo -73.99 122.81 7.93 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 122.323 2.015 . . . . 0.62 109.688 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 70.55 143.18 0.05 Allowed 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.251 0.548 . . . . 2.31 109.587 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.3 112.9 6.16 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.445 -0.784 . . . . 1.31 109.42 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -125.03 -49.71 1.71 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 3.75 110.607 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 t 70.03 78.22 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 N-CA-C 109.318 -0.623 . . . . 1.38 109.318 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -125.29 69.56 0.49 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.668 -1.373 . . . . 1.54 109.668 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 117.823 -1.084 . . . . 1.7 109.981 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttm . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.797 -0.445 . . . . 5.02 109.797 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.66 84.1 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.552 -0.907 . . . . 4.6 108.552 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.46 109.48 1.98 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.269 -1.132 . . . . 5.33 110.269 -178.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.93 0.24 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.131 -1.188 . . . . 6.11 110.131 179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 t -87.15 161.14 18.25 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.586 -0.949 . . . . 5.25 110.371 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.81 -37.51 35.01 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.647 -0.871 . . . . 4.36 108.647 178.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.71 46.53 18.22 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.436 0.636 . . . . 3.3 110.12 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.4 p -77.96 111.79 14.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.428 -0.795 . . . . 2.67 109.532 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 p -77.48 -41.14 40.57 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.052 -0.721 . . . . 2.04 109.052 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.33 152.11 27.63 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.443 -0.577 . . . . 1.26 109.443 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.13 -60.82 4.6 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.612 -1.395 . . . . 1.17 109.612 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.2 p -94.75 120.61 35.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.709 -0.877 . . . . 0.95 109.814 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -141.89 154.57 45.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.579 -0.701 . . . . 1.79 109.782 179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.05 141.88 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.774 -0.579 . . . . 0.54 109.603 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.6 p -98.69 147.62 24.67 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.611 -0.681 . . . . 0.74 109.664 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -127.27 147.47 50.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.68 109.967 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.47 118.75 22.61 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.893 -0.78 . . . . 3.39 108.893 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.577 HG21 HD12 ' A' ' 86' ' ' LEU . 4.1 mp -121.3 129.68 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.372 -0.83 . . . . 0.78 110.662 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' H ' ' HA ' ' A' ' 85' ' ' ARG . 2.6 m -126.42 147.21 49.82 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.777 -0.823 . . . . 0.84 108.777 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -68.27 139.93 55.98 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.206 -0.934 . . . . 1.31 109.67 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -84.82 -46.36 11.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.669 -0.644 . . . . 0.99 110.131 -179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.59 -55.0 5.91 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.557 -0.714 . . . . 1.38 109.841 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 20' ' ' LEU . 2.4 t70 -78.75 132.71 63.86 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.685 -0.635 . . . . 2.13 110.104 -179.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.0 94.85 1.06 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.715 2.277 . . . . 1.84 109.165 179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.84 124.54 47.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.618 -0.676 . . . . 1.86 110.355 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -65.86 -55.84 20.57 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 109.455 -0.572 . . . . 1.71 109.455 179.254 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 26' ' ' LEU . 35.9 Cg_endo -78.38 165.52 25.34 Favored 'Trans proline' 0 C--N 1.323 -0.811 0 C-N-CA 122.519 2.146 . . . . 1.23 110.403 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -136.71 161.39 36.09 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.489 -0.757 . . . . 1.38 110.104 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.54 ' HB2' ' HE1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -80.36 119.48 23.13 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.606 -0.684 . . . . 0.92 109.912 -179.829 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.4 t -100.2 120.65 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.71 -0.848 . . . . 0.83 108.71 179.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -117.74 110.84 18.33 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.636 -0.665 . . . . 0.83 110.049 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.6 m -106.1 100.29 9.84 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.057 -0.72 . . . . 0.85 109.057 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.6 m -134.08 160.01 70.18 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.627 -0.67 . . . . 0.72 109.687 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.0 Cg_endo -74.01 163.13 37.53 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.55 2.167 . . . . 0.62 110.684 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.85 -29.23 68.15 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.784 -0.572 . . . . 0.75 110.202 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -37.81 86.57 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.585 -0.697 . . . . 1.08 109.943 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.2 m -62.65 125.27 85.84 Favored Pre-proline 0 N--CA 1.498 1.966 0 O-C-N 121.566 -0.709 . . . . 0.56 109.245 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 35.9 Cg_endo -78.08 163.47 28.07 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.826 2.35 . . . . 0.45 111.37 -179.519 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 6.1 t80 -66.62 -17.19 64.7 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.611 -0.681 . . . . 0.56 109.859 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.5 p -60.17 -46.26 90.3 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.547 -0.909 . . . . 0.74 108.547 178.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.53 -37.48 63.05 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.415 -0.587 . . . . 0.42 109.415 179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' HA ' HD22 ' A' ' 31' ' ' LEU . 87.2 t -60.63 -51.38 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.051 -0.722 . . . . 0.47 109.051 179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -63.36 -33.31 75.25 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.122 -0.696 . . . . 0.53 109.122 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.81 -51.83 68.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.826 -0.546 . . . . 3.04 109.843 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HB2' HD21 ' A' ' 31' ' ' LEU . 12.5 m-85 -65.56 -40.45 92.81 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.84 -0.537 . . . . 1.58 110.124 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.0 -48.2 82.92 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.627 -0.67 . . . . 0.47 109.404 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 52' ' ' VAL . . . -66.16 -33.39 75.65 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.612 -0.68 . . . . 0.47 109.978 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -60.27 -49.87 75.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.535 -0.728 . . . . 0.88 109.621 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -31.1 69.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.897 -0.502 . . . . 0.9 109.972 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.54 ' HE1' ' HB2' ' A' ' 29' ' ' LYS . 10.6 m-85 -81.51 -4.36 55.72 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.453 -0.779 . . . . 0.89 110.931 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.14 36.71 7.05 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.205 -0.934 . . . . 2.64 110.036 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 19.8 m -130.73 156.68 79.51 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.386 -0.821 . . . . 0.61 109.46 179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HG2' ' HB ' ' A' ' 56' ' ' THR . 34.9 Cg_endo -77.04 127.06 9.07 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 122.684 2.256 . . . . 0.62 110.44 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.03 -35.49 78.36 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.824 -0.547 . . . . 0.55 109.964 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.71 -33.46 75.7 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.67 -0.644 . . . . 0.68 110.052 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 89' ' ' ARG . 3.1 m -108.11 34.05 3.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.54 -0.725 . . . . 0.71 109.747 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 m -148.95 150.89 33.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.203 -0.936 . . . . 0.59 110.038 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -133.13 169.67 16.52 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.341 -0.614 . . . . 0.46 109.341 179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 13.2 mt -123.15 122.12 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.436 -0.79 . . . . 0.54 109.4 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.2 pt -98.61 173.29 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.726 . . . . 0.76 109.751 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 8.9 t -118.14 174.6 6.12 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.392 -0.817 . . . . 0.73 110.22 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -66.18 -21.59 66.33 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.654 -0.654 . . . . 1.25 110.597 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -79.09 -22.36 45.36 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.377 -0.827 . . . . 1.14 110.403 -179.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.27 45.67 1.43 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.591 -1.403 . . . . 0.88 109.591 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 39.9 t -126.23 128.18 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.72 -0.87 . . . . 0.88 108.973 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.86 87.86 1.25 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.818 -1.313 . . . . 0.58 109.818 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.577 HG11 HD12 ' A' ' 76' ' ' ILE . 22.1 t -67.09 130.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.921 -0.752 . . . . 0.75 109.447 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 69' ' ' PRO . 9.5 p30 -108.01 163.78 16.21 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.619 -0.675 . . . . 1.04 109.73 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 68' ' ' ASN . 36.4 Cg_endo -77.8 67.31 7.99 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.104 2.536 . . . . 0.52 111.02 -179.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -136.54 -43.41 0.61 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.583 -0.698 . . . . 0.69 110.057 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.3 mt-30 -75.0 159.24 83.3 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.503 -0.748 . . . . 1.16 110.05 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.4 Cg_endo -77.11 156.74 33.92 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.739 2.293 . . . . 0.43 110.593 179.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.42 -38.33 68.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.702 -0.624 . . . . 0.48 110.371 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.9 -46.55 94.33 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.983 -1.247 . . . . 0.42 109.983 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -68.41 -38.65 81.45 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.733 -0.863 . . . . 0.93 110.02 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.577 HD12 HG11 ' A' ' 67' ' ' VAL . 41.2 mm -61.47 -45.31 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.66 -0.65 . . . . 0.5 109.595 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -71.62 -37.22 70.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.699 -0.625 . . . . 0.61 109.803 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.97 -40.22 94.66 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.55 -0.719 . . . . 0.8 110.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -55.21 4.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.495 -0.753 . . . . 2.82 110.736 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.442 ' NE2' HG22 ' A' ' 67' ' ' VAL . 86.8 m-70 -97.43 -61.73 1.35 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.583 -0.698 . . . . 1.28 110.102 -178.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 122.34 -130.79 8.1 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.81 -1.316 . . . . 0.64 109.81 -179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.9 t -104.58 -36.21 7.57 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.691 -0.888 . . . . 0.68 110.095 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -59.38 105.79 0.38 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.531 -0.731 . . . . 2.31 110.167 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.6 mt -141.09 167.64 21.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.776 -0.578 . . . . 0.75 109.771 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -138.6 158.88 43.41 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.58 -0.7 . . . . 1.86 109.7 179.847 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.577 HD12 HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -107.47 128.25 54.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.508 -0.745 . . . . 0.91 109.991 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.6 pt -127.76 155.41 77.33 Favored Pre-proline 0 N--CA 1.497 1.886 0 N-CA-C 109.333 -0.617 . . . . 0.61 109.333 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.94 55.59 5.65 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.709 2.273 . . . . 0.57 110.712 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HD3' ' HA ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 65.47 167.67 0.19 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.512 -0.742 . . . . 0.96 110.356 179.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.7 t70 69.51 152.9 0.1 Allowed 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.401 0.619 . . . . 1.08 110.314 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 44.2 tpt85 -77.68 101.21 6.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.431 -0.793 . . . . 1.39 109.32 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.2 m -138.27 140.29 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.652 -0.655 . . . . 1.11 109.661 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.63 -70.05 1.36 Allowed Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.558 -1.417 . . . . 1.62 109.558 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.0 t60 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 117.852 -1.07 . . . . 1.56 109.757 179.935 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 4' ' ' GLY . 24.3 ttm . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.292 0.568 . . . . 6.77 109.765 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.5 OUTLIER -95.85 -44.4 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.597 -0.689 . . . . 3.86 109.459 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' HA2' ' C ' ' A' ' 11' ' ' GLY . . . -108.13 80.45 0.27 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.844 -1.302 . . . . 4.06 109.844 -179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 1' ' ' MET . . . -144.89 -66.08 0.02 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.847 -1.301 . . . . 3.94 109.847 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.2 m -100.08 -15.41 18.22 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.685 -0.891 . . . . 4.44 110.055 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 7' ' ' ALA . . . -88.67 97.93 11.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.228 -0.92 . . . . 2.28 109.373 179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.674 ' CB ' ' HB3' ' A' ' 10' ' ' ALA . . . 68.8 124.02 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 108.93 -0.767 . . . . 2.25 108.93 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 35.1 p -69.43 -37.63 77.51 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.477 -0.764 . . . . 2.27 111.688 -178.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 p -105.5 -18.71 14.01 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.078 -1.013 . . . . 2.4 111.518 -179.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.674 ' HB3' ' CB ' ' A' ' 7' ' ' ALA . . . -78.82 -58.71 3.1 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.0 -1.063 . . . . 2.04 109.526 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.422 ' C ' ' HA2' ' A' ' 3' ' ' GLY . . . 99.16 -117.31 5.83 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.994 -1.243 . . . . 1.37 109.994 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 48.0 p -77.19 -59.17 2.89 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.474 -1.015 . . . . 1.24 109.83 -179.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -129.34 164.9 22.56 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.513 -0.742 . . . . 1.5 109.701 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG12 ' CB ' ' A' ' 10' ' ' ALA . 3.2 m -110.06 120.63 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.584 -0.698 . . . . 0.74 109.63 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -98.62 134.15 41.96 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.809 -0.812 . . . . 0.76 108.809 179.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' HB3' HD12 ' A' ' 84' ' ' LEU . 62.5 m-85 -118.95 135.13 54.75 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.638 -0.664 . . . . 0.64 110.477 -179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.97 105.32 15.04 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.337 -0.986 . . . . 2.03 108.337 179.011 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 86' ' ' LEU . 2.4 mp -107.69 128.15 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.538 -0.726 . . . . 0.59 110.223 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 28' ' ' PHE . 73.6 p -116.4 138.53 51.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.724 -0.61 . . . . 0.67 109.401 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD23 ' CD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -68.3 125.58 26.89 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.316 -0.865 . . . . 0.69 108.903 179.543 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.545 HG22 ' NH2' ' A' ' 85' ' ' ARG . 29.2 p -85.05 -44.28 13.17 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.568 -0.707 . . . . 0.72 110.904 -178.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.09 -45.45 66.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.422 -0.799 . . . . 1.31 110.752 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.559 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -99.56 112.59 63.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.52 -0.738 . . . . 2.42 110.142 -179.439 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.68 -30.19 4.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.781 2.321 . . . . 1.58 110.599 179.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -37.15 85.43 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.517 -0.739 . . . . 2.5 109.913 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HD1' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.74 132.87 95.35 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.521 -0.737 . . . . 1.35 109.881 -179.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.48 160.59 31.9 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.0 2.467 . . . . 0.97 111.606 -179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.686 ' HB3' HG22 ' A' ' 19' ' ' THR . 53.3 p90 -70.58 162.83 28.17 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.671 -0.643 . . . . 1.08 110.649 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.0 129.9 47.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.746 -0.596 . . . . 1.66 109.684 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -105.26 123.95 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.675 -0.641 . . . . 0.91 109.275 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.79 115.08 26.44 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.595 -0.691 . . . . 0.94 109.718 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.3 p -104.21 107.41 18.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.601 -0.687 . . . . 0.82 109.346 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.45 HG21 HG22 ' A' ' 42' ' ' VAL . 15.2 m -134.98 159.05 73.53 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.569 -0.707 . . . . 0.67 109.605 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 33.6 Cg_endo -74.75 163.82 34.92 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 122.53 2.153 . . . . 0.72 110.716 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.662 -0.649 . . . . 1.08 110.103 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.89 -38.52 82.5 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.516 -0.74 . . . . 1.21 109.83 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.7 m -64.25 125.32 88.02 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.699 -0.625 . . . . 0.63 109.329 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.83 160.29 27.58 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 C-N-CA 122.732 2.288 . . . . 0.49 111.112 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.51 ' CD1' HG13 ' A' ' 76' ' ' ILE . 8.5 t80 -64.56 -20.04 66.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.639 -0.663 . . . . 0.54 109.925 179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.48 HG22 ' HB2' ' A' ' 69' ' ' PRO . 25.2 p -60.48 -44.42 95.95 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.399 -0.813 . . . . 0.59 108.899 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.79 -37.95 62.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.347 -0.612 . . . . 0.44 109.347 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 33' ' ' VAL . 84.0 t -61.33 -48.08 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.658 -0.651 . . . . 0.53 109.299 179.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD12 HD12 ' A' ' 59' ' ' ILE . 3.9 tt -63.92 -35.23 79.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.828 -0.545 . . . . 0.7 109.736 179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -65.43 -50.91 63.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.628 -0.67 . . . . 2.78 109.713 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -61.48 -43.9 98.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.676 -0.64 . . . . 1.72 109.669 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.86 92.66 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.549 -0.72 . . . . 0.51 109.622 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -43.64 88.17 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.661 -0.649 . . . . 0.63 109.859 179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.53 -44.99 95.47 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.666 -0.646 . . . . 1.13 109.611 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.17 -26.97 64.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.631 -0.668 . . . . 1.01 109.579 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.902 ' CD1' HD23 ' A' ' 20' ' ' LEU . 3.0 m-85 -84.98 3.97 35.94 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.525 -0.734 . . . . 0.76 110.791 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.1 mttt 63.35 37.45 10.87 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.458 -0.776 . . . . 1.74 110.142 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.23 156.56 79.76 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.527 -0.733 . . . . 0.9 109.296 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.04 123.1 7.08 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 122.607 2.205 . . . . 1.07 110.797 -179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.29 -29.67 66.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.998 -0.439 . . . . 0.91 110.197 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.5 90.59 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.531 -0.731 . . . . 1.01 109.978 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -113.12 41.13 2.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.576 -0.702 . . . . 1.19 109.647 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.59 155.94 43.05 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.818 . . . . 0.77 109.946 179.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -141.02 162.43 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.094 -0.706 . . . . 0.47 109.094 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.446 HD12 HD12 ' A' ' 43' ' ' LEU . 26.5 mt -123.78 112.1 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.327 -0.858 . . . . 0.47 109.369 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.673 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -98.0 178.4 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 109.231 -0.655 . . . . 0.56 109.231 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.527 HG22 HD23 ' A' ' 84' ' ' LEU . 74.8 p -115.57 162.89 16.57 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.355 -0.841 . . . . 0.58 110.375 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -62.13 -23.49 66.59 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.786 -0.571 . . . . 1.75 110.165 179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.12 -41.94 27.42 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.436 -0.79 . . . . 0.91 109.224 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 131.4 52.1 0.09 OUTLIER Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.82 -1.312 . . . . 0.75 109.82 179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.4 t -128.34 118.2 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.682 -0.893 . . . . 0.77 108.933 179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.673 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -77.91 85.25 1.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.88 -1.288 . . . . 0.62 109.88 -179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG11 HD12 ' A' ' 76' ' ' ILE . 31.9 t -72.74 131.77 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.821 -0.811 . . . . 0.58 109.527 179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 41.5 m-20 -115.12 165.87 13.15 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.72 -0.613 . . . . 1.36 109.836 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 68' ' ' ASN . 35.7 Cg_endo -77.78 63.76 8.09 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 122.939 2.426 . . . . 0.63 110.188 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -133.39 28.73 4.01 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.598 -0.689 . . . . 0.8 109.654 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.632 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -158.9 165.16 19.03 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.469 -0.769 . . . . 0.91 109.331 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 34.7 Cg_endo -76.17 155.71 37.68 Favored 'Trans proline' 0 C--N 1.316 -1.153 0 C-N-CA 122.56 2.173 . . . . 0.63 111.101 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 14' ' ' VAL . . . -60.71 -36.76 79.64 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.746 -0.596 . . . . 0.62 109.8 179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.44 -42.18 93.67 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.517 -1.433 . . . . 0.83 109.517 179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -68.82 -37.31 79.11 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.727 -0.866 . . . . 1.12 109.557 179.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.51 HG13 ' CD1' ' A' ' 39' ' ' PHE . 25.3 mm -62.03 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.731 -0.606 . . . . 0.72 109.478 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 13.0 t80 -67.32 -37.11 82.81 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.718 -0.614 . . . . 0.92 109.519 179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 78' ' ' LEU . 1.4 mm? -67.84 -35.6 78.86 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.721 -0.612 . . . . 1.17 109.982 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -76.09 -57.77 3.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.775 -0.578 . . . . 1.58 109.962 -179.769 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.5 ' CE1' HG21 ' A' ' 61' ' ' THR . 96.5 m-70 -112.15 -59.92 1.93 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.779 -0.576 . . . . 1.06 109.922 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 77' ' ' PHE . . . 120.66 -117.82 3.64 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.5 -1.44 . . . . 1.05 109.5 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -100.51 -13.11 18.79 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.691 -0.888 . . . . 1.24 110.62 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -76.33 102.77 6.04 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.206 -0.933 . . . . 0.72 109.599 -179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.527 HD23 HG22 ' A' ' 61' ' ' THR . 20.9 mt -143.33 166.96 23.29 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.654 -0.654 . . . . 0.58 110.209 -179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' NH2' HG22 ' A' ' 21' ' ' THR . 4.5 mtt-85 -146.38 144.23 29.61 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.705 -0.622 . . . . 1.63 109.475 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.676 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -104.76 139.17 39.95 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.344 -0.848 . . . . 0.76 110.141 -179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 tt -146.4 125.56 6.57 Favored Pre-proline 0 N--CA 1.495 1.793 0 N-CA-C 108.814 -0.81 . . . . 0.56 108.814 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -75.13 102.18 1.56 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 122.565 2.176 . . . . 0.89 110.554 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.16 101.37 3.93 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.229 -0.656 . . . . 2.47 109.229 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -166.57 155.95 11.2 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.597 -0.689 . . . . 1.51 109.71 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.7 -46.23 72.87 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 2.86 110.271 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.31 130.39 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.474 -0.766 . . . . 2.37 110.251 -179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.23 51.06 14.52 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.996 -1.242 . . . . 2.69 109.996 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 117.7 -1.143 . . . . 2.92 110.389 179.856 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.919 0.866 . . . . 5.48 110.561 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.89 171.76 19.52 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.332 -0.618 . . . . 5.93 109.332 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.88 -34.44 10.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.845 -1.302 . . . . 4.27 109.845 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.06 -68.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.892 -1.147 . . . . 3.5 110.604 -179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.1 m -129.21 117.2 20.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.647 -0.914 . . . . 3.41 110.447 -178.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.07 138.84 31.69 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.81 -0.811 . . . . 2.93 108.81 179.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -107.4 -38.81 5.84 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.472 -0.768 . . . . 4.77 111.399 -178.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.2 p -59.47 111.5 1.42 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.314 -0.866 . . . . 3.76 108.823 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 m -121.43 132.44 54.74 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.563 -0.855 . . . . 3.2 111.388 -178.213 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -114.81 -30.01 6.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.424 -0.954 . . . . 1.94 108.424 178.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 131.75 -130.02 5.83 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 108.664 -1.774 . . . . 1.55 108.664 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.95 112.37 17.13 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.384 -0.969 . . . . 1.44 108.384 179.209 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 34' ' ' PRO . 18.3 mttt -121.94 156.12 34.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.387 -0.821 . . . . 2.05 110.816 -178.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 73' ' ' ALA . 17.2 m -110.09 135.69 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.961 -0.755 . . . . 0.55 108.961 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 p -98.64 145.78 26.51 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.435 -0.791 . . . . 0.68 109.791 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -128.01 142.01 51.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.63 -0.669 . . . . 0.65 109.847 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -121.66 101.32 7.52 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.819 -0.808 . . . . 1.39 108.819 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.788 HG21 HD12 ' A' ' 86' ' ' LEU . 3.2 mp -99.81 129.67 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.616 -0.678 . . . . 0.65 109.889 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.6 m -116.15 122.4 44.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.666 -0.647 . . . . 0.61 109.285 179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.857 HD22 ' HB3' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -67.03 137.43 56.44 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.632 . . . . 0.54 109.549 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.6 p -64.61 -51.71 61.24 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.555 -0.716 . . . . 0.58 109.803 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -21.98 33.88 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.732 -0.605 . . . . 1.2 110.14 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 17.2 m-20 60.13 67.58 1.64 Allowed Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.687 -0.633 . . . . 0.79 109.547 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 23' ' ' ASP . 36.1 Cg_endo -78.46 87.85 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.964 2.443 . . . . 0.82 110.053 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER 77.61 -34.76 0.2 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.019 -0.426 . . . . 3.51 110.76 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.22 133.57 22.91 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 1.54 109.898 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.73 -59.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 122.743 2.295 . . . . 0.57 110.753 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -143.89 161.66 38.12 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -0.767 . . . . 1.03 110.347 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 128.4 36.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.653 -0.654 . . . . 1.6 109.695 -179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.0 t -102.29 124.54 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.995 -0.742 . . . . 0.67 108.995 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -117.35 119.36 34.89 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.62 -0.675 . . . . 0.85 109.859 -179.632 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 t -107.3 108.96 20.6 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.655 -0.653 . . . . 0.71 109.277 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 15.7 m -141.39 158.87 62.72 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.635 -0.665 . . . . 0.65 109.785 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 34.1 Cg_endo -75.33 162.58 36.06 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.679 2.253 . . . . 0.48 110.629 179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.27 -25.4 64.06 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.697 -0.627 . . . . 0.91 110.55 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -40.38 95.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.567 -0.708 . . . . 0.97 109.844 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 50.2 m -66.08 125.99 91.1 Favored Pre-proline 0 N--CA 1.498 1.969 0 N-CA-C 109.125 -0.694 . . . . 0.55 109.125 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.3 Cg_endo -78.35 163.69 27.17 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.689 2.259 . . . . 0.44 111.255 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 4.4 t80 -65.44 -19.06 65.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.632 -0.667 . . . . 0.43 109.878 179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -59.94 -47.38 86.04 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.375 -0.828 . . . . 0.86 108.769 178.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.56 -37.82 68.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.48 -0.563 . . . . 0.43 109.48 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.0 t -61.63 -48.88 86.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.709 -0.619 . . . . 0.52 109.52 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.08 -35.1 79.63 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.58 109.828 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -65.36 -48.43 72.96 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.614 -0.679 . . . . 2.48 110.108 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.494 ' HB3' HD21 ' A' ' 31' ' ' LEU . 4.3 t80 -64.69 -43.38 93.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.726 -0.609 . . . . 1.01 109.926 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.71 -49.08 74.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.545 -0.722 . . . . 0.5 109.651 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -62.94 -36.47 83.52 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.709 -0.619 . . . . 0.52 110.092 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.51 -48.04 83.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.613 -0.679 . . . . 0.76 109.793 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.54 -26.6 60.93 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.592 -0.693 . . . . 0.72 110.126 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CG ' HD23 ' A' ' 20' ' ' LEU . 6.2 m-85 -81.13 -0.25 39.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.479 -0.763 . . . . 0.66 110.82 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 50' ' ' PHE . 1.2 mttt 64.83 36.6 7.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.44 -0.787 . . . . 2.3 109.99 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG23 ' HB1' ' A' ' 47' ' ' ALA . 16.7 m -132.7 156.49 80.03 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.508 -0.745 . . . . 0.7 109.41 179.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.16 124.3 7.8 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 122.604 2.203 . . . . 0.71 110.746 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.9 -36.95 75.8 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.872 -0.517 . . . . 0.65 109.96 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.34 80.78 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.677 -0.639 . . . . 0.72 109.906 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.6 m -107.2 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.57 -0.706 . . . . 0.73 109.4 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -139.87 158.48 44.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.319 -0.863 . . . . 0.75 110.253 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB1' ' OD2' ' A' ' 90' ' ' ASP . . . -144.32 167.34 22.68 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.266 -0.642 . . . . 0.42 109.266 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.3 mt -133.48 128.63 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.307 -0.87 . . . . 0.45 109.8 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.1 pt -103.94 166.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.526 -0.734 . . . . 0.56 109.301 179.158 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 63' ' ' ASP . 8.9 t -109.49 173.01 6.52 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.293 -0.88 . . . . 0.45 109.997 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.95 -17.81 64.56 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.584 -0.698 . . . . 1.28 110.519 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' H ' HG23 ' A' ' 61' ' ' THR . 13.7 m-20 -79.26 -20.66 47.56 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.344 -0.848 . . . . 0.88 110.148 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.99 43.62 1.89 Allowed Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.539 -1.425 . . . . 0.71 109.539 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.56 131.5 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.712 -0.876 . . . . 0.51 108.92 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.61 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -79.47 88.38 1.22 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.767 -1.333 . . . . 0.33 109.767 -179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG22 ' CE1' ' A' ' 80' ' ' HIS . 15.2 t -63.83 130.57 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 122.037 -0.684 . . . . 0.36 109.488 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -107.47 160.16 27.61 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.722 -0.611 . . . . 0.49 109.723 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' O ' HG23 ' A' ' 40' ' ' THR . 36.0 Cg_endo -77.97 67.36 8.07 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 123.061 2.507 . . . . 0.59 110.017 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.91 -45.88 0.35 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.565 -0.709 . . . . 0.76 110.1 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.489 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -70.3 158.13 88.3 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.538 -0.726 . . . . 1.14 110.255 -179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.6 Cg_endo -77.28 153.92 31.84 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.864 2.376 . . . . 0.52 110.666 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB1' ' CG2' ' A' ' 14' ' ' VAL . . . -53.9 -38.29 64.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.72 -0.612 . . . . 0.46 110.336 -179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.72 -50.28 68.89 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.936 -1.266 . . . . 0.49 109.936 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -69.0 -36.33 77.69 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.689 -0.889 . . . . 1.2 110.186 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 67' ' ' VAL . 26.8 mm -61.22 -43.92 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.57 -0.706 . . . . 0.4 109.518 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.44 -34.19 63.12 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.479 -0.763 . . . . 0.82 110.204 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.2 mt -70.59 -39.64 73.72 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.505 -0.747 . . . . 0.9 110.74 -179.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.37 -51.04 5.48 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.396 -0.815 . . . . 1.2 110.898 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' HG22 ' A' ' 67' ' ' VAL . 72.8 m-70 -87.67 -61.17 1.78 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.485 -0.76 . . . . 0.68 110.19 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.72 -136.47 11.41 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.946 -1.262 . . . . 0.65 109.946 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -112.45 -44.13 3.41 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.656 -0.908 . . . . 0.66 110.207 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.73 106.24 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 1.2 109.926 -179.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 mt -136.96 161.53 35.79 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.291 0.567 . . . . 0.79 109.816 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.89 150.61 49.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.564 -0.71 . . . . 1.34 109.314 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.857 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -103.8 120.54 41.18 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.378 -0.826 . . . . 0.61 109.695 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HD2' ' A' ' 88' ' ' PRO . 9.4 pt -121.01 159.71 48.07 Favored Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 121.736 -0.602 . . . . 0.54 109.625 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 87' ' ' ILE . 34.7 Cg_endo -76.7 100.95 1.45 Allowed 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 122.511 2.141 . . . . 0.62 110.431 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 71.4 141.34 0.05 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 121.465 0.65 . . . . 1.19 110.582 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 92' ' ' VAL . 0.7 OUTLIER -84.31 -37.84 21.15 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.726 -0.609 . . . . 0.59 109.413 179.626 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 60.36 55.41 3.54 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.569 0.7 . . . . 4.39 110.081 179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 90' ' ' ASP . 9.3 m -130.4 42.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 109.085 -0.709 . . . . 1.44 109.085 179.176 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 103.59 60.2 0.7 Allowed Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.561 -1.416 . . . . 1.24 109.561 -179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.69 -0.888 . . . . 1.53 109.702 -179.892 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.983 -0.377 . . . . 3.77 109.983 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 p -96.59 -48.32 5.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.619 -0.675 . . . . 2.88 109.738 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.9 104.22 0.77 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.619 -1.392 . . . . 3.2 109.619 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.55 -75.45 0.42 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 109.798 -1.321 . . . . 3.47 109.798 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.1 m -106.39 132.07 52.85 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.581 -0.953 . . . . 4.79 109.347 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 51.03 48.33 23.27 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.455 0.645 . . . . 3.06 109.594 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.43 128.11 34.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.48 -0.762 . . . . 1.73 110.27 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.23 137.93 31.94 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.655 -0.653 . . . . 1.63 109.24 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.6 m -65.11 104.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.117 -0.698 . . . . 1.49 109.117 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.73 122.55 36.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.646 -0.659 . . . . 1.9 109.64 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.12 -114.92 2.53 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.07 -1.212 . . . . 1.46 110.07 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.85 -48.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.924 . . . . 1.62 110.326 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt -114.29 166.22 11.88 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.422 -0.799 . . . . 1.9 110.086 -179.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -112.74 134.76 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.597 -0.689 . . . . 0.48 109.787 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.6 t -100.45 158.49 15.87 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.569 -0.707 . . . . 0.55 109.833 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -137.82 142.78 40.8 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.383 -0.823 . . . . 0.63 110.167 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -119.56 111.24 17.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.639 -0.874 . . . . 2.52 108.639 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' A' ' 86' ' ' LEU . 2.7 mp -122.52 126.74 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.63 110.067 -178.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -116.8 151.5 36.36 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.256 -0.646 . . . . 0.92 109.256 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 26' ' ' LEU . 12.1 tp -70.73 133.48 46.63 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.334 -0.854 . . . . 0.92 109.947 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.5 p -90.37 -23.69 21.02 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.815 -0.553 . . . . 1.1 110.097 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.21 -51.1 67.66 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.502 -0.749 . . . . 1.49 110.069 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -138.93 152.54 70.47 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.556 -0.715 . . . . 1.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.25 -6.55 14.84 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 123.018 2.479 . . . . 1.21 111.298 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -58.84 -58.81 6.96 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.357 -0.839 . . . . 3.41 109.692 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' CD1' HD22 ' A' ' 20' ' ' LEU . 2.0 mt -65.58 123.8 85.56 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.606 -0.684 . . . . 1.25 109.473 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.49 -173.85 1.89 Allowed 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.71 2.274 . . . . 0.91 111.495 -179.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.74 160.31 31.91 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.514 0.673 . . . . 0.71 110.293 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.16 122.24 37.93 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.84 -0.8 . . . . 1.03 108.84 179.577 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.3 119.29 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.499 -0.751 . . . . 0.74 109.47 -179.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -119.83 106.64 12.28 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.318 -0.623 . . . . 0.88 109.318 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.05 106.29 18.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.611 -0.681 . . . . 0.91 109.613 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 42' ' ' VAL . 16.1 m -134.5 157.18 77.92 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.713 -0.617 . . . . 0.64 109.412 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.33 161.69 37.41 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.556 2.17 . . . . 0.6 110.71 179.796 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HG3' ' HA3' ' A' ' 74' ' ' GLY . 0.6 OUTLIER -57.19 -33.56 67.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.761 -0.587 . . . . 0.88 109.913 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -55.63 -41.48 73.6 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.618 -0.676 . . . . 0.58 110.009 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.7 m -65.34 124.47 87.14 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.567 -0.708 . . . . 0.5 109.333 179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 72' ' ' PRO . 36.4 Cg_endo -78.41 165.28 25.57 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.794 2.33 . . . . 0.48 111.388 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 69' ' ' PRO . 5.8 t80 -66.0 -17.85 64.95 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.682 -0.636 . . . . 0.54 109.94 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.9 p -61.16 -45.21 95.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.337 -0.852 . . . . 0.49 108.754 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.55 62.89 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.255 -0.646 . . . . 0.43 109.255 179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 33' ' ' VAL . 91.7 t -61.63 -45.86 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.692 -0.63 . . . . 0.45 109.359 179.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.97 -37.34 84.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.621 -0.674 . . . . 0.6 109.796 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -63.57 -45.35 90.87 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.645 -0.659 . . . . 2.53 109.921 -179.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -66.09 -44.25 84.94 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.594 -0.691 . . . . 1.38 109.53 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.99 91.02 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.64 -0.663 . . . . 0.46 109.529 179.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -64.58 -36.11 83.17 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.744 -0.598 . . . . 0.39 109.626 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.75 -45.89 90.84 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.616 -0.677 . . . . 0.74 109.422 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.04 -29.12 64.95 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.717 -0.615 . . . . 0.63 109.754 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.1 m-85 -82.22 -3.28 54.77 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.598 -0.689 . . . . 0.56 110.785 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.65 36.79 6.19 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.401 -0.812 . . . . 1.65 109.777 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.506 HG21 HD21 ' A' ' 86' ' ' LEU . 17.6 m -131.36 156.51 80.03 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.51 -0.744 . . . . 0.63 109.521 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 57' ' ' SER . 34.3 Cg_endo -76.57 125.27 8.16 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.653 2.236 . . . . 0.59 110.646 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . . . -64.73 -37.25 86.97 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.966 -0.459 . . . . 0.57 110.161 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.16 82.41 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.675 -0.641 . . . . 0.7 110.26 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 53' ' ' PRO . 2.7 m -106.19 42.47 1.26 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.492 -0.755 . . . . 0.69 109.555 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -149.1 160.44 43.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.371 -0.83 . . . . 1.04 110.346 179.767 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -142.7 168.01 20.72 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.031 -0.729 . . . . 0.45 109.031 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -126.21 118.29 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.853 . . . . 0.45 109.277 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.702 HG22 ' HA2' ' A' ' 66' ' ' GLY . 1.5 pt -98.37 169.5 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.614 -0.679 . . . . 0.58 109.469 179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 74.4 p -96.95 170.54 9.08 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.532 -0.73 . . . . 0.56 109.897 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.47 -24.38 65.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.615 -0.678 . . . . 0.89 109.817 179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -80.42 -54.48 5.66 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.543 -0.723 . . . . 1.36 109.406 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 149.31 56.56 0.01 OUTLIER Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.98 -1.248 . . . . 0.72 109.98 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 48.7 t -130.31 119.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.671 -0.9 . . . . 0.73 109.051 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.702 ' HA2' HG22 ' A' ' 60' ' ' ILE . . . -75.56 87.47 0.83 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.019 -1.233 . . . . 0.51 110.019 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG22 ' CE1' ' A' ' 80' ' ' HIS . 20.9 t -71.31 132.61 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.974 -0.721 . . . . 0.53 109.419 179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' PRO . 63.1 m-80 -110.29 161.75 23.27 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.713 -0.617 . . . . 1.12 109.821 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 39' ' ' PHE . 35.8 Cg_endo -77.88 66.16 8.19 Favored 'Trans proline' 0 C--N 1.318 -1.062 0 C-N-CA 122.936 2.424 . . . . 0.56 110.011 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.42 -40.65 1.11 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.87 110.243 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -83.36 162.66 53.1 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.459 -0.775 . . . . 1.61 110.117 -179.615 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.18 156.97 33.73 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.802 2.335 . . . . 0.52 110.691 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.09 70.73 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.564 -0.71 . . . . 0.44 110.326 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HG3' ' A' ' 35' ' ' GLU . . . -58.83 -47.4 90.69 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 110.068 -1.213 . . . . 0.52 110.068 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB2' ' HG2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -68.09 -38.99 82.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.928 . . . . 1.6 110.016 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG21 ' CE1' ' A' ' 39' ' ' PHE . 28.4 mm -61.28 -40.66 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.608 -0.682 . . . . 0.57 109.427 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.19 -37.11 66.62 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.646 -0.659 . . . . 0.97 109.874 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.02 -39.27 83.18 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.415 -0.803 . . . . 0.84 110.627 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -54.57 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 2.59 110.898 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' VAL . 43.8 m-70 -90.69 -56.04 3.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.542 -0.724 . . . . 0.86 110.126 -178.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 112.89 -129.72 9.1 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.82 -1.312 . . . . 0.67 109.82 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.41 -40.82 3.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.718 -0.872 . . . . 0.77 110.277 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -60.47 103.3 0.23 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.42 -0.8 . . . . 1.02 110.107 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.51 174.2 10.75 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.766 -0.584 . . . . 0.86 109.992 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -141.67 153.61 44.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.6 -0.688 . . . . 1.9 109.837 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD21 HG21 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -104.68 125.52 50.86 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.412 -0.805 . . . . 0.77 109.978 179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.555 HG13 ' HD2' ' A' ' 88' ' ' PRO . 11.8 tt -123.05 130.99 24.38 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.212 -0.662 . . . . 0.71 109.212 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.555 ' HD2' HG13 ' A' ' 87' ' ' ILE . 33.6 Cg_endo -74.96 123.84 8.2 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.649 2.233 . . . . 0.86 110.746 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.47 156.31 24.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.748 -0.595 . . . . 1.75 110.199 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -69.97 148.97 48.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.813 -0.554 . . . . 1.35 110.24 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 111.38 22.83 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.546 -0.721 . . . . 2.95 109.167 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 93' ' ' GLY . 3.1 m -131.62 -50.91 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.722 -0.612 . . . . 2.25 109.424 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.403 ' H ' HG23 ' A' ' 92' ' ' VAL . . . -155.83 59.06 0.37 Allowed Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.904 -1.278 . . . . 2.01 109.904 179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.5 m80 . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 117.873 -1.06 . . . . 3.37 109.81 -179.933 . . . . . . . . 0 0 . 1 stop_ save_